LipidBank - Glycosphingolipid

No	Structure	COMMON NAME	NAME	DATA No	INFORMANT	SYMBOL	FORMULA	MOL.WT(ave)	Download	BIOOGICAL ACTIVITY	PHYSICAL AND CHEMICAL PROPERTIES						SPECTRAL DATA					CHROMATOGRAM DATA	SOURCE	CHEMICAL SYNTHESIS	METABOLISM	GENETIC INFORMATION	NOTE	REFERENCES
No	Structure	COMMON NAME	NAME	DATA No	INFORMANT	SYMBOL	FORMULA	MOL.WT(ave)	Download	BIOOGICAL ACTIVITY	MELTING POINT	BOILING POINT	DENSITY	REFRACTIVE INDEX	OPTICAL ROTATION	SOLUBILITY	UV SPECTRA	IR SPECTRA	NMR SPECTRA	MASS SPECTRA	OTHER SPECTRA	CHROMATOGRAM DATA	SOURCE	CHEMICAL SYNTHESIS	METABOLISM	GENETIC INFORMATION	NOTE	REFERENCES
1		Galactosyl sulfatide	Galactosylceramide 3-sulfate	GSG0069	Ineo Ishizuka	SM4s, SGC				Review (Ref. 0208). Inhibition of the arylsulfatase A activity (Ref. 0003/0006/0010/0011/0012/0013/0016/0047/0048/0054). Myelin components (Ref. 0016/0023). Interaction with GM2 activator protein (Ref. 0238). Stimulation of the evolution of oxygen radicals in polymorphonuclear leukocytes (Ref. 0024). Cannot be hydrolyzed by glucosulfatase (Ref. 0015). Mouse monoclonal antibodies (Ref. 0043/0050). Regulation of sulfotransferase activity (Ref. 0240).						Behavior in the Folch partition (Ref. 0027). Precipitates from hot methanol (Ref. 0004).		820cm^-¹ (Ref. 0001/0029/0031).	H-C COSY spectrum of sulfatide (Ref. 1498) [Spectrum 0001](I.Ishizuka) DQF COSY spectrum of sulfatide [Spectrum 0002](I.Ishizuka)	EI-MS (Ref. 0033), SI-MS (Ref. 0036).TLC-blotting/negative-ion LSIMS of galactosyl sulfatide [Spectrum 0003](I.Ishizuka)	Absorption of the complex with Azure A the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).	2D TLC of male [Chromatogram 0001]and female [Chromatogram 0002] wild type and CGK-KO mice(I.Ishizuka). DEAE Sephadex column chromatography of female wild type and CGK-KO mice [Chromatogram 0003](I.Ishizuka).	Review (Ref. 0208). Bull frog and axolotl (Ref. 0237); Human brain (Ref. 0002/0001); the white and gray matter of the human brain (Ref. 0009); rabbit brain, white matter (Ref. 0057). Rat brain (Ref. 0017/0020), effect of chronic treatment with diazepam (Ref. 0055), regional distribution (Ref. 0020). Human kidney (aged, 0.39; middle age, 0.40; juvenile, 0.48mg/g dry tissue (Ref. 0004). Porcine pancreas (Ref. 0031), rabbit stomach (antrum, pylorus), duodenum jejunum (Ref. 0053). Brain (review) (Ref. 0016). C6 glioma derived from rat brain (Ref. 0032), cod brain (Ref. 0021). Mouse (C57BL) kidney (Ref. 0230), brain, liver, kidney (Ref. 0231).				The fatty acid composition, human kidney:22:0, 23:0, 24:0, 24:1, h24:0, h23:0, h24:1 (Ref. 0004)	[0001] / [0002] / [0003] / [0004] / [0006] / [0009] / [0010] / [0011] / [0012] / [0013] / [0015] / [0016] / [0017] / [0020] / [0021] / [0023] / [0024] / [0027] / [0029] / [0031] / [0032] / [0033] / [0036] / [0043] / [0047] / [0048] / [0050] / [0053] / [0054] / [0055] / [0057] / [0208] / [0230] / [0231] / [0237] / [0238] / [0240] / [1498]
2		Lactosylsulfatide	HSO₃-3Galb1-4GlcCer	GSG0070	Ineo Ishizuka	SM3				Inhibition of the arylsulfatase A activity (Ref. 0010/0048). Interaction with laminin, thrombospondin, and von willebrand factor (Ref. 0044/0056). Interaction with Sulph I monoclonal antibody (Ref. 0050).						Behavior in the Folch partition (Ref. 0027).		Similar to galactosylsulfatide except for smaller 1240cm^-¹ (Ref. 0004).		EI-MS (permethylated) [Spectrum 0001] (Ref. 0033), SI-MS [Spectrum 0002](Ref. 0036).TLC-blotting/negative-ion LSIMS of mouse lactosyl sulfatide (SM3) [Spectrum 0003](I.Ishizuka)	Absorption of the complex with Azure A, the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).		Review (Ref. 0208). Human kidney (Ref. 0004/1244) Faged, 0.14mg/g, middle age, 0.18mg/g juvenile, 0.20mg/g dry weight. Human kidney (Ref. 0010) cultured kidney epithelial cell lines MDCK (Ref. 0046/0019) JTC-12 (Ref. 0019) MDBK, LLC-PK1 (Ref. 0025). Trout (salmon?) testis (Ref. 0014), suncus kidney (Ref. 0034) rat kidney (Ref. 0026) dolphin kidney (Ref. 0039). Canine small intestine(Ref. 1245). Porcine gastric mucosa(Ref. 1246)				Human kidney, the major fatty acids, 22:0, 24:0, 24:1, 24h:0, 24h:1 (Ref. 0004)	[0004] / [0010] / [0014] / [0019] / [0025] / [0026] / [0027] / [0033] / [0034] / [0036] / [0039] / [0044] / [0046] / [0048] / [0050] / [0056] / [0208] / [1244] / [1245] / [1246]
3		Gangliotriaosylceramide sulfate	Gangliotriaosylceramide sulfate	GSG0071	Ineo Ishizuka	SM2a				Interaction with laminin, thrombospondin, and von willebrand factor (Ref. 0044/0056/0078).						Behavior in the Folch partition (Ref. 0027).		OH, 3600-3100cm^-¹; sulfate (eq), 1230 and 815cm^-¹ (Ref. 0076).	¹H-NMR in C/M, 2:1 at 55C; 4.81 ppm (³J/₁,₂ = 8.0), GalNAc; 4.50 ppm (³J/₁,₂ = 7.4), Gal; ¹H-NMR in DMSO, 25C; 4.46 ppm (J = 7.9), GalNAc; 4.30 (J = 7.4), Gal; 4.20 (J = 7.7), Glc (Ref. 0026).	EI-MS (permethylated) (Ref. 0033), SI-MS (Ref. 0036). Negative-mode LSIMS and CID (Ref. 0214).	Absorption of the complex with Azure A,the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).		Review (Ref. 0208). Rat kidney (Ref. 0076/0026) A kidney epithelial cell line JTC-12 (Ref. 0025/0077).				The long-chain base is predominantly t18:0 (Ref. 0208)	[0025] / [0026] / [0027] / [0033] / [0036] / [0044] / [0056] / [0076] / [0077] / [0078] / [0208] / [0214]
4		bis-sulfo-Gangliotriaosylceramide	bis-sulfo-Gangliotriaosylceramide	GSG0072	Ineo Ishizuka	SB2				Interaction with laminin, thrombospondin, and von willebrand factor (Ref. 0044).						Behavior in the Folch partition (Ref. 0027).		The sulfate ester, 1240,820cm^-¹ (Ref. 0079).	¹H-NMR (Ref. 0080).	EI-MS (trideuteriomethylated after permethylation-soluvolysis) (Ref. 0080); Hex, m/z 219+3; Hex-CD3OH, m/z 187 (Ref. 0080/0033), SI-MS (Ref. 0036). Negative-mode LSIMS and CID (Ref. 0214).	Absorption of the complex with Azure A,the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).		Review (Ref. 0208). Rat kidney (Ref. 0079/0080).				The long-chain base is predominantly t18:0 (Ref. 0208)	[0027] / [0033] / [0036] / [0044] / [0079] / [0080] / [0208] / [0214]
5		Sulfogangliotetraosylceramide	Sulfogangliotetraosylceramide	GSG0073	Ineo Ishizuka	SM1a										Behavior in the Folch partition (Ref. 0027).				EI-MS (permethylated) (Ref. 0033). Negative-mode LSIMS and CID (Ref. 0214).	Absorption of the complex with Azure A, the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).		Review (Ref. 0208).				The long-chain base is predominantly t18:0 (Ref. 0208)	[0027] / [0033] / [0208] / [0214]
6		Sulfogangliotetraosylceramide	Sulfogangliotetraosylceramide	GSG0074	Ineo Ishizuka	SM1b				Interaction with laminin (Ref. 0044).									¹H-NMR (Ref. 0082).	FAB-MS (Ref. 0082).Negative-ion LSIMS and CID of gangliotetraosylceramide sulfate (SM1b) [Spectrum 0001](I.Ishizuka)			Review (Ref. 0208). Mouse intestine (Ref. 0044).				The long-chain base is predominantly t18:0 (Ref. 0208)	[0044] / [0082] / [0208]
7		Bis-sulfo-gangliotetraosylceramide	Bis-sulfo-gangliotetraosylceramide	GSG0075	Ineo Ishizuka	SB1a				Interaction with laminin, thrombospondin, and von willebrand factor (Ref. 0044). Interaction with monoclonal antibodies 2H6G5 (IgM) and 4A9E10 (IgG3) (Ref. 0083).						Behavior in the Folch partition (Ref. 0027).			¹H-NMR in C/M 1:1 at 55C: 4.46 ppm (J = 7.8 Hz), Gal (two doublets); 4.74 ppm (J = 7.4 Hz), GalNAc; in DMSO, 60C: 4.51 ppm (J = 8.0), GalNAc; 4.32 ppm (J = 8.1), the terminal Gal; 4.33 ppm (J = 7.8), the internal Gal (Ref. 0081).	EI-MS (permethylated): m/z 222, 3-deuteriomethylated-2,4,6-trimethyl-Gal; m/z 187, 222-CD3OH (Ref. 0081/0033) SI-MS (Ref. 0036). Negative-mode LSIMS and CID (Ref. 0214).TLC-blotting/negative-ion LSIMS of mouse kidney SB1a [Spectrum 0001](I.Ishizuka)	Absorption of the complex with Azure A,the abssorption of the acetates of sulfoglycolipids with Azure A (Ref. 0027).		Review (Ref. 0208). Rat kidney (Ref. 0081) human hepatoma PLC/PRF/5 (Ref. 0083).				The long-chain base is predominantly t18:0 (Ref. 0208)	[0027] / [0033] / [0036] / [0044] / [0081] / [0083] / [0208] / [0214]
8		Sulfoglobotetraosylceramide	Sulfoglobotetraosylceramide	GSG0076	Ineo Ishizuka	SMGb4Cer				Interaction with thrombospondin (Ref. 0056).								1240, 810cm^-¹: sulfate (Ref. 0056).	¹H-NMR (anomeric protons) (Ref. 0056).	Negative SI-MS (Ref. 0056).			Review (Ref. 0208). Human kidnedy (Ref. 0056). Rat kidney, 0.07 nmol/g tissue (Ref. 0212).				Fatty acids 24:0, 48%; 22:0, 16% (Ref. 0056) LCB t18:0, 100%	[0056] / [0208] / [0212]
9		Globopentaosylceramide sulfate	Globopentaosylceramide sulfate	GSG0077	Ineo Ishizuka	SMGb5Cer				Interaction with thrombospondin (Ref. 0084).								1240 cm^-¹: SO stretching, 810cm^-¹: C-O-S vibration (Ref. 0084).	¹H-NMR: H-1-H-4 double-relayed COSY (Ref. 0084).	Negative SI-MS (Ref. 0084).			Review (Ref. 0208). Human kidney (Ref. 0084).				Fatty acids 24:0, 27%; 22:0, 24%; 16:0, 19% (Ref. 0084).	[0084] / [0208]
10			SMUnLc4Cer	GSG0078	Ineo Ishizuka	SGGL, SMUnLc4Cer				An adhesion molesule of neurons (Ref. 0223).										FAB-MS: Pertrimethylsilylated desulfated or permethylated desulfated derivative (Ref. 0085).			Review (Ref. 0208/0223). Human peripheral nerve (Ref. 0085).				Fatty acids 16:0, 13%; 18:1, 16%; 18:0, 11%; 24:1, 13%; 24:0, 15% (Ref. 0085).	[0085] / [0208] / [0223]
11		HNK-1 antigen glycolipid	HNK-1 antigen glycolipid	GSG0079	Ineo Ishizuka	SGGL, SMUnLc6Cer																	Review (Ref. 0208/0223). Human peripheral nerve (Ref. 0085).			Expression cloning of the sulfotransferase (Ref. 0241).		[0085] / [0208] / [0223]
12			Galactosylceramide 6-sulfate	GSG0080	Ineo Ishizuka	SM4s-6				Interaction with laminin, thrombospondin, and von willebrand factor (Ref. 0044/0208).	165-170 (Ref. 0088).				[a]/589 = -0.4 (2.4% in pyridine) (Ref. 0088).	Sparingly soluble in acetone (Ref. 0088).		Identical with galactosylceramide 3-sulfate (Ref. 0088).					Chemical synthesis (Ref. 0088). Review (Ref. 0208).					[0044] / [0088] / [0208]
13			8-Sulfo-N-glycolylneuraminyl-(a2-6)-glucosyl-(1-8)-N-glycolylneuraminyl-(a2-6)-glucosyl-(1-1)-ceramide	GSG0081	Ineo Ishizuka					Protects embryonic cells from toxic amines (Ref. 0089).								1220cm^-¹: S=O stretching, 800cm^-¹: C-O-S vibration (Ref. 0089).		As TMS derivative of methylated-reduced glycolipid (Ref. 0089).			Sea urchin (Strongylocentrotus intermedius) egg and embryo (Ref. 0089). Review (Ref. 0208).				Hydroxy and nonhydroxy fatty acids (Ref. 0089) Long-chain base, t18:0 (Ref. 0089)	[0089] / [0208]
14			8-Sulfo-N-glycolylneuraminosyl-(a2-6)-b-D-glucopyranosyl-(1-1)-ceramide	GSG0082	Ineo Ishizuka													1283cm^-¹: S-O vibration, 810cm^-¹: S-O bond (Ref. 0090).		Permethylated asialo-derivative (Ref. 0090).Negative-ion LSIMS and high-energy CID of GM1a sulfate [Spectrum 0001](I.Ishizuka)		DEAE Sephadex column chromatography of GM1a sulfate [Chromatogram 0001]	Sea urchin Echinocardium cordatum, gonads (Ref. 0090). Review (Ref. 0208).				Fatty acids, 15:0, 24h:0, 22h:0, 22h:1, 18h:0, 23h:0 (Ref. 0090) LCB, t18:0, t16:0, t17:0 (Ref. 0090)	[0090] / [0208]
15		Lysosulfatide	3-Sulfogalactosyl-b-(1-1)-sphingosine	GSG0083	Ineo Ishizuka						C								(Ref. 0097).	MALDI-TOFMS [Spectrum 0001] (T.Taketomi) (Ref. 3072)(Ref. 0097).			Sulfation of psychosine by rat stomach mucosa (Ref. 0022). Review (Ref. 0208).					[0022] / [0097] / [0208] / [3072]
16		Glucosylsulfatide	Glucosylceramide 3-sulfate	GSG0084	Ineo Ishizuka	SM4s-Glc												1230cm^-¹: S=O stretching, 815cm^-¹: C-O-S vibration (Ref. 0093).	¹H-NMR: double-relayed COSY (Ref. 0093).	SI-MS [M-H]^- (Ref. 0093).			Review (Ref. 0208). Rat kidney (Ref. 0093).					[0093] / [0208]
17		Sulfo-isoglobotetraosylceramide	Sulfo-isoglobotetraosylceramide	GSG0092	Ineo Ishizuka	SMiGb4Cer												Sulfate (Ref. 0212).	DQF-COSY (Ref. 0212).	LSIMS (Ref. 0212).		Silica beads (Ref. 0212).	Review (Ref. 0208). Rat kidney, 0.27 nmol/g tissue (Ref. 0212).				Fatty acids 24:0, 37%; 22:0, 19%; 23:0, 15% (Ref. 0212).	[0208] / [0212]
18		Sulfo-isoglobopentaosylceramide	Sulfo-isoglobopentaosylceramide	GSG0093	Ineo Ishizuka													FT-IR, sulfate ester (Ref. 1062).	¹H-NMR, DQF-COSY (Ref. 1062).	LSIMS, CID (Ref. 0212).			Rat kidney, 0.11 nmol/g tissue (Ref. 1062). Review (Ref. 0208).				Fatty acids 24:0, 23%; 22:0, 22% (Ref. 1062) LCB t18:0, 89%	[0208] / [0212] / [1062]
19		Gangliotriaosylceramide sulfate	Gangliotriaosylceramide sulfate	GSG0094	Ineo Ishizuka	SM2b												FT-IR (Ref. 0215).	¹H-NMR, DQF-COSY (Ref. 0215).	Negative-mode LSIMS, CID (Ref. 0215).			Rat kidney, 50 pmol/g tissue (Ref. 0215). Review (Ref. 0208).				Fatty acids 24:0, 31%; 22:0, 22%; 23:0, 12%; LCB t18:0, 76% (Ref. 0215).	[0208] / [0215]
20		Sulfated GM1a ganglioside	Sulfated GM1a ganglioside	GSG0095	Ineo Ishizuka	SMGM1a												FT-IR (Ref. 0217).	¹H-NMR, DQF-COSY (Ref. 0217).	Negative LSIMS and CID (Ref. 0217).			Rat kidney, 120 pmol/g tissue (Ref. 0217). Review (Ref. 0208).				Fatty acids 24:0, 34%; 22:0, 20%; LCB t18:0, 96% (Ref. 0217).	[0208] / [0217]
21		6-O-acyl sulfatide	6-O-acylgalactosylceramide 3-sulfate	GSG0113	Ineo Ishizuka														1H-NMR (Ref. 0243).	FAB-MS (Ref. 0243).		DEAE Sephadex (Ref. 0243).	Equine brain (Ref. 0243).				The fatty acid composition of the O-acyl group, 18:0, 16:0 (Ref. 0243)	[0243]
22			GalNAcb1-4(Ac-O-9-NeuAc2-8NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1001	Kazuo Nakamura															FAB-MS (Ref. 0030)		TLC(Ref. 0030)	Alaskan pollack brain (Ref. 1030)					[0030] / [1030]
23			NeuAc2-3Galpb1-3(Fuca1-4)GlcpNAcb1-3(Galpb1-4GlcpNAcb1-6)Galpb1-4GlcCer	GSG1002	Kazuo Nakamura														1H-NMR (Ref. 1031)				Human rectal adenocarcinoma (Ref. 1031)					[1031]
24			NeuAc2-3Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1003	Kazuo Nakamura	sLea-X													1H-NMR (Ref. 1031)				Human rectal adenocarcinoma (Ref. 1031)					[1031]
25			NeuAc2-3Galb1-3(Fuca1-4)GlcNAcb1-3{Galb1-4(Fuca1-3)GlcNAcb1-6}galb1-4GlcCer	GSG1004	Kazuo Nakamura														1H-NMR (Ref. 1031)				Human rectal adenocarcinoma (Ref. 1031)					[1031]
26			NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1005	Kazuo Nakamura														1H-NMR 500MHz (Ref. 1032)	Negative FAB-MS (Ref. 1032)		Mobility on TLC with C/M/W(50:40:10): between GD1a and GD1b (Ref. 1032)	Human erythrocyte, Chicken skeletal muscle (Ref. 1032), starfish, Asterina pectinifera. II. (Ref. 1248)				Ceramides Human erythrocyte: 24:0-d18:1 and 22:0-d18:1 ; chicken keletal muscle 18:0-d18:1 (Ref. 1032)	[1032] / [1248]
27			NeuGc2-3Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1006	Kazuo Nakamura														1-d 1H-NMR (Ref. 1034)	FAB-MS (Ref. 1034)		Mobility on TLC with C/M/W (55:45:10), slightly lower than GD1b; with C/M/1.5N ammmonia (55:45:10), lower than GQ1b; with tetrahydrofuran/0.1%KCl (75:15) between GT1b and GQ1b (Ref. 1034)	Bovine erythrocytes (Ref. 1034)				Fatty acids 18:1(22.3%), 22:1(13.5%), 18:0(11.1%), C16:0(10.8%) (Ref. 1034) LCB d18:0(5%), d18:1(95% ) (Ref. 1034)	[1034]
28			NeuAc2-6Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1007	Kazuo Nakamura														500MHz 1-d 1H NMR (Ref. 1035)	Negative FAB-MS (Ref. 1035)		Mobility on TLC with C/M/0.2%CaCl2 (60:40:9), slightly higher than blood group I-active ganglioside (Ref. 1035)	Human meconium (Ref. 1035)				Ceramides 16h:0-d18:1, 22h:0-d18:1, 24h:0-d18:1 (Ref. 1035)	[1035]
29			NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1008	Kazuo Nakamura					Reactive with anti-cholinergic neuron specific antibody (Ref. 1036)									600MHz 1-d 1H (Ref. 1036)	Negative FAB-MS (Ref. 1036)		Mobility on TLC with C/M/12mM MgCl2 (5:4:1), C/M/12mM MgCl2/15M NH4OH(5:4:0.7:0.3), lower than GQ1b (Ref. 1036)	Bovine brain (Ref. 1036)				Fatty acids 16:0 (1.2%), 18:0 (91.3%), 20:0(4.4%), 22:0 (3% ) (Ref. 1036)	[1036]
30			NeuGc2-3Galb1-4GlcNAcb1-3Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1009	Kazuo Nakamura														1d 1H, 2d HOHAHA (Ref. 1037)	Negative FAB-MS (Ref. 1037)		Mobility on TLC with C/M/0.2%CaCl2 (60:40:9), between GD1b anad GT1b; withC/M/2.5N NH4OH (60:40:9), lower than GT1b.(Ref. 1037)	Rat spleen lymphosytes (Ref. 1037)				Fatty acids 18:0(4%), 20:0(9%), 21:0(2%), 22:0(14%), 23:0(5%), 24:1(44%), 24:0(22%) (Ref. 1037) LCB d18:1 (Ref. 1037)	[1037]
31			NeuAc2-?Galb1-?Galb1-?Gala1-?Galb1-?GlcCer	GSG1010	Kazuo Nakamura														500MHz 1-d 1H (Ref. 1038)			Mobility on TLC with C/M/0.2%CaCl2 (6:4:1) slightly higher than GD1a (Ref. 1038)	Mouse hematopoietic cell line BM216 (Ref. 1038)					[1038]
32			GalNAcb1-4(NeuAc2-3)Galb1-3GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1011	Kazuo Nakamura					Reactive with serum IgM from an amyotrophic lateral aclerosis-like patient (Ref. 1039)									400MHz 1-d 1H (Ref. 1039)	Negative FAB-MS (Ref. 1039)		Mobility on TLC with C/M/12mM MgCl2(5:4:1), slightly higher than GD1a; with C/M/12mM MgCl2/2.5M ammonia(50:40:7:3), slightly higher than GD1b (Ref. 1039)	Bovine brain (Ref. 1039)				Ceramides C18:0-d18:1 or C18:0-d20:1 (Ref. 1039)	[1039]
33			GalNAcb1-4(NeuAca2-3)Galb1-3GlcNAcb1-3(Galb1-3GalNAcb1-4)Galb1-4GlcCer	GSG1012	Kazuo Nakamura					Reactive with serum IgM from an amyotrophic lateral aclerosis-like patient (Ref. 1039)									400MHz 1-d 1H (Ref. 1039)	Negative FAB-MS (Ref. 1039)		Mobility on TLC with C/M/12mM MgCl2(5:4:1), between GD1a and GD1b; with C/M/12mM MgCl2/2.5M ammonia (50:40:7:3), higher than GQ1b (Ref. 1039)	Bovine brain (Ref. 1039)				Ceramides C18:0-d18:1 or C18:0-d20:1 (detected with FAB-MS) (Ref. 1039)	[1039]
34			Galb1-6Galb1-6GlcCer	GSG1013	Kazuo Nakamura														500MHz 1H-NMR [Spectrum 0001] (Ref. 0040)	NEGATIVE FAB-MS [Spectrum 0002] (Ref. 0040)		TLC, lower than CTH with C/M/W(65:25:4) [Chromatogram 0001] (Ref. 1040)	Eggs of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1040)				Fatty acids 22:1(61.4%), 22h:1(27.3%) (Ref. 1040) LCB n-t18:0 (92.9%) (Ref. 1040)	[0040] / [1040]
35			Fuca1-3GalNAcb1-4(Fuca1-3)GlcNAcb1-4GlcCer	GSG1014	Kazuo Nakamura														2d-HOHAHA, DQF-COSY, 1d 1H 600MHz, NOESY (Ref. 1055)	NEGATIVE FAB-MS [Spectrum 0001] (Ref. 1041)		TLC [Chromatogram 0001] (Ref. 1041)	Eggs of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1041)				Fatty acids 22:1(47.1%), 22h:1(25.1%), 23:1(10.3%) (Ref. 1041) LCB n-t18:0(89.7%) (Ref. 1041)	[1041] / [1055]
36			Galb1-6(Fuca1-3)Galb1-6GalCer	GSG1015	Kazuo Nakamura															LSI-MS (Ref. 1042)			Metacestodes of Echinococcus multilocularis (cestode) (Ref. 1042)				Fatty acids C16 and C18h, LCB d18:0 are major (Ref. 1042)	[1042]
37			Fuca1-3Galb1-6GalCer	GSG1016	Kazuo Nakamura															LSI-MS (Ref. 1042)			Metacestodes of Echinococcus multilocularis (cestode) (Ref. 1042)				Fatty acids C16 and C18h, LCB d18:0 are major (Ref. 1042)	[1042]
38			Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1017	Kazuo Nakamura					Reactive with mAb NCC-ST-421 (raised against human gastric adenocarcinoma) (Ref. 1043)									1d 1H 500MHz (Ref. 1043)	Positive FAB-MS (Ref. 1043)			Human colonic Adenocarcinoma cell line Colo 205 (Ref. 1043)				Ceramides C24h:0-d18:1, C24h:1-d18:1, C24h:1-t18:0 (Ref. 1043)	[1043]
39			KDNa2-3Galb1-4GlcCer	GSG1018	Kazuo Nakamura	(KDN)GM3													1D 400MHz 1H [Spectrum 0001], HOHAHA [Spectrum 0002](Ref. 1044)	(-)FAB-MS [Spectrum 0003](Ref. 1044) 1		Mobility on TLC with C/M/0.2% CaCl2(55:45:10), slightly lower than (NeuAc)GM3 [Chromatogram 0001](Ref. 1044)	Sperm of rainbow trout (Ref. 1044)				Fatty acids 16:0(95%), C24:1(5%) (Ref. 1044) LCB d18:1 (Ref. 1044)	[1044]
40			Galb1-3Gala1-4Galb1-4GlcCer	GSG1019	Kazuo Nakamura					One of the mAb (ST-3) specific for this glycosphingolipid inhibited macrophage invasion by amastigotes and promastigote (Ref. 1045)									500MHz 1d 1H (Ref. 1045)	Negative FAB-MS (Ref. 1045)			Amastigote form of Leishmania amazonensis (protozoan) (Ref. 1045)				Ceramides C16:0-d18:1 (Ref. 1045)	[1045]
41			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-3GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1020	Kazuo Nakamura					Antigen to mAb 188C1 (raised against skin tissue of bullfrogs). This antibody recognize a common antigen in neural and intestinal tissues of chicken. (Ref. 1046)									1d 1H (400MHz) (Ref. 1046)	Negative FAB-MS (Ref. 1046)		Mobility on TLC with C/M/14mM MgCl2(5:4:1), between GD1a and GD1b (Ref. 1046)	Chick intestinal tissues (Ref. 1046), Small intestine of guinea pig(Ref. 1202)				Fatty acids 16h:0( 24.9%), C22h:0 (31.3%); t18:0 (57.4%) (Ref. 1046) LCB t18:0 (57.4%), d18:1 (19.1%) (Ref. 1046)	[1046] / [1202]
42			GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1021	Kazuo Nakamura	Ab				Blood group A active, A^b (Ref. 1047)									1d 1H (Ref. 1047)	EI-MS (Ref. 1047), TLC/(-)SIMS [Spectrum 0001] (Ref. 1499), peracetylated sample TLC/(+)SIMS [Spectrum 0002]		TLC (Ref. 1047)	Epithelial cells of the small intestine of inbred rats (DA and LOU/M) (Ref. 1047)				Ceramide, C16:h0-t18:0 (Ref. 1047)	[1047] / [1499]
43			NeuAc2-3Galb1-3GalNAcb1-4(NeuAc2-8NeuGc2-3)Galb1-4GlcCer	GSG1022	Kazuo Nakamura														1d 1H (Ref. 1048)	Negative FAB-MS (Ref. 1048)		Mobility on TLS with C/M/12mM MgCl2(5:4:1), slightly higher than GT1b; with C/M/12mM MgCl2/2.5M ammonia (50:40:7:3), between GT1b and GQ1b (Ref. 1048)	Bovine brain (Ref. 1048)				Ceramide C18:0-d20:0 (Ref. 1048)	[1048]
44			1-O-b-D-{6-O-[2'-(Trimethylammonio)-ethylphosphoryl]}GalCer	GSG1023	Kazuo Nakamura														1H 400MHz (Ref. 1049)	FAB-MS (Ref. 1049)		TLC (Ref. 1049)	Neanthes diversicolor (marine annelid) (Ref. 1049)					[1049]
45		Epidermoside(Ref. 1050)	Glucosylb-N-(w-O-linoleoyl)-acylsphingosine	GSG1024	Kazuo Nakamura					Suggested to be a barrier preventing the loss of water from the body surface <<>>									1H-HMR (360MHz) (Ref. 1483), 1H-HMR (500MHz) [Spectrum 0002] (Ref. 1050), Note, GL-I3:(omega-O-linoleoyl)-triacontanoyl and - and -dotriacontamonoenoyl-eicosashpingenine GL-II3:(omega-O-linoleoyl)-triacontanoyl-tri-hydroxyeicosasphingenine 1H-HMR (400MHz)(Ref. 1485)	(-)FAB-MS [Spectrum 0001] (Ref. 1050) Note, GL-I3:(omega-O-linoleoyl)-triacontanoyl and - and -dotriacontamonoenoyl-eicosashpingenine GL-II3:(omega-O-linoleoyl)-triacontanoyl-tri-hydroxyeicosasphingenine		TLC [Chromatogram 0001] (Ref. 1050)	pig epidermis (Ref. 1483), human epidermis (Ref. 1050), guinea pig epidermis (Ref. 1485), cultured human keratinocytes (Ref. 1484)				Ceramides Pig and human epidermis 30h:0-(w18:2)-d20:1, 32h:0-(w18:2)-d20:1 (Ref. 1050/1483), Human epidermis 30h:0-(w18:2)-t20:1(Ref. 1050) , Guinea pigs epidermis 24h:0-(w18:2) (Ref. 1485) Cultured keratinocytes, w hydroxy acid; 30:0, 30:1, 32:1, 34:1 (Ref. 1484) LCB Cultured keratinocytes, d18:1 (Ref. 1484)	[1050] / [1483] / [1484] / [1485]
46			3,4-O-Cyclic fatty acetal-GalCer	GSG1025	Kazuo Nakamura															FAB-MS (Ref. 1051)			Human brain (Ref. 1051)				Fatty acids C16:0,C18:1,C18:0,C24:1 (Ref. 1051) LCB d18:1 (Ref. 1051)	[1051]
47			4,6-O-Cyclic fatty acetal-GalCer	GSG1026	Kazuo Nakamura															FAB-MS (Ref. 1051)			Human brain (Ref. 1051)				Fatty acids C16:0,C18:1,C18:0,C24:1 (Ref. 1051) LCB d18:1 (Ref. 1051)	[1051]
48			Gala1-2Galb1-4(2-AEP1-6)GlcCer	GSG1027	Kazuo Nakamura															FAB-MS (Ref. 1052)			Aplysia juliana (sea hare) (Ref. 1052)				Fatty acids 16:0(61.9%), 18:0(24.2%) (Ref. 1052) LCB d18:1(19.4%), branched d19:1(54.4%) (Ref. 1052)	[1052]
49		(F-9)	[3,4-O-(S-1-Carboxyethylidene)]Galb1-3GalNAca1-3[6'-O-(2-aminoethylphosphonyl)Gala1-2](2-aminoethylphosphoryl-6)Galb1-4GlcCer	GSG1028	Kazuo Nakamura														1D 1H-NMR (400MHz) [Spectrum 0001](Ref. 1053)	(-)FAB-MS [Spectrum 0002](Ref. 1053)		TLC [Chromatogram 0001] (Ref. 1053)	Aplysia kurodai (sea hare) (Ref. 1053)				Fatty acids 16:0(92%), 18:0(8%) (Ref. 1053) LCB d18:1(37%), anteiso-d19:1(55%) (Ref. 1053)	[1053]
50		(FGL-I)	[3,4-O-(S-1-Carboxyethylidene)]Galb1-3GalNAca1-3(Fuca1-2)(2-aminoethylphosphoryl1-6)Galb1-4GlcCer	GSG1029	Kazuo Nakamura														1D 1H-NMR (400MHz) [Spectrum 0001](Ref. 1053)	(-)FAB-MS [Spectrum 0002] (Ref. 1053)		TLC [Chromatogram 0001] (Ref. 1053)	Aplysia kurodai (sea hare) (Ref. 1053)				Fatty acids 16:0(94%), 17:0(3%), 18:0(3%) (Ref. 1053) LLCB d18:1(39%), anteiso d19:1(48%) (Ref. 1053)	[1053]
51			2-Aminoethylphosphoryl-6GlcNAcb1-3Manb1-4GlcCer	GSG1030	Kazuo Nakamura													960 cm^-¹ [Spectrum 0001] (Ref. 1054)	1H NMR [Spectrum 0002](Ref. 1054)	(+)FAB-MS [Spectrum 0003] (Ref. 1054)		TLC: lane 2 [Chromatogram 0001] (Ref. 1054)	Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)larvae of the green-bottle fly, Lucilia caesar(Ref. 2060)				Fatty acids 22:0(49.3%), 24:0(25.0%) (Ref. 1054) LCB br-d18:1(54.7%), d18:1(24.5%), br-d19:1(20.8%) (Ref. 1054)	[1054] / [1490] / [2060]
52			GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1031	Kazuo Nakamura														1H NMR (SP0001) (Ref. 1054)	(+)FAB-MS [Spectrum 0002] (Ref. 1054)		TLC : lane 3 [Chromatogram 0001] (Ref. 1054)	Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)larvae of the green-bottle fly, Lucilia caesar(Ref. 2060)				Fatty acids 22:0(56.0%), 24:0(20.9%) (Ref. 1054) LCB br-d18:1(52.5%), d18:1(18.7%), br-19:1(28.8%) (Ref. 1054)	[1054] / [1490] / [2060]
53			Galb1-3GalNAcb1-4(NeuNa2-3)Galb1-4GlcCer	GSG1032	Kazuo Nakamura	De-N-Acetylated GM1				Reactive with cholera toxin B-subunit (Ref. 1056)									1-d1H (Ref. 1056)	FAB-MS (Ref. 1056)			Bovine brain (Ref. 1056)					[1056]
54			Manb1-4(Fuca1-3)GlcCer	GSG1033	Kazuo Nakamura														400MHz 1H-NMR : b-GLUCOSE : 4.21ppm(J1,2=7.9Hz), b-MANNOSE : 4.65ppm, a-FUCOSE : 5.26ppm(J1,2=3.6Hz), FUCOSE H-5 : 4.30ppm (Ref. 1057)	(-)FAB-MS : [M-H]-=1104,1090,1076, [M-Fuc-H)-=958,944,930, [M-Man-H]-=942, 928,914, [M-Fuc-Man-H]-=796,782,768, CERAMIDE=634,620,606 (Ref. 1057)			Parafontaria laminata armigera (millipede)(Ref. 1057)				Fatty acids normal 27.9% (16:0,22:0,23:0,24:0), 2-hydroxy 32.6% (22:0,23:0,24:0), 3-hydroxy 39.5% (22:0,23:0,24:0) LCB branched d17:1 8.6%, d17:1 28.4%, d17:0 15.3% , branched d18:1 23.5%, d18:1 24.2% (Ref. 1057)	[1057]
55			Cholinephosphoryl-6(Mana1-4)Gal1-6GalCer	GSG1034	Kazuo Nakamura													3400cm^-¹, 1620cm^-¹, 1540cm^-¹, 1220cm^-¹, 960cm^-¹ (Ref. 1058)	500MHz 1H (Ref. 1058)	(+)FAB-MS (Ref. 1058)			Pheretima hilgendorfi (earthworm) (Ref. 1058)				Fatty acids 24:0(21.8%), 23:0(11.2%), 22:0(51.7%) (Ref. 1058) LCB br-d18:1(53.4%), d18:1(20.0%), br-d19:1 (26.4%) (Ref. 1058)	[1058]
56			GalNAca1-4GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1035	Kazuo Nakamura													3400cm^-¹, 1620cm^-¹, 1540cm^-¹, 1220cm^-¹, 960cm^-¹(Ref. 1058)	500MHz 1H (Ref. 1058)	(+)FAB-MS (Ref. 1058)			Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)larvae of the green-bottle fly, Lucilia caesar(Ref. 2060)				Fatty acids 22:0(50.8%), 23:0(11.9%), 24:0(21.7%) (Ref. 1058) LCB br-d18:1(55.4%), d18:1(19.3%), br-d18:1 (25.3% ) (Ref. 1058)	[1058] / [1490] / [2060]
57			GalNAcb1-4(NeuAc2-3)Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1036	Kazuo Nakamura	GalNAc-GD1a(Neu5Ac/Neu5Gc)													500MHz 1H, 125Hz 13C-NMR, HSQC, ROESY (Ref. 1059)				Bovine brain (0.12% of total gangliosides) (Ref. 1059)					[1059]
58			GalNAcb1-4(NeuGc2-3)Galb1-3GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1037	Kazuo Nakamura	GalNAc-GD1a(Neu5Gc/Neu5Ac)													500MHz 1H, 125Hz 13C-NMR, HSQC, ROESY (Ref. 1059)				Bovine brain (0.08% of total ganglioseides) (Ref. 1059)					[1059]
59			Gala1-3(Fuca1-2)Galb1-3Galb1-4GlcCer	GSG1038	Kazuo Nakamura					Blood group B acitive. Anti-B antibody stains blastula cell (Ref. 1060)									400MHz 1H (Ref. 1060)	(-)FAB-MS (Ref. 1060)			Blastula cells of Xenopus laevis (Ref. 1060)				An upper band on TLC, hydroxy fatty acid 46.3% (22h:0, 24h:0); a lower band on TLC, hydroxy fatty acid 66.3% (22h:0, 24h:0, 24h:1) (Ref. 1060)	[1060]
60			GalNAcb1-3Gala1-3(Fuca1-2)Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1039	Kazuo Nakamura					Blood group B active (Ref. 1061)									400MHz 1H [Spectrum 0003] (Ref. 1061)	EI (in Beam) [Spectrum 0001], [Spectrum 0002] (Ref. 1061)		TLC (Ref. 1061)	Rat (Wister/Furth) testis (Ref. 1061)				Fatty acids 16:0 to 24:0 (hydroxy and non-hydroxy), 16:0, 24:0, 16h:0, 24h:0 LCB d18:0, t18:0 (Ref. 1061)	[1061]
61			KDN2-3Galb1-3GalNAcb1-4(KDN2-3)Galb1-4GlcCer	GSG1042	Kazuo Nakamura	KDNGDla				Reacted with mAb. kdn3G (KDNa2-3Galb1-epitope). Expression of KDN-gangliosides are changed during spermatogenesis. KDN/NeuAcGD1a is found in testis throughout all satages during spermatogenesis (Ref. 1064)									500MHz 1H-NMR: terminal KDN: H-3ax 1.55ppm,H-3eq 2.45ppm, innner KDN: H-3eq 2.61ppm (Ref. 1064)	FAB-MS intact and methylated (Ref. 1064)			Rainbow trout testis (Ref. 1064)				Ceramides A: C16:0 (20%) /C24:0 (80%) and d18:1 (80%)/ t18:0 (20%) b: C16:0 (1% )/C24:0 (99% ) and d18:1 (97%)/ t18:0 (3% ) (Ref. 1064)	[1064]
62			KDN2-3Galb1-3GalNAcb1-4(Neu5Ac2-3)Galb1-4GlcCer	GSG1043	Kazuo Nakamura	(KDN,Neu5Ac)GD1a				Reacted with mAb. kdn3G (KDNa2-3Galb1-epitope). Expression of KDN-gangliosides are changed during spermatogenesis. KDN/NeuAcGD1a is found in testis throughout all satages during spermatogenesis (Ref. 1064)									500MHz 1H-NMR:terminal KDN:H-3ax 1.55ppm,H-3eq 2.45ppm, innner NeuAc:H-3eq 2.61ppm (Ref. 1064)	FAB-MS intact and methylated (Ref. 1064)			Rainbow trout testis (Ref. 1064)				Ceramides C24:1(99%) - d18:1(80%)/t18:0(20%), C16:0(36%)/24:1(64%) - d18:1/t18:0 (Ref. 1064)	[1064]
63			NeuAc2-3Galb1-3GalNAcb1-4(KDN2-3)Galb1-4GlcCer	GSG1044	Kazuo Nakamura	(Neu5Ac,KDN)GD1a				Reacted with mAb. kdn3G (KDNa2-3Galb1-epitope). Expression of KDN-gangliosides are changed during spermatogenesis.(Ref. 1064)									500MHz 1H-NMR:terminal NeuAc:H-3eq 2.72ppm, innner KDN: H-3ax 1.62ppm,H-3eq 2.59ppm (Ref. 1064)	FAB-MS intact and methylated (Ref. 1064)			Rainbow trout testis (Ref. 1064)				Ceramides 24:1(99%)- d18:1(80% )/t18:0(20%), C16:0(36% )/24:1(64%)- d18:1 /t18:0 (Ref. 1064)	[1064]
64			KDN2-3Galb1-3(KDN2-6)GalNAcb1-4Galb1-4GlcCer	GSG1045	Kazuo Nakamura	KDN GD1a2				Reacted with mAb. kdn3G (KDNa2-3Galb1-epitope). Expression of KDN-gangliosides are changed during spermatogenesis. KDN GDla emerged at later stage of development, 2-3 months prior to spermiation. (Ref. 1064)									500MHz 1H-NMR: terminal KDN: H-3ax 1.19ppm,H-3eq 2.53ppm, inner KDN:H-3ax 1.30ppm,H-3eq 2.62ppm (Ref. 1064)	FAB-MS intact and methylated (Ref. 1064)			Rainbow trout testis (Ref. 1064)				Ceramide 16:0 (1%)/24:1 (99%) - d18:1 (97% )/t18:0 (3%), 16:0 (54% )/24:1 (46%) - d18:1 /t18:0 (Ref. 1064)	[1064]
65			KDNa2-3Galb1-3(Neu5Ac2-6)GalNAcb1-4Galb1-4GlcCer	GSG1046	Kazuo Nakamura	(KDN,Neu5Ac)GD1a2				Reacted with mAb. kdn3G (KDNa2-3Galb1-epitope). Expression of KDN-gangliosides are changed during spermatogenesis. KDN GDla emerged at later stage of development, 2-3 months prior to spermiation. (Ref. 1064)									500MHz 1H-NMR:terminal KDN:H-3ax 1.18ppm,H-3eq 2.51ppm, innner NeuAc:H-3ax 1.33ppm, H-3eq 2.75ppm (Ref. 1064)	FAB-MS. intact and methylated (Ref. 1064)			Rainbow trout testis (Ref. 1064)				Ceramide 16:0(2%)/24:1(98%)-d18:1(97%)/t18:0(3%),16:0(71%)/24:1(29%)-d18:1 /t18:1 (Ref. 1064)	[1064]
66			3-O-Methyl-Gala1-3[6'-O-(2-aminoethylphosphonyl)Gala1-2](2-aminoethylphosphonyl-6)Galb1-4(2-aminoethylphosphonyl-6)GlcCer	GSG1047	Kazuo Nakamura														400MHz 1H (HF treated sample). COSY. [Spectrum 0002] (Ref. 1065)	(-)FAB-MS [[Sp0001] (Ref. 1065)		TLC [Chromatogram 0001] (Ref. 1065)	Eggs of Aplysia kurodai (sea hare) (Ref. 1065)				Fatty acids 16:0(43.9%), 17:0(7.6%), 18:0(45.0%) (Ref. 1065) LCB d18:1(21.7%), 16-Methyl d19:1(45.5%), d18:1 (21.7%), 16-Methyl d19:1(45.5% ) (Ref. 1065)	[1065]
67			Mana1-2Gala1-6GlcNa1-4GlcCer	GSG1048	Kazuo Nakamura														1H, 13C (Ref. 1066)	LD-MS (Ref. 1066)			Sphingomonas paucimobilis (synonym: Pseudomonas paucimobilis, bacterium) (Ref. 1066)				Fatty acids 14h:0 LCB d18:0, d18:1 (Ref. 1066)	[1066]
68			Galb1-3(2-aminoethylphosphonyl-6)Mana1-3Mana1-4(2-aminoethylphosphonyl-6)GlcNa1-6Ino-phospho-Cer	GSG1049	Kazuo Nakamura																		Leptomonas samueli (protozoan) (Ref. 1068)					[1068]
69			2-Aminoethylphosphony-6Mana1-3Mana1-4(2-aminoethylphosphonyl-6)GlcNa1-6Ins-phospho-Cer	GSG1050	Kazuo Nakamura														600MHz 1H, COSY, ROESY, COSY-45, 13C-NMR (Ref. 1068)	FAB-MS (Ref. 1068)			Leptomonas samueli (protozoan) (Ref. 1068)				Fatty acids 18:0(21.2%), 24:0(26.0%) (Ref. 1068) LCB br-C19:0(7.7%), t20:0, t21:0 (Ref. 1068)	[1068]
70			Fuca1-4(3-phosphoethanolaminyl)Inoa1-phospho-Cer	GSG1051	Kazuo Nakamura														1H-NMR 31P-NMR HOHAHA, COSY, NOE, ROESY, 2-d long-range 1H{31P}scalarcorelation (Ref. 1069)	LAIMS, CID MS/MS (Ref. 1069) FAB-MS, FAB MS/MS (Ref. 1067)			Tritrichomonas foetus (protozoan) (Ref. 1067/1069)				Ceramides C16:0-d18:0, C16:0-d18:1 (Ref. 1067)	[1067] / [1069]
71			3-phospho-Ino-phospho-Cer	GSG1052	Kazuo Nakamura															CID-MS (Ref. 1067), LAIMS (Ref. 1069)			Tritrichomonas foetus (protozoan) (Ref. 1067/1069), Trichomonas vaginalis (protozoan) (Ref. 1069)				Ceramides C16:0-d18:0, C16:0-d18:1	[1067] / [1069]
72			3-phosphoethanolaminyl-Inoa1-phospho-Cer	GSG1053	Kazuo Nakamura															CID MS/MS (Ref. 1069)			Trichomonas vaginalis (protozoan) (Ref. 1069)				Ceramides C16:0-d18:0, C16:0-d18:1(Ref. 1069)	[1069]
73			GlcUa1-3Glca1-4Xylb1-4Xylb1-4(Rhaa1-3)Mana1-2Mana1-3(2-AEPl-6)Mana1-3Mana1-4(2-AEPl-6)GlcNa1-6Ino(1or2)-phospho-Cer	GSG1054	Kazuo Nakamura														1H-NMR(500MHz) 13C-NMR : COSY, TOCSY, ROESY (Ref. 1070)	FAB-MS (Ref. 1070)			Promastigotes of Leptomonas samueli (protozoan) (Ref. 1070)					[1070]
74			Xylb1-3Xylb1-4Xylb1-4(Rhaa1-3)Mana1-2Mana1-3(2-AEPl-6)Mana1-3Mana1-4(2-AEPl-6)GlcNa1-6Ino(1or2)-phospho-Cer	GSG1055	Kazuo Nakamura														500MHz 1H-NMR, 13C-NMR : TOCSY, COSY, ROESY (Ref. 1070)	FAB-MS (Ref. 1070)			Promastigotes of Leptomonas samueli (protozoan) (Ref. 1070)					[1070]
75			Xylb1-4Xylb1-4(Rhaa1-3)Mana1-2Mana1-3(2-AEPl-6)Mana1-3Mana1-4(2-AEPl-6)GlcNa1-6Ins(1or2)-phospho-Cer	GSG1056	Kazuo Nakamura														500MHz 1H-NMR, 13C-NMR : TOCSY, COSY, ROESY (Ref. 1070)	FAB-MS (Ref. 1070)			Promastigotes of Leptomonas samueli (protozoan) (Ref. 1070)					[1070]
76		OPHIDIACEREBROSIDE	Glucosylceramide/(2S,3R,4E,8E,10E)-1-(b-D-glucopyranosyloxy)-3-hydroxy-2[((r)-2-hydroxydocosanoyl)amino]-9-methyl-4,8,10-octadecatriene	GSG1057	Kazuo Nakamura					Cytotoxic for murine leukemia cell L1210 (Ref. 1071)													Ophidiaster ophidiamus (starfish) (Ref. 1071)				(2S,3R,4E,8E,10E)-1-(b-D-)-3-hydroxy-2[((r)-2-hydroxydocosanoyl)amino]-9-methyl-4,8,10-octadecatriene	[1071]
77			Galb1-3(NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG1059	Kazuo Nakamura	GM1a				Reactive with anti-cholinergic neuron specific antibody (anti-Chol-1) (Ref. 1074)										FAB-MS(-) (Ref. 1074)		Mobility on TLC with (C:M:12mM MgCl2=5:4:1), between GM1 and GD1a (Ref. 1074)	Bovine brain (Ref. 1074)				Ceramides C18:0-d20:1, C18:0-d18:1	[1074]
78			Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1060	Kazuo Nakamura	GD1aa				Reactive with anti-cholinergic neuron specific antibody (anti-Chol-1) (Ref. 1074)										FAB-MS(-) (Ref. 1074)		Mobility on TLC with C:M:12mM MgCl2=5:4:1, higher than GD1b (Ref. 1074)	Bovine brain (Ref. 1074)				Ceramide C18:0-d18:1 (Ref. 1074)	[1074]
79			Galb1-3(NeuAc2-6)GalNAcb1-4(NeuGc2-8NeuAc2-3)Galb1-4GlcCer	GSG1061	Kazuo Nakamura	GT1ba				Reactive with anti-cholinergic neuron specific antibody (anti-Chol-1) (Ref. 1074)										FAB-MS(-) (Ref. 1074)		mpbolity on TLC with (C:M:12mM MgCl2=5:4:1), between GT1b and GQ1b (Ref. 1074)	Bovine brain (Ref. 1074)				Ceramides C18:0-d20:1, C18:0-d18:1 (Ref. 1074)	[1074]
80			NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1062	Kazuo Nakamura	X0 ganglioside, sLex-8				Reactive with mAb CSLEX1 (which recognizes sialyl Lewis x structure). Not reactive with mAb CDW65 (VIM-2 specific) nor CD15 (anti-sialyl Lewis x). Strong riactivity with mAb AM3 (which recognizes sialyl Lewis x sequence). (Ref. 1075)										FAB-MS(+) (Ref. 1075)			Human granulocyte (Ref. 1075)				Ceramides C16:0-d18:1 (Ref. 1075)	[1075]
81			NeuAc2-3Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1063	Kazuo Nakamura					Reactive with mAb CDW65 (i.e. having VIM-2 motif), but not reactive with mAb CSLEX1 (which recognize the sialyl Lewis x structure) (Ref. 1075)										FAB-MS(+) of permethylated samples. spectrum is not shown. Text only. [MH]+=2980,[Mna]+=3002,[NeuAcGalG1cNAc]+=1448, close spots on TLC gave ion peaks [MH]+=2870 and [Mna]+=2892 (difference of fatty acid) (Ref. 1075)			Human granulocyte (Ref. 1075)				Ceramides 24:0-d18:1, 16:0-d18:1 (Ref. 1075)	[1075]
82			NeuAc2-6GlcCer	GSG1064	Kazuo Nakamura														1H-NMR Glc,H-1,J1.2=84Hz(d=1.14ppm) blinkage (Ref. 1076)	FAB-MS(-) [M-H]-=1033, 1047, 1061, 1075, 1089 corresponding to C18:1, C19:1, C20:1, C21:1, C22:1, respectively. Long chain base is t18:0 (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076),sea urchin (anthocidaris crassispina) spermatozoa(Ref. 1136)				Fatty acids 20:1(30mol%), 21:1(20mol%), 22:1(30mol%) (Ref. 1076) LCB t18:0 (Ref. 1076)	[1076] / [1136]
83			NeuAc2-8NeuAc2-6GlcCer	GSG1065	Kazuo Nakamura														1H-NMR Glc H-1,J1.2=7.3Hz (d=4.12ppm) blinkage (Ref. 1076)	FAB-MS(-) [M-H]-=1325, 1339, 1353, 1367, 1381(corresponding ot C18:1, C19:1, C20:1, C21:1, C22:1, respectively) Long chain base is t18:0 (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076)				Fatty acids 20:1, 21:1, 22:1 (Ref. 1076) LCB t18:0 (Ref. 1076)	[1076]
84			NeuAc2-8NeuAc2-8NeuAc2-6GlcCer	GSG1066	Kazuo Nakamura															FAB-MS(+) of permethylated samples. NeuAc=376, (NeuAc)2=737, (NeuAc)3=1099, 2H-acetylated samples gave peaks corresponding to lactonyzed (Neu5Ac)3(Hex) (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076)					[1076]
85			HSO3-8NeuAc2-6GlcCer	GSG1067	Kazuo Nakamura														1H-NMR Glc,H-1, d=4.10ppm, J1.2=8.4Hz(blinkage),NeuAc,H-3eq, d=2.48ppm,H-3axd=1.45ppm(alinkage) (Ref. 1076)	[M-H]-=1113, 1127, 1141, 1155, 1169 (corresponding to C18:1, C19:1, C20:1, C21:1, C22:1, respectively. long chain base is t18:0) (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076)				Fatty acids C20:1 C21:1, C22:1 (Ref. 1076) LCB t18:0 (Ref. 1076)	[1076]
86			NeuAc2-8NeuAc2-8NeuAc2-8NeuAc2-6GlcCer	GSG1068	Kazuo Nakamura														1H-NMR Glc, H-1, d=4.10ppm, J1.2=8.4Hz ; NeuAc, H-3eq, 2.48ppm, H-3ax, 1.45ppm (Ref. 1076)	FAB-MS(-) [M-H]-=1113, 1127, 1141, 1155, 1169(corresponding to C18:1, C19:1, C20:1, C21:1, C22:1, respectively. Long chain base : t18:0) (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076)					[1076]
87			HSO3-8NeuAc2-8NeuAa2-6GlcCer	GSG1069	Kazuo Nakamura														1H-NMR	FAB-MS(-) [M-H]-=1387, 1401, 1415, 1429, 1443 (corresponding to C18:1, C19:1, C20:1, C21:1, C22:1, respectively. long chain base is t18:0. Ion peaks corresponding to lactonized molecules were detedted (Ref. 1076)			Sperm of Hemicentrotus pulcherrimus (sea urchin) (Ref. 1076)				Fatty acids 20:1, 21:1, 22:1 (Ref. 1076) LCBt18:0 (Ref. 1076)	[1076]
88			Gala1-2Ins-phospho-Cer	GSG1071	Kazuo Nakamura													OH- 3400,1040cm^-¹; amide I 1650cm^-¹; amide II 1550cm^-¹, phospnate; 1220cm^-¹ (Ref. 1078)	Gal, H-1, 5.05ppm(J1.2=3.30Hz) (Ref. 1078)	FAB-MS(-) [M-H]-=1070, 1056, P-Cer derived ions M/Z = 746,732 (Ref. 1078)			Ascaris suum (porcine roundworm) (Ref. 1078)				Fatty acids 16:0(1.4%), 18:0(1.7%), 24:0(25.1%), 22h:0(5.6%), 23h(0.3%), 24h:0 (63.2%) (Ref. 1078) LCB, br-d17:0(30.7%), d18:0(69.3% ) (Ref. 1078)	[1078]
89		Spirometoside	Galb1-4(Fuca1-3)Glcb1-3(Galb1-6)GalCer	GSG1072	Kazuo Nakamura														1D 1H-NMR [Spectrum 0002], TOCSY [Spectrum 0003](Ref. 1079)	FAB-MS(-),[M-H]-=1472,1498 (C26:0-d18:0,C28:1,C28:0-D18:0) [Spectrum 0001]and 1488,1514(C26:-t18:0,C28:1-t18:0)(Ref. 1079)		TLC: [Chromatogram 0001](Ref. 1079)	Plerocercoids of Spirometra erinacei (cestode) (Ref. 1079)				Fatty acids Upper band on TLC: C28:1(30.2%), C26:0 (21.9%)/d18:0(45.1%),t18:0(54.9%). Lower band on TLC: C28:0(21.7%), C26:0(10.3%), C18:1(13.8%), C16:0(11.0%)/t18:0(90.3%) (Ref. 1079)	[1079]
90			Ac-O-9-NeuGc2-3Galb1-4GlcCer	GSG1073	Kazuo Nakamura	9-O-Ac GM3(GC)													Methylane proton of NeuGc C-9 shifted to lower field (H-9a,3.95ppm, H-9b,4.22ppm) (Ref. 1080)	FAB-MS(-) [M-H-]=1321,[HexHexCer-H]-=972 (Ref. 1080)			Equine erythrocytes (Ref. 1080)				Fatty acid C24:0(32.2%) (Ref. 1080) LCB d18:1(98.7%) (Ref. 1080)	[1080]
91			Ac-O-6'-NeuGca1-3Galb1-4GlcCer	GSG1074	Kazuo Nakamura	6'-O-Ac GM3(GC)													(Ref. 1080)	FAB-MS(-) [Ac-HexHexCer-H]-=1014(Ref. 1080)			Equine erythrocytes (Ref. 1080)				Fatty acid 24:0(26.8%) (Ref. 1080) d18:1(97.5%) (Ref. 1080)	[1080]
92			2-O-Acyl-b-D-glucopyranosylceramide	GSG1075	Kazuo Nakamura													Carbonyl ester1738cm^-¹, -CH stretching, 2922; 2852cm^-¹(Ref. 1004)				TLC(Ref. 1004)	Alaskan pollack brain (Ref. 1004)				Fatty acic and sphingoid comopsition (Ref. 1004) Fatty acic and sphingoid comopsition (Ref. 1004)	[1004]
93			3-O-Acyl-b-D-glucopyranosylceramide	GSG1076	Kazuo Nakamura													carbonyl ester,1738cm^-¹; -CH stretching 2922, 2852cm^-¹ (Ref. 1004)					Alaskan pollack brain (Ref. 1004) porcine and human epidermis (Ref. 1016)				Fatty acic and sphingoid comopsition (Ref. 1004) Fatty acic and sphingoid comopsition (Ref. 1004)	[1004] / [1016]
94			6-O-Acyl-b-D-glucopyranosylceramide	GSG1077	Kazuo Nakamura													Carbonyl ester,1738cm^-¹; -CH stretching 2922, 2852cm^-¹ (Ref. 1004)					Alaskan pollack brain (Ref. 1004)Spleen of Gaucher disease patient (Ref. 1015)				Fatty acic and sphingoid comopsition (Ref. 1004) Fatty acic and sphingoid comopsition (Ref. 1004)	[1004] / [1015]
95			2-O-acyl-b-D-galactopyranosylceramide	GSG1078	Kazuo Nakamura													1730cm^-¹ carbonyl ester (Ref. 1004)				TLC (Ref. 1004)	Alaskan pollack brain (Ref. 1004) human and bovine brain (Ref. 1013) whale brain (Ref. 1014)				Fatty acic and sphingoid comopsition (Ref. 1004) Fatty acic and sphingoid comopsition (Ref. 1004)	[1004] / [1013] / [1014]
96			3-O-acyl-b-D-galactopyranosylceramide	GSG1079	Kazuo Nakamura										[a]_DIN CHCl₃ FrII.=-5.0, FrIII.=+3.0, FrIV.=+0.6 (Ref. 0002)			carbonyl ester, 1730cm^-¹; amide1640cm^-¹ (Ref. 1002/1004)				TLC (Ref. 1001/1002/1003/1004/1011)	Bovine brain (Ref. 1001/1002/1003) 1.1% of sphingolipid fraction of bovine brain (Ref. 1002) human brain (Ref. 1011/1013) Alaskan pollack brain (Ref. 1004) porcine stomach (Ref. 1012) whale brain (Ref. 1014)				Fatty acic and sphingoid comopsition (Ref. 1002/1003/1004/1011) Fatty acic and sphingoid comopsition (Ref. 1002/1003/1004/1011)	[0002] / [1001] / [1002] / [1003] / [1004] / [1011] / [1012] / [1013] / [1014]
97			4-O-acyl-b-D-galactopyranosylceramide	GSG1080	Kazuo Nakamura													carbonyl ester, 1738cm^-¹; -CH Stretching 2922,2852cm^-¹(Ref. 1004)				TLC (Ref. 1003/1004)	Alaskan pollack brain (Ref. 1003/1004), porcine stomach(Ref. 1012) human and bovine brain (Ref. 1013) whale brain (Ref. 1014)				Fatty acic and sphingoid comopsition (Ref. 1004) Fatty acic and sphingoid comopsition (Ref. 1004)	[1003] / [1004] / [1012] / [1013] / [1014]
98			6-O-acyl-b-D-galactopyranosylceramide, Acyl-O-6-Galb1-1Cer	GSG1081	Kazuo Nakamura										[a]_DIN CHCl3 FrII.=-5.0, FrIII.=+3.0, FrIV.=+0.6 (002)			1730cm^-¹ carbonyl ester,1640,1530cm^-¹ amide (Ref. 1001/1002/1004)					Bovine brain (Ref. 1001/1002/1008/1013)1.1% of sphingolipid fraction of bovine brain (Ref. 1002)Alaskan pollack and Pasific cod brain (Ref. 1003/1004)distributin in Alaskan pollack brain (Ref. 1003)Alaskan pollack brain (molecular species) (Ref. 1004)human brain (Ref. 1009/1011/1013)porcine brain (Ref. 1010/1017) porcine stomach (Ref. 1012)whale brain (Ref. 1014)Brain (Ref. 1010), pig stomach mucosa(Ref. 1012)				Combiantion of hydroxy and non-hydorxy (Ref. 1001/1002), fatty acid and sphingoid (Ref. 1002/1004/1010)	[1001] / [1002] / [1003] / [1004] / [1008] / [1010] / [1011] / [1012] / [1013] / [1014] / [1017]
99		Spirometoside	Galb1-4(Fuca1-3)Glcb1-3GalCer	GSG1084	Kazuo Nakamura														1H 1D-NMR; intact(A) and lyso(B) [Spectrum 0002], TOCSY [Spectrum 0003], ROESY [Spectrum 0004](Ref. 1027)	Intact (-)FAB-MS [Spectrum 0001](Ref. 1027)		TLC [Chromatogram 0001] (Ref. 1027)	Plerocercoids of Spirometra erinacei (cestode) (Ref. 1027)				Fatty acids 18:0(30.6%), 18:1(24.2%), 18h:0(13.9%) (Ref. 1027) LCB d18:0(44.4%), t18:0(55.6%) (Ref. 1027)	[1027]
100			NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1085	Kazuo Nakamura	GT1aa				Cholinergic-specific antigen Chol-1a-a (Reacted with anti-cholinergic neuron specific antibody) (Ref. 1028) Monoclonal antibody: GGR-41 (reacted also with GQ1ba) (Ref. 1124)									1D 1H-NMR (Ref. 1026/1028) [Spectrum 0002] HOHAHA (Ref. 1028) [Spectrum 0003]	INTACT FAB-MS [Spectrum 0001] (Ref. 1026/1028)		TLC [Chromatogram 0001] [Chromatogram 0002] (Ref. 1026/1028)	Dogfish (shark) (Squalus acanthias) brain (Ref. 1026) bovine brain (Ref. 1028) Rat liver (Ref. 1123) Rat: intense immunoreactivity was found in the neuropil of the spinal cord dorsal horn, spinal trigeminal nucleus, solitary tract nucleus, superior colliculus, interpeduncular nucleus, hypothalamus and septal area(Ref. 1124)	The suitably protected sialyl alpha-(2-->6) ganglioside was glycosylated with the phenylthioglycoside of sialic acid in the presence of N-iodosuccinimide (NIS)-trimethylsilyl trifluoromethanesulfonate (TMSOTf), followed by further glycosylation with the methyl thioglycoside promoted by dimethyl(methylthio)sulfonium triflate (DMTST), to give the heptasaccharide. The oligosaccharide obtained was converted into the title ganglioside by the introduction of ceramide and then complete deprotection. (Ref. 1128)			Fatty acids 16:0(15.0%), 16:1(9.3%), 18:0(8.6%), 18:1(9.0%), 22:1(38.4%), 24:0(13%), 24:1(6.7%) (Ref. 1026) LCB d18:0(43%) , d18:1(57%) (Ref. 1026)	[1026] / [1028] / [1123] / [1124] / [1128]
101			Galb1-3GalNAcb1-4(HSO₃-3)Galb1-4GlcCer	GSG1086	Kazuo Nakamura
102			NeuAca2-3Galb1-3GalNAcb1-4GalCer	GSG1087	Kazuo Nakamura																		Human erythrocytes(Ref. 1091)					[1091]
103			GalNAcb1-4(NeuAca2-3)Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1088	Kazuo Nakamura	GalNAc-GM1b																	Human brain (Ref. 1100), (Ref. 1092)					[1092] / [1100]
104			NeuAca2-3Galb1-4GlcCer	GSG1089	Kazuo Nakamura	GM3														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			(Ref. 1093)					[1093] / [3072]
105			GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1090	Kazuo Nakamura	GM2														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			(Ref. 1094)(Ref. 1138)(Ref. 1137)					[1094] / [1137] / [1138] / [3072]
106			Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1091	Kazuo Nakamura	GM1				Binding to: tetanus toxin (Ref. 1149), cholera toxin(Ref. 1150), botulinum toxin (Ref. 1151), interaction with hormones (FSH, LH, HCG) <<>>										MALDI-TOFMS [Spectrum 0001] (T.Taketomi) (Ref. 3072)			peripheral nerve myelin(Ref. 1144), myelin(Ref. 1145), human leukemic polymorphonuclear leukocytes(Ref. 1146), synaps(Ref. 1147/1394) (Ref. 1094)					[1094] / [1144] / [1145] / [1146] / [1147] / [1149] / [1150] / [1151] / [1394] / [3072]
107			Galb1-3GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1092	Kazuo Nakamura																		Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)					[1490]
108			Galx1-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1093	Kazuo Nakamura	Gal-GM1																	fat tissue (Ref. 1096)					[1096]
109			Galx1-3(Fuca1-2)Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1094	Kazuo Nakamura																		rat liver and in rat hepatoma induced by N-2-acetylaminofluorene(Ref. 1097)					[1097]
110			Galb1-3Galx-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1095	Kazuo Nakamura																		fat tissue (Ref. 1096)					[1096]
111			Galx1-3Galb1-3Galx1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1096	Kazuo Nakamura																		fat tissue (Ref. 1096)					[1096]
112			NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1097	Kazuo Nakamura	GD1a														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			(Ref. 1098)					[1098] / [3072]
113			NeuAca2-8NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1098	Kazuo Nakamura	GT1a																	Human brain(Ref. 1099)					[1099]
114			GalNAcb1-4(NeuAca2-3)Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1100	Kazuo Nakamura	GalNAc-GD1a														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			Human plasma, red cells, muscle, brain(2 micro moles/kg wet wt), peripheral nerve (femoral nerve)(23micro moles/kg wet wt)(Ref. 1183), human brain(Ref. 1101)					[1101] / [1183] / [3072]
115			NeuAca2-8NeuAca2-3Galb1-4GlcCer	GSG1101	Kazuo Nakamura	GD3														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			(Ref. 1093)					[1093] / [3072]
116			GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1102	Kazuo Nakamura	GD2														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			(Ref. 1102)					[1102] / [3072]
117			Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1103	Kazuo Nakamura	GD1b														MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			Human brain (Ref. 1098/1130), Bovine adrenal medula(Ref. 1131)					[1098] / [1130] / [1131] / [3072]
118			Fuca1-2GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1104	Kazuo Nakamura	Fuc-GD1b																	Pig cerebellum<1182>(Ref. 1103)				Fatty acids 18:0(80.4%), 20:0(16.0%) LCB d18:1(60%), d20:1(40%)	[1103]
119			NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1105	Kazuo Nakamura	GT1b																	(Ref. 1098)					[1098]
120			NeuAca2-8NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1106	Kazuo Nakamura	GQ1b																	Fish brain(Ref. 1104)					[1104]
121			NeuAca2-8NeuAca2-8NeuAca2-3Galb1-4GlcCer	GSG1107	Kazuo Nakamura	GT3																	Fish brain(Ref. 1105)					[1105]
122			GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1108	Kazuo Nakamura	GT2																	Pig adipose tissue(Ref. 1106), fish brain(Ref. 1133)					[1106] / [1133]
123			Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1109	Kazuo Nakamura	GT1c																	Cod fish brain (Ref. 1104)					[1104]
124			NeuAca2-8NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1110	Kazuo Nakamura	GP1c																	Cod fish brai(Ref. 1104)					[1104]
125			NeuAca2-6(NeuAca2-3)Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1111	Kazuo Nakamura																		Human erythrocytes (Ref. 1107)					[1107]
126			NeuAca2-6Galb1-3GalNAcb1-3Gala1-3Galb1-4GlcCer	GSG1112	Kazuo Nakamura																		rat small intestine(Ref. 1201)					[1201]
127			NeuAca2-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1113	Kazuo Nakamura																		Human carcinomas(Ref. 1109)					[1109]
128			NeuAca2-3Galb1-3(Fuca1-4)GalNAcb1-4Galb1-4GlcCer	GSG1114	Kazuo Nakamura	Sialyl-Le^a																	Gastrointestinal cancer(Ref. 1110)					[1110]
129			Galb1-3(NeuAca2-6)(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1115	Kazuo Nakamura																		Human adenocarcinoma(Ref. 1111)					[1111]
130			NeuAca2-8NeuAca2-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1116	Kazuo Nakamura																		(Ref. 1112)					[1112]
131			NeuAca2-3Galb1-3(NeuAca2-6)GlcNAcb1-3Galb1-4GlcCer	GSG1117	Kazuo Nakamura																		Human adenocarcinoma(Ref. 1111)					[1111]
132		sialosylparagloboside	NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1118	Kazuo Nakamura																		(Ref. 1113)					[1113]
133			NeuAca2-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1119	Kazuo Nakamura	sLex-6																	Human kidney(Ref. 1114/1211), adenocarcinoma (Ref. 1212), leukocytes (Ref. 1213)				Fatty acids 16:0(24%)	[1114] / [1211] / [1212] / [1213]
134			NeuAca2-8NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1120	Kazuo Nakamura																		Human kidney(Ref. 1184), Hog kidney (Ref. 1115), Human erythrocytes (Ref. 1107)					[1107] / [1115] / [1184]
135			NeuAca2-8NeuAca2-8NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1121	Kazuo Nakamura																		Hog kidney cortex(Ref. 1115)					[1115]
136			NeuAca2-3Galb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1122	Kazuo Nakamura																		Human erythrocyte membranes(Ref. 1090)					[1090]
137			NeuAca2-3GalNAcx1-3Galb1-4GlcNAcb1-3(Fuca1-2)Galb1-4GlcCer	GSG1123	Kazuo Nakamura																		Human erythrocytes (Ref. 1116)					[1116]
138			NeuAca2-6Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1124	Kazuo Nakamura																		(Ref. 1095)					[1095]
139		Sialosyllactosaminylparagloboside, G6 ganglioside	NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1125	Kazuo Nakamura																		Human spleen(Ref. 1117/1203), placenta(Ref. 1221), granulocytes(Ref. 1222); Bovine erythrocytes (Ref. 1223/1224); Chicken skeltal muscle(Ref. 1211)					[1117] / [1203] / [1211] / [1221] / [1222] / [1223] / [1224]
140			NeuAca2-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1126	Kazuo Nakamura	sialyl dimeric Lex																	Human adenocarcinoma(Ref. 1118)					[1118]
141			NeuAca2-6Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1127	Kazuo Nakamura																		Human erythrocyte membranes(Ref. 1090)					[1090]
142			NeuAca2-6Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1128	Kazuo Nakamura																		Human adenocarocinoma (Ref. 1119)					[1119]
143			NeuAc2-3Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1129	Kazuo Nakamura																		Human erythrocyte membranes(Ref. 1120)					[1120]
144			NeuAca2-3Galb1-4GlcNAcb1-3(Fucx1-xGalb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1130	Kazuo Nakamura																		erythrocyte (Ref. 1121)					[1121]
145			NeuAca2-3Galb1-4GlcNAcb1-3(NeuAca2-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1131	Kazuo Nakamura																		Human erythrocytes(Ref. 1107)					[1107]
146			NeuAca2-3Galb1-4GlcNAcb1-3{Galx1-3(Fuca1-2)Galb1-4GlcNAcb1-6}Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1132	Kazuo Nakamura																		Human erythrocyte membranes(Ref. 1120)					[1120]
147			9-O-Ac-KDN2-3Galb1-3GalNAcb1-4(KDN2-3)Galb1-4GlcCer	GSG1134	Kazuo Nakamura																		Trout Ovarian Fluid
148			Ac-O-9NeuAca2-8NeuAca2-8NeuAca2-3Galb1-4GlcCer	GSG1135	Kazuo Nakamura	Ac-O-9GT3																	Chicken and rat brain (Ref. 1424)					[1424]
149		galgactocerebroside	Galb1-1Cer	GSG1136	Kazuo Nakamura														13C-NMR [Spectrum 0001] (Ref. 1498)				Rat(Ref. 1411/1412), human brain<<>>, distribution in human brain(Ref. 1413), alterlation with age (Ref. 1419), bovine axon(Ref. 1140), peripheral nerve (Ref. 1403/1414/1415), human kidney(Ref. 1416), neuron(Ref. 1418), (Ref. 1417). Pheretima hilgendorfi (earthworm) (Ref. 2061), Tylorrhynchus heterochetus (lugworm) (Ref. 2063)				Fatty acids Pheretima hilgendorfi (earthworm) 16:0(0.4%), 18:0(2.0%), 19:0(0.4%), 20:0(3.3%), 21:0(2.5%), 22:0(48.2%), 23:0(11.7%), 24:0(31.5%); br-d18:1(36.6%) (Ref. 2061) Tylorrhynchus heterochetus (lugworm),16:0(82.3%), 17:0(8.5%), 18:0(9.2%) (Ref. 2063) LCB Pheretima hilgendorfi (earthworm),br-d18:1(36.6%), d18:1(44.4%), br-d19:1(19.0%) (Ref. 2061) Tylorrhynchus heterochetus (lugworm), d18:1(57.3%), d18:2(42.7%) (Ref. 2063)	[1140] / [1403] / [1411] / [1412] / [1413] / [1414] / [1415] / [1416] / [1417] / [1418] / [1419] / [1498] / [2061] / [2063]
150			Galb1-1Cer(sphingosine 3-O-Acyl)	GSG1138	Kazuo Nakamura																		Brain (Ref. 1011/1002)					[1002] / [1011]
151			Galb1-1Cer(sphingosine 3-O-alkyl)	GSG1139	Kazuo Nakamura																		Bovine brain (Ref. 1420)					[1420]
152		Psychosine	Galb1-1Sphingosine	GSG1140	Kazuo Nakamura
153		glucocerebroside	Glcb1-1Cer	GSG1141	Kazuo Nakamura														13C-NMR [Spectrum 0001] (Ref. 1498)				Human, bovine, equine spleen (Ref. 1396/1400), spleen of Gaucher's disease patient (Ref. 1421), human brain (Ref. 1422), rat and bovine brain (Ref. 1423)					[1396] / [1400] / [1421] / [1422] / [1423] / [1498]
154			Galb1-3GalNAca1-4GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1142	Kazuo Nakamura																		Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)larvae of the green-bottle fly, Lucilia caesar(Ref. 2060)					[1490] / [2060]
155		glucopsychosine	Glcb1-1Sphingosine	GSG1143	Kazuo Nakamura																		Spleen of Gaucher's disease patient (Ref. 1387/1388), microsome from rat brain (Ref. 1389)					[1387] / [1388] / [1389]
156			L-Fuca1-1Cer	GSG1144	Kazuo Nakamura																		Human colon tumors(Ref. 1390)					[1390]
157			Xylb1-1Cer	GSG1145	Kazuo Nakamura																		salt gland of the herring gull(Ref. 1391)					[1391]
158			Fuca1-3GalNAcb1-4(Fuca1-3)GlcNAcb1-4GlcCer	GSG1146	Kazuo Nakamura																		<<>>
159		cytolipin H, lactosylceramide	Galb1-4Glcb1-1Cer	GSG1147	Kazuo Nakamura	LacCer													13C-NMR [Spectrum 0001] (Ref. 1498)				Structure (Ref. 1395), spleen and kidney (Ref. 1396/1137/1253), erythrocytes (Ref. 1397/1398); (Ref. 1399), human hepatoma tissue (Ref. 1401), human gastric carcinoma (Ref. 1402), human skeletal muscle (Ref. 1403), astroglia of rat brain (Ref. 1404), Bovine spleen(Ref. 1237), erythrocytes(Ref. 1238), kidney(Ref. 1239); Human adenocarcinoma(Ref. 1238), kidney(Ref. 1240), neutrophils(Ref. 1241)	(Ref. 1405)				[1137] / [1237] / [1238] / [1239] / [1240] / [1241] / [1253] / [1395] / [1396] / [1397] / [1398] / [1399] / [1401] / [1402] / [1403] / [1404] / [1405] / [1498]
160		Galabiosylceramide	Gala1-4Galb1-1Cer	GSG1148	Kazuo Nakamura					Level varies in mouse due to sex hormones(22)													kidney of a patient with Fabry's disease (Ref. 1251/1406), pancreas of a patient with Fabry's disease (Ref. 1407), hamster fibroblasts (Ref. 1408), human (normal) kidney (Ref. 0004/1240/1253), normal human leucocytes (Ref. 1409), mouse kidneys (BALB/c, C57/BL, A strain) (Ref. 1254), human hepatoma tissue (Ref. 1401), Porcine pancreas (Ref. 1255). (Ref. 1250/1252)					[0004] / [1240] / [1250] / [1251] / [1252] / [1253] / [1254] / [1255] / [1401] / [1406] / [1407] / [1408] / [1409]
161			Manb1-4Galb1-1Cer	GSG1149	Kazuo Nakamura																		starfish (Asterina pectinifera) (Ref. 1393)					[1393]
162			GlcNAcb1-3Galb1-3GalNAca1-4GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1150	Kazuo Nakamura																		Pupae of Calliphora vicina (Insecta: Diptera)(Ref. 1490)larvae of the green-bottle fly, Lucilia caesar(Ref. 2060)					[1490] / [2060]
163			GlcUb1-3Galb1-3GalNAca1-4GalNAcb1-4(2aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4GlcCer	GSG1151	Kazuo Nakamura																		larvae of the green-bottle fly, Lucilia caesar(Ref. 2057)					[2057]
164			Gala1-6GlcCer	GSG1153	Kazuo Nakamura																		Starfish eggs(Ref. 1488)					[1488]
165		globoside I/cytolipin K	GalNAcb1-3Gala1-4Galb1-4Glcb1-1Cer	GSG1154	Kazuo Nakamura																		Human erythrocytes(Ref. 1423/1422/5080), kidney(Ref. 1396), meconium(Ref. 1260), teratocarcinoma cells(Ref. 1400); Human and porcine plasma(Ref. 1257/1411/1412),Tissues of Tay Sachs' disease variant(Ref. 1421); Rat intestine(Ref. 1140) Canine kidney(Ref. 5082)					[1140] / [1257] / [1260] / [1396] / [1400] / [1411] / [1412] / [1421] / [1422] / [1423] / [5080] / [5082]
166		Cytolipin R	GalNAcb1-3Gala1-3Galb1-4Glcb1-1Cer	GSG1155	Kazuo Nakamura																		Rat lymphosarcoma (Ref. 1425), rat kidney (Ref. 1453)					[1425] / [1453]
167		asialo-GM1 (AM1)	Galb1-3GalNAcb1-4Galb1-4Glcb1-1Cer	GSG1156	Kazuo Nakamura															MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			Epithelial cells of mouse small intestine (Ref. 1427)					[1427] / [3072]
168		paragloboside	Galb1-4GalNAcb1-3Galb1-4GlcCer	GSG1157	Kazuo Nakamura	nLc4Cer													13C-NMR [Spectrum 0001] (Ref. 1498)				Human erythrocytes (Ref. 1428), neutrophils(Ref. 1161); Bovine spleen, erythrocytes (Ref. 1429)					[1161] / [1428] / [1429] / [1498]
169			GalNAca1-3GalNAcb1-3Gala1-4GalCer	GSG1158	Kazuo Nakamura					Forsman acitive													Hamster fibroblasts(Ref. 1408)					[1408]
170			L-Fuca1-2Gala1-3Galb1-4GlcCer	GSG1159	Kazuo Nakamura					Blood group H activity													Hog-stomach mucosa(Ref. 1430)					[1430]
171			GlcNAcb1-2Manb1-3Manb1-4GlcCer	GSG1160	Kazuo Nakamura																		fresh-water bivalve, Hyriopsis schlegelii (Ref. 1431)					[1431]
172		Forssman antigen	GalNAca1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1161	Kazuo Nakamura					Forssman antigen													(DB144)(Ref. 1423), Sheep blood cells (Ref. 1397); caprine (goat) erythrocyte (Ref. 1433); Human stomach tumor tissues (Ref. 1173/1434); Horse (Ref. 1435); Guinea pig kidney (Ref. 1436); transplanted canine kidney (Ref. 5082)					[1173] / [1397] / [1423] / [1433] / [1434] / [1435] / [1436] / [5082]
173			Gala1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1162	Kazuo Nakamura																		Erythrocytes and reticulocytes of rabbit (Ref. 1438); Human erythrocyte (Ref. 5126); Bovine erythrocyte (Ref. 1160)					[1160] / [1438] / [5126]
174		galgactosyl-paragloboside	Galb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1163	Kazuo Nakamura																		Human erythrocyte membrane (Ref. 5126)					[5126]
175		H1 glycolipid	Fuca1-2Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1164	Kazuo Nakamura					H1 antigen													Human erythrocytes (Ref. 1439/5216); Bovine erythrocyte membrane (Ref. 1160)					[1160] / [1439]
176			Fuca1-2Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1165	Kazuo Nakamura					Blood group H acitive													rat ascites hepatoma cell, AH 7974F (Ref. 1440)	fucosyltransferase of rat ascites hepatoma cell, AH 7974F (Ref. 1440)				[1440]
177		Lewis a	Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1166	Kazuo Nakamura	Lea				Le a													Human intestine <<>>, adenocarcinoma, erythrocytes <<>>, plasma <<>>	Le^a antigen
178			Gala1-4Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1167	Kazuo Nakamura					blood group P1 antigen													Human erythrocyte(Ref. 1441)					[1441]
179		X-hapten, SSEA-1, Lex	Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1168	Yasushi Kawakami	Lex-5																	Human adenocarcinoma (Ref. 1326/1327), granulocytes(Ref. 1308), kidney(Ref. 1304); Dog intestine(Ref. 1328); Hog gastric mucosa(Ref. 1313)					[1304] / [1308] / [1313] / [1326] / [1328]
180			GlcNAcb1-2Manb1-3(Xylb1-2)Manb1-4GlcCer	GSG1169	Kazuo Nakamura																		spermatozoa of Hyriopsis schlegelii(Fresh-water bivalves) (Ref. 5134)					[5134]
181			GalNAcb1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1170	Kazuo Nakamura					Blood group active, A^a										TLC/(-)SIMS [Spectrum 0001] (Ref. 1499)			Human erythrocytes (Ref. 1442/1443); Dog small intestine (Ref. 1444)					[1442] / [1443] / [1444] / [1499]
182			Gala1-3(Fuca1-2)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1171	Kazuo Nakamura					Blood group B acitive													Pancreas of a patient with Fabry's disease (Ref. 1407)					[1407]
183			Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1172	Kazuo Nakamura					Blood group B1 acitive													Human erythrocyte membrane (Ref. 1160/1439/1446)					[1160] / [1439] / [1446]
184			GalNAca1-3(Fuca1-2)Galb1-3Galb1-4Galb1-4GlcCer	GSG1173	Kazuo Nakamura					Blood group A active (weak)													hog stomach mucosa (Ref. 1447)					[1447]
185			Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1174	Kazuo Nakamura																		Bovine erythrocytes (Ref. 1160)					[1160]
186			Fuca1-2Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1175	Kazuo Nakamura					Blood group H2													Human erythrocytes (Ref. 1160/1439/5216)					[1160] / [1439]
187			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(Galb1-6)Galb1-4GlcCer	GSG1176	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1448)					[1448]
188			Gala1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1177	Kazuo Nakamura																		Bovine erythrocytes(Ref. 1160)					[1160]
189			GalNAca1-3(Fuca1-2)Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1178	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1449)					[1449]
190			GalNAca1-3(Fuca1-2)Galb1-4GlcNAc1-3Galb1-4GlcNAc1-3Galb1-4Galb1-4GlcCer	GSG1179	Kazuo Nakamura																		Human erythrocytes (Ref. 1442)					[1442]
191			Fuca1-2Gal1-4(Fuc-)GlcNAc1-3Gal1-4GlcNAc1-3Gal1-4GlcCer	GSG1180	Kazuo Nakamura																		Human tumor tissue (Ref. 1450)					[1450]
192			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(GalNAca1-3Galb1-6)Galb1-4GlcCer	GSG1181	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1451)					[1451]
193			GalNAca1-3(Fuca1-2)Galb1-3(GalNAca1-3Galb1-6)Galb1-4Galb1-4GlcCer	GSG1182	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1451)					[1451]
194			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(GalNAcb1-4Galb1-6)Galb1-4GlcCer	GSG1183	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1451)					[1451]
195			Galb1-4(Fuca1-3)GlcNAcb1-4Galb1-3(GlcNAcb1-4Galb1-6)Galb1-4GlcCer	GSG1184	Yasushi Kawakami																		Hog gastric mucosa (Ref. 1448)					[1448]
196			NeuGca2-3Galb1-4GlcCer	GSG1185	Kazuo Nakamura	GM3																	(Ref. 1093)					[1093]
197			NeuAca2-3GalCer	GSG1186	Kazuo Nakamura	GM4																	(Ref. 1093)Human myelin(Ref. 1132); Human cerebral white matter,8.6%, gray matter, 1.5% and spinal cord, 12.8%; Cat cerebral white matter, 0.8% and spinal cord, 1.1%), not detected in Rabbit; Human cerebrum myelin, 26.6%, spinal cord myelin 25.3%; Cat cerebrum myelin, 1.0%, spinal cor myelin 1.7%(Ref. 1134); Human brain (white matter, 8.6%; gray matter, 1.5%); White matter of Chimpanzee(8.8%), Monkey(9.0%), Chick(10.8%), Bovine, Sheep(0.6%), Pig(0.7%), Rat(less than 0.1%)(Ref. 1133)				Major normal acid, C24:1, C16:0; major hydroxy acid, 24h:0, 24h:1, 23h:0 (Ref. 1132)	[1093] / [1132] / [1133] / [1134]
198			8-sulfo-NeuGca2-6GlcCer	GSG1188	Kazuo Nakamura													1235cm^-¹, 810cm^-¹<1135>					sea urchin (Echinocardium cordatum)<1135>				Fatty acids Normal acid, 15:0(32.5%); hydroxy acid, 24h:0(19.0%), 22h:0(18.0%), 22h:1(15.4%), (Ref. 1135) LCB t18:0(56.0%), t16:0(16.7%) (Ref. 1135)	[1135]
199			Methyl-O-8NeuGca2-3Galb1-4Glc	GSG1189	Kazuo Nakamura																		starfish Aphelasterias japonica(Ref. 1491)					[1491]
200			Methyl-O-8NeuGca2-5(methyl-O-8)NeuGca2-3Galb1-4Glc	GSG1190	Kazuo Nakamura																		starfish Aphelasterias japonica(Ref. 1491)					[1491]
201			Arab1-6Galb1-4(Galb1-8)NeuGc2-3Galb1-4GlcCer	GSG1191	Kazuo Nakamura																		Star fish (Asterina pectinifera)<1168>
202			NeuGca2-8NeuGca2-3Galb1-4GlcCer	GSG1192	Kazuo Nakamura	GD3																	(Ref. 1093)					[1093]
203			NeuAca2-3Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1193	Kazuo Nakamura	GQ1c																	Cod fish brain(Ref. 1188)					[1188]
204			Gala1-3Gala1-4Galb1-4GlcCer	GSG1194	Kazuo Nakamura																		Rat small intestine (Ref. 1300); PC12h pheochromocytoma cells(Ref. 1452)					[1300] / [1452]
205			Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1195	Kazuo Nakamura																		Rat intestine (Ref. 1300); PC12h pheochromocytoma cells(Ref. 1301)					[1300] / [1301]
206			Gala1-3Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1196	Kazuo Nakamura																		Pheochromcytoma cells PC12h(Ref. 1259)					[1259]
207		SSEA-3 antigen	Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1197	Kazuo Nakamura																		Human kidney (Ref. 1453), teratocarcinoma cells (Ref. 1454/1455); Mouse kidney (Ref. 1231)					[1231] / [1453] / [1454] / [1455]
208			GalNAcb1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1198	Kazuo Nakamura																		Rat intestine (Ref. 1233); PC12h pheochromocytoma cells (Ref. 1301)					[1233] / [1301]
209			GalNAcb1-3Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1199	Kazuo Nakamura																		Rat intestine (Ref. 1233)					[1233]
210			GalNAcb1-3Gala1-3Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1200	Kazuo Nakamura																		Rat intestine (Ref. 1233)					[1233]
211		Amino CTH	GlcNAcb1-3Galb1-4GlcCer	GSG1201	Kazuo Nakamura																		Human spleen <<>>, erythrocutes (Ref. 1456), neutrophils (Ref. 1241)					[1241] / [1456]
212			Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1202	Kazuo Nakamura	LM1, iso-LM1																	Human spleen <<>>, embryonal carcinoma cells (Ref. 1457), meconium (Ref. 1378)					[1378] / [1457]
213		P antigen	GalNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1203	Kazuo Nakamura																		Human erythrocytes (Ref. 1271/1458)					[1271] / [1458]
214			Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1204	Kazuo Nakamura					monoclonal antibody NUH2 oncodevelopmentally regulated antigen													Human colonic adenocarcinoma (Ref. 1459)					[1459]
215			N-Methylaminoethylphosphonyl-6GlcCer	GSG1205	Kazuo Nakamura																		antarctic krill,euphausia superba(Ref. 2038)					[2038]
216			Gala1-3Galb1-4GlcNAcb1-3(Gala1-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3(Gala1-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1206	Kazuo Nakamura					Blood group I/i-active													Rabbit erythrocyte membranes (Ref. 1460)					[1460]
217			GlcNAcb1-4(GalNAcb1-3)Galb1-4GlcCer	GSG1207	Kazuo Nakamura					Presence in undifferentiated murine leukemia cells and dependence on differentiation													Murine leukemia cells (Ref. 1268)					[1268]
218			GalNAcb1-4(Gala1-3Galb1-4GlcNAcb1-3)Galb1-4GlcCer	GSG1208	Kazuo Nakamura					Presence in undifferentiated murine leukemia cells and dependence on differentiation													Murine leukemia cells (Ref. 1268)					[1268]
219			Glcb1-1N-(O-linoleoyl)w-hydroxylignoceroyl sphingpsine	GSG1209	Kazuo Nakamura																		Epidermis from footpad and dorsal skin of guinea pigs (Ref. 1461)					[1461]
220			NeuGc2-3GalCer	GSG1210	Kazuo Nakamura																		Mouse erythrocytes (Ref. 1462)					[1462]
221		deacetyl GM3	NeuNH2-3Galb1-4GlcCer	GSG1211	Kazuo Nakamura					strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth (Ref. 1463)													A431 cells and B16 melanoma cells (Ref. 1463)					[1463]
222			NeuGc2-8NeuAc2-3Galb1-4GlcCer	GSG1212	Kazuo Nakamura																		Rabbit thymus (Ref. 1172>; Bovine liver, kidney, spleen, thyroid					[1172]
223			NeuAc2-8NeuGc2-3Galb1-4GlcCer	GSG1213	Kazuo Nakamura																		Cat and sheep erythrocytes (Ref. 1464)					[1464]
224			Ac-O-9NeuAc2-8NeuAc2-3Galb1-4GlcCer	GSG1214	Kazuo Nakamura																		Human melanoma (Ref. 1465)					[1465]
225			Ac-O-9NeuAc2-8NeuAc2-8NeuAc2-3Galb1-4GlcCer	GSG1216	Kazuo Nakamura	9-O-Ac GT3																	embrio chicken brain (Ref. 1424)					[1424]
226			GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1217	Kazuo Nakamura					Hanganutziu-Deicher active Monoclonal antibody (Ref. 1466)													(Ref. 1095)(Ref. 1429)					[1095] / [1429] / [1466]
227			Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1218	Kazuo Nakamura																		spermatozoa of the sea urchin Anthocidaris crassispina (Ref. 1136)					[1136]
228			Ac-O-9NeuAc2-3Galb1-3GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1219	Kazuo Nakamura																		Rat erythrocytes (Ref. 1467)					[1467]
229			Gala1-3Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4GlcCer	GSG1220	Kazuo Nakamura					Monoclonal antibody AA4 (which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells) (Ref. 1468).													Rat leukemia cells (Ref. 1468), Rat basophilic leukemia cells (RBL-2H3) (Ref. 1209)					[1209] / [1468]
230			Gala1-3Gala1-3Galb1-3GalNAcb1-4(NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1221	Kazuo Nakamura					Monoclonal antibody AA4 (which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells) (Ref. 1468).													Rat leukemia cells (Ref. 1468)					[1468]
231			Gala1-3(Fuca1-2)Galb1-3GalNAcb1-4(NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1222	Kazuo Nakamura																		PC 12 pheochromocytoma cells (Ref. 1199)					[1199]
232			NeuAc2-3Galb1-3GalNAcb1-4(Ac-O-9NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1223	Kazuo Nakamura																		Mouse brain(Ref. 1469)					[1469]
233			Fuca1-2Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1224	Kazuo Nakamura																		(Ref. 1095)					[1095]
234			N-methylaminoethylphosphonyl-6Gal1-6Gal1-6GalCer	GSG1225	Kazuo Nakamura
235		GalNAc-GM1	GalNAcb1-4Galb1-3GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1226	Kazuo Nakamura																		Human brain (Ref. 1100)					[1100]
236			GalNAca1-3GalNAcb1-3Galb1-3GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1227	Kazuo Nakamura																		liver of the English sole (Parophrys vetulus) (Ref. 1470)					[1470]
237			NeuAc2-3Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1228	Kazuo Nakamura	GD1a (NeuAc/NeuGc)
238			NeuGc2-3Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-4GlcCer	GSG1229	Kazuo Nakamura	GD1a (NeuGc/NeuGc)																	(Ref. 1095/1429)					[1095] / [1429]
239			NeuGc2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1230	Kazuo Nakamura																		Mouse spleen (Ref. 1471)					[1471]
240			GalNAcb1-4(NeuGc2-3)Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1231	Kazuo Nakamura																		Mouse spleen (Ref. 1193)					[1193]
241			Galb1-3GalNAcb1-4(NeuGc2-3)Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1232	Kazuo Nakamura																		Mouse spleen (Ref. 1471)					[1471]
242		GD1a, GD1e	NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG1234	Kazuo Nakamura																		Rat ascites hepatoma cells (Ref. 1472/1478); Differentiation-resistant clone of mouse myeloid leukemia cells, M1-R1 (Ref. 1474)					[1472] / [1474] / [1478]
243			NeuAc2-3Galb1-3(NeuAc2-8NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG1235	Kazuo Nakamura																		(Ref. 1475)					[1475]
244			NeuAc2-8NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG1236	Kazuo Nakamura																		(Ref. 1475)					[1475]
245			NeuAc2-8NeuAc2-3Galb1-3(NeuAc2-8NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG1237	Kazuo Nakamura																		(Ref. 1475)					[1475]
246			NeuAc2-6Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcCer	GSG1238	Kazuo Nakamura																		Bovine buttermilk(Ref. 1476)					[1476]
247		SSEA-4 antigen	NeuAc2-3Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1239	Kazuo Nakamura					SSEA-4 antigen													Human teratocaricinoma (Ref. 1455/1454); Rat intestine (Ref. 1300)					[1300] / [1454] / [1455]
248			NeuGc2-3Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1240	Kazuo Nakamura																		Roe of striped mullet, Mugil cephalus(Ref. 1477/1478)					[1477] / [1478]
249			NeuAc2-8NeuAc2-3Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1241	Kazuo Nakamura
250			NeuGc2-8NeuGc2-3Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1242	Kazuo Nakamura																		Roe of striped mullet, Mugil cephalus(Ref. 1477)					[1477]
251			GalNAcb1-4(NeuAc2-3)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1244	Kazuo Nakamura																		Human meconium (Ref. 1479)					[1479]
252			NeuAc2-3Galb1-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1245	Kazuo Nakamura
253		disialyl Lea	NeuAc2-3Galb1-3(NeuAc2-6)(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1246	Kazuo Nakamura																		human colonic adenocarcinoma (Ref. 1111)					[1111]
254			NeuGc2-8NeuGc2-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1247	Kazuo Nakamura																		Human gastrointesinal adenocarcinoma and human gastric cancer cell MKN74 (Ref. 1480)					[1480]
255			NeuAc2-8NeuGc2-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1248	Kazuo Nakamura																		Erythrocytes of cat and sheep (Ref. 1464)					[1464]
256			GalNAcb1-4(NeuAc2-3)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1249	Kazuo Nakamura																		Roe of striped mullet, Mugil cephalus(Ref. 1477)					[1477]
257			NeuGca2-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4GlcCer	GSG1250	Kazuo Nakamura																		Bovine thyroid and adrenal gland
258			NeuAc2-3Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1251	Kazuo Nakamura																		Chronic myelogenous leukemia cells(Ref. 1481)					[1481]
259			NeuAc2-3Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1252	Kazuo Nakamura
260			NeuAc2-3Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1253	Kazuo Nakamura																		Human myeloid cells (Ref. 1482)					[1482]
261			NeuAc2-3Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1254	Kazuo Nakamura																		Human erythrocytes (Ref. 1116)					[1116]
262			NeuAc2-3Galb1-4GlcNAca1-3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1255	Kazuo Nakamura																		human erythrocyte membranes (Ref. 1120)					[1120]
263			NeuAc2-3Galb1-4GlcNAca1-3(NeuAca2-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1256	Kazuo Nakamura																		human erythrocytes (Ref. 1107)					[1107]
264			NeuAc2-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3or6(NeuAca2-3Galb1-4GlcNAcb1-6or3)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1257	Kazuo Nakamura																		Human colonic adenocarcinoma (Ref. 1459)					[1459]
265			NeuAc2-3Galb1-4GlcNAcb1-3(NeuAc2-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3or6(NeuAca2-3Galb1-4GlcNAcb1-6or3)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1258	Kazuo Nakamura																		Human colonic adenocarcinoma (Ref. 1459)					[1459]
266			NeuAc2-3Galb1-4GlcNAcb1-3(Gala1-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1259	Kazuo Nakamura
267			NeuAc2-3Galb1-4GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1260	Kazuo Nakamura																		Roe of striped mullet, Mugil cephalus(Ref. 1477)					[1477]
268			GalNAcb1-4(NeuAc2-3)Galb1-4GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1261	Kazuo Nakamura																		Roe of striped mullet, Mugil cephalus(Ref. 1477)					[1477]
269			NeuAc2-3Galb1-3GalNAcb1-4GlcCer	GSG1262	Kazuo Nakamura																		Human erythrocytes (Ref. 1090)					[1090]
270			4,6-O-Linked plasmalopsychosine	GSG1263	Kazuo Nakamura					Enhances p140trk (Trk A) phosphorylation and mitogen-activated protein kinase (MAPK) activity and as a consequence induces neurite outgrowth in PC12 cells. (Ref. 1129)										(+)FAB-MS (NBA and NBA/sodium acetate matrix) , (-)FAB-MS (triethanolamine/15-crown 5 matrix) [Spectrum 0001], (+)FAB-MS after acid treatment, (+)FAB-MS after acetylation (Ref. 1122)		TLC: Compund B in Fig. , Lane 5 [Chromatogram 0001] (Ref. 1122)	Human brain (white matter). Detected from white matter, cerebellum and brainstem but not from gray matter. (Ref. 1122)					[1122] / [1129]
271		(Compound A)	3,4-O-Linked plasmalopsychosine	GSG1264	Kazuo Nakamura					Enhances p140trk (Trk A) phosphorylation and mitogen-activated protein kinase (MAPK) activity and as a consequence induces neurite outgrowth in PC12 cells. (Ref. 1129)										(+)FAB-MS (NBA matrix) [Spectrum 0001], (+)FAB-MS after acid treatment, (+)FAB-MS after acetylation (Ref. 1122)		TLC: Lane 2 [Chromatogram 0001](Ref. 1122)	Human brain (white matter). Detected from white matter, cerebellum and brainstem but not from gray matter. (Ref. 1122)				Fatty aldehyde:	[1122] / [1129]
272		(SGL-II)	3-O-Methyl-galactosylb1-3N-acetylgalactosaminyla1-3[6'-O-(2-aminoethylphosphonyl)galactosyla1-2](2-aminoethylphosphonyl-6)galactosylb1-4glucosylceramide	GSG1265	Kazuo Nakamura					Activate cyclic adenosine 3',5'-monophosphte-dependent protein kinase from rat brain. (Ref. 1126)									1D 1H-NMR (400MHz) [Spectrum 0001] (Ref. 1125)	(+)FAB-MS [Spectrum 0002] (Ref. 1125)			Skin of Aplysia kurodai (sea hare) (Ref. 1125)				Fatty acids 16:0(89.8%), 17:0(4.7%), 18:0(2.3%) (Ref. 1125) LCB d18:1(50.5%), anteiso-d19:1(38.3%) (Ref. 1125)	[1125] / [1126]
273			Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1267	Yasushi Kawakami	Ley-6																	Human colonic carcinoma (Ref. 1331), Dog intestine (Ref. 1328)					[1328] / [1331]
274			GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1268	Kazuo Nakamura	GlcNAc-Lex-5																	human cataractous lense (Ref. 1486)					[1486]
275			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1269	Yasushi Kawakami	Lex-7																	Human erythrocytes (Ref. 1362), granulocytes (Ref. 1222)					[1222] / [1362]
276			Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1270	Yasushi Kawakami	Ley-8																	Human colonic caricinoma (Ref. 1363)					[1363]
277			Galbl-4(Fucal-3)GlcNAcb1-6(Galb1-3)GalNAcbbl-3Galal-4Galbl-4GlcCer	GSG1272	Kazuo Nakamura	globo-Lex-9																	mouse kidney (Ref. 1231)					[1231]
278			Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1273	Yasushi Kawakami	trimeric LeY-9																	Human colonic carcinoma (Ref. 1363)					[1363]
279			Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1274	Yasushi Kawakami	Ley-A-9																	Human meconium (Ref. 1379)					[1379]
280			Galbl-4(Fucal-3)GlcNAcbl-3Galbl-4GlcNAcb1-3Galbl-4GlcNAcbl-3Galbl-4Glcbl-l'Cer	GSG1275	Kazuo Nakamura	Lex-9																	human granulocytes (Ref. 1308), human erythrocytes (Ref. 1362)					[1308] / [1362]
281			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1277	Yasushi Kawakami																		Human colonic and liver carcinoma (Ref. 1364)					[1364]
282			NeuAca2-3Galbl-4(Fucal-3)GlcNAcbl-3Galbl-4(Fucal-3)GlcNAcbl-3Galbl-4GlcNAcbl-3Galb31-4GlcCer	GSG1281	Kazuo Nakamura	X3 ganglioside																	human granulocytes (Ref. 1075)					[1075]
283			NeuAca2-3Galb1-4(Fucal-3)GlcNAcbl-3Galbl-4GlcNAcbl-3Galbl-4(Fucal-3)GlcNAcbl-3Galbl-4GlcCer	GSG1282	Kazuo Nakamura	X3 ganglioside																	human granulocytes (Ref. 1075)					[1075]
284			NeuAca2-3Galbl-4(Fucal-3)GlcNAcb1-3Galbl-4(Fucal-3)GlcNAcbl-3Galb1-4(Fucal-3)GlcNAcbl-3Galbl-4GlcCer	GSG1283	Kazuo Nakamura	X4 ganglioside																	human granulocytes (Ref. 1075)					[1075]
285			NeuAca2-3Galbl-4(Fucal-3)GlcNAcbl-3(Galbl-4(Fucal-3)GlcNAcbl-3)nGalbl-4Glcbl-l'Cer	GSG1284	Kazuo Nakamura	Band 6																	Human blood platelets (Ref. 1487)					[1487]
286			Galb1-3(Fucal-4)GlcNAcb1-3Galb1-4(Fucal-3)GlcNAcb1-3Galb1-4GlcCer	GSG1285	Kazuo Nakamura	Lea-X																	Human squamous lung cancer (Ref. 1343)					[1343]
287			NeuAca2-3Galb1-3(Fuca1-4)GlcNAcb1-3[Galb1-4(Fuca1-3)GlcNAcb1-6]Galb1-4Glcb1-1Cer	GSG1287	Kazuo Nakamura	sLea-Lex																	Human rectal adenocarcinoma (Ref. 1031)					[1031]
288			NeuAcGalGalCer	GSG1288	Kazuo Nakamura																		Human brain of Niemann-Pick disease and gargoylism (Ref. 1190)					[1190]
289			HSO3-8NeuAca2-8NeuAca2-3Galb1-4Glcb1-1Cer	GSG1289	Kazuo Nakamura																		Bovine gastric mucosa (Ref. 1191)				Fatty acids 22:1(21.4%), 24:1(16.3%), 16:0(13.9%), 18:0(13.6%) 18h:0(3.9%), 22h:0(9.9%) (Ref. 1191) LCB d18:1(85.6%), d18:0(5.2%), t18:1(7.8%) (Ref. 1191)	[1191]
290			NeuAc-Gal-3Gal-3Gal-Cer	GSG1290	Kazuo Nakamura																		Human brain (Ref. 1207)					[1207]
291			NeuAca2-3Galb1-4(Fuca1-3)GlcNAcb1-3Gala1-3Galb1-4Glcb1-1Cer	GSG1291	Kazuo Nakamura																		Salmon gill(Ref. 1494)					[1494]
292			NeuAca2-3Galb1-4(Fuca1-3)GlcNAcb1-3Gala1-3(GalNAcb1-4)Galb1-4Glcb1-1Cer	GSG1292	Kazuo Nakamura																		Salmon gill(Ref. 1494)					[1494]
293			NeuAca2-3GalNAcb1-3Gala1-4Galb1-4Glcb1-1Cer	GSG1293	Kazuo Nakamura																	TLC CMW 55:45:10 Ca2+ between GM3 and GM1	Human teratocarcinoma cell line, HT-E(833K) (Ref. 1192)					[1192]
294			NeuAca2-3Galb1-3GalNAcb1-3Gala1-3Galb1-4Glcb1-1Cer	GSG1294	Kazuo Nakamura																		Rat (Sprague-Dawley and a hooded strain (black-white)) small intestine (Ref. 1201)				d18:1-(16-24:0) d18:1-(16-24:0)	[1201]
295			NeuAca2-3Galb1-3GalNAcb1-4Galb1-4Glcb1-1Cer	GSG1295	Kazuo Nakamura	cis GM1, GM1b													1D-H(400MHz)(Ref. 1194)	(-)FABMS, comparison with GM1a(Ref. 1194)		TLC with CMW 50:45:10 Ca2+ slightly slower then GM1a (241)	ICR mouse spleen (Ref. 1193), human brain (whole)(Ref. 1194), rat ascite hepatoma cell lines (AH7974F) (Ref. 1195) tumor(Ref. 1089), human erythrocyte(Ref. 1090), rat ascites hepatoma cells (Ref. 1153), tumor(Ref. 1089), human erythrocyte(Ref. 1090), rat ascites hepatoma cells (Ref. 1153)				Fatty acids ICR mouse spleen, 24:1(33%), 16:0(15%) (Ref. 1193). Human brain, 18:0(81.4%) (Ref. 1194). 24:1(26.4%), 24:0(19.7%) (Ref. 1089) LCB Human brain, d18:1(7.6%), d20:1(40.0%) (Ref. 1194). d18:0(57.6%),d18:0(27.6%) (Ref. 1089)	[1089] / [1090] / [1153] / [1193] / [1194] / [1195]
296			Fuca1-2Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1296	Kazuo Nakamura	Fuc-GM1													400MHz 1D-H	Direct prove MS (Ref. 1097), GC/MS of PMAA (Ref. 1198), (-)FABMS(Ref. 1199), MALDI-TOFMS [Spectrum 0001] (T.Taketomi) Method (Ref. 3072)			N-2-Acetylaminofluorene-fed Fischer rat liver(Ref. 1196), rat hepatoma HTC and H35 cells, rat liver and hepatocyte (Ref. 1197), Bovine thyroid (Ref. 1198), PC-12 phenochromocytoma cells (Ref. 1199) Bovine liver (Ref. 1095), brain (Ref. 1156); Boar testis (Ref. 1157), pig adipose tissue (Ref. 1158)				Fatty acids Normal acids less than 10% , 16:0(45%), 2-hydroxy acids more than 90% , 16h:0(42%) 24:0(23.4%), 24:1(20.7%) (Ref. 1199)	[1095] / [1097] / [1156] / [1157] / [1158] / [1196] / [1197] / [1198] / [1199] / [3072]
297			Fuc1-3Gal1-3GalNAc1-4(NeuAc??-3)Gal1-4Glc1-1Cer	GSG1297	Kazuo Nakamura																		Pig adipose tissue (Ref. 1204)				Fatty acids 22:0(25%), 24:0(21%)	[1204]
298		Galactosylfucosyl-GM1	Gala1-3(Fuca1-2)Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1298	Kazuo Nakamura					Developmental change in rat stomach (251)													N-2-Acetylaminofluorene-fed Fischer rat liver and rat hepatoma (Ref. 1196); Rat stomach (Sprague-Dawley)(Ref. 1200)				Fatty acids Normal 22:0(15.3%), Hydroxy 24h:0(22.9%), 22h:0(12.8%) (Ref. 1200) LCB d18:1(23.7%), d20:0(55.2%) (Ref. 1200)	[1196] / [1200]
299			Fuca1-3GalNAcb1-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1299	Kazuo Nakamura																		Salmon kidney and gill (Ref. 1494)					[1494]
300			Galb1-3GalNAcb1-4GlcNAcb1-3Manb1-4GlcCer	GSG1300	Kazuo Nakamura																		(Ref. 1490)					[1490]
301			Galb?Gala?Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1301	Kazuo Nakamura																		Frog muscle
302			Gala1-3Galb1-3Gala1-3Galb1-3GalNAcb1-4(NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1302	Kazuo Nakamura																		Fat body of frog (Rana catesbeiana) (Ref. 1482)				Fatty acids C24:0(20%), C16:0(16%) (Ref. 1482)	[1482]
303			Fuca1-2Galb1-3GalNAcb1-4(NeuAca2-8NeuAca2-3)Galb1-4Glcb1-1Cer	GSG1303	Kazuo Nakamura														400MHz 1d-H(Ref. 1199)	(-)FABMS(Ref. 1199)			PC12 pheochromocytoma cells (Ref. 1199),Pig cerebellum (263), Miniature pig (type Gottingen) nervous tissues (Ref. 1208)				Fatty acids 24:0(21.8%), 22:0(19.4%) (Ref. 1199) 18:0(80.4%), 20:0(16%), d18:1(60%), d20:1(40%) (Ref. 1103) LCB d18:1(60%), d20:1(40%) (Ref. 1103)	[1103] / [1199] / [1208]
304			Methyl-O-3Galb1-3GalNAca1-3(2aminoethylphosphonyl-6Gala1-2)Galb1-4GlcCer	GSG1304	Kazuo Nakamura																		sea hare, Aplysia kurodai(Ref. 2050)					[2050]
305			NeuAca2-?GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1306	Kazuo Nakamura																		Human lymphocytes, neutrophils (Ref. 1210)					[1210]
306			NeuAca2-3GalNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1308	Kazuo Nakamura																		Human erythrocytes (Ref. 1214)					[1214]
307			Galb1-3(NeuAca2-6)GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1309	Kazuo Nakamura																		Human meconium (Ref. 1215), colorectal carcinoma (Ref. 1216), lung (Ref. 1217)					[1215] / [1216] / [1217]
308			NeuAca2-3Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1310	Kazuo Nakamura																		Human gastrrointestinal tumor (Ref. 1218), liver metastases of pancreatic adenocarcinoma (Ref. 1219/1220), lung (Ref. 1217)					[1217] / [1218] / [1219] / [1220]
309			NeuAca2-3Galb1-4GlcNAcb1-3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1312	Kazuo Nakamura																		Human erythrocytes(Ref. 1225/1226)					[1225] / [1226]
310			NeuAca2-3Galb1-4GlcNAcb1-3(Gala1-3(Fuca1-2)Galb1-4GlcNAcb6)Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1313	Kazuo Nakamura																		Human erythrocytes(Ref. 1226)					[1226]
311			NeuAca2-3Galb1-4GlcNAcb1-3(GlcNAca1-3(Fuca1-2)Galb1-4GlcNAcb6)Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1314	Kazuo Nakamura																		Human erythrocytes(Ref. 1226)					[1226]
312			NeuAca2-8NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1315	Kazuo Nakamura																		Adult bovine nasal cartilage(Ref. 1227)					[1227]
313			NeuAca2-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1316	Kazuo Nakamura																		Human erythrocytes(Ref. 1228); Rabbit skeltal muscle(Ref. 1229)					[1228] / [1229]
314			HSO3-?NeuGca2-6Glcb1-8NeuGca2-6Glcb1-1Cer	GSG1317	Kazuo Nakamura																		Echinocardium cordatum gonads(Ref. 1205)					[1205]
315			NeuGca2-6Glcb1-8NeuGca2-6Glcb1-1Cer	GSG1318	Kazuo Nakamura																		Echinocardium cordatum gonads(Ref. 1205)					[1205]
316			Ara?1-3Gal?1-3Gal?1-4NeuAca2-?Galb1-4Glcb1-1Cer	GSG1319	Kazuo Nakamura																		Hepatopancreas of starfish Patiria pectinifera(Ref. 1026)					[1026]
317			Ara?1-6Gal?1-3Gal?1-4NeuAca2-?Galb1-4Glcb1-1Cer	GSG1320	Kazuo Nakamura																		Hepatopancreas of starfish Patiria pectinifera(Ref. 1026)					[1026]
318			Ara?1-6Gal?1-3(m8)NeuGca2-3Galb1-4Glcb1-1Cer	GSG1321	Kazuo Nakamura																		Starfish Asterina pectinifera (whole tissue)(Ref. 1247/1248/1249)					[1247] / [1248] / [1249]
319			Ara?1-6Gal?1-3NeuGca2-3Galb1-4Glcb1-1Cer	GSG1322	Kazuo Nakamura																		Starfish Asterina pectinifera (whole tissue) (Ref. 1247/1248/1249)					[1247] / [1248] / [1249]
320			Ara?1-6Gal?1-3(Gal?1-6)NeuGca2-3Galb1-4Glcb1-1Cer	GSG1323	Kazuo Nakamura																		Starfish Asterina pectinifera (whole tissue)(Ref. 1248)					[1248]
321			HSO3-3Gal?1-4Galb1-4GlcCer	GSG1327	Kazuo Nakamura																		Porcine gastric mucosa(Ref. 1246)					[1246]
322			Gala1-4Galb1-4GlcCer	GSG1328	Kazuo Nakamura					Pk blood group activity(Ref. 1496)													Tissues of Fabry's disease(Ref. 1250/1256), most external tissues (Ref. 1257/1258). Normal human Kidney tissue, Fabry's disease patient kidney tissue. (Ref. 5081) Human erythrocyte and hamster fibloblast. (Ref. 5080)					[1250] / [1256] / [1257] / [1258] / [1496] / [5080] / [5081]
323			GlcNAcb1-3Gala1-4Galb1-4GlcCer	GSG1330	Kazuo Nakamura																		Human meconium(Ref. 1260)					[1260]
324		Isoglobotriglycosylceramide	Gala1-3Galb1-4GlcCer	GSG1331	Kazuo Nakamura																		Rat intestine(Ref. 1201), spleen(Ref. 1261), Rat spleen microsome (Ref. 5087)					[1201] / [1261] / [5087]
325		asialo-GM2, GA2, Tay-Sachs globoside	GalNAcb1-4Galb1-4GlcCer	GSG1332	Kazuo Nakamura																		Guinea pig erythrocytes (Ref. 1262/1263); Tissue of Tay Sachs' disease (Ref. 1137/1264/1265/1266/1267)					[1137] / [1262] / [1263] / [1264] / [1265] / [1266] / [1267]
326			GalNAc?1-4(HSO3-3)Gal?1-4GlcCer	GSG1333	Kazuo Nakamura																		Rat kidney<<>>
327			Glcb1-4GlcCer	GSG1334	Kazuo Nakamura																		(Ref. 1489)					[1489]
328			GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1335	Kazuo Nakamura																		Murine leukemia cells M1(Ref. 1268)					[1268]
329			SO3-6GlcNAcb1-3Galb1-4GlcCer	GSG1336	Kazuo Nakamura	III6SO3-Lc3Cer																	Hog gastric mucosa(Ref. 1269)					[1269]
330		Para-Forssman x3b	GalNAcb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1338	Kazuo Nakamura																		Human erythrocytes(Ref. 1270/1271)					[1270] / [1271]
331		Branched Forssman	GalNAca1-3GalNAcb1-3(Galb1-3GalNAcb1-4)Gala1-4Galb1-4GlcCer	GSG1339	Kazuo Nakamura																		Dog gastric mucosa(Ref. 1272)					[1272]
332			HSO3-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1342	Kazuo Nakamura																		Mouse small intestine(Ref. 1273/1202); Rat kidney(Ref. 1274)					[1202] / [1273] / [1274]
333			Glcb1-6GlcCer	GSG1343	Kazuo Nakamura																		(Ref. 1498)					[1498]
334			Gala1-3Galb1-4GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1345	Kazuo Nakamura	II3GalNAcb, IV3Gala-nLc4Cer																	Murine leukimia cells M1(Ref. 1275)					[1275]
335			HSO3-3GlcUb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1346	Kazuo Nakamura																		Human cauda equina tissure(Ref. 1276), Human peripheral nerve(Ref. 1277)					[1276] / [1277]
336			Galb1-4(HSO3-6)GlcNAcb1-3Galb1-4GlcCer	GSG1347	Kazuo Nakamura																		Hog gastric mucosa (Ref. 1278)					[1278]
337			Galb1-4GlcNAcb1-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1348	Kazuo Nakamura	VI3(Galb1-4GlcNAcb)-Lc4Cer																	Human meconium (Ref. 1378/1379)					[1378] / [1379]
338			SO3-3GlcUb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1349	Kazuo Nakamura																		Human cauda equina tissue(Ref. 1276)					[1276]
339			Gala1-3Galb1-4GlcNAcb1-3(Gala1-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1350	Kazuo Nakamura																		Rabbit erythrocyte (Ref. 1380)					[1380]
340			Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1351	Kazuo Nakamura																		Human granulocytes (Ref. 1381)					[1381]
341			Fuca1-1Cer	GSG1352	Kazuo Nakamura																		Human colon carcinoma (Ref. 1382)					[1382]
342			Fuca1-2Galb1-4GlcCer	GSG1353	Kazuo Nakamura																		Rat intestine (Ref. 1383), murine B cell hybridomas (Ref. 1384)					[1383] / [1384]
343			GalNAca1-3(Fuca1-2)Galb1-4GlcCer	GSG1354	Yasushi Kawakami																		Rat small intestine (Ref. 1310)					[1310]
344			9-O-Acetyl-NeuAca2-8NeuAca2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1355	Yasushi Kawakami	9-O-Acetyl GD1b				Recogonized by serum antibodies in Guillain-Barre syndrome(Ref. 1492)													bovine brain (Ref. 1492)					[1492]
345			Gala1-3(Fuca1-2)Galb1-4GlcCer	GSG1356	Yasushi Kawakami																		Rat large intestine (Ref. 1319)					[1319]
346			Fuca1-2Gala1-3Gala1-4Galb1-4GlcCer	GSG1357	Yasushi Kawakami																		Rat intestine (Ref. 1300);PC 12h pheochromocytoma cells(Ref. 1301)					[1300] / [1301]
347	No image		GalNAca1-3(Fuca1-2)Gal?1-3Gal?1-4GlcCer	GSG1358	Yasushi Kawakami																		Hog gastric mucosa (Ref. 1313)					[1313]
348			Fuca1-cGalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1359	Yasushi Kawakami																		Human teratocarcinoma (Ref. 1192)					[1192]
349			Fuca1-2Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1360	Yasushi Kawakami																		Human mammary gland (Ref. 1315), erythrocytes (Ref. 1316), meconium (Ref. 1260), teratocarcinoma cells (Ref. 1303)					[1260] / [1303] / [1315] / [1316]
350			GalNAca1-3(Fuca1-2)Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1361	Yasushi Kawakami																		Human kidney (Ref. 1317), erythrocytes (Ref. 1318)					[1317] / [1318]
351			GalNAca1-3GalNAcb1-3(Fuca1-2Galb1-3GalNAcb1-4)Gala1-4Galb1-4GlcCer	GSG1362	Yasushi Kawakami					Forsmann active, blood group A and H active													Dog gastric mucosa (Ref. 1319)					[1319]
352			Galb1-3(Galb1-4(Fuca1-3)GlcNAcb1-6)GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1363	Yasushi Kawakami																		Mouse kidney (Ref. 1305)					[1305]
353			Gala1-3(Fuca1-2)Galb1-3GalNAcb1-3Gala1-3Galb1-4GlcCer	GSG1364	Yasushi Kawakami																		Rat gastric mucosa (Ref. 1320)					[1320]
354			Gala1-3(Fuca1-2)Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1365	Yasushi Kawakami																		Rat gastric mucosa (Ref. 1320), bone marrow, spleen, thymus, ascites hepatoma cells (AH7974F) (Ref. 1322)					[1320] / [1322]
355			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3GalCer	GSG1368	Yasushi Kawakami					Blood group A active													Human erythrocytes (Ref. 1334), pancreas (Ref. 1335), lung (Ref. 1336); Dog intestine (Ref. 1337)					[1334] / [1335] / [1336] / [1337]
356			Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1369	Yasushi Kawakami					Blood group A active													Human erythrocytes (Ref. 1116)					[1116]
357			Gala1-3(Fuca1-2)Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1370	Yasushi Kawakami																		Rabbit intestine (Ref. 1339). Human gastric carcinoma (Ref. 1479). Rat large intestine (Ref. 1341)					[1339] / [1341] / [1479]
358			Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1371	Yasushi Kawakami																		Human erythrocytes (Ref. 1324)					[1324]
359			Gala1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1372	Yasushi Kawakami	Gala1-3Le^x																	pig kidney(Ref. 1493)					[1493]
360			Fuca1-2Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1373	Yasushi Kawakami																		Human erythrocytes (Ref. 1344)					[1344]
361			GalNAca1-3(Fuca1-2)Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1374	Yasushi Kawakami																		Human erythrocytes (Ref. 1334)					[1334]
362			Fuca1-2Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1375	Yasushi Kawakami																		Human small intestine(Ref. 1346),pancreas(Ref. 1347),meconium(Ref. 1307);Rat intenstine(Ref. 1300)					[1300] / [1307] / [1346] / [1347]
363			Fuca1-2Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1376	Yasushi Kawakami																		Human intestine(Ref. 1328/1335/1346/1352), erythrocytes(Ref. 1353)					[1328] / [1335] / [1346] / [1352] / [1353]
364			GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1377	Yasushi Kawakami																		Rat intestine(Ref. 1310); Human pancreas(Ref. 1335), erythrocytes(Ref. 1354), plasma(Ref. 1355)					[1310] / [1335] / [1354] / [1355]
365			Fuca1-2Galb1-4GlcNAcb1-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1378	Yasushi Kawakami																		Human meconium(Ref. 1307)					[1307]
366			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-3GlcNAcb1-4Galb1-4GlcCer	GSG1379	Yasushi Kawakami																		Human meconium(Ref. 1307)					[1307]
367			GalNAca1-3(Fuca1-2)Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1380	Yasushi Kawakami																		Human intestine(Ref. 1328/1335/1346),erythrocytes(Ref. 1354)					[1328] / [1335] / [1346] / [1354]
368			Gala1-3(Fuca1-2)Galb1-3(Fuca1-4)GlcNAcb1-3Galb1-4GlcCer	GSG1381	Yasushi Kawakami																		Human intestine(Ref. 1335/1356)					[1335] / [1356]
369			Fuca1-2Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1382	Yasushi Kawakami																		Human meconium(Ref. 1307)					[1307]
370			Gala1-3(Fuca1-2)Galb1-3GalNAcb1-3Galb1-4GlcCer	GSG1384	Yasushi Kawakami																		Rat granuloma and macrophage(Ref. 1306)					[1306]
371			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(GalNAca1-3Galb1-6)Galb1-4Galb1-4GlcCer	GSG1385	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1360)					[1360]
372			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1388	Yasushi Kawakami																		Human colonic and liver carcinoma(Ref. 1364),granulocytes(Ref. 1308)					[1308] / [1364]
373			Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1389	Yasushi Kawakami																		Human erythrocytes(Ref. 1325)					[1325]
374			GalNAca1-3(Fuca1-2)Galb1-4JB3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1390	Yasushi Kawakami																		Human erythrocytes(Ref. 1333)					[1333]
375			Fuca1-2Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1392	Yasushi Kawakami																		Human erythrocytes(Ref. 1309)					[1309]
376			Fuca1-2Galb1-4GlcNAcb1-3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1393	Yasushi Kawakami																		Human erythrocytes(Ref. 1333/1361/1365)					[1333] / [1361] / [1365]
377			GalNAca1-3(Fuca1-2)Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1394	Yasushi Kawakami																		Human erythrocytes(Ref. 1334)					[1334]
378			Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-3(Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3GalCer	GSG1395	Yasushi Kawakami																		Human erythrocytes(Ref. 1366)					[1366]
379			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3(GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1396	Yasushi Kawakami																		Human erythrocytes(Ref. 1333/1334/1367)					[1333] / [1334] / [1367]
380			Fuca1-2Galb1-3GlcNAcb1-3(Fuca1-2Galb1-3GlcNAcb1-6)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1397	Yasushi Kawakami																		Rat intestine(Ref. 1368)					[1368]
381			Fuca1-2Galb1-3GlcNAcb1-3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1398	Yasushi Kawakami																		Rat intestine(Ref. 1368)					[1368]
382			GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-3(GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-6)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1399	Yasushi Kawakami																		Rat intestine(Ref. 1369)					[1369]
383			GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-3(GlcNAcca1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-3GlcNAcb1-3Galb1-4GlcCer	GSG1400	Yasushi Kawakami																		Rat intestine(Ref. 1369)					[1369]
384			HSO₃-3Gal?1-4Gal?1-4GlcCer	GSG1401	Yasushi Kawakami																		Hog stomach mucosa (Ref. 1246)					[1246]
385			Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1402	Yasushi Kawakami																		Human erythrocytes(Ref. 1362),granulocytes(Ref. 1308)					[1308] / [1362]
386			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1403	Yasushi Kawakami																		Human erythrocytes(Ref. 1334)					[1334]
387			Fuca1-2Galb1-4GlcNAcb1-3Galb1-4GalNAcb3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1405	Yasushi Kawakami																		Human erythrocytes(Ref. 1367)					[1367]
388			Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3(Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1406	Yasushi Kawakami																		Human erythrocytes(Ref. 1366)					[1366]
389			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3(GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1407	Yasushi Kawakami																		Human erythrocytes(Ref. 1334/1367)					[1334] / [1367]
390			Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4Galb1-4(Gala1-3(Fuca1-2)Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1408	Yasushi Kawakami																		Human erythrocytes(Ref. 1366)					[1366]
391			Fuca1-2Galb1-4GlcNAcb1-3(Fuca1-2Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1409	Yasushi Kawakami																		Human erythrocytes(Ref. 1370/1371)					[1370] / [1371]
392			Kc3(Fuca1-2)Gal?1-4GlcNAc?1-3(Fc2Gal?1-4GlcNAcb1-6)Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcNAc?1-3Gal?1-4GlcCer	GSG1410	Yasushi Kawakami																		Human erythrocytes(Ref. 1372)					[1372]
393			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(GlcNAcca1-3Galb1-6)Galb1-4GlcCer	GSG1411	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1360)					[1360]
394			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(GlcNAcca1-4Galb1-6)Galb1-4GlcCer	GSG1412	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1360)					[1360]
395			GlcNAcca1-3(Fuca1-2)Gal?1-4(GlcNAcca1-3(Fuca1-2)Gal?1-4GlcNAc?1-6)GlcNAc?1-3(GlcNAc?1-4GlcNAc?1-4)Gal?1-4GlcNAc?1-4(GlcNAc?1-4Gal?1-4GlcNAc?1-6)GlcNAc?1-3HC4GlcCer	GSG1413	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1373)					[1373]
396			GlcNAcca1-3(Fuca1-2)Gal?1-4GlcNAc?1-3(GlcNAc?1-4GlcNAc?1-6)Gal?1-4GlcNAc?1-4GlcNAc?1-3(GlcNAc?1-6)Gal?1-4GlcCer	GSG1414	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1360)					[1360]
397			GalNAca1-3(Fuca1-2)Galb1-3GlcNAcb1-3Galb1-4Galb1-4GlcCer	GSG1415	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1374)					[1374]
398			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4Galb1-4GlcCer	GSG1416	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1374)					[1374]
399			GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3(Fuca1-2Galb1-3/4GlcNAcb1-6)Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-3/6(Galb1-4GlcNAcb1-3/6)Galb1-4GlcNAcb1-6)Galb1-4Galb1-4GlcCer	GSG1417	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1375)					[1375]
400			GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3(Fuca1-2Galb1-3/4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4Galb1-4GlcCer	GSG1418	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1376)					[1376]
401			GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3(Fuca1-2Galb1-3/4GlcNAcb1-6)Galb1-4GlcNAcb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1419	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1376)					[1376]
402			GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3(Fuca1-2Galb1-3/4GlcNAcb1-6)Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4Galb1-4GlcCer	GSG1420	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1376)					[1376]
403			GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3(Fuca1-2Galb1-3/4GlcNAcb1-6)Galb1-4GlcNAcb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6) Galb1-4GlcCer	GSG1421	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1376)					[1376]
404			GalNAca1-3(Fuca1-2)Galb1-4Galb1-3(Galb1-6)Galb1-4GlcCer	GSG1422	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1377)					[1377]
405			Fuca1-2Galb1-3/4GlcNAcb1-6(GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3)Galb1-4GlcNAcb1-4GlcNAcb1-3/6(GalNAca1-3(Fuca1-2)Galb1-3/4GlcNAcb1-3)(Galb1-4GlcNAcb1-6)(Galb1-4GlcNAcb1-3/6)Galb1-4GlcCer	GSG1424	Yasushi Kawakami																		Hog gastric mucosa(Ref. 1378)					[1378]
406			NeuGca2-3Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Glcb1-1Cer	GSG1428	Kazuo Nakamura																		(Ref. 1223)bovine erythrocyte(Ref. 1224)Marek's disease lymphoma-derived chicken cell line, MSB1(Ref. 1230)					[1223] / [1224] / [1230]
407			Galb1-3(GlcNAcb1-6)GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1429	Kazuo Nakamura																		mouse kidney(Ref. 1231/1232)					[1231] / [1232]
408			Galb1-3(Galb1-4GlcNAcb1-6)GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG1430	Kazuo Nakamura																		mouse kidney(Ref. 1231)					[1231]
409			GalNAcb1-3Gala1-3Gala1-3Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1432	Kazuo Nakamura
410			GalNAcb1-3Gala1-3Gala1-3Gala1-3Gala1-3Gala1-3Gala1-4Galb1-4GlcCer	GSG1433	Kazuo Nakamura																		Rat intestine(Ref. 1233)					[1233]
411			GalNAcb1-3Gala1-3Gala1-3Galb1-4GlcCer	GSG1434	Kazuo Nakamura																		Rat intestine(Ref. 1233)					[1233]
412			Galb1-4GlcNAcb1-3Galb1-4(Fuca1-3)GlcNAcb1-3Galb1-4GlcCer	GSG1435	Kazuo Nakamura					Monoclonal antibody ACFH-18													Human gastrointesinal adenocarcinoma and human gastric cancer cell MKN74 (Ref. 1480)					[1480]
413			GalNAca1-3Galb1-4GlcNAcb1-3(Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1436	Kazuo Nakamura																		(Ref. 1442)					[1442]
414			Fuca1-3GalNAcb1-3Gala1-3Galb1-4GlcNAcb1-3(GalNAcb1-4)Galb1-4GlcCer	GSG1437	Kazuo Nakamura																		liver of the English sole (Parophrys vetulus) (Ref. 1481)					[1481]
415			GalNAca1-3(Fuca1-2)Galb1-4GlcNAcb1-3Galb1-4GlcNAcb1-3Galb1-4Galb1-4GlcCer	GSG1438	Kazuo Nakamura																		Human erythrocytes (Ref. 1442)					[1442]
416			Galb1-4GlcNAcb1-3Galb1-3GalNAcb1-4(NeuGca2-3)Galb1-4GlcCer	GSG1439	Kazuo Nakamura																		Rat spleen (Ref. 1234)					[1234]
417			Gala1-3Galb1-4GlcNAcb1-3Galb1-3GalNAcb1-4(NeuGca2-3)Galb1-4GlcCer	GSG1440	Kazuo Nakamura																		Rat spleen(Ref. 1234)					[1234]
418			NeuAca2-8NeuAca2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1441	Kazuo Nakamura	(GD1c)																	Spontaneous murine thymoma (Ref. 1235)					[1235]
419			NeuGca2-8NeuGca2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1442	Kazuo Nakamura																		WHT/Ht Mouse thymoma and thymocytes (Ref. 1236)					[1236]
420			NeuGca2-8NeuAca2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1443	Kazuo Nakamura																		WHT/Ht mouse thymoma and thymocytes(Ref. 1236)					[1236]
421			NeuAca2-8NeuGca2-3Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG1444	Kazuo Nakamura																		WHT/Ht Mouse thymoma and thymocytes (Ref. 1236)					[1236]
422			NeuAca2-3Galb1-4GlcNAcb1-3(NeuAca2-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3(NeuAca2-3Galb1-4GlcNAcb1-6)Galb1-4GlcNAcb1-3Galb1-4GlcCer	GSG1446	Kazuo Nakamura																		Human colonic adenocarcinoma (Ref. 1459)					[1459]
423			Glucosylb-N-(w-O-acyl)-acylsphingosine	GSG1447	Kazuo Nakamura					Epidermosides are markers for keratinocytes (Ref. 1484)									1H NMR (500MHz) (Ref. 1484)	(-)FAB-MS (Ref. 1484)			Cultured human keratinocytes (Ref. 1484)				Fatty acids 14:1(21.9%), 16:0(4.0%), 16:1(22.1%), 18:0(1.7%), 18:1(31.9%), 18:2(18.4%) w-hydroxy fatty acid 30h:0, 30h:1, 32h:1, 34h:1 (Ref. 1484) d18:1 (Ref. 1484)	[1484]
424			GalNAcb1-4(NeuAca2-3)Galb1-4GlcNAcb1-6(GalNaca1-3GalNAcb1-3Gala1-3)Galb1-4GlcCer	GSG1448	Kazuo Nakamura					Forssman active(Ref. 1495)									2D-HOHAHA, 2D-ROESY(Ref. 1495)	Positive MALDI TOF-MS (native and methylated samples) Negative SIMS (ceramides)(Ref. 1495)			Equine kidney(Ref. 1495)				Fatty Acids C20h:0,C23h:0,C24h:0,C25h:0(Ref. 1495) LCB hydroxysphinganine(Ref. 1495) hybrid of isoglobo-, ganglio- and neolacto-series(Ref. 1495)	[1495]
425	No image		NeuAc2-8NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-3)Galb1-4GlcCer	GSG1449	Kazuo Nakamura	GQ1aa														MALDI-TOF(+)(permethylated sample) (Ref. 1497)		TLC (Ref. 1497)	skate (cartilaginous fish), Bathyraja smirnovi (Ref. 1497)					[1497]
426	No image		NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-8NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1450	Kazuo Nakamura	GP1ca				Neuritogenic activity (Ref. 1497)										MALDI-TOF(+)(permethylated sample) (Ref. 1497)		TLC (Ref. 1497)	skate (cartilaginous fish), Bathyraja smirnovi (Ref. 1497)					[1497]
427	No image		NeuAca2-8NeuAc2-3Galb1-3(NeuAc2-6)GalNAcb1-4(NeuAc2-8NeuAc2-8NeuAc2-3)Galb1-4GlcCer	GSG1451	Kazuo Nakamura	GH1ca														MALDI-TOF(+)(permethylated sample) (Ref. 1497)		TLC (Ref. 1497)	skate (cartilaginous fish), Bathyraja smirnovi (Ref. 1497)					[1497]
428			Manb1-4Glcb1-1Cer	GSG2001	Mutsumi Sugita											C-M(2:1)							Corbicula sandai(Ref. 2022), Lucilia caesar(Ref. 2023), Hyriopsis schlegelii (Ref. 2024), Meretrix lusoria(Ref. 2025), Euphausia superba (antarctic krill) (Ref. 2064), Macrobrachium nipponense (fresh-water shrimp) (Ref. 2064), Ascaris suum (porcine roundworm) (Ref. 2066)				Fatty acids L.caesar, 16:0(11.5%), br-16:0(1.7%), 18:0(16.2%), br-18:0(2.6%), 19:0(2.5%), 20:0(49.8%), 22:0(15.7%) (Ref. 2023) Ascaris suum (porcine roundworm) 16:0(4.3%), 18:0(3.3%), 22:0(8.6%), 21h:0(3.1%), 22h:0(9.7%), 23h:0(4.8%), 24h:0(66.2%) (Ref. 2066) LCB L.caesar, d14:1(84.2%), d16:1(15.8%) (Ref. 2023) Ascaris suum (porcine roundworm), br-d17:1(37.1%), br-d17:0(62.9%) (Ref. 2066)	[2022] / [2023] / [2024] / [2025] / [2064] / [2066]
429			Mana1-4Manb1-4Glcb1-1Cer	GSG2002	Mutsumi Sugita											C-M(2:1)							Corbicula sandai(fresh-water bivalves)(Ref. 2022/5094)					[2022] / [5094]
430			GlcNAcb1-2Mana1-3Manb1-4Glcb1-1Cer	GSG2003	Mutsumi Sugita											C-M(1:1)							Hyriopsis schlegelii(Ref. 2026) Meretrix lusoria(Ref. 2025)				Fatty acids H.schlegelii, 16:0(22.7%), 17:0(8.3%), 18:0(51.8%), 19:0(6.4%), 20:0(8.5%), 21:0(2.3%) LCB H.schlegelii, d18:1(97%), iso-d18:1(3%)	[2025] / [2026]
431			b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-2)a-MANNOSYL(1-3)[b-XYLOSYL(1-2)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2004	Mutsumi Sugita											C-M(1:1)							Hyriopsis schlegelii(Ref. 2027) Meretrix lusoria(Ref. 2025)				Ceramides H.schlegelii, 16:0(20.5%), 17:0(5.3%), 18:0(52.5%), 19:0(6.7%), 20:0(9.8%), 21:0(2.3%). 22:0(2.8%); LCB d18:1(97%), iso-d18:1(3%)	[2025] / [2027]
432			b-4-O-METHYLGALACTOSYL(1-3)b-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-3)a-FUCOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-2)a-MANNOSYL(1-3)[a-XYLOSYL(1-2)][2'-AMINOETHYLPHOSPHORYL(-6)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2005	Mutsumi Sugita											C-M-W(6:4:1)							Corbicula sandai(Ref. 2028)					[2028]
433			a-MANNOSYL(1-3)[b-XYLOSYL(1-2)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2006	Mutsumi Sugita											C-M(1:1)							Hyriopsis schlegelii(Ref. 2029)				Fatty acids 14:0(0.4%), 15:0(0.5%), 16:0(12.2%), 17:0(1.7%), 18:0(20.1%), 19:0(7.5%), 20:0(22.8%), 21:0(3.3%), 22:0(12.5%), 23:0(10.5%), 24:0(8.6%) (Ref. 2029) d17:1(2.5%), d18:1(68.7%), iso-d18:1(5.2%), d19:1(8.0%), iso-d19:1(3.0%), anteiso-d19:1(12.6%) (Ref. 2029)	[2029]
434			a-3-O-METHYLFUCOSYL(1-2)b-3-O-METHYLXYLOSYL(1-4)[a-3-O-METHYL-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-3)]a-FUCOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-2)a-MANNOSYL(1-3)[b-XYLOSYL(1-2)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2007	Mutsumi Sugita											C-M(1:1)			Proton (Ref. 2030)				Hyriopsis schlegelii(Ref. 2030) Meretrix lusoria(Ref. 2025)				Fatty acids 14:0(1.0%), 15:0(3.5%), 16:0(23.2%), 17:0(5.3%), 18:0(53.7%), 19:0(6.4%), 20:0(6.5%), 21:0(1.1%) d18:1(96.8%), iso-d18:1(3.2%)	[2025] / [2030]
435			b-4-O-METHYLGLUCURONYL(1-4)[a-3-O-METHYL-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-3)]a-FUCOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-2)a-MANNOSYL(1-3)[ bXYLOYL(1-2)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2008	Mutsumi Sugita					Immunohistochemical studies indicated the existence on the cell surface of Hyriopsis spermatozoa.Specific distribution may provide clues to understanding of the molecular basis of the recognition between the spermatozoa and eggs in fertiligation.(Ref. 0032)						C-M-W(6:4:1), water			Proton(Ref. 2031)				Hyriopsis schlegelii(Ref. 2031) Meretrix lusoria(Ref. 2025)				Fatty acids 14:0(0.6%), 15:0(0.4%), 16:0(18.0%), 17:0(5.1%), 18:0(41.3%), 19:0(3.5%), 20:0(6.0%), 21:0(2.6%), 22:0(13.1%), 23:0(3.6%), 24:0(4.7%) d18:1(97.2%), iso-d18:1(2.8%)	[0032] / [2025] / [2031]
436			b-4-METHYLGALACTOSYL(1-3)b-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-3)aFUCOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-2)a-MANNOSYL(1-3)[a-XYLOSYL(1-2)bMANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2009	Mutsumi Sugita											C-M-W(6:4:1), water			Proton				Corbicula sandai(Ref. 2033)					[2033]
437			b-MANNOSYL(1-2)b-MANNOSYL(1-1)CERAMIDE	GSG2010	Mutsumi Sugita											C-M(2:1)							Hyriopsis schlegelii(Ref. 2024)					[2024]
438			a-MANNOSYL(1-3)b-MANNOSYL(1-2)b-MANNOSYL(1-1)CERAMIDE	GSG2011	Mutsumi Sugita											C-M(2:1)							Hyriopsis schlegelii(Ref. 2024)					[2024]
439			a-MANNOSYL(1-3)b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2012	Mutsumi Sugita											C-M(2:1)							Hyriopsis schlegelii(Ref. 2029/2024) Meretrix lusoria(Ref. 2025)					[2024] / [2025] / [2029]
440			a-MANNOSYL(1-3)[b-GALACTOSYL(1-2)]b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2013	Mutsumi Sugita											C-M(1:1), C-M-W(6:4:1)							Hyriopsis schlegelii (ova) (Ref. 2035)					[2035]
441			a-GALACTOSYL(1-3)b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2014	Mutsumi Sugita											C-M(2:1)							Meretrix lusoria(Ref. 2025)					[2025]
442			ARABINOSYL(1-6)b-GALACTOSYL[b-GALACTOSYL(1-8)]N-GLYCOLYLNEURAMINYL(2-3)b-GALACTOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2015	Mutsumi Sugita											C-M-W(30:60:8), Folch supernatant		1640,1540cm^-¹(AMIDE LINKAGE), 1000-1100cm^-¹(ALCOHOLIC OH) (Ref. 2036)					Asterina pectinifera(Ref. 2036)				Fatty acids 14:0(2.0%), 16:0(6.0%), 17:0(1.2%), 18:0(2.8%), 19:0(0.6%), 20:0(1.2%), 21:0(2.8%), 22:0(47.8%), 23:0(24.5%), 24:0(11.1%) iso-t16:0(7.2%), t16:0(15.3%), iso-t17:0(28.8%), anteiso-t17:0(13.4%), t17:0(5.3%), iso-t18:0(16.1%), anteiso-t18:0(5.8%), t18:0(8.1%)	[2036]
443			b-ARABINOSYL(1-6)b-GALACTOSYL(1-4)8-O-METHYL-N-GLYCOLYLNEURAMINYL(2-3)b-GALACTOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2016	Mutsumi Sugita											C-M-W(30:60:8), Folch supernatant							Asterina pectinifera(Ref. 2037), Star fish (Asterina pectinifera)<1168>					[2037]
444			b-ARABINOSYL(1-6)b-GALACTOSYL(1-4)N-GLYCOLYLNEURAMINYL(2-3)b-GALACTOSYL (1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2017	Mutsumi Sugita											C-M-W(30:60:8), Folch supernatant							Asterina pectinifera(Ref. 2037), Star fish (Asterina pectinifera)<1168>					[2037]
445			GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2018	Mutsumi Sugita											C-M(1:1)		1540,1645cm^-¹(AMIDE LINKAGE), 3300cm^-¹(FREE OH) (Ref. 2023)					Lucilia caesar(Ref. 2023), Macrobrachium nipponense (fresh-water shrimp) (Ref. 2065), Euphausia superba (antarctic krill) (Ref. 2065), Ascaris suum (porcine roundworm) (Ref. 2066)				Fatty acids Lucilia caesar, 16:0(14.2%), br-16:0(1.1%), 18:0(18.6%), br-18:0(2.4%), 19:0(4.9%), 20:0(41.2%), 22:0(17.6%) (Ref. 2023) Macrobrachium nipponense (fresh-water shrimp) 16:0(5.1%), 18:0(3.8%), 22:0(11.0%), 21h:0(1.9%), 22h:0(6.0%), 23h:0(3.8%), 24h:0(68.4%) (Ref. 2065) Ascaris suum(porcine roundworm) 16:0(5.1%), 18:0(3.8%), 22:0(11.0%), 21h:0(1.9%), 22h:0(6.0%), 23h:0(3.8%), 24h:0(68.4%) (Ref. 2066) LCB Lucilia caesar, d14:1(83.4%), d16:1(16.6%) (Ref. 2023) Macrobrachium nipponense (fresh-water shrimp) br-d17:1(32.8%), br-d17:0(67.2%) (Ref. 2065)	[2023] / [2065] / [2066]
446			b-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-3) b-MANNOSYL(1-4)b-GLUCOSYL(1-1)CERAMIDE	GSG2019	Mutsumi Sugita											C-M(1:1)		1540,1645cm^-¹(AMIDE LINKAGE), 3300cm^-¹(FREE OH) (Ref. 2023)					Lucilia caesar (Ref. 2023), Ascaris suum (porcine roundworm) (Ref. 2066)				Fatty acids Lucilia caesar 16:0(9.2%), br-16:0(1.6%), 18:0(13.1%), br-18:0(3.1%), 19:0(3.8%), 20:0(50.7%), 22:0(18.5%) (Ref. 2023) Ascaris suum 16:0(2.2%), 18:0(1.7%), 22h:0(10.6%), C23h:0(5.8%), C24h:0(79.7%) (Ref. 2066) LCB Lucilia caesar d14:1(82.3%), d16:1(17.7%) (Ref. 2023) Ascaris suum br-d17:1(33.6%), br-d17:0(66.4%) (Ref. 2066)	[2023] / [2066]
447			a-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GALACTOSYL(1-4)b-2-ACETAMIDE-2-DEOXY-GLUCOSYL(1-3)b-MANNOSYL(1-4)b-GLUCOSYL(1-1) CERAMIDE	GSG2020	Mutsumi Sugita											C-M(1:1)							Lucilia caesar (Ref. 2038)				Fatty acids 16:0(4.0%), 18:0(15.0%), 19:0(7.0%), 20:0(55.0%), 21:0(3.0%), 22:0(16.0%) (Ref. 2038) LCB d14:1(82.5%), d16:1(17.5%) (Ref. 2038)	[2038]
448			GlcUb1-3Galb1-3GalNAca1-4GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2021	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2057)				Fatty acids 16:0(6.3%), 18:0(12.4%), 20:0(53.1%), 22:0(23.0%), 24:0(5.2%) (Ref. 2057) LCB d14:1(81.8%), d16:1(18.2%) (Ref. 2057)	[2057]
449			GlcUb1-3Galb1-3GalNAca1-4GalNAcb1-4(ethanolamine-P-6)GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2022	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2057)				Fatty acids 16:0(6.9%), 18:0(13.3%), 20:0(51.3%), 22:0(22.4%), 24:0(6.1%) (Ref. 2057) LCB d14:1(80.6%), d16:1(19.4%) (Ref. 2057)	[2057]
450			GalNAcb1-3GlcNAcb1-3Galb1-3GalNAca1-4GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2023	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2058)				Fatty acids 16:0(2.6%), 18:0(18.9%), 19:0(5.1%), 20:0(53.9%), 21:0(3.3%), 22:0(16.2%) (Ref. 2058) LCB d14:1(70.6%), d16:1(29.4%) (Ref. 2058)	[2058]
451			Galb1-3GalNAcb1-3GlcNAcb1-3Galb1-3GalNAca1-4GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1Cer	GSG2024	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2058)				Fatty acids 16:0(2.1%), 18:0(20.3%), 19:0(4.7%), 20:0(54.6%), 21:0(3.7%), 22:0(14.6%) (Ref. 2058) LCB d14:1(70.4%), d16:1(29.6%) (Ref. 2058)	[2058]
452			6'-O-(N-methyl-2-aminoethylphosphonyl)Glcb1-1ceramide	GSG2025	Mutsumi Sugita																		Euphausia superba (antarctic krill) (Ref. 2059)				Fatty acids 22:0(3.0%), 22:1(17.4%), 22h:1(37.7%), 24:0(2.0%), 24:1(10.5%), 24h:1(23.8%), unidentified(5.6%) (Ref. 2059) LCB d14:1(17.4%), br-d18:3(24.3%), d18:3(48.2%), unidentified(10.1%) (Ref. 2059)	[2059]
453			2'-aminoethylphosphoryl-6GlcNAcb1-3Manb1-4Glcb1-1Ceramide	GSG2026	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2060)				Fatty acids 20:0 (Ref. 2060) LCB d14:1 (Ref. 2060)	[2060]
454			GalNAcb1-4(2'-aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2027	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2060)				Fatty acids 20:0 (Ref. 2060) LCB d14:1 (Ref. 2060)	[2060]
455			GalNAca1-4GalNAcb1-4(2'-aminoethylphosphoryl-6GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2028	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2060)				Fatty acids 20:0 (Ref. 2060) LCB d14:1 (Ref. 2060)	[2060]
456			Galb1-3GalNAca1-4GalNAcb1-4(2'-aminoethylphosphoryl-6)GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2029	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2060)				Fatty acids 20:0 (Ref. 2060) LCB d14:1 (Ref. 2060)	[2060]
457			GlcNAcb1-3Galb1-3GalNAcla1-4GalNAclb1-4(2'-aminoethylphosphoryl-6)GlcNAclb1-3Manlb1-4Glclb1-1ceramide	GSG2030	Mutsumi Sugita																		Lucilia caesar (green-bottle fly) (Ref. 2060)				Fatty acids 20:0 (Ref. 2060) LCB d14:1 (Ref. 2060)	[2060]
458			Galb1-6Galb1-1ceramide	GSG2032	Mutsumi Sugita																		Pheretima hilgendorfi (earthworm) (Ref. 2061)				Fatty acids C16:0(0.2%), C18:0(1.5%), C19:0(0.2%), C20:0(3.6%), C21:0(1.0%), C22:0(47.8%), C23:0(10.5%), C24:0(35.2%) (Ref. 2061) LCB br-d18:1(18.8%), d18:1(77.0%), br-d19:1(4.2%) (Ref. 2061)	[2061]
459			Galb1-6Galb1-6Galb1-1ceramide	GSG2033	Mutsumi Sugita																		Pheretima hilgendorfi(earthworm) (Ref. 2061)				Fatty acids C16:0(0.2%), C18:0(1.0%), C19:0(0.7%), C20:0(4.3%), C21:0(1.5%), C22:0(46.9%), C23:0(11.4%), C24:0(34.0%) (Ref. 2061) LCB br-d18:1(12.6%), d18:1(82.7%), br-d19:1(4.7%) (Ref. 2061)	[2061]
460			choline-P-6Galb1-6Galb1-1ceramide	GSG2034	Mutsumi Sugita																		Pheretima hilgendorfi (earthworm) (Ref. 2062)				Fatty acids 16:0(1.5%), 18:0(5.8%), 20:0(4.9%), 21:0(3.7%), 22:0(56.0%), 23:0(7.1%), 24:0(20.9%) (Ref. 2062) LCB, br-d18:1(52.5%) , d18:1(18.7%), br-d19:1(28.8%) (Ref. 2062)	[2062]
461			Choline-P-6Galb1-1ceramide	GSG2036	Mutsumi Sugita													960 cm^-¹ [Spectrum 0001] (Ref. 1054)	1H NMR [Spectrum 0002](Ref. 1054)	(+)FAB-MS [Spectrum 0003] (Ref. 1054)		TLC: lane 2 [Chromatogram 0001] (Ref. 1054)	Tylorrhynchus heterochetus (lugworm) (Ref. 2063), Hirudo nipponia (leech) (Ref. 2069)				Fatty acids Tylorrhynchus heterochetus (lugworm) 16:0(82.6%), 17:0(8.5%), 18:0(8.9%) (Ref. 2063) Hirudo nipponia (leech) 16:0(13.2%), 17:0(5.4%), 18:0(19.1%), 22:0(24.0%), C24:0(31.2%), unknown(7.1%) (Ref. 2069) LCB Tylorrhynchus heterochetus (lugworm), d18:1(57.8%), d18:2(42.4%) (Ref. 2063) Hirudo nipponia (leech), br-d18:1(9.6%), d18:1(48.5%), br-d19:1(18.4%), d22:3(23.5%) (Ref. 2069)	[1054] / [2063] / [2069]
462			Gala1-3GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2041	Mutsumi Sugita																		Ascaris suum (porcine roundworm) (Ref. 2066)				Fatty acids 16:0(3.2%), 18:0(2.1%), C22h:0(12.7%), C23h:0(4.6%), C24h:0(77.4%) (Ref. 2066) LCB br-d17:1(31.3%), br-d17:0(68.7%) (Ref. 2066)	[2066]
463			Mana1-4Galb1-6Galb1-1ceramide	GSG2045	Mutsumi Sugita																		Pheretima hilgendorfi (earthworm) (Ref. 2067)				Fatty acids 16:0(1.7%), 18:0(4.6%), 20:0(8.3%), 21:0(4.1%), 22:0(49.4%), 23:0(11.3%), 24:0(20.6%); (Ref. 2067) LCB, br-d18:1(59.6%) , d18:1(14.6%), br-d19:1(25.8%) (Ref. 2067)	[2067]
464			Gala1-6(Mana1-4)Galb1-6Galb1-1ceramide	GSG2046	Mutsumi Sugita																		Pheretima hilgendorfi (earthworm) (Ref. 2067)				Fatty acids 22:0(30.7%), 23:0(27.2%), 24:0(42.1%) (Ref. 2067) LCB br-d18:1(47.4%), d18:1(23.9%), br-d19:1(28.7%) (Ref. 2067)	[2067]
465			Choline-P-6Galb1-6Galb1-6Galb1-1ceramide	GSG2047	Mutsumi Sugita													3400, 1620, 1540, 1220, 960cm^-¹ (Ref. 2068)	500MHz 1H (Ref. 2068)	(+)FAB-MS (Ref. 2068)			Pheretima hilgendorfi (earthworm) (Ref. 2068)				Fatty acids 16:0(1.4%), 18:0(4.4%), 20:0(5.1%), 21:0(4.7%), 22:0(50.8%), 23:0(11.9%), 24:0(21.7%) (Ref. 2068) LCB, d18:1(19.3%), br-d19:1(25.3%) (Ref. 2068)	[2068]
466			Choline-P-6Galb1-6Galb1-1ceramide	GSG2048	Mutsumi Sugita														1H NMR (SP0001) (Ref. 1054)	(+)FAB-MS [Spectrum 0002] (Ref. 1054)		TLC : lane 3 [Chromatogram 0001] (Ref. 1054)	Hirudo nipponia (leech) (Ref. 2069), Pheretima hilgendorfi (earthworm) (Ref. 1054)				Fatty acids 16:0(11.3%), 18:0(11.2%), 22:0(27.3%), 24:0(41.4%), unknown(8.8%) (Ref. 2069) LCB, d18:1(6.0%), t18:0(24.7%), br-d19:1(13.5%), d19:1(6.8%), br-t19:0(29.5%), d22:3(19.5%) (Ref. 2069)	[1054] / [2069]
467			Gala1-6Gala1-6Gala1-6Galb1-1ceramide	GSG2050	Mutsumi Sugita																		Hirudo nipponia (leech) (Ref. 2069)				Fatty acids 16:0(8.5%), 18:0(11.2%), 22:0(44.2%), 24:0(27.8%), unknown(8.3%) (Ref. 2069) LCB br-d18:1(3.4%), d18:1(13.5%), d18:0(5.0%), t18:0(7.1%), br-d19:1(18.5%), d19:1(22.9%), d22:3(29.6%) (Ref. 2069)	[2069]
468			Gala1-6Gala1-6Galb1-1ceramide	GSG2051	Mutsumi Sugita																		Hirudo nipponia (leech) (Ref. 2069)				Fatty acids 16:0(12.1%), 18:0(7.3%), 22:0(34.3%), 24:0(37.5%), unknown(8.7%) (Ref. 2069) LCB, br-d18:1(4.0%), d18:1(23.8%), d18:0(8.6%) , br-d19:1(43.2%), d19:1(7.8%), d22:3(12.6%) (Ref. 2069)	[2069]
469			Gala1-6Galb1-1ceramide	GSG2052	Mutsumi Sugita																		Hirudo nipponia (leech) (Ref. 2069)				Fatty acids 16:0(15.3%), 18:0(6.2%), 22:0(28.2%), 24:0(42.2%), unknown(8.1%) (Ref. 2069) LCB br-d18:1(5.2%), d18:1(23.0%), d18:0(6.8%), br-d19:1(51.5%), d19:1(8.5%), d22:3(5.0%) (Ref. 2069)	[2069]
470			Glca1-4Galb1-6Galb1-1ceramide	GSG2053	Mutsumi Sugita																		Pheretima sp.(earthworm) (Ref. 2070)				Fatty acids 20:0(2.4%), 22:0(49.7%), 23:0(5.2%), 24:0(42.7%) (Ref. 2070) LCB br-d18:1(7.1%), d18:1(92.9%) (Ref. 2070)	[2070]
471			Glca1-4Galb1-6Galb1-6Galb1-1ceramide	GSG2054	Mutsumi Sugita																		Pheretima sp.(earthworm) (Ref. 2070)				Fatty acids 22:0(62.8%), 23:0(4.9%), 24:0(32.3%) (Ref. 2070) LCB br-d18:1(3.0%), d18:1(97.0%) (Ref. 2070)	[2070]
472			Glca1-4Galb1-6(Glca1-4)Galb1-6Galb1-1ceramide	GSG2055	Mutsumi Sugita																		Pheretima sp.(earthworm) (Ref. 2070)				Fatty acids 18:0(5.4%), 20:0(8.2%), 21:0(4.6%), 22:0(41.4%), 23:0(13.7%), 24:0(26.7%) (Ref. 2070) LCB br-d18:1(7.3%), d18:1(92.7%) (Ref. 2070)	[2070]
473			InoMe(1-)-P-ceramide	GSG2056	Mutsumi Sugita																		Tylorrhynchus heterochetus (lugworm) (Ref. 2071)				Fatty acids 16h:0(10.0%), 17h:0(9.0%), 18h:0(43.1%), 19h:0(7.6%), 20h:0(7.3%), 21h:0(4.3%), h-C22h:0(6.8%), 23h:0(3.5%), 24h:0(8.4%) (Ref. 2071) LCB t18:0(100%) (Ref. 2071)	[2071]
474			Fuc-InoMe(1-)-P-ceramide	GSG2057	Mutsumi Sugita																		Tylorrhynchus heterochetus (lugworm) (Ref. 2071)				Fatty acids 16h:0(22.9%), 17h:0(11.5%), 18h:0(45.9%), 19h:0(6.8%), 20h:0(3.7%), 21h:0(1.8%), 22h:0(2.8%), 23h:0(1.4%), 24h:0(3.2%) (Ref. 2071) LCB t18:0(100%) (Ref. 2071)	[2071]
475			Ino(1-)-P-ceramide	GSG2058	Mutsumi Sugita																		Tylorrhynchus heterochetus (lugworm) (Ref. 2071)				Fatty acids 16:0(50.9%), 17:0(7.5%), 18:0(28.6%), 20:0(5.8%), 22:0(7.2%) (Ref. 2071) LCB d18:1(81.2%), d18:0(18.8%) (Ref. 2071)	[2071]
476			Manb1-1ceramide	GSG2059	Mutsumi Sugita																		Hyriopsis schlegelii(Ref. 2077)					[2077]
477			GlcNAcb1-3Galb1-3GalNAca1-4GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2060	Mutsumi Sugita																		Lucilia caesar (green-bottle fly)(Ref. 2037)					[2037]
478			Galb1-3GalNAca1-4GalNAcb1-4GlcNAcb1-3Manb1-4Glcb1-1ceramide	GSG2061	Mutsumi Sugita																		Lucilia caesar (green-bottle fly)(Ref. 2037)					[2037]
479			Galb1-4Galb1-1ceramide	GSG2062	Mutsumi Sugita																		Hyriopsis schlegelii hepatopancreas(Ref. 2024)					[2024]
480			Mana1-2Ino(GlcNAca1-4GlcNAca1-6)(1-P-)1-1ceramide	GSG2063	Mutsumi Sugita																		Corn seed(Ref. 2078/2079)					[2078] / [2079]
481			Man1-2Ino-(1-P)-1ceramide	GSG2064	Mutsumi Sugita																		Yeast(Ref. 2080),fungi(Ref. 2081)					[2080] / [2081]
482			(Gal, Ara, Man)-GlcNH₂-GlcU-Ino-(1-P)-1Ceramide	GSG2065	Mutsumi Sugita																		Peanuts(Ref. 2082)					[2082]
483			Ino-P-Ino-(1-P)-1Ceramide	GSG2066	Mutsumi Sugita																		Yeast(Ref. 2083), Fungi(Ref. 2081/2084)					[2081] / [2083] / [2084]
484			Ino-P-Man-Ino-(1-P)-1Cer	GSG2067	Mutsumi Sugita																		Yeasr,Fungi(Ref. 2083)					[2083]
485			(Man, Gal)-Ino-(1-P)-1Ceramide	GSG2068	Mutsumi Sugita																		Aspergillus niger(Ref. 2085/2086)					[2085] / [2086]
486			(Man, Gal, Glc)-Ino-(1-P)-Ceramide	GSG2069	Mutsumi Sugita																		Aspergillus niger(Ref. 2085/2086)					[2085] / [2086]
487			(Man₂, Gal₃)-Ino-(1-P)-1Ceramide	GSG2070	Mutsumi Sugita																		Aspergillus niger(Ref. 2085/2086)					[2085] / [2086]
488			GlcNAca1-4GlcUa1-2Ino(1-P)-1Cer	GSG2071	Mutsumi Sugita																		Tabacco(Ref. 2087/2088/2089/2090/2091)					[2087] / [2088] / [2089] / [2090] / [2091]
489			Galb1-4GlcNAca1-4GlcUa1-2Ino(1-P)-1Cer	GSG2072	Mutsumi Sugita																		Tabacco(Ref. 2092)					[2092]
490			Gal1-6Gal1-4GlcNAca1-4GlcUa1-2Ino(1-P)-1Cer	GSG2073	Mutsumi Sugita																		Tabacco(Ref. 2093)					[2093]
491			Ara1-6Gal1-4GlcNAca1-4GlcAa1-2Ins(1-P)-1Cer	GSG2074	Mutsumi Sugita																		Tabacco(Ref. 2093)					[2093]
492			Gal/Ara1-3Gal(Gal/Ara1-6)1-4GlcNAca1-4GlcUa1-2Ino(1-P)-1Cer	GSG2075	Mutsumi Sugita																		Tabacco(Ref. 2093)					[2093]
493			Mana1-3Mana1-2/6Ino(1-P)-1Cer(OH)	GSG2076	Mutsumi Sugita																		H. capsulataum(Ref. 2094)					[2094]
494			Mana1-3(Galb1-6)Mana1-2/6Ino(1-P)-1Cer(OH)	GSG2077	Mutsumi Sugita																		H. capsulataum(Ref. 2094)					[2094]
495			Mana1-3(Galb1-4)Mana1-2/6Ino(1-P)-1Cer(OH)	GSG2078	Mutsumi Sugita																		H. capsulataum(Ref. 2094)					[2094]
496			H2N-CH2-CH2-PO4-6Gal-Cer	GSG2079	Mutsumi Sugita																		T, cornutus(Ref. 2095/2096/2097), Monodona labio(marine gastropod)(Ref. 2097)					[2095] / [2096] / [2097]
497			CH₃-HN-CH₂-CH₂-PO₄-6Gal-Cer	GSG2080	Mutsumi Sugita																		T, cornutus(Ref. 2095/2096/2098)					[2095] / [2096] / [2098]
498			N-acetylneraminyla2-3galactosylb1-4glucosylceramide	GSG3001	Hideharu Ishida	GM3	C₅₅H₁₀₀N₂O₂₁	1125.383		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+1.8(Ref. 3001)			(Ref. 3001)	1D 1H-NMR (Ref. 3001)				Chemical Synthesis	Coupling of a-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, prepared from 2-(trimethylsilyl)ethyl b-lactoside by selective 3'-O-benzylation, O-bezoylation, and subsequent removal of the benzyl group, with methyl(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-a-D-galacto-2-nonulopyranosid)onate using dimethyl(methylthio)sulfonium triflate as a glycosyl promoterm gave 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, which was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the a-N-acetylneuraminyl-(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with afforded the b-glycoside, which was converted, via selective of the azide group, coupling with tetradecanoic acid, O-deacylation, and de-esterification, into the title compounds. (Ref. 3001)			Fatty acid C14:0 LCB d18:1	[3001] / [3002] / [3046]
499			N-acetylneraminyla2-3galactosylb1-4glucosylceramide	GSG3002	Hideharu Ishida	GM3	C₅₉H₁₀₈N₂O₂₁	1181.490		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+1.8(Ref. 3001)			(Ref. 3001)	1D 1H-NMR (Ref. 3001)				Chemical Synthesis	Coupling of a-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, prepared from 2-(trimethylsilyl)ethyl b-lactoside by selective 3'-O-benzylation, O-bezoylation, and subsequent removal of the benzyl group, with methyl(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-a-D-galacto-2-nonulopyranosid)onate using dimethyl(methylthio)sulfonium triflate as a glycosyl promoterm gave 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, which was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the a-N-acetylneuraminyl-(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with afforded the b-glycoside, which was converted, via selective of the azide group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the title compounds. (Ref. 3001)			Fatty acid C18:0 LCB d18:1	[3001] / [3002] / [3046]
500			N-acetylneraminyla2-3galactosylb1-4glucosylceramide	GSG3003	Hideharu Ishida	GM3	C₆₅H₁₂₀N₂O₂₁	1265.649		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+0.8(Ref. 3001)			(Ref. 3001)	1D 1H-NMR (Ref. 3001)				Chemical Synthesis	Coupling of a-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, prepared from 2-(trimethylsilyl)ethyl b-lactoside by selective 3'-O-benzylation, O-bezoylation, and subsequent removal of the benzyl group, with methyl(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-a-D-galacto-2-nonulopyranosid)onate using dimethyl(methylthio)sulfonium triflate as a glycosyl promoterm gave 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside, which was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the a-N-acetylneuraminyl-(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with afforded the b-glycoside, which was converted, via selective of the azide group, coupling with tetracosanoic acid, O-deacylation, and de-esterification, into the title compounds. (Ref. 3001)			Fatty acid C24:0 LCB d18:1	[3001] / [3002] / [3046]
501			N-acetylneraminyla2-3galactosylceramide	GSG3004	Hideharu Ishida	GM4	C₄₉H₉₀N₂O₁₆	963.243		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+2.5(Ref. 3003)			(Ref. 3003)	1D 1H-NMR (Ref. 3003)				Chemical Synthesis	The glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside with the methyl a-thioglycoside derivativem derived from methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2-S-acetyl-3,5-dideoxy-2-thio-D-glycero-a-D-galacto-2-nonulopyranosonate via selective S-deacetylation and subsequent S-methylation, using dimethyl(methylthio)sulfonium triflate (DMTST) gave the corresponding a-glycosides of Neu5Ac, respectively. Coupling of the trichloroacetimidates, obtained by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and imidate formation, with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted via selective reduction of the azide group, condensation with tetradecanoic acid, O-deacylation, and hydrolysis of the methyl ester group into the title compound. (Ref. 3003)			Fatty acid C14:0 LCB d18:1	[3002] / [3003] / [3046]
502			N-acetylneraminyla2-3galactosylceramide	GSG3005	Hideharu Ishida	GM4	C₅₃H₉₈N₂O₁₆	1019.349		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+2.2(Ref. 3003)			(Ref. 3003)	1D 1H-NMR (Ref. 3003)				Chemical Synthesis	The glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside with the methyl a-thioglycoside derivativem derived from methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2-S-acetyl-3,5-dideoxy-2-thio-D-glycero-a-D-galacto-2-nonulopyranosonate via selective S-deacetylation and subsequent S-methylation, using dimethyl(methylthio)sulfonium triflate (DMTST) gave the corresponding a-glycosides of Neu5Ac, respectively. Coupling of the trichloroacetimidates, obtained by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and imidate formation, with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group into the title compound. (Ref. 3003)			Fatty acid C18:0 LCB d18:1	[3002] / [3003] / [3046]
503		sialyl-lactotetraosylceramide	N-acetylneraminyla2-3galactosylb1-3-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3006	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822		This ganglioside was the most potent ganglioside bound by Influenza Virus A/PR/8.(Ref. 3032) This ganglioside gave a negative reaction to a lymphocyte homing receptor, L-selectin (LECAM-1). (Ref. 3035) This ganglioside was more sensitive to the sialidase of influenza B virus isolates than the corresponding sialyl a2-6gal isomer. (Ref. 3036) This ganglioside was recognized by the hemagglutinin of human influenza B virus isolates as well as the sorreponding 2-6 isomer. (Ref. 3038)					-6.2(Ref. 3004)			(Ref. 3004)	1D 1H-NMR (Ref. 3004)				Chemical Synthesis	Methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside, the key glycosyl donor, was prepared, from the 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O- benzoyl-b-D-galactopyranoside, via benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Coupling of 2-(trimethylsilyl)ethyl 2,3,6,2',4',6'-hexa-O-benzyl- b-D-galactopyranoside, prepared from 2-(trimethylsilyl)ethyl b-D-lactoside via selective 3'-O-(4-methyoxybenzylation), benzylation, and selective removal of the 4-methyoxybenzyl group, with 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimide-D-glucopyranosyl bromide gave a trisaccharide derivative, from which the phthaloyl and O-acetyl groups were removed. N-Acetylation then gave 2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside. Dimethyl(methylthio)sulfonium triflate promoted coupling of the disaccharide donor with the trisaccharide acceptor, prepared by 4,6-O-benzylidenation, gave the corresponding pentasaccharide. This oligosacharide was converted into the corresponding a-trichloroacetimidates which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycosides. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the final product.(Ref. 3004)			Fatty acid C18:0 LCB d18:1	[3004] / [3032] / [3035] / [3036] / [3038]
504		sialyl-neolactotetraosylceramide/sialyl-paragloboside	N-acetylneraminyla2-3galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3007	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822		This ganglioside gave a negative reaction to a lymphocyte homing receptor, L-selectin (LECAM-1). (Ref. 3035) A new monoclonal antibody directed to this ganglioside was prepared, and which was applied for detection of human gastrointestinal neoplasmas (Ref. 3050)					-3.8(Ref. 3004)			(Ref. 3004)	1D 1H-NMR (Ref. 3004)				Chemical Synthesis	Methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside, the key glycosyl donor, was prepared, from the 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy -D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O-benzoyl-b-D- galactopyranoside, via benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Coupling of 2-(trimethylsilyl)ethyl 2,3,6,2',4',6'-hexa-O-benzyl-b-D-galactopyranoside, prepared from 2-(trimethylsilyl)ethyl b-D-lactoside via selective 3'-O-(4-methyoxybenzylation), benzylation, and selective removal of the 4-methyoxybenzyl group, with 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimide-D-glucopyranosyl bromide gave a trisaccharide derivative, from which the phthaloyl and O-acetyl groups were removed. N-Acetylation then gave 2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside. Dimethyl(methylthio)sulfonium triflate promoted coupling of the disaccharide donor with the trisaccharide acceptor, prepared by 4,6-O-benzylidenation, 3-O-(4-methoxybenzylation) and reductive opening of the benzylidene acetal, gave the corresponding pentasaccharide derivatives 16 and 20 in good yields. This oligosacharide was converted into the corresponding a-trichloroacetimidates which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycosides. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the final product.(Ref. 3004)			Fatty acid C18:0 LCB d18:1	[3004] / [3035] / [3050]
505		sialyl-Lex	N-acetylneraminyla2-3galactosylb1-4(fucosyla1-3)N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3008	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₆	1708.963		This ganglioside was recognized by none of the selectin receptor family. (Ref. 3033) This ganglioside was weakly recognized by monoclonal antibody AM-3 which raised against a sialomucin from human coloretal carcinoma. (Ref. 3034) This ganglioside was bound by a lymphocyte homing receptor, L-selectin (LECAM-1) but lower than the sulfatide. (Ref. 3035) One of the monoclonal antibodies, which raised against this ganglioside, is found to react sellectively to helper memory T cells. (Ref. 3037) This ganglioside inhibits lung metastasesprduced by i.v. co-injection of B16-BL-6 melanpmacells. (Ref. 3042) High affinity antibodies against this ganglioside was obtained from a phage display library. (Ref. 3044) This ganglioside was not the carbohydrate ligand of E-selectin. (Ref. 3051)					-17.5(Ref. 3005)			(Ref. 3005)	1D 1H-NMR (Ref. 3005)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-D-glucopyranoside with methyl 2,3,4-tri-O-benzyl-1-thio-b-L-fucopyranoside gave the a-glycoside, which was converted by reductive ring-opening of the benzylidene acetal into the glycosyl acceptor. Dimethyl(methylthio)sulfonium triflate-promoted coupling of 6 with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside afforded the desired hexasaccharide in good yield. This oligosaccharide was converted into the a-trichloroacetimidate, via reductive removal of the benzyl groups, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and treatment with trichloroacetonitrile, which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title compound.(Ref. 3005)			Fatty acid C18:0 LCB d18:1	[3005] / [3033] / [3034] / [3035] / [3037] / [3042] / [3044] / [3051]
506		sialyl-(2-6)lactotetraosylceramide	N-acetylneraminyla2-6galactosylb1-3-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3009	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822		This ganglioside was restrictively bound by Influenza Virus B/Lee/40, but weakly by Influenza Virus A/PR/8, but.(Ref. 3032) This ganglioside was less sensitive to the sialidase of influenza B virus isolates than the corresponding sialyl a2-6gal isomer. (Ref. 3036) This ganglioside was recognized by the hemagglutinin of human influenza B virus isolates as well as the sorreponding 2-6 isomer. (Ref. 3038)					-5.2(Ref. 3006)				1D 1H-NMR (Ref. 3006)				Chemical Synthesis	Methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2,4-di-O-benzoyl-3-O-benzyl-1-thio-b-D-galactopyranoside, the key glycosyl donor was prepared, via glycosylation of 2-(trimethylsilyl)ethyl 3-O-benzyl-b-D-galactopyranoside with the methyl a-thio-glycoside of N-acetylneuraminic acid, benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with (methylthio)-trimethylsilane. Coupling of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3')-per-O-benzyl-b-lactoside with the disaccharide donor gave the pentasaccharide in good yields. The oligosaccharide was converted into the corresponding a-trichloroacetimidate which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-de-acylation, and hydrolysis of the methyl ester group, into the final compound. (Ref. 3006)			Fatty acid C18:0 LCB d18:1	[3006] / [3032] / [3036] / [3038]
507		sialyl-(2-6)-neolactotetraosylceramide/sialyl(2-6)-paragloboside	N-acetylneraminyla2-6galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3010	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822							-1.5(Ref. 3006)				1D 1H-NMR (Ref. 3006)				Chemical Synthesis	Methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2,4-di-O-benzoyl-3-O-benzyl-1-thio-b-D-galactopyranoside, the key glycosyl donor was prepared, via glycosylation of 2-(trimethylsilyl)ethyl 3-O-benzyl-b-D-galactopyranoside with the methyl a-thio-glycoside of N-acetylneuraminic acid, benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with (methylthio)-trimethylsilane. Coupling of 2-(trimethylsilyl)ethyl O-(2-acetamido-3-O-acetyl-6-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3')-per-O-benzyl-b-lactoside with the disaccharide donor gave the pentasaccharide in good yields. The oligosaccaride was converted into the corresponding a-trichloroacetimidate which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-de-acylation, and hydrolysis of the methyl ester group, into the final compound. (Ref. 3006)			Fatty acid C18:0 LCB d18:1	[3006]
508			N-acetylneraminyla2-3galactosylb1-3-N-acetyl-galactosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3011	Hideharu Ishida	GM1b, cis GM1	C₇₃H₁₃₁N₃O₃₂	1562.822		This ganglioside is potent neuronal ligands for myelin-associated glycoprotein. (Ref. 3040)					+5.7(Ref. 3007)			(Ref. 3007)	1D 1H-NMR (Ref. 3007)				Chemical Synthesis	Coupling of 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-a-D-galactopyranosyl bromide and 2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-trio-O-benzyl-b-D-galactopyranoside gave a trisaccharide, which after removal of O-acetyl-and phthaloylgroups was converted by benzylidenation into two a acceptor. This were suitable for C-3 glycosylation reaction, promoted by dimethyl(methylthio)sulfonium triflate (DMTST), with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside . The reations gave the pentasaccharide derivative in high yield, and this were transformed into the a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the a-trichloroacetimidate gave the corresponding b-glycosides, which on channeling through selective reductionof the azido group, coupling of thus formed aminogroup with octadecanoic acid, O-deacetylation, and saponification of the methyl ester group, gave the target compound. (Ref. 3007)			Fatty acid C18:0 LCB d18:1	[3007] / [3040]
509		sialyl-(2-6)-Lex	N-acetylneraminyla2-6galactosylb1-3-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3012	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₆	1708.963		This ganglioside was recgnized by the three members of the selectin receptor family as a a common carbohydrate epitope. (Ref. 3033) This ganglioside was not the carbohydrate ligand of E-selectin. (Ref. 3051>					-16.6(Ref. 3008)				1D 1H-NMR (Ref. 3008)				Chemical Synthesis	Dimethyl(methylthio)sulfonium triflate-promoted coupling of 2-(trimethylsilyl)ethyl O-(2,3,4-tri-O-benzyl-a-L-fucopyranosyl)-(1-3)-O-(2-acetamido-6-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2,4-di-O-benzoyl-3-O-benzyl-1-thio-b-D-galactopyranoside afforded the desired hexasaccharide. This was converted into the a-trichloroacetimidate, via reductive removal of the benzyl groups, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and treatment with trichloroacetonitrile, which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title compound.(Ref. 3008)			Fatty acid C18:0 LCB d18:1	[3008] / [3033] / [3051]
510			N-acetylneuraminyla2-3galactosylb1-3(N-acetylneuraminyla2-6)N-acetyl- -galactosaminylb1-4galactosylb1-4glucosylceramide	GSG3013	Hideharu Ishida	GD1a	C₈₄H₁₄₈N₄O₃₉	1838.077		This ganglioside is enriched in Purkinje cells and may have a role in Purkinje cell functions in the cerebellum. (Ref. 3041)					+3.4(Ref. 3009)			(Ref. 3009)	1D 1H-NMR (Ref. 3009)				Chemical Synthesis	Suitably protected pentasaccharide derivatives, derived from known pentasaccharide precursors, were selected as the glycosyl acceptors. Using our facile method of stereoselective a-glycosidation of sialic acid, these acceptors were coupled with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate in acetonitrile medium in the presence of dimethyl(methylthio)sulfonium triflate (DMTST) to get the desired di-a-sialyl hexasaccharide derivative in moderate yield. The hexasaccharide trichloroacetimidate upon coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-linked sphingosine glycoside in high yield. This was subjected in sequence to selective reduction of the azido group and coupling of the thus formed amino group with octadecanoic acid, O-deacylation, and saponification of the methyl ester groups to obtain ganglioside GD1a . (Ref. 3009)			Fatty acid C18:0 LCB d18:1	[3009] / [3041]
511			N-acetyl-galactosaminylb1-4(N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3014	Hideharu Ishida	GM2	C₆₇H₁₂₁N₃O₂₆	1384.682							+11.3(Ref. 3010)				1D 1H-NMR (Ref. 3010)				Chemical Synthesis	Coupling of 2- (trimethylsilyl)ethyl O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside, prepared from 2-(trimethylsilyl)ethyl b-lactoside by selective 3',4'-O-isopropylidenation, O-benzylation, and subsequent removal of the isopropylidene group, with methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate using N-iodosuccinimide (NIS), gave the trisaccharide), which on condensation with methyl 6-O-benzoyl -2-deoxy-3,4-O-isopropylidene-2-phthalimido-1-thio-b-D-galactopyranoside , gave the protected ganglioside GM2 oligosaccharide. This was transformed, via O-deisopropylidenation, O-acetylation, removal of the phthaloyl group, N-acetylation, removal of the benzyl groups followed by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the final glycosyl donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the a-trichloroacetimidate gave the b-glycoside, which on channeling through selective reduction of the azide group, coupling of the amino group with octadecanoic acid, O-deacylation and saponification of the methyl ester group, gave the title ganglioside. (Ref. 3010)			Fatty acid C18:0 LCB d18:1	[3010]
512			N-acetylneraminyla2-8-N-acetylneraminyla2-3galactosylb1-4glucosylceramide	GSG3015	Hideharu Ishida	GD3	C₇₀H₁₂₅N₃O₂₉	1472.744							-2.6(Ref. 3011)				1D 1H-NMR (Ref. 3011)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl 2,3,6, 2',6'-penta-O-benzyl-b-lactoside, with methyl [phenyl 5-acetamido-4,7-di-O-acetyl-3,5-dideoxy-2-thio-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-D-glycero-D-galacto-2-nonulopyranosid]onate, which was prepared from O-(5-acetamido-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonic acid)-(2-8)-5-acetamido-3,5-dideoxy-D-glycero-D-galacto-2-nonulopyranosonic acid by treatment with Amberlite IR-120 (H+) in methanol, O-acetylation, and subsequent replacement of the anomeric acetoxy group with phenyl thio, using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) as a promoter, gave the corresponding a-glycoside. The tetrasaccharide was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into a-trichloroacetimidate which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally,this was easily transformed, via selective reduction of the azido group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester and lactone, into ganglioside GD3. (Ref. 3011)			Fatty acid C18:0 LCB d18:1	[3011]
513			KDNa2-3galactosylb1-4glucosylceramide	GSG3016	Hideharu Ishida	KDN-GM3	C₅₈H₁₀₉NO₂₁	1156.480		This ganglioside was cleaved by a novel sialidase isolated from the liver of loach, to release KDO. (Ref. 3039) This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002/3043)					-12.0(Ref. 3012)				1D 1H-NMR (Ref. 3012)				Chemical Synthesis	KDN, prepared by the condensation of oxalacetic acid with D-mannose, was converted via methylesterification, O-acetylation and replacement of the anomeric acetoxy group with phenylthio, into methyl (phenyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate . Glycosylation of the donor with 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside was performed, using N-iodosuccinimide-trimethylsilyl trifluoromethanesulfonate as the glycosyl promoter, to give 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-(6-O-benzoyl-b-D-galactopyrano-syl)-(1-4)-(2,6-di-O-benzoyl-b-D-glucopyranoside. The trysaccharide was converted via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation, into the corresponding trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with thedonor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which wasa transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation and de-esterification, into the target ganglioside. (Ref. 3012)			Fatty acid C18:0 LCB d18:1	[3002] / [3012] / [3039] / [3043]
514			KDNa2-3galactosylceramide	GSG3017	Hideharu Ishida	KDN-GM4	C₅₅H₁₀₃NO₁₆	1034.403		This ganglioside have the immunosuppressive properties of the natural molecules and are useful in probing which elements of ganglioside structure are critical to their biological activity.(Ref. 3002)					-17.2(Ref. 3012)				1D 1H-NMR (Ref. 3012)				Chemical Synthesis	KDN, prepared by the condensation of oxalacetic acid with D-mannose, was converted via methylesterification, O-acetylation and replacement of the anomeric acetoxy group with phenylthio, into methyl (phenyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate . Glycosylation of 2 with 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside was performed, using N-iodosuccinimide-trimethylsilyl trifluoromethanesulfonate as the glycosyl promoter, to give 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O-benzoyl-b-D-galacto-pyranoside. The disaccharide was converted via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation, into the corresponding trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycosides, which was transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation and de-esterification, into the target ganglioside. (Ref. 3012)			Fatty acid C18:0 LCB d18:1	[3002] / [3012]
515		KDN-lactotetraosylceramide	KDNa2-3galactosylb1-3-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3018	Hideharu Ishida		C₇₅H₁₃₆N₂O₃₂	1577.877							-6.8(Ref. 3013)			(Ref. 3013)	1D 1H-NMR (Ref. 3013)				Chemical Synthesis	4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside was prepared from 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O-benzyl-b-D-galactopyra-noside, via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyra-nosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the disaccharide donor gave the corresponding pentasaccharide in good yield. This oligosaccharide was converted via reductive removal of the benzyl groups and benzylidene group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the corresponding trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which was transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation and de-esterification, into the target ganglioside in high yield. (Ref. 3013)			Fatty acid C18:0 LCB d18:1	[3013]
516		KDN-neolactotetraosylceramide/KDN-paragloboside	KDNa2-3galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3019	Hideharu Ishida		C₇₅H₁₃₆N₂O₃₂	1577.877							-10.6(Ref. 3013)			(Ref. 3013)	1D 1H-NMR (Ref. 3013)				Chemical Synthesis	Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside was prepared from 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O-benzyl-b-D-galactopyra-noside, via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the disaccharide donor gave the corresponding pentasaccharide in good yield. This oligosaccharide was converted via reductive removal of the benzyl groups and benzylidene group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the corresponding trichloroacetimidate Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which was transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation and de-esterification, into the target ganglioside in high yield. (Ref. 3013)			Fatty acid C18:0 LCB d18:1	[3013]
517		KDN-Lex	KDNa2-3galactosylb1-4(fucosyla1-3)N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3020	Hideharu Ishida		C₈₁H₁₄₆N₂O₃₆	1724.018							-16.0(Ref. 3013)			(Ref. 3013)	1D 1H-NMR (Ref. 3013)				Chemical Synthesis	Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside was prepared from 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-6-O-benzyl-b-D-galactopyra-noside, via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with methylthiotrimethylsilane. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside (5) or 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside, prepared from 5 via O-benzylation and reductive opening of the benzylidene acetal ring, with 4 gave the corresponding pentasaccharides 9 and 13 in good yields. In the same way, 4 was reacted with 2-(trimethylsilyl)ethyl O-(2,3,4-tri-O-benzyl-a-L-fucopyranosyl)-(1-3)-O-(2-acetamido-6-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopy-ranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranosidewith the disaccharide donor gave the hexasaccharide. This oligosaccharide was converted via reductive removal of the benzyl groups and benzylidene group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the corresponding trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which were transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation and de-esterification, into the target ganglioside. (Ref. 3013)			Fatty acid C18:0 LCB d18:1	[3013]
518			galactosylb1-3(N-acetylneuraminyla2-6)N-acetyl- -galactosaminylb1-4galactosylb1-4glucosylceramide	GSG3021	Hideharu Ishida	GM1a	C₇₃H₁₃₁N₃O₃₂	1562.822		This gangliosideis is not recognized by myelin-associated glycoprotein. (Ref. 3040) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					+5.4(Ref. 3014)				1D 1H-NMR (Ref. 3014)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the suitably protected galactosamine donor, methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-b-D-galactopyranoside gave the desired trisaccharide, which was transformed into the trisaccharide acceptor via removal of the phthaloyl and o-acetyl groups followed by N-acetylation. Glycosylation of this acceptor with methyl 3-O-benzyl-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside gave the asialo GM1 saccharide derivative, which was transformed into the acceptor by removal of benzylidene group. Coupling of this gangliotetraose acceptor with phenyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate by use of NIS-TfOH afforded the desired GM1a oligosaccharide derivative in high yield, which was transformed, via removal of the benzyl group followed by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation, into the final glycosyl donor. Condensation of this imidate derivative with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the b-glycoside, which on channeling through selective reduction of the azido group, coupling of the amino group with octadecanoic acid, O-deacylation and saponification of the methyl ester group, gave the title compound GM1a . (Ref. 3014)			Fatty acid C18:0 LCB d18:1	[3014] / [3040] / [3046]
519		KDN-(2-6)lactotetraosylceramide	KDNa2-6galactosylb1-3-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3022	Hideharu Ishida		C₇₅H₁₃₈N₂O₃₂	1579.893							-8.2(Ref. 3015)				1D 1H-NMR (Ref. 3015)				Chemical Synthesis	Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2,4-di-O-benzoyl-3-O-benzyl-1-thio-b-D-galactopyranoside was prepared from the phenyl b-thioglycoside derivative of KDN and 2-(trimethylsilyl)ethyl 3-O-benzyl-b-D-galactopyranoside in four steps. Coupling of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3')-per-O-benzyl-b-lactoside with the donor gave the pentasaccharide in good yield. The pentasaccharide was converted into the corresponding a-trichloroacetimidate which, on glycosylation with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, this was transformed, via selective reduction of the azido group, condensation with octadecanoic acid, O-deacylation, and saponification of the methyl ester group, into the target compound. (Ref. 3015)			Fatty acid C18:0 LCB d18:1	[3015]
520		KDN-(2-6)-neolactotetraosylceramide/sialyl-(2-6)-paragloboside	KDNa2-6galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3023	Hideharu Ishida		C₇₅H₁₃₆N₂O₃₂	1577.877							-6.1(Ref. 3015)				1D 1H-NMR (Ref. 3015)				Chemical Synthesis	Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2,4-di-O-benzoyl-3-O-benzyl-1-thio-b-D-galactopyranoside was prepared from the phenyl b-thioglycoside derivative of KDN and 2-(trimethylsilyl)ethyl 3-O-benzyl-b-D-galactopyranosidein four steps. Coupling of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3')-per-O-benzyl-b-D-lactoside, with the donor gave the pentasaccharidein good yields. This pentasaccharide was converted into the corresponding a-trichloroacetimidate which, on glycosylation with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, this was transformed, via selective reduction of the azido group, condensation with octadecanoic acid, O-deacylation, and saponification of the methyl ester group, into the target compound. (Ref. 3015)			Fatty acid C18:0 LCB d18:1	[3015]
521		3-sulfoglucuronylparagloboside	3-sulfoglucuronylb1-3galactosyl-b1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3024	Hideharu Ishida	SGPG	C₆₈H₁₁₉N₂O₃₂SNa₂	1554.712												FAB-MS (negative ion mode); m/z 1531.91 (M-Na)^-, 1553.89 (M-H)^- (Ref. 3016)			Chemical Synthesis	Methyl (4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-a-D-glucopyranosyl trichloroacetimidate)uronate) was prepared from methyl [2-(trimethylsilyl)ethyl b-D-glucopyranosid]uronate via selective 4-O-acetylation, 2-O-benzoylation, 3-O-levulinoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation. The coupling of the donor with 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside using trimethylsilyl trifluoromethanesulfonate gave 2-(trimethylsilyl)ethyl O-(methyl 4-O-acetyl-2-O-ben-zoyl-3-O-levulinoyl-b-D-glucopyranosyluronate)-(1-3)-2,4,6-tri-O-benzyl-b-D-galact-opyranoside, which was transformed via removal of the benzyl group, benzoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the disaccharide donor. On the other hand, 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside as the acceptor was prepared from 2-(trimethylsilyl)ethyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-glucopyranoside via O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, imidate formation, coupling with 2-(trimethylsilyl)ethyl O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyrano-side, removal of the O-acetyl and N-phthaloyl group followed by N-acetyla-tion. Condensation of thedisaccharide donor with the trisaccharide acceptor using trimethylsilyl trifluoromethanesulfonate afforded the desired pentasaccharide, which was transformed by removal of the benzyl group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the pentasaccharide donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol withthe imidate gave the desired b-glycoside, which was transformed into the target compound, via reduction of the azido group, coupling with octadecanoic acid, selective removal of the levulinoyl group, O-sulfation, hydrolysis of the methyl ester group and O-deacylation. (Ref. 3016)			Fatty acid C18:0 LCB d18:1	[3016]
522		3-sulfoglucuronylparagloboside	3-sulfoglucuronylb1-3galactosyl-b1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3025	Hideharu Ishida	SGPG	C₇₄H₁₃₁N₂O₃₂SNa₂	1638.872												FAB-MS (negative ion mode); m/z 1615.85 (M-Na)^-, 1637.66 (M-H)^- (Ref. 3016)			Chemical Synthesis	Methyl (4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-a-D-glucopyranosyl trichloroacetimidate)uronate) was prepared from methyl [2-(trimethylsilyl)ethyl b-D-glucopyranosid]uronate via selective 4-O-acetylation, 2-O-benzoylation, 3-O-levulinoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation. The coupling of the donor with 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside using trimethylsilyl trifluoromethanesulfonate gave 2-(trimethylsilyl)ethyl O-(methyl 4-O-acetyl-2-O-ben-zoyl-3-O-levulinoyl-b-D-glucopyranosyluronate)-(1-3)-2,4,6-tri-O-benzyl-b-D-galact-opyranoside, which was transformed via removal of the benzyl group, benzoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the disaccharide donor. On the other hand, 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside as the acceptor was prepared from 2-(trimethylsilyl)ethyl 3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-glucopyranoside via O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, imidate formation, coupling with 2-(trimethylsilyl)ethyl O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyrano-side, removal of the O-acetyl and N-phthaloyl group followed by N-acetyla-tion. Condensation of thedisaccharide donor with the trisaccharide acceptor using trimethylsilyl trifluoromethanesulfonate afforded the desired pentasaccharide, which was transformed by removal of the benzyl group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the pentasaccharide donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol withthe imidate gave the desired b-glycoside, which was transformed into the target compound, via reduction of the azido group, coupling with tetracosanoic acid, selective removal of the levulinoyl group, O-sulfation, hydrolysis of the methyl ester group and O-deacylation.(Ref. 3016)			Fatty acid C24:0 LCB d18:1	[3016]
523			N-acetyl-galactosaminylb1-4(KDNa2-3)galactosylb1-4glucosylceramide	GSG3026	Hideharu Ishida	KDN-GM2	C₆₅H₁₁₈N₂O₂₇	1359.630							+8.2(Ref. 3017)				1D 1H-NMR (Ref. 3017)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(2,6-di-O-benzyl-b-D-galac-topyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl 6-O-benzyl-2-deoxy-3,4-O-isopropylidene-2-phthalimido-1-thio-b-D-galactopyranoside gave the tetrasaccharide, which was converted, via de-esterification, removal of the phthaloyl group, N-acetylation, and O-deisopropylidenation, into the tetrasaccharide acceptor. Reductive removal of the benzyl groups in 9, O-acetylation and subse-quent removal of the 2-(trimethylsilyl)ethyl group followed by imidate formation, gave the KDN-GM2 oligosaccharide glycosyl donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which was transformed in good yield, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target ganglioside.(Ref. 3017)			Fatty acid C18:0 LCB d18:1	[3017]
524			galactosylb1-3N-acetyl-galactosaminylb1-4(KDNa2-3)galactosylb1-4glucosylceramide	GSG3027	Hideharu Ishida	KDN-GM1	C₇₁H₁₂₈N₂O₃₂	1521.770							+3.5(Ref. 3017)				1D 1H-NMR (Ref. 3017)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(2,6-di-O-benzyl-b-D-galac-topyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl 6-O-benzyl-2-deoxy-3,4-O-isopropylidene-2-phthalimido-1-thio-b-D-galactopyranoside gave the tetrasaccharide, which was converted, via de-esterification, removal of the phthaloyl group, N-acetylation, and O-deisopropylidenation, into the tetrasaccharide acceptor. Glycosylation of the acceptor with methyl 2,4,6-tri-O-benzoyl-3-O-benzyl-1-thio-b-D-galacto-pyranoside, using dimethyl(methylthio)sulfonium triflate (DMTST), gave the pentasaccharide, which was converted via reductive removal of their benzyl groups, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and reaction with trichloroacetonitrile, into the corresponding a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which was transformed in good yield, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target ganglioside.(Ref. 3017)			Fatty acid C18:0 LCB d18:1	[3017]
525			KDNa2-3galactosylb1-3N-acetyl-galactosaminylb1-4(KDNa2-3)galactosylb1-4glucosylceramide	GSG3028	Hideharu Ishida	KDN-GD1a	C₈₀H₁₄₂N₂O₄₀	1771.973							-3.4(Ref. 3017)				1D 1H-NMR (Ref. 3017)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(2,6-di-O-benzyl-b-D-galac-topyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl 6-O-benzyl-2-deoxy-3,4-O-isopropylidene-2-phthalimido-1-thio-b-D-galactopyranoside gave the tetrasaccharide, which was converted, via de-esterification, removal of the phthaloyl group, N-acetylation, and O-deisopropylidenation, into the tetrasaccharide acceptor. Glycosylation of the acceptor with methyl (methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside, using dimethyl(methylthio)sulfonium triflate (DMTST), gave the hexasaccharide, which was converted via reductive removal of their benzyl groups, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and reaction with trichloroacetonitrile, into the corresponding a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor in the presence of boron trifluoride etherate afforded the expected b-glycoside, which was transformed in good yield, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target ganglioside. (Ref. 3017)			Fatty acid C18:0 LCB d18:1	[3017]
526			N-acetylneraminyla2-3galactosylb1-3-N-acetyl-galactosaminyl-b1-3galactosyl-a1-3galactosylb1-4glucosylceramide	GSG3029	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₇	1724.963							-1.0(Ref. 3018)				1D 1H-NMR (Ref. 3018)				Chemical Synthesis	2-(Trimethylsilyl)ethyl 2-O-benzyl-4,6-O-benzylidene-a-D-galactopyranosyl-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranosyl-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside, the core structure of isoglobo-series gangliosides was prepared by the glycosylation of 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl 3-O-acetyl-2-O-benzyl-4,6-O-benzylidene-1-thio-b-D-galactopyranoside, and subsequent de-O-acetylation. Coupling of the trisaccharide acceptor and methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-b-D-galactopyranoside gave a isoglobotetraoside derivative, from which the phthaloyl and O-acetyl groups were removed. N-Acetylation then gave a tetrasaccharide acceptor. Dimethyl(methylthio)sulfonium triflate-promoted coupling of the accptor with methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranosidegave the hexasaccharide derivativein good yield. Theoligosaccharide was converted into the corresponding a-trichloroimidate which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, this was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the titleproduct. (Ref. 3018)			Fatty acid C18:0 LCB d18:1	[3018]
527		3-sulfoglucuronyllactotsylparagloboside	3-sulfoglucuronylb1-3galactosylb1-4-N-acetyl-glucosaminylb1-3galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3030	Hideharu Ishida	SGLPG	C₈₂H₁₄₃N₃Na₂O₄₄S	1953.052												FAB-MS (negative ion mode); m/z 1896.82 (M-Na)^-, 1918.69 (M-H)^- (Ref. 3019)			Chemical Synthesis	Condensation of 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside with 4-O-acetyl-3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-glucopyranosyl trichloroacetimidate gave the desired b-glycoside, which was converted into 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranoside via removal of the O-acetyl and N-phthaloyl groups, followed by N-acetylation. Glycosylation ofthe disaccharide with O-(methyl 4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-b-D-glucopyranosyluronate)-(1-3)-2,4,6-tri-O-benzoyl-a-D-galactopyranosyl trichloroacetimidate using trimethylsilyl trifluoromethanesulfonate gave the target tetrasaccharide, which was transformed via removal of the benzyl group, O-benzoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the tetrasaccharide donor. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1- 3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1 - 4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the imidate donor using trimethylsilyl trifluoromethanesulfonate gave the desired heptasaccharide which was transformed into the heptasaccharide imidate donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the heptasaccharide donor gave b-glycoside, which was transformed into the target compound, via reduction of the azido group, coupling with octadecanoic acid, selective removal of the levulinoyl group, O-sulfation, hydrolysis of the methyl ester group and O-deacylation. (Ref. 3019)			Fatty acid C18:0 LCB d18:1	[3019]
528		3-sulfoglucuronyllactotsylparagloboside	3-sulfoglucuronylb1-3galactosylb1-4-N-acetyl-glucosaminylb1-3galactosylb1-4-N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3031	Hideharu Ishida	SGLPG	C₈₈H₁₅₅N₃Na₂O₄₂S	2005.213												FAB-MS (negative ion mode); m/z 1980.92 (M-Na)^-, 2003.85 (M-H)^- (Ref. 3019)			Chemical Synthesis	Condensation of 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside with 4-O-acetyl-3,6-di-O-benzyl-2-deoxy-2-phthalimido-b-D-glucopyranosyl trichloroacetimidate gave the desired b-glycoside, which was converted into 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranoside via removal of the O-acetyl and N-phthaloyl groups, followed by N-acetylation. Glycosylation ofthe disaccharide with O-(methyl 4-O-acetyl-2-O-benzoyl-3-O-levulinoyl-b-D-glucopyranosyluronate)-(1-3)-2,4,6-tri-O-benzoyl-a-D-galactopyranosyl trichloroacetimidate using trimethylsilyl trifluoromethanesulfonate gave the target tetrasaccharide, which was transformed via removal of the benzyl group, O-benzoylation, removal of the 2-(trimethylsilyl)ethyl group and imidate formation into the tetrasaccharide donor. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-b-D-glucopyranosyl)-(1- 3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1 - 4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the imidate donor using trimethylsilyl trifluoromethanesulfonate gave the desired heptasaccharide which was transformed into the heptasaccharide imidate donor. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the heptasaccharide donor gave b-glycoside, which was transformed into the target compound, via reduction of the azido group, coupling with tetracosanoic acid, selective removal of the levulinoyl group, O-sulfation, hydrolysis of the methyl ester group and O-deacylation. (Ref. 3019)			Fatty acid C24:0 LCB d18:1	[3019]
529		sialyl-dimeric Lex	N-acetylneuraminyla2-3galactosylb1-4(fucosyla1-3)N-acetyl-glucosaminylb1-3galactosylb1-4(fucosyla1-3)N-acetyl-glucosaminylb1-3galactosylb1-4glucosylceramide	GSG3032	Hideharu Ishida		C₉₇H₁₇₁N₃O₅₁	2195.385							-37.9(Ref. 3020)				1D 1H-NMR (Ref. 3032)				Chemical Synthesis	Regioselective glycosylation of the suitably protected Lewis X (Lex) pentasaccharide derivative with phenyl 4-O-acetyl-6-O-benzyl-2-deoxy-3-O-(4-methoxybenzyl)-2-phthalimido-1-thio-b-D-glucopyranoside gave the hexasaccharide, which was converted, via removal of the phthaloyl groups and selective N-acetylation, into the hexasaccharide acceptor. Dimethyl(methylthio)sulfonium triflate (DMTST) promoted glycosylation of the acceptor with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2 - 3) - 2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside afforded regioselectively the expected octasaccharide, which was converted into the acceptor via O-acetylation and removal of the methoxybenzyl group. Fucosylation of the acceotor with the methyl thioglycoside was performed by use of N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid(TfOH) as a promoter to give the desired nonasaccharide . After replacing the benzyl groups by the acetyl groups, the 2-(trimethylsilyl)ethyl group at the reducing end was selectively transformed into the a-trichloroacetimidate Coupling of the donor with (2S,3R,4E)-2-azido-3-O-tert-butyldiphenylsilyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-desilylation, O-deacylation, and hydrolysis of the methyl ester group, into the title ganglioside in good yield. (Ref. 3020)			Fatty acid C18:0 LCB d18:1	[3020] / [3032]
530		VIM-II	N-acetylneuraminyla2-3galactosylb1-4N-acetyl-glucosaminylb1-3galactosylb1-4(fucosyla1-3)N-acetyl-glucosaminylb1-3galactosylb1-4glucosylceramide	GSG3033	Hideharu Ishida		C₉₁H₁₆₁N₃O₄₇	2049.244							-17.4(Ref. 3021)				1D 1H-NMR (Ref. 3033)				Chemical Synthesis	Phenyl 2,3,4-tri-O-benzoyl-6-O-benzyl-b-D-galactopyranosyl-(1-4)-6-O-benzyl-2-deoxy-2-phthalimido-1-thio-b-D-glucopyranoside, a key intermediate prepared by condensation of phenyl 6-O-benzyl-2-deoxy-2-phthalimido-1-thio-b-D-glucopyranoside and 2,3,4-tri-O-benzoyl-6-O-benzyl-a-D-galactopyranosyl bromide, was glycosylated with methyl 2,3,4-tri-O-benzyl-1-thio-b-L-fucopyranoside to give the trisaccharide donor, which, on coupling with 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranosyl-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside, afforded the pentasaccharide. The regioselective glycosylation of the acceptor, with phenyl 2,3,4-tri-O-benzoyl-6-O-benzyl-b-D-galactopyranosyl-(1-4)-6-O-benzyl-2-deoxy-2-phthalimido-1-thio-b-D-glucopyranoside, gave the heptasaccharide, which was converted by treatment with hydrazine monohydrate and subsequent N-acetylation into the hexasaccharide acceptor. The stereo- and regioselective glycosylation of the acceptor with methyl (phenyl 5-acetamido-4,7,8,9-O-benzoyl-3,5-dideoxy-2-thio-D-glycero-b-D-galacto-2-nonulopyranosid)onategave the desired octasaccharide. Hydrogenolytic removal of the benzyl groups and successive O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and treatment with trichloroacetonitrile gave the a-trichloroacetimidate which was then coupled with (2S,3R,4E)-2-azido-3-O-(tert-butyldiphenylsilyl)-4-octadecene-1,3-diol. The ompound was transformed, via selective reduction of the azido group, N-introduction of octadecanoic acid, O-desilylation, O-deacylation, and saponification of the methyl ester group, into the title VIM-2 ganglioside. (Ref. 3021)			Fatty acid C18:0 LCB d18:1	[3021] / [3033]
531		sialyl-Lea	N-acetylneraminyla2-3galactosylb1-3(fucosyla1-4)N-acetyl-glucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3034	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₆	1708.963							-18.8(Ref. 3022)				1D 1H-NMR (Ref. 3022)				Chemical Synthesis	Methylsulfenyl bromide-silver triflate-promoted coupling of 2-(trimethylsilyl)ethyl O-(2-acetamido-6-O-benzy-2-deoxy-b-D-glucopyranosyl)-(1-3)-O-(2,4,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside afforded the pentasaccharide in good yield. Glycosylation of the pentasaccharide with methyl 2,3,4-tri-O-benzyl-1-thio-b-L-fucopyranoside by use of N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) as a promoter, gave the desired hexasaccharide. This was converted into the a-trichloroacetimidate, via reductive removal of benzyl groups, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and treatment with trichloroacetonitrile, which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title ganglioside in good yield. (Ref. 3022)			Fatty acid C18:0 LCB d18:1	[3022]
532			N-acetylneuraminyla2-3galactosylb1-3(N-acetylneuraminyla2-6)N-acetyl- -galactosaminylb1-4(N-acetylneraminyla2-8N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3035	Hideharu Ishida	GQ1ba	C₁₀₆H₁₈₂N₆O₅₅	2420.587		This ganglioside is the most potent neuronal ligands for myelin-associated glycoprotein. (Ref. 3040) Binding specificites of the sialoadhesin family of I-type lectins was examined by employing this ganglioside. (Ref. 3046)					-13.0(Ref. 3023)				1D 1H-NMR (Ref. 3023)				Chemical Synthesis	Regio- and stereo-selective monosialylation of C-6 of N-acetylgalactosamine residue and the subsequent disialylation with methyl (phenyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate of C-3 of galactose residue with methyl [phenyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid]onateon 2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-3,4-O-isopropylidene-b-D-galactopyranosyl)-(1-4)-O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-O-2,3,6-tri-O-benzyl-b-D-glucopyranoside by use of N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) as a promoter gave the corresponding hexasaccharide, containing a-glycosidicaly-linked monomeric sialic acid at C-6 of N-acetylgalactosamine residue and dimeric sialic acid at C-3 of galactose residue on gangliotriose moiety, which was transformed into the acceptor by removal of isopropylidene group. Condensation of methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside with the hexasaccharide acceptor, using dimethyl(methylthio)sulfonium triflate (DMTST) as a promoter, gave the desired octasaccharide derivative in high yield. The introduction of the ceramide moiety into the octasaccharide, O-deacylation, and hydrolysis of the methyl ester group gave the title ganglioside in good yield. (Ref. 3023)			Fatty acid C18:0 LCB d18:1	[3023] / [3040] / [3046]
533			N-acetylneraminyla2-8N-acetylneuraminyla2-3galactosylb1-3(N-acetylneraminyla2-8N-acetylneuraminyla2-6)N-acetyl- -galactosaminylb1-4galactosylb1-4glucosylceramide	GSG3036	Hideharu Ishida	GQ1b	C₁₀₆H₁₈₂N₆O₅₅	2420.587		This gangliosideis is not recognized by myelin-associated glycoprotein. (Ref. 3040)					+24.9(Ref. 3024)				1D 1H-NMR (Ref. 3024)				Chemical Synthesis	A fiRegio- and stereoselective dimeric sialylation of the hydroxyl group at C-6 of the GalNAc residue in 2-(trimethylsilyl)ethyl O-(2-acetamido-2-deoxy-3-O-levulinyl-b-D-galactopyranosyl)-(1-4)-O-(2,3,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-O-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl [phenyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galac-to-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero -D-galacto-2-nonulopyra-nosid]onate using N-iodosuccinimide (NIS)-trifluo-romethane-sulfonic acid (TfOH) as a promoter gave the desired pentasaccharide containing a-glycosidically-linked dimeric sialic acids. This was trans-formed into the acceptor by removal of the levulinyl group. Condensation of methyl O-[methyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-D-glycero-D-galacto-2-nonulopyranosylonate]-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside with the pentasaccharide acceptor, using dimethyl(methylthio)sulfonium triflate (DMTST) as a promoter, gave the desired octasaccharide derivative in high yield. The compound was converted into a-trichloroacetimidate, via reductive removal of the benzyl groups, O-acety-la-tion, removal of the 2-(trimethylsilyl)ethyl group, and treatment with trichloroace-toni-trile, which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the octasaccharide was transformed, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title ganglioside in good yield.(Ref. 3024)				[3024] / [3040]
534		SSEA-4	N-acetylneraminyla2-3galactosylb1-3-N-acetyl-galactosaminyl-b1-3galactosyl-a1-4galactosylb1-4glucosylceramide	GSG3037	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₇	1724.963							-3.0(Ref. 3025)				1D 1H-NMR (Ref. 3025)				Chemical Synthesis	a-Selective glycosylation of 2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the suitably protected galactose donor, methyl 3-O-acetyl-2-O-benzyl-4,6-O-benzylidene-1-thio-b-D-galactopyranoside gave the desired trisaccharide, which was transformed into the trisaccharide acceptor, by removal of the O-acetyl group. Glycosylation of this acceptor with methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-b-D-galactopyranoside gave the globotetraose derivative, which was transformed into the acceptor by removal of the phthaloyl and O-acetyl groups followed by N-acetylation. DMTST promoted coupling of this acceptor with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-ben-zoyl-1-thio-b-D-galactopyranoside afforded the desired sialyl globopentaoside derivative in good yield, which was transformed, by removal of the benzyl and benzylidene groups followed by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation, into the final glycosyl donor. Condensation of this imidate derivative with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the b-glycoside, which on channeling through selective reduction of the azido group, coupling of the amino group with octadecanoic acid, O-deacylation and saponification of the methyl ester group, gave the title compound, sialyl globopentaosyl ceramide.(Ref. 3025)			Fatty acid C18:0 LCB d18:1	[3025]
535		6-sulfo sialyl-Lex	N-acetylneraminyla2-3galactosylb1-4(fucosyla1-3)N-acetyl-6-sulfoglucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3038	Hideharu Ishida		C₇₉H₁₃₉N₃Na₂O₃₉S	1832.991		This ganglioside, the putative L-selectin ligand, was detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies. (Ref. 3045) This ganglioside is the preferred ligand for L-selectin and de-N-acetylation of the sialic acid enhances the binding strength. (Ref. 3047) IA major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes was identified as 6-sulfo sialyl Lewis X. (Ref. 3048)					-5.7(Ref. 3026)			(Ref. 3026)	1D 1H-NMR (Ref. 3026)	FAB-MS (negative ion mode); m/z 1794 (M-Na)^-, 1771 (M-2Na)^-² (Ref. 3026)			Chemical Synthesis	Coupling of the suitably protected N-acetyl-D-glucosaminyl-b(1-3)-lactose derivative with the sialyl a(2-3)-D-galactopyranosyl trichloroacetimidate, via glycosylation of 2-(trimethylsilyl)ethyl 4,6-O-benzylidene-b-D-galactopyranoside with phenyl 2-thioglycoside derivative of N-acetylneuraminic acid (Neu5Ac) using N-iodosuccinimide/TfOH, O-benzoylation, removal of the benzylidene group, selective 6-O-levulinoylation, O-benzoylation, removal of the 2-(trimethylsilyl)ethyl group, and imidate formation, or via O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, then imidate formation, gave the pentasaccharide. The glycosylation of the pentasaccharide acceptors, with phenyl 1-thioglycoside derivative of L-fucose using dimethyl(methylthio)sulfonium triflate (DMTST) afforded the corresponding hexasaccharides, which were transformed in good yields, via reductive removal of their benzyl groups, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, imidate formation, coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol in the presence of boron trifluoride etherate, selective reduction of the azido group, coupling with octadecanoic acid, selective removal of the levulinoyl groups, treatment with sulfur trioxide-pyridine complex, then removal of the protecting groups, into the desired sulfated sialyl Lex ganglioside analogues .(Ref. 3026)			Fatty acid C18:0 LCB d18:1	[3026] / [3045] / [3047] / [3048]
536		6'-sulfo sialyl-Lex	N-acetylneraminyla2-3(6-sulfo)galactosylb1-4(fucosyla1-3)N-acetylglucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3039	Hideharu Ishida		C₇₉H₁₃₉N₃Na₂O₃₉S	1832.991		This ganglioside was not detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies. (Ref. 3045)					-8.7(Ref. 3026)			(Ref. 3026)	1D 1H-NMR (Ref. 3026)	FAB-MS (negative ion mode); m/z 1794 (M-Na)^-, 1771 (M-2Na)^-²(Ref. 3026)			Chemical Synthesis	Coupling of the suitably protected N-acetyl-D-glucosaminyl-b(1-3)-lactose derivative with the sialyl a(2-3)-D-galactopyranosyl trichloroacetimidate, via glycosylation of 2-(trimethylsilyl)ethyl 4,6-O-benzylidene-b-D-galactopyranoside with phenyl 2-thioglycoside derivative of N-acetylneuraminic acid (Neu5Ac) using N-iodosuccinimide/TfOH, O-benzoylation, removal of the benzylidene group, selective 6-O-levulinoylation, O-benzoylation, removal of the 2-(trimethylsilyl)ethyl group, and imidate formation, or via O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, then imidate formation, gave the pentasaccharide. The glycosylation of the pentasaccharide acceptors, with phenyl 1-thioglycoside derivative of L-fucose using dimethyl(methylthio)sulfonium triflate (DMTST) afforded the corresponding hexasaccharides, which were transformed in good yields, via reductive removal of their benzyl groups, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, imidate formation, coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol in the presence of boron trifluoride etherate, selective reduction of the azido group, coupling with octadecanoic acid, selective removal of the levulinoyl groups, treatment with sulfur trioxide-pyridine complex, then removal of the protecting groups, into the desired sulfated sialyl Lex ganglioside analogues .(Ref. 3026)			Fatty acid C18:0 LCB d18:1	[3026] / [3045]
537		6,6'-bis-sulfo sialyl-Lex	N-acetylneraminyla2-3(6-sulfo)galactosylb1-4(fucosyla1-3)N-acetyl-6-sulfoglucosaminyl-b1-3galactosyl-b1-4glucosylceramide	GSG3040	Hideharu Ishida		C₇₉H₁₃₉N₃Na₂O₃₉S	1832.991		This ganglioside, the putative L-selectin ligand, was detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies. (Ref. 3045)					-10.3(Ref. 3026)			(Ref. 3026)	1D 1H-NMR (Ref. 3026)	FAB-MS (negative ion mode); m/z 1895 (M-Na)^- (Ref. 3026)			Chemical Synthesis	Coupling of the suitably protected N-acetyl-D-glucosaminyl-b(1-3)-lactose derivative with the sialyl a(2-3)-D-galactopyranosyl trichloroacetimidate, via glycosylation of 2-(trimethylsilyl)ethyl 4,6-O-benzylidene-b-D-galactopyranoside with phenyl 2-thioglycoside derivative of N-acetylneuraminic acid (Neu5Ac) using N-iodosuccinimide/TfOH, O-benzoylation, removal of the benzylidene group, selective 6-O-levulinoylation, O-benzoylation, removal of the 2-(trimethylsilyl)ethyl group, and imidate formation, or via O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, then imidate formation, gave the pentasaccharide. The glycosylation of the pentasaccharide acceptors, with phenyl 1-thioglycoside derivative of L-fucose using dimethyl(methylthio)sulfonium triflate (DMTST) afforded the corresponding hexasaccharides, which were transformed in good yields, via reductive removal of their benzyl groups, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, imidate formation, coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol in the presence of boron trifluoride etherate, selective reduction of the azido group, coupling with octadecanoic acid, selective removal of the levulinoyl groups, treatment with sulfur trioxide-pyridine complex, then removal of the protecting groups, into the desired sulfated sialyl Lex ganglioside analogues .(Ref. 3026)			Fatty acid C18:0 LCB d18:1	[3026] / [3045]
538			N-acetyl-galactosaminylb1-6(N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3041	Hideharu Ishida	6'-GM2	C₆₇H₁₂₁N₃O₂₆	1384.682		Structural basis for the resistance of Tay-sachs ganglioside GM2 to enzymatic degradation. was clarified by employing this ganglioside as a useful probe.(Ref. 3049)					+30.0(Ref. 3027)				1D 1H-NMR (Ref. 3027)				Chemical Synthesis	Removal of benzylidene group from 2-(trimethylsilyl)ethyl 2-O-benzyl-4,6-O-benzylidene-3-O-(4-methoxybenzyl)-b-D-galactopyranosyl-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside gave the lactose acceptor. The glycosylation of this compound with the oxazoline, which was prepared from the peracetylated derivative of GalNAc, in the presence of pyridinium p-toluenesulfonategave the desired b-glycoside in 61% yield. Removal of the 4-methoxybenzyl group afforded the expected glycosyl acceptor in 67% yield. Glycosylation of the acceptor with the phenyl 2-thioglycoside of Neu5Ac in the presence of N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) gave the expected a-glycoside. Removal of the benzyl groups and subsequent acetylation gave the peracetylated tetrasaccharide in 88% yield, which was converted into the corresponding trichloroacetimidate in good yield by selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation. The final glycosylation of (2S,3R,4E)-2-azido-3-O-(tert-butyldiphenylsilyl)-4-octadecene-1,3-diol with with the donor gave only the b-glycoside. Selective reduction of the azido group gave the amine , which on condensationwith octadecanoic acid furnished the fully protected target compound as follows: desilylation, and O-deacylation with sodium methoxide in methanol, and subsequent saponification of the methyl ester group, yielded the desired 6'-GM2 ganglioside. (Ref. 3027)			Fatty acid C18:0 LCB d18:1	[3027] / [3049]
539			N-acetylneraminyla2-8N-acetylneuraminyla2-3galactosylb1-3N-acetyl- -galactosaminylb1-4galactosylb1-4glucosylceramide	GSG3042	Hideharu Ishida	GD1c	C₈₄H₁₄₈N₄O₄₀	1854.077							+5.4(Ref. 3028)				1D 1H-NMR (Ref. 3028)				Chemical Synthesis	Condensation of methyl O-[methyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate]-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-gala-ctopyranoside with 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-galactopyranosyl)-(1-4)-O-(2,3,6-tri-O-benzyl-b-D-galactopy-ranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranosidegave the hexasaccharide derivative. This oligosaccharides was converted into the a-trichloroacetimidate via reductive removal of the benzyl groups and/or benzylidene group, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and treatment with trichloroacetonitrile, which, on coupling with 2-azidosphingosine derivative gave the b-glycoside. Finally, this was transformed, via selective reduction of the azido group, coupling with octadecanoic acid and removal of all protecting groups, into the title gangliosides GD1c. (Ref. 3028)			Fatty acid C18:0 LCB d18:1	[3028]
540			N-acetylneraminyla2-8N-acetylneuraminyla2-3galactosylb1-3N-acetyl- -galactosaminylb1-4(N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3043	Hideharu Ishida	GT1a	C₉₅H₁₆₅N₅O₄₇	2129.332							+2.0(Ref. 3028)				1D 1H-NMR (Ref. 3028)				Chemical Synthesis	Condensation of methyl O-[methyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate]-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-gala-ctopyranoside with 2-(trimethylsilyl)ethyl O-(2-acetamido-6-O-benzyl-2-deoxy-b-D-galactopyranosyl)-(1-4)-O-[methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)]-O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyra-noside in the presence of dimethyl(methylthio)sulfonium triflate (DMTST) gave the heptasaccharide derivative. This oligosaccharides was converted into the a-trichloroacetimidate via reductive removal of the benzyl groups and/or benzylidene group, O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and treatment with trichloroacetonitrile, which, on coupling with 2-azidosphingosine derivative gave the b-glycoside. Finally, this was transformed, via selective reduction of the azido group, coupling with octadecanoic acid and removal of all protecting groups, into the title ganglioside GT1a 19. (Ref. 3028)			Fatty acid C18:0 LCB d18:1	[3028]
541			N-acetyl- galactosaminylb1-4(N-acetylneraminyla2-8N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3044	Hideharu Ishida	GD2	C₇₈H₁₃₈N₄O₃₅	1691.936							-7.1(Ref. 3029)				1D 1H-NMR (Ref. 3029)				Chemical Synthesis	The glycosylation of the disialyl lactose acceptor with the suitably protected galactosamine donorin the presence of N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid gave the expected b-glycoside. Removal of the isopropylidene group gave andcatalytic hydrogenolysis of the benzyl group and subsequent O-acetylation, gave the peracetlated oligosaccharide. Treatment of the product with trifluoroacetic acid gave the 1-hydroxy compound. Treatment with trichloroacetonitrile gave the a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol23,24 with the donor afforded the desired b-glycoside . Selective reduction of the azido group gave the amine which, on condensation with octadecanoic acid, using 1-ethyl-3-(3-dimethylaminopropyl)carbodi-imide hydrochloride (WSC) in dichloromethane, gave the acylated ganglioside. Finally O-deacylation with sodium methoxide in methanol, subsequent hydrolysis of the methyl ester and lactone, and treatment with ethylenediamine in n-butanol for 1 h at 70			Fatty acid C18:0 LCB d18:1	[3029]
542			galactosylb1-3N-acetyl- galactosaminylb1-4(N-acetylneraminyla2-8N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3045	Hideharu Ishida	GD1b	C₈₄H₁₄₈N₄O₄₀	1854.077							-1.2(Ref. 3030)				1D 1H-NMR (Ref. 3030)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-6-O-benzyl-2-deoxy-3,4-O-iso-propylidene-b-D-galactopyranosyl)-(1-4)-O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl [phenyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid]onate using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) in acetonitrile gave the protected GD2 pentasaccharide, which was converted into the pentasaccharide acceptor by de-O-isopropylidenation. Glycosylation of the acceptor with methyl thioglycoside derivativeof galactose by use of dimethyl(methylthio)sulfonium triflate (DMTST) gave the protected GD1 oligosaccharide. The compound was transformed into the corresponding a-trichloroacetimidate via reductive removal of benzyl groups, O-acetylation, selective removal of 2-(trimethylsilyl)ethyl group, and treatment of trichloroacetonitrile. Condensation of the imidate with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted, via selective reduction of azido group, coupling with octadecanoic acid, de-O-acylation, and saponification of methyl esters and lactone groups, into the corresponding gangliosides GD1b.(Ref. 3030)			Fatty acid C18:0 LCB d18:1	[3030]
543			galactosylb1-3N-acetyl- galactosaminylb1-4(N-acetylneraminyla2-8N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3046	Hideharu Ishida	GD1b	C₉₅H₁₆₅N₅O₄₈	2145.331							-12.9(Ref. 3030)				1D 1H-NMR (Ref. 3030)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-6-O-benzyl-2-deoxy-3,4-O-iso-propylidene-b-D-galactopyranosyl)-(1-4)-O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl [phenyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyra-nosid]onate using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) in acetonitrile gave the protected GD2 pentasaccharide, which was converted into the pentasaccharide acceptor by de-O-isopropylidenation. Glycosylation of the acceptor with methyl thioglycoside derivative of sialyl galactose by use of dimethyl(methylthio)sulfonium triflate (DMTST) gave the protected ganglioside GT1b oligosaccharide. This was transformed into the corresponding a-trichloroacetimidate via reductive removal of benzyl groups, O-acetylation, selective removal of 2-(trimethylsilyl)ethyl group, and treatment of trichloroacetonitrile. Condensation of the imidate with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted, via selective reduction of azido group, coupling with octadecanoic acid, de-O-acylation, and saponification of methyl esters and lactone groups, into the corresponding ganglioside GT1b.(Ref. 3030)			Fatty acid C18:0 LCB d18:1	[3030]
544			galactosylb1-3N-acetyl- galactosaminylb1-4(N-acetylneraminyla2-8N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3047	Hideharu Ishida	GD1b	C₁₀₆H₁₈₂N₆O₅₆	2436.586							-22.0(Ref. 3030)				1D 1H-NMR (Ref. 3030)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-6-O-benzyl-2-deoxy-3,4-O-iso-propylidene-b-D-galactopyranosyl)-(1-4)-O-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl [phenyl 5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone)-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyra-nosid]onate using N-iodosuccinimide (NIS)-trifluoromethanesulfonic acid (TfOH) in acetonitrile gave the protected GD2 pentasaccharide, which was converted into the pentasaccharide acceptor by de-O-isopropylidenation. Glycosylation of the acceptor with methyl thioglycoside derivative of disialyl galactose by use of dimethyl(methylthio)sulfonium triflate (DMTST) gave the protected ganglioside GQ1b oligosaccharide. This was transformed into the corresponding a-trichloroacetimidate via reductive removal of benzyl groups, O-acetylation, selective removal of 2-(trimethylsilyl)ethyl group, and treatment of trichloroacetonitrile. Condensation of the imidate with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted, via selective reduction of azido group, coupling with octadecanoic acid, de-O-acylation, and saponification of methyl esters and lactone groups, into the corresponding ganglioside GQ1b.(Ref. 3030)			Fatty acid C18:0 LCB d18:1	[3030]
545			N-acetylneuraminyla2-3galactosylb1-3(N-acetylneuraminyla2-6)N-acetyl- -galactosaminylb1-4(N-acetylneraminyla2-3)galactosylb1-4glucosylceramide	GSG3048	Hideharu Ishida	GT1aa	C₉₅H₁₆₅N₅O₄₈	2145.331							+2.0				1D 1H-NMR (Ref. 3031)	FAB MS (negative ion mode, triethanolamine matrix): 2172.04 [M-Na]^-, 2150.06, 2149.07 [M-2Na]^-, 2127.06 [M - 3Na]^-,			Chemical Synthesis	The suitably protected sialyl-a-(2-6)-gangliotriose (III6NeuAc-GgOse) derivative was glycosylated with the phenyl 2-thioglycoside of sialic acid in the presence of N-iodosuccinimide (NIS) and trimethylsilyl trifluoromethanesulfonate (TMSOTf) in acetonitrile medium, giving the disialogangliotriose (III6NeuAcII3NeuAc-GgOse) derivative which contains both sialyl-a(2-6)-GalNAc and sialyl-a(2-3)-Gal structures. This pentasaccharide was efficiently synthesized by the coupling of (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-2-deoxy-4,6-O-isopropylidene-2-phthalimido-D-galactopyranosyl trichloroacetimidate with 2-(trimethylsilyl)ethyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-(2,6-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside, followed by conversion of the phthalimido group to the acetamido group. O-Deisopropylidenation and further glycosylation with methyl (methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-2,4,6-tri-O-benzoyl-1-thio-b-D-galactopyranoside, promoted by dimethyl(methylthio)sulfonium triflate (DMTST), gave the desired trisialogangliotetraose (IV3NeuAcIII6NeuAcII3NeuAc-GgOse4) derivative, which was converted stepwise into the title ganglioside GT1aa- by the introduction of the ceramide part and then complete deprotection. (Ref. 3031)			LCB d18:1	[3031]
546			N-acetylneraminyla2-8N-acetylneraminyla2-8N-acetylneraminyla2-3galactosylb1-4glucosylceramide	GSG3049	Hideharu Ishida	GT3	C₈₁H₁₄₂N₄O₃₇	1763.999							-11.6(Ref. 3052)				1D 1H-NMR (Ref. 3052)				Chemical Synthesis	Methyl [phenyl 5-acetamido-8-O-[5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1",9'-lactone)-4,7-di-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone]-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid]onate was prepared from free, trimeric sialic acid, via lactonization, methyl esterification of the carboxyl group at the reducting end, O-acetylation and conversion of the anomeric acetoxy group into a phenylthio group. Iodonium promoted glycosylation of the donor with the lactose acceptor gave the pentasaccharidesaving the (Neu5Ac)3-Lac structure. The peracylated oligosaccharide was converted into the a-trichloroacetimidate and coupled with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to afford the corresponding b-glycoside. This protected azidosphingosine derivative was transformed into the target ganglioside GT3 via selective reduction of the azido group, subsequent coupling with octadecanoic acid, O-deacylation and saponification of the methyl ester and lactone groups. (Ref. 3052)				[3052]
547			N-acetylneraminyla2-8N-acetylneraminyla2-8N-acetylneraminyla2-3galactosylceramide	GSG3050	Hideharu Ishida	GT4	C₇₅H₁₃₂N₄O₃₂	1601.858							-11.6(Ref. 3052)				1D 1H-NMR (Ref. 3052)				Chemical Synthesis	Methyl [phenyl 5-acetamido-8-O-[5-acetamido-8-O-(5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1",9'-lactone)-4,7-di-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylono-1',9-lactone]-4,7-di-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid]onate was prepared from free, trimeric sialic acid, via lactonization, methyl esterification of the carboxyl group at the reducting end, O-acetylation and conversion of the anomeric acetoxy group into a phenylthio group. Iodonium promoted glycosylation of the donor with 2-(trimethylsilyl)ethyl 2,6-di-O-benzyl-b-D-galacto-pyranoside gave the corresponding tetrasaccharide having the (Neu5Ac)3-Gal structure. The peracylated oligosaccharide was converted into the a-trichloroacetimidate and coupled with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to afford the corresponding b-glycoside. This protected azidosphingosine derivative was transformed into the target ganglioside GT3 via selective reduction of the azido group, subsequent coupling with octadecanoic acid, O-deacylation and saponification of the methyl ester and lactone groups. (Ref. 3052)				[3052]
548		sulfatide	3-sulfo-GalCer	GSG3051	Hideharu Ishida		C₄₂H₈₂NNaO₁₁S	832.156		Sulfatide does not support MAG-mediated adhesion.(Ref. 3040) Sulfatide is a ligand for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain.(Ref. 3066) Sulfatide has significant in vivo protective effects in neutrophil and selectin-dependent models of lung injury.(Ref. 3067) Sulfatide showed inhbitory activity on B cell proliferation and Ig production as a ligand for L-selectin.(Ref. 3068) Sulfatide showed in vitro and in vivo selectin-blocking activities(Ref. 3069)	217-219(decomp)(Ref. 3053)								1D 1H-NMR (Ref. 3053)		ion-spray MS (negative ion mode): m/z 806.5 [M-Na]^-, (positive ion mode): m/z 808.5 [M-Na+2H]^-		Chemical Synthesis	The 3-O-levulinoyl derivative of galactopyranosyl trichloroacetimidate was coupled with (2S,3R,4E)-3-O-acetyl-2-octadecanamido-4-octadecene-1,3-diol. The resulting glycolipid was transformed, by selective removal of the levulinoyl group, and successive sulfation and de-O-acylation, into the sulfatide.(Ref. 3053)			Fatty acid 18:0 LCB d18:1	[3040] / [3053] / [3066] / [3067] / [3068] / [3069]
549		GM4 position isomer	NeuAc2-6GalCer	GSG3052	Hideharu Ishida		C₄₉H₉₀N₂O₁₆	963.243							+1.0(Ref. 3003)			(Ref. 3003)	1D 1H-NMR (Ref. 3003)				Chemical Synthesis	The glycosylation of 2-(trimethylsilyl)ethyl 3-O-benzoyl-b-D-galactopyranoside with the sialyl donor using dimethyl(methylthio)sulfonium triflate (DMTST) gave the corresponding a-glycosides of Neu5Ac. Coupling of the trichloroacetimidate with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted via selective reduction of the azide group, condensation with tetradecanoic acid, O-deacylation, and hydrolysis of the methyl ester group into the title compound. (Ref. 3003)			Fatty acid 18:0 LCB d18:1	[3003]
550		GM4 analog	NeuAc2-6GlcNAcCer	GSG3053	Hideharu Ishida		C₅₅H₁₀₁N₃O₁₆	1060.401							-38.8(Ref. 3054)			(Ref. 3054)	1D 1H-NMR (Ref. 3054)				Chemical Synthesis	2-(Trimethylsilyl)ethyl sialyl-a(2-6)-2-acetamido-2-deoxy-b-D-glucopyranoside was converted into the corresponding oxazoline which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside. Finally, the b-glycoside was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation and hydrolysis of the methyl ester group, into the title compound.(Ref. 3054)			Fatty acid 18:0 LCB d18:1	[3054]
551		GM4 analog	NeuAc2-6GlcCer	GSG3054	Hideharu Ishida		C₅₅H₁₀₁N₃O₁₆	1060.401							-11.1(Ref. 3054)				1D 1H-NMR (Ref. 3054)				Chemical Synthesis	2-(Trimethylsilyl)ethyl sialyl-a(2-6)-b-D-glucopyranoside derivative was converted into the corresponding a-trichloroacetimidate which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside. Finally, the b-glycoside was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation and hydrolysis of the methyl ester group, into the title compound.(Ref. 3054)			Fatty acid 18:0 LCB d18:1	[3054]
552		GM3 positional isomer	NeuAc2-6Galb1-4GlcCer	GSG3055	Hideharu Ishida		C₅₉H₁₀₈N₂O₂₁	1181.490		This ganglioside is not a substrate of the trypanosoma crusi trans-sialidase.(Ref. 3070)					+8.9(Ref. 3055)				1D 1H-NMR (Ref. 3055)				Chemical Synthesis	Reductive removal of the benzyl groups in 2-(trimethylsilyl)ethyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-6)-(2-O-acetyl-3-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-acetyl-b-D-glucopyranoside, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group , and treatment with trichloroacetonitrile, which, on coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, the compound was transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title compound.(Ref. 3055)			Fatty acid 18:0 LCB d18:1	[3055] / [3070]
553		GM1b positional isomer	NeuAc2-6Galb1-3GalNAcb1-4Galb1-4GlcCer	GSG3056	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822							-4.2(Ref. 3007)			(Ref. 3007)	1D 1H-NMR (Ref. 3007)				Chemical Synthesis	Sialyl a2-6Gal donor was coupled with 3'''-OH of the suitably protected GalNAcb1-4Lac to give the pentasaccharide, which was transformed into the a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the a-trichloroacetimidate gave the corresponding b-glycosides, which on channeling through selective reductionof the azido group, coupling of thus formed aminogroup with octadecanoic acid, O-deacetylation, and saponification of the methyl ester group, gave the target compound. (Ref. 3007)			Fatty acid 18:0 LCB d18:1	[3007]
554		GM1b positional isomer	NeuAc2-3Galb1-6GalNAcb1-4Galb1-4GlcCer	GSG3057	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822							+12.0(Ref. 3007)			(Ref. 3007)	1D 1H-NMR (Ref. 3007)				Chemical Synthesis	Sialyl a2-3Gal donor was coupled with 6'''-OH of the suitably protected GalNAcb1-4Lac to give the pentasaccharide, which was transformed into the a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the a-trichloroacetimidate gave the corresponding b-glycosides, which on channeling through selective reductionof the azido group, coupling of thus formed aminogroup with octadecanoic acid, O-deacetylation, and saponification of the methyl ester group, gave the target compound. (Ref. 3007)			Fatty acid 18:0 LCB d18:1	[3007]
555		GM1b positional isomer	NeuAc2-6Galb1-6GalNAcb1-4Galb1-4GlcCer	GSG3058	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₂	1562.822							+11.5(Ref. 3007)			(Ref. 3007)	1D 1H-NMR (Ref. 3007)				Chemical Synthesis	Sialyl a2-6Gal donor was coupled with 6'''-OH of the suitably protected GalNAcb1-4Lac to give the pentasaccharide, which was transformed into the a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the a-trichloroacetimidate gave the corresponding b-glycosides, which on channeling through selective reductionof the azido group, coupling of thus formed aminogroup with octadecanoic acid, O-deacetylation, and saponification of the methyl ester group, gave the target compound. (Ref. 3007)			Fatty acid 18:0 LCB d18:1	[3007]
556		GD3 positional isomer	NeuAc2-9NeuAc2-3Galb1-4GlcCer	GSG3059	Hideharu Ishida		C₇₀H₁₂₅N₃O₂₉	1472.744		This ganglioside is not a substrate of the trypanosoma crusi trans-sialidase..(Ref. 3070)					+8.2(Ref. 3056)				1D 1H-NMR (Ref. 3056)				Chemical Synthesis	Coupling of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-9)-(methyl 5-acetamido-4,7,8-tri-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate using N-iodosuccinimide-trifluoromethanesulfonic acid as a glycosyl promoter, gave the tetrasaccharide, which was converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the O-(a-Neu5Ac)-(2-9)-O-(a-Neu5Ac)-(2-3')-a-lactosyl trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the title ganglioside.(Ref. 3056)			Fatty acid 18:0 LCB d18:1	[3056] / [3070]
557		sialyl-Lex (pentasaccharide homolog)	NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-3GalCer	GSG3060	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₁	1546.823		This ganglioside, sLex penta glycolipid was recognized by pl-ELAM COS cells, but not as avidly as sLex hexa glycolipid.(Ref. 3051) All three selectins bound to adsorbed sLex-penta-cer.(Ref. 3071)					-18.5(Ref. 3057)				1D 1H-NMR (Ref. 3057)				Chemical Synthesis	Königs-Knorr condensation of 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside with 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-D-glucopyranosyl bromide gave the desired b-linked disaccharide, which was further coupled with methyl 2,3,4-tri-O-benzyl-1-thio-b-L-fucopyranoside to give the fucosylated derivative, which was transformed by reductive ring-opening of the benzylidene acetal into the trisaccharide acceptor. Dimethyl(methylthio)sulfonium triflate (DMTST)-promoted coupling of the acceptor with the NeuAc2-3Gal donor afforded the desired pentasaccharide, which was converted into the a-trichloroacetimidate and condensed with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to give the b-glycoside, which was transformed into the title compound, via reduction of the azido group, coupling with octadecanoic acid, O-deacylation and hydrolysis of the methyl ester group.(Ref. 3057)			Fatty acid 18:0 LCB d18:1	[3051] / [3057] / [3071]
558		GD1a positional isomer	NeuAc2-6Galb1-3(NeuAc2-6)GalNAcb1-4Galb1-4GlcCer	GSG3061	Hideharu Ishida		C₈₄H₁₄₈N₄O₃₉	1838.077							+1.2(Ref. 3009)			(Ref. 3009)	1D 1H-NMR (Ref. 3009)				Chemical Synthesis	Suitably protected sialyl2-6gangliotetraose derivative was coupled with methyl O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-2-thio-D-glycero-D-galacto-2-nonulopyranosid)onate in acetonitrile medium in the presence of dimethyl(methylthio)sulfonium triflate (DMTST) to get the desired di-a-sialyl hexasaccharide derivative in moderate yield. The hexasaccharide trichloroacetimidate upon coupling with (2S, 3R, 4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-linked sphingosine glycoside in high yield. This was subjected in sequence to selective reduction of the azido group and coupling of the thus formed amino group with octadecanoic acid, O-deacylation, and saponification of the methyl ester groups to obtain a positional isomer of ganglioside GD1a . (Ref. 3009)			Fatty acid 18:0 LCB d18:1	[3009]
559		sialyl-Lex positional isomer	NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-6Galb1-4GlcCer	GSG3062	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₆	1708.963							-28.3(Ref. 3058)				1D 1H-NMR (Ref. 3058)				Chemical Synthesis	Tetrasaccharide containing GlcNAcb1-6Gal residue was obtained by glycosylation of 2-(trimethylsilyl)ethyl O-(2,3-di-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with methyl O-(2,3,4-tri-O-benzyl-a-L-fucopyranosyl)-(1-3)-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-b-D-glucopyranoside. The tretrasaccharide obtained was transformed into the acceptor. Dimethyl (methylthio)sulfonium triflate (DMTST)-promoted coupling of the accrptor with the NeuAc2-3Gal donor gave the desired hexasaccharide, which was converted , into the desired positional isomer of sialylLex gangliosides by our established procedures.(Ref. 3058)			Fatty acid 18:0 LCB d18:1	[3058]
560		sialyl-Lex (tetrasaccharide homolog)	NeuAc2-3Galb1-4(Fuca1-3)GlcCer	GSG3063	Hideharu Ishida		C₆₅H₁₁₈N₂O₂₅	1327.631							-21.5(Ref. 3059)				1D 1H-NMR (Ref. 3059)				Chemical Synthesis	Condensation of O-(methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonate)-(2-3)-O-(4-O-acetyl-2,6-di-O-benzoyl-b-D-galactopyranosyl)-(1-4)-O-[(2,3,4-tri-O-acetyl-a-L-fucopyranosyl)-(1-3)]-2,4-di-O-benzoyl-a-D-glucopyranosyl trichloroacetimidate with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the corresponding b-glycoside, which was converted into the gangliosid via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and saponification of the methyl ester group.(Ref. 3059)			Fatty acid 18:0 LCB d18:1	[3059]
561		sialyl-Lex (pentasaccharide homolog)	NeuGc2-3Galb1-4(Fuca1-3)GlcNAcb1-3GalCer	GSG3064	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₁	1546.823							-16.8(Ref. 3060)				1D 1H-NMR (Ref. 3060)				Chemical Synthesis	Königs-Knorr condensation of 2-(trimethylsilyl)ethyl 2,4,6-tri-O-benzyl-b-D-galactopyranoside with 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-D-glucopyranosyl bromide gave the desired b-linked disaccharide, which was further coupled with methyl 2,3,4-tri-O-benzyl-1-thio-b-L-fucopyranoside to give the fucosylated derivative, which was transformed by reductive ring-opening of the benzylidene acetal into the trisaccharide acceptor. Dimethyl(methylthio)sulfonium triflate (DMTST)-promoted coupling of the acceptor with the NeuGc2-3Gal donor afforded the desired pentasaccharide, which was converted into the a-trichloroacetimidate and condensed with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to give the b-glycoside, which was transformed into the title compound, via reduction of the azido group, coupling with octadecanoic acid, O-deacylation and hydrolysis of the methyl ester group.(Ref. 3060)			Fatty acid 18:0 LCB d18:1	[3060]
562		SSEA-4 positional isomer	NeuAc2-6Galb1-3GalNAcb1-3Gala1-4Galb1-4GlcCer	GSG3065	Hideharu Ishida		C₇₉H₁₄₁N₃O₃₇	1724.963							-2.0(Ref. 3025)				1D 1H-NMR (Ref. 3025)				Chemical Synthesis	a-Selective glycosylation of 2-(trimethylsilyl)ethyl O-(2,3,6-tri-O-benzyl-b-D-galactopyranosyl)-(1-4)-2,3,6-tri-O-benzyl-b-D-glucopyranoside with the suitably protected galactose donor, methyl 3-O-acetyl-2-O-benzyl-4,6-O-benzylidene-1-thio-b-D-galactopyranoside gave the desired trisaccharide, which was transformed into the trisaccharide acceptor, by removal of the O-acetyl group. Glycosylation of this acceptor with methyl 3-O-acetyl-4,6-O-benzylidene-2-deoxy-2-phthalimido-1-thio-b-D-galactopyranoside gave the globotetraose derivative, which was transformed into the acceptor by removal of the phthaloyl and O-acetyl groups followed by N-acetylation. DMTST promoted coupling of this acceptor with NeuAc-(2-6)-Gal donor afforded the positional isomer of sialyl globopentaoside derivative in good yield, which was transformed, by removal of the benzyl and benzylidene groups followed by O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group and subsequent imidate formation, into the final glycosyl donor. Condensation of this imidate derivative with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol gave the b-glycoside, which on channeling through selective reduction of the azido group, coupling of the amino group with octadecanoic acid, O-deacylation and saponification of the methyl ester group, gave the title compound, sialyl globopentaosyl ceramide.(Ref. 3025)			Fatty acid 18:0 LCB d18:1	[3025]
563		6-sulfo-de-N-acetyl sialyl-Lex	Neu2-3Galb1-4(Fuca1-3)(6-sulfo)GlcNAcb1-3Galb1-4GlcCer	GSG3066	Hideharu Ishida		C₇₇H₁₃₇N₃Na₂O₃₇S	1774.955		This ganglioside is a superio ligand for human L-selectin.(Ref. 3061)											FAB-MS (negative ion mode, triethanolamine matrix): m/z 1795.6 (M-H+Na)^-, 1773.0 (M-H)^-, 1750.6 (M-Na)^- (Ref. 3061)		Chemical Synthesis	Glycosylation of NeuTFAc donor, which was readily prepared from phenyl 2-thioglycoside of NeuAc, and the Gal acceptor was performed to give the desired sialyla(2-3)Gal derivative, which was converted into the trichloroacetimidate derivative. Coupling of the donor with the suitably protected trisaccharide acceptor gave the sialyla(2-3)neolactotetraose derivative. The 3-OH of the GlcNAc residue was then fucosylated . The resulting sialyl Lex hexasaccharide derivative was converted to the trichloroacetimidate . Glycosylation of the azidosphingosine derivative with the donor, and successive reduction of the azido group and N-acylation were carried out by the established method. The levulinoyl group was selectively removed by treatment with hydrazine monoacetate without cleavage of the TFAc group. The deprotected 6-OH of the GlcNAc residue was then sulfated by treatment with sulfur trioxide-pyridine complex. Finally, removal of all protective groups under the basic conditions furnished the target molecule .(Ref. 3061)			Fatty acid 18:0 LCB d18:1	[3061]
564		GT4 positional isomer	NeuAc2-8NeuAc2-8NeuAc2-6GalCer	GSG3067	Hideharu Ishida		C₇₅H₁₃₂N₄O₃₂	1601.858							-11.6(Ref. 3052)				1D 1H-NMR (Ref. 3052)				Chemical Synthesis	Trineric NeuAc donor was prepared from free, trimeric sialic acid, via lactonization, methyl esterification of the carboxyl group at the reducting end, O-acetylation and conversion of the anomeric acetoxy group into a phenylthio group. Iodonium promoted glycosylation of the donor with 2-(trimethylsilyl)ethyl 2,3-di-O-benzyl-b-D-galactopyranoside gave the corresponding tetrasaccharide having the a2-6 linked (Neu5Ac)3-Gal structure. The peracylated oligosaccharide was converted into the a-trichloroacetimidate and coupled with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol to afford the corresponding b-glycoside. This protected azidosphingosine derivative was transformed into the GT4 positional isomer via selective reduction of the azido group, subsequent coupling with octadecanoic acid, O-deacylation and saponification of the methyl ester and lactone groups. (Ref. 3052)			Fatty acid 18:0 LCB d18:1	[3052]
565		GM3 analog	8-epi-NeuAc2-3Galb1-4GlcCer	GSG3068	Hideharu Ishida		C₅₉H₁₀₈N₂O₂₁	1181.490		8-Epi-GM3 was almost devoid of immunosupressive activity compared with native GM3.(Ref. 3002) C-8-Epimerizationn in the neuraminic acid of GM3 impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid. (Ref. 3070)					-0.7(Ref. 3062)			(Ref. 3062)	1D 1H-NMR (Ref. 3062)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 8-epi-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3062)			Fatty acid 18:0 LCB d18:1	[3002] / [3062] / [3070]
566		GM3 analog	4-methoxy-NeuAc2-3Galb1-4GlcCer	GSG3069	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₁	1195.516		C-4-Methylation in the neuraminic acid of GM3 impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid. (Ref. 3070)					+3.0(Ref. 3062)			(Ref. 3062)	1D 1H-NMR (Ref. 3062)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 4-methoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3062)			Fatty acid 18:0 LCB d18:1	[3062] / [3070]
567		GM3 analog	9-methoxy-NeuAc2-3Galb1-4GlcCer	GSG3070	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₁	1195.516		C-9-Methylation in the neuraminic acid of GM3 does not impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid.. (Ref. 3070)					-0.7(Ref. 3062)			(Ref. 3062)	1D 1H-NMR (Ref. 3062)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 9-methoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3062)			Fatty acid 18:0 LCB d18:1	[3062] / [3070]
568		GM3 analog	9-deoxy-NeuAc2-3Galb1-4GlcCer	GSG3071	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₀	1179.517		9-Deoxy-GM3 evidenced the reduced immunosuppressive activity compared with GM3 with an unmodified sialic acid.(Ref. 3002) C-9-Deoxygenation in the neuraminic acid of GM3 does not impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid.. (Ref. 3070)					-0.5(Ref. 3063)			(Ref. 3063)	1D 1H-NMR (Ref. 3063)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 9-deoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3063)			Fatty acid 18:0 LCB d18:1	[3002] / [3063] / [3070]
569		GM3 analog	4-deoxy-NeuAc2-3Galb1-4GlcCer	GSG3072	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₀	1179.517		C-4-Deoxygenation in the neuraminic acid of GM3 impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid (Ref. 3070)					-14.0(Ref. 3063)				1D 1H-NMR (Ref. 3063)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 4-deoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3063)			Fatty acid 18:0 LCB d18:1	[3063] / [3070]
570		GM3 analog	7-deoxy-NeuAc2-3Galb1-4GlcCer	GSG3073	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₀	1179.517		C-7-Deoxygenation in the neuraminic acid of GM3 impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid. (Ref. 3070)					-9.2(Ref. 3063)				1D 1H-NMR (Ref. 3063)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 7-deoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3063)			Fatty acid 18:0 LCB d18:1	[3063] / [3070]
571		GM3 analog	8-deoxy-NeuAc2-3Galb1-4GlcCer	GSG3074	Hideharu Ishida		C₆₀H₁₁₀N₂O₂₀	1179.517		C-8-Deoxygenation in the neuraminic acid of GM3 impair the ability of trypanosoma crusi trans-sialidase to donate the modified sialic acid (Ref. 3070)					-1.2(Ref. 3063)			(Ref. 3063)	1D 1H-NMR (Ref. 3063)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(6-O-benzoyl-b-D-galactopyranosyl)-(1-4)-2,6-di-O-benzoyl-b-D-glucopyranoside with the methylthio glycoside of 8-deoxy-NeuAc gave the corresponding 2-(trimethylsilyl)ethyl sialyl a(2-3')-b-lactoside, which were converted, via O-acetylation, selective removal of the 2-(trimethylsilyl)ethyl group, and subsequent imidate formation, into the sialyl a(2-3')-lactose trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the corresponding b-glycoside, which was transformed, via selective reduction of the azide group, coupling with octadecanoic acid, O-deacylation, and hydrolysis of the methyl ester group, into the end product.(Ref. 3063)			Fatty acid 18:0 LCB d18:1	[3063] / [3070]
572		sialyl-Lex analog	C8-NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-3GalCer	GSG3075	Hideharu Ishida		C₇₂H₁₂₉N₃O₂₉	1500.797		The modification, shortening the glycerol side chain, in the sialic acid of the sLex was tolerated by all three selectins. (Ref. 3071)					-28.1(Ref. 3064)			(Ref. 3064)	1D 1H-NMR (Ref. 3064)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside with the phenyl 2-thioglycoside derivative of C8-NeuAc gave the required 2-(trimethylsilyl)ethyl sialyl-(2-3)-b-galactopyranoside, which was converted into the corresponding methyl thio glycoside as the glycosyl donor. Glycosylation of the suitbly protected Fuc-(1-3)-O-GlcNAc-(1-3)-Gal trisaccharide with the donor in the presence of DMTST afforded the expected b-glycoside, which was converted into the corresponding a-trichloroacetimidate, which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, these were transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and de-esterification into the target compound.(Ref. 3064)			Fatty acid 18:0 LCB d18:1	[3064] / [3071]
573		sialyl-Lex analog	8-epi-NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-3GalCer	GSG3076	Hideharu Ishida		C₇₃H₁₃₁N₃O₃₀	1530.823		The modification, epimerization at C-8, in the sialic acid of the sLex was tolerated by all three selectins. (Ref. 3071)					-20.0(Ref. 3064)			(Ref. 3064)	1D 1H-NMR (Ref. 3064)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside with the methyl 2-thioglycoside derivative of 8-epi-NeuAc gave the required 2-(trimethylsilyl)ethyl sialyl-(2-3)-b-galactopyranoside, which was converted into the corresponding methyl thio glycoside as the glycosyl donor. Glycosylation of the suitbly protected Fuc-(1-3)-O-GlcNAc-(1-3)-Gal trisaccharide with the donor in the presence of DMTST afforded the expected b-glycoside, which was converted into the corresponding a-trichloroacetimidate, which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, these were transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and de-esterification into the target compound.(Ref. 3064)			Fatty acid 18:0 LCB d18:1	[3064] / [3071]
574		sialyl-Lex analog	C7-NeuAc2-3Galb1-4(Fuca1-3)GlcNAcb1-3GalCer	GSG3077	Hideharu Ishida		C₇₁H₁₂₇N₃O₂₈	1470.771							-17.8(Ref. 3064)			(Ref. 3064)	1D 1H-NMR (Ref. 3064)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl 6-O-benzoyl-b-D-galactopyranoside with the phenyl 2-thioglycoside derivative of C7-NeuAc gave the required 2-(trimethylsilyl)ethyl sialyl-(2-3)-b-galactopyranoside, which was converted into the corresponding methyl thio glycoside as the glycosyl donor. Glycosylation of the suitbly protected Fuc-(1-3)-O-GlcNAc-(1-3)-Gal trisaccharide with the donor in the presence of DMTST afforded the expected b-glycoside, which was converted into the corresponding a-trichloroacetimidate, which, on coupling with (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol, gave the b-glycoside. Finally, these were transformed, via selective reduction of the azide group, condensation with octadecanoic acid, O-deacylation, and de-esterification into the target compound.(Ref. 3064)			Fatty acid 18:0 LCB d18:1	[3064]
575		sialyl-Lex analog	NeuAc2-3Galb1-4(2-deoxy-Fuca1-3)GlcNAcb1-3GalCer	GSG3078	Hideharu Ishida		C₇₃H₁₃₁N₃O₂₉	1514.824		Removal of oxygen at the C-2 position of the fucose residue of sLex completely eliminated recognition by E- and L-selectin. P-selectin, however , was able to recognize this structure.(Ref. 3071)					-5.3(Ref. 3065)				1D 1H-NMR (Ref. 3065)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranoside with the methyl 1-thioglycoside derivative of 2-deoxyfucose gave the required trisaccharide. This transformed into the glycosyl acceptor. DMTST promoted glycosylation of the trisaccharide acceptor with NeuAc-(2-3)-Gal donor afforded the desired pentasaccharide, which was converted into the corresponding a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the expected b-glycoside, which was transformed, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target compound.(Ref. 3065)			Fatty acid 18:0 LCB d18:1	[3065] / [3071]
576		sialyl-Lex analog	NeuAc2-3Galb1-4(3-deoxy-Fuca1-3)GlcNAcb1-3GalCer	GSG3079	Hideharu Ishida		C₇₃H₁₃₁N₃O₂₉	1514.824		Removal of oxygen at the C-3 position of the fucose residue of sLex completely eliminated recognition by all three selectins.(Ref. 3071)					-5.4(Ref. 3065)				1D 1H-NMR (Ref. 3065)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranoside with the methyl 1-thioglycoside derivative of 3-deoxyfucose gave the required trisaccharide. This transformed into the glycosyl acceptor. DMTST promoted glycosylation of the trisaccharide acceptor with NeuAc-(2-3)-Gal donor afforded the desired pentasaccharide, which was converted into the corresponding a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the expected b-glycoside, which was transformed, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target compound.(Ref. 3065)			Fatty acid 18:0 LCB d18:1	[3065] / [3071]
577		sialyl-Lex analog	NeuAc2-3Galb1-4(4-deoxy-Fuca1-3)GlcNAcb1-3GalCer	GSG3080	Hideharu Ishida		C₇₃H₁₃₁N₃O₂₉	1514.824		Removal of oxygen at the C-4 position of the fucose residue of sLex completely eliminated recognition by E- and L-selectin. P-selectin, however , was able to recognize this structure.(Ref. 3071)					-13.5(Ref. 3065)				1D 1H-NMR (Ref. 3065)				Chemical Synthesis	Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-b-D-glucopyranosyl)-(1-3)-2,4,6-tri-O-benzyl-b-D-galactopyranoside with the methyl 1-thioglycoside derivative of 4-deoxyfucose gave the required trisaccharide. This transformed into the glycosyl acceptor. DMTST promoted glycosylation of the trisaccharide acceptor with NeuAc-(2-3)-Gal donor afforded the desired pentasaccharide, which was converted into the corresponding a-trichloroacetimidate. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with the donor afforded the expected b-glycoside, which was transformed, via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target compound.(Ref. 3065)			Fatty acid 18:0 LCB d18:1	[3065] / [3071]
578			Glucronosyla1-1ceramide	GSG6001	Nagatoshi Fujiwara					Stimulation of phagocytosis and phagosome-lysosome fusion(Ref. 6005) Induction of apoptosis in HL-60 cell						Chloroform/methanol(2:1, v/v)		IR [Spectrum 6002](Ref. 6001)		FAB-MS(-),[M-H]^-=742,702(2OH-C14:0-dDC21:0,2OH-C14:0-dC18:0)(Ref. 6004) [Spectrum 6001]		TLC with developing solvent Chloroform/methanol/acetic acid/water(100:20:12:5, by vol.) or Chloroform/methanol/water(65:25:4, by vol.)(Ref. 6006) [Chromatogram 6001] GC of alditol acetate derivatives(Ref. 6004) [Chromatogram 6003]	Sphingomonas species(Ref. 6004) Flavobacterium devorans ATCC 10829 (Ref. 1392)				Fatty acid 2OH-C14:0 LCB dD21:0, d18:0	[1392] / [6001] / [6004] / [6005] / [6006]
579			Glucosaminyla1-4glucuronosyla1-1ceramide	GSG6002	Nagatoshi Fujiwara											Chloroform/methanol(2:1, v/v)				FAB-MS(-),[M-H]^-=903,863,945(2OH-C14:0-dDC21:0,2OH-C14:0-dC18:0)(Ref. 6004) [Spectrum 6003]		Two-dimensional TLC with developing solvent 1st; Chloroform/methanol/water(65:25:4, by vol.), 2nd; Chloroform/methanol/water(65:25:10, by vol.)(Ref. 6004) [Chromatogram 6002] GC of alditol acetate derivatives(Ref. 6004) [Chromatogram 6003]	Sphingomonas species(Ref. 6004)				Fatty acid 2OH-C14:0 LCB dD21:0, d18:0	[6004]
580			Galactosyla1-6glucosaminyla1-4glucuronosyla1-1ceramide	GSG6003	Nagatoshi Fujiwara											Chloroform/methanol(2:1, v/v)				FAB-MS(-),[M-H]^-=1065,1025,1107(2OH-C14:0-dDC21:0,2OH-C14:0-dC18:0)(Ref. 6004) [Spectrum 6004]		Two-dimensional TLC with developing solvent 1st; Chloroform/methanol/water(65:25:4, by vol.), 2nd; Chloroform/methanol/water(65:25:10, by vol.)(Ref. 6004) [Chromatogram 6002] GC of alditol acetate derivatives(Ref. 6004) [Chromatogram 6003]	Sphingomonas species(Ref. 6004)				Fatty acid 2OH-C14:0 LCB dD21:0, d18:0	[6004]
581			Mannosyla1-2Galactosyla1-6glucosaminyla1-4glucuronosyla1-1ceramide	GSG6004	Nagatoshi Fujiwara					Stimulation of phagocytosis and phagosome-lysosome fusion(Ref. 6005) Induction of apoptosis in HL-60 cell						Chloroform/methanol(1:4, v/v)			¹H NMR and ¹³C NMR(Ref. 6003) [Table 6001]	FAB-MS(-),[M-H]^-=1227,1187,1269(2OH-C14:0-dDC21:0,2OH-C14:0-dC18:0)(Ref. 6004) [Spectrum 6005]		Two-dimensional TLC with developing solvent 1st; Chloroform/methanol/water(65:25:4, by vol.), 2nd; Chloroform/methanol/water(65:25:10, by vol.)(Ref. 6004) [Chromatogram 6002] GC of alditol acetate derivatives(Ref. 6004) [Chromatogram 6003]	Sphingomonas species(Ref. 6004)				Fatty acid 2OH-C14:0 LCB dD21:0, d18:0	[6003] / [6004] / [6005]

Reference

[0001]

AUTHOR	:	Yamakawa, T., Kiso, N., Handa, S., Makita, A., and Yokoyama, S.
TITLE	:	On the structure of brain cerebroside sulfuric ester and ceramide dihexoside of erythrocytes PubMed ID:14002299
JOURNAL	:	J Biochem (Tokyo).
VOL	:	52 PAGE : 226-227 (1962)

[TOP]

[0002]

AUTHOR	:	Thudichum,J.L.W.(1874) Researches on the chemical constitution of the brain in report of the Medical Officer of the Privy Council, London, n.S., No. 3, append. 5, pp113-247
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[0003]

AUTHOR	:	Mehl, E., and Jatzkewitz, H.
TITLE	:	[A cerebrosidesulfatase from swine kidney] PubMed ID:5829234
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	339 PAGE : 260-276 (1964)

[TOP]

[0004]

AUTHOR	:	Martensson, E.
TITLE	:	Sulfatides of human kidney. Isolation, identification, and fatty acid composition PubMed ID:5963014
JOURNAL	:	Biochim Biophys Acta.
VOL	:	116 PAGE : 521-531 (1966)

[TOP]

[0006]

AUTHOR	:	Mehl,E., and Jatzkewitz,H.
TITLE	:	Cerebroside 3-sulfate as a physiological substrate of arylsulfatase A PubMed ID:5646041
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	151 PAGE : 619-627 (1968)

[TOP]

[0009]

AUTHOR	:	Neskovic,N.,Sarlieve,L.,Nussbaum,J.-L.,Kostic,D., and Mandel,P.
TITLE	:	Quantitative thin-layer chromatography of glycolipids in animal tissues. PubMed ID:5031779
JOURNAL	:	Clin. Chim. Acta
VOL	:	38 PAGE : 147-153 (1972)

[TOP]

[0010]

AUTHOR	:	Harzer, K., and Benz, H. U.
TITLE	:	Deficiency of lactosyl sulfatide sulfatase in metachromatic leucodystrophy (sulfatidosis) PubMed ID:4140140
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	355 PAGE : 744-748 (1974)

[TOP]

[0011]

AUTHOR	:	Mraz, W., and Jatzkewitz, H.
TITLE	:	Cerebroside sulphatase activity of arylsulphatases from various invertebrates PubMed ID:4435712
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	355 PAGE : 33-44 (1974)

[TOP]

[0012]

AUTHOR	:	Stinshoff,K., and Jatzkewitz,H.
TITLE	:	Comparison of the cerebroside sulphatase and the arylsulphatase activity of human sulphatase a in the absence of activators. PubMed ID:235289
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	377 PAGE : 126-138 (1975)

[TOP]

[0013]

AUTHOR	:	Fischer, G., and Jatzkewitz, H.
TITLE	:	The activator of cerebroside sulphatase. Purification from human liver and identification as a protein PubMed ID:239890
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	356 PAGE : 605-613 (1975)

[TOP]

[0014]

AUTHOR	:	Levine, M., Bain, J., Narashimhan, R., Palmer, B., Yates, A. J., and Murray, R. K.
TITLE	:	A comparative study of the glycolipids of human, bird and fish testes and of human sperm PubMed ID:952980
JOURNAL	:	Biochim Biophys Acta.
VOL	:	441 PAGE : 134-145 (1976)

[TOP]

[0015]

AUTHOR	:	Hatanaka,H.,Egami,F.,Ishizuka,I., and Nagai,Y.
TITLE	:	Sulphogalatolipid sulphohydrolase activity of arylsulfatase purified from a marine gastropod Charonia lampas. PubMed ID:938679
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	438 PAGE : 176-185 (1976)

[TOP]

[0016]

AUTHOR	:	Farooqui,A.A.,Rebel,G., and Mandel, P.
TITLE	:	Sulphatide metabolism in brain. PubMed ID:320417
JOURNAL	:	Life Sci.
VOL	:	20 PAGE : 569-583 (1977)

[TOP]

[0017]

AUTHOR	:	Pollet, S., Ermidou, S., Le Saux, F., Monge, M., and Baumann, N.
TITLE	:	Microanalysis of brain lipids: multiple two-dimensional thin-layer chromatography PubMed ID:712251
JOURNAL	:	J Lipid Res.
VOL	:	19 PAGE : 916-921 (1978)

[TOP]

[0019]

AUTHOR	:	Tadano, K., and Ishizuka, I.
TITLE	:	Enzymatic sulfation of galactosyl- and lactosylceramides in cell lines derived from renal tubules PubMed ID:117838
JOURNAL	:	Biochim Biophys Acta.
VOL	:	575 PAGE : 421-430 (1979)

[TOP]

[0020]

AUTHOR	:	Nonaka,G., and Kishimoto,Y.
TITLE	:	Levels of cerebrosides, sulfatides, and galactosyl diglycerides in different regions of rat brain.Change during maturation and distributionin subcellular fractions of gray and white matter of sheep brain. PubMed ID:435504
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	572 PAGE : 432-441 (1979)

[TOP]

[0021]

AUTHOR	:	Tamai,Y.,Kojima,H.,Abe,K.,and Saito,S.(1982) Glycolipid composition of fish brains and its bearing on the phylogeny in New Vistas in Glycolipid Research , (Makita,A., Handa,S., Taketomi, T., and nagai,Y., eds), pp315-323, Plenum press, New York.
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[0022]

AUTHOR	:	Lin, Y. N., and Horowitz, M. I.
TITLE	:	Cerebroside sulfotransferase in rat gastric mucosa PubMed ID:6957358
JOURNAL	:	Int J Biochem.
VOL	:	14 PAGE : 831-838 (1982)

[TOP]

[0023]

AUTHOR	:	Burkart, T., Caimi, L., Siegrist, H. P., Herschkowitz, N. N., and Wiesmann, U. N.
TITLE	:	Vesicular transport of sulfatide in the myelinating mouse brain. Functional association with lysosomes? PubMed ID:6949901
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 3151-3156 (1982)

[TOP]

[0024]

AUTHOR	:	Kakinuma, K., Yamaguchi, T., Suzuki, H., and Nagai, Y.
TITLE	:	Sulfatide activation of the oxygen radical generating system of leucocytes PubMed ID:7128820
JOURNAL	:	FEBS Lett.
VOL	:	145 PAGE : 16-20 (1982)

[TOP]

[0025]

AUTHOR	:	Ishizuka,I.,and Tadano,K.(1982) The sulfoglycolipid, highly acidic amphiphiles of mammalian renal tubules,in New Vistas in Glycolipid Research, ed. (Makita,A.,Handa,s., Taketomi,T, and Nagai,Y.,eds), pp195-206, Plenum press, New York.
TITLE	:
JOURNAL	:
VOL	:	PAGE : 195-206 (1982)

[TOP]

[0026]

AUTHOR	:	Tadano, K., and Ishizuka, I.
TITLE	:	Isolation and characterization of the sulfated gangliotriaosylceramide from rat kidney PubMed ID:7056729
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 1482-1490 (1982)

[TOP]

[0027]

AUTHOR	:	Tadano-Aritomi,K., and Ishizuka,I.
TITLE	:	Determination of peracetylated sulfoglycolipids using the azure A method. PubMed ID:6196425
JOURNAL	:	J. Lipid Res.
VOL	:	24 PAGE : 1368-1375 (1983)

[TOP]

[0029]

AUTHOR	:	Saito,S., and Tamai,Y.
TITLE	:	Characteristic constituents of glycolipids from frog and sciatic nerve. PubMed ID:6603493
JOURNAL	:	J. Neurochem.
VOL	:	41 PAGE : 737-744 (1983)

[TOP]

[0030]

AUTHOR	:	Farooqui, A. A., and Horrocks, L. A.
TITLE	:	Biochemical aspects of globoid and metachromatic leukodystrophies PubMed ID:6152665
JOURNAL	:	Neurochem Pathol.
VOL	:	2 PAGE : 189-218 (1984)

[TOP]

[0031]

AUTHOR	:	Nakamura,K.,Fujita,R.,Uemo,K., and Handa,S.
TITLE	:	Glycosphingolipids of porcine pancreas. PubMed ID:6746593
JOURNAL	:	J. Biochem.
VOL	:	95 PAGE : 1137-1144 (1984)

[TOP]

[0032]

AUTHOR	:	Tocque, B., Albouz, S., Boutry, J. M., Le Saux, F., Hauw, J. J., Bourdon, R., Baumann, N., and Zalc, B.
TITLE	:	Desipramine elicits the expression of opiate receptors and sulfogalactosylceramide synthesis in rat C6 glioma cells PubMed ID:6321658
JOURNAL	:	J Neurochem.
VOL	:	42 PAGE : 1101-1106 (1984)

[TOP]

[0033]

AUTHOR	:	Ishizuka, I., and Tadano-Aritomi, K.
TITLE	:	Characterization of sulfoglycosphingolipids by direct probe electron impact mass spectrometry PubMed ID:6501265
JOURNAL	:	J Biochem (Tokyo).
VOL	:	96 PAGE : 829-839 (1984)

[TOP]

[0034]

AUTHOR	:	Nagai, K., Ishizuka, I., and Oda, S.
TITLE	:	Acidic glycolipids from kidney of suncus (Insectivora) PubMed ID:6746617
JOURNAL	:	J Biochem (Tokyo).
VOL	:	95 PAGE : 1501-1511 (1984)

[TOP]

[0036]

AUTHOR	:	Kushi, Y., Handa, S., and Ishizuka, I.
TITLE	:	Secondary ion mass spectrometry for sulfoglycolipids: application of negative ion detection PubMed ID:4008462
JOURNAL	:	J Biochem (Tokyo).
VOL	:	97 PAGE : 419-428 (1985)

[TOP]

[0039]

AUTHOR	:	Nagai, K., Tadano-Aritomi, K., Kawaguchi, K., and Ishizuka, I.
TITLE	:	Acidic glycolipids from dolphin kidney PubMed ID:4066654
JOURNAL	:	J Biochem (Tokyo).
VOL	:	98 PAGE : 545-559 (1985)

[TOP]

[0040]

AUTHOR	:	Roberts,D.D.,Haverstick,D.M.,Dixit,V.M.,Frazier,W.A.,Santoro,S.A., and Ginsburg,V.
TITLE	:	The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. PubMed ID:3926767
JOURNAL	:	J. Biol. Chem.
VOL	:	260 PAGE : 9405-9411 (1985)

[TOP]

[0043]

AUTHOR	:	Goujet-Zalc,C.,Guerci,A.,Dubois,G., and Zalc,B.
TITLE	:	Schwann cell marker defined by a monoclonal antibody (224-58) with species cross-reactivity. II. Molecular characterization of the epitope. PubMed ID:2416875
JOURNAL	:	J. Neurochem.
VOL	:	46 PAGE : 435-439 (1986)

[TOP]

[0044]

AUTHOR	:	Roberts, D. D., Rao, C. N., Liotta, L. A., Gralnick, H. R., and Ginsburg, V.
TITLE	:	Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids PubMed ID:3486185
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 6872-6877 (1986)

[TOP]

[0046]

AUTHOR	:	Niimura,Y., and Ishizuka,I.
TITLE	:	Glycosphingolipid composition of a renal cell line (MDCK) and its ouabain-resistant mutant. PubMed ID:3818564
JOURNAL	:	J. Biochem.
VOL	:	100 PAGE : 825-835 (1986)

[TOP]

[0047]

AUTHOR	:	Conzelmann, E., and Sandhoff, K.
TITLE	:	Activator proteins for lysosomal glycolipid hydrolysis PubMed ID:2885714
JOURNAL	:	Methods Enzymol.
VOL	:	138 PAGE : 792-815 (1987)

[TOP]

[0048]

AUTHOR	:	Farooqui,A.A.
TITLE	:	Clinical and metabolic aspects of sulfohydrolases in man. PubMed ID:3307326
JOURNAL	:	Adv. Clin. Chem.
VOL	:	26 PAGE : 157-201 (1987)

[TOP]

[0050]

AUTHOR	:	Fredman,P.,Mattson,L.,Andersson,K.,Davidsson,P.,Ishizuka,I.,Jeansson,S., Mansson,J.E., and Svennerholm,L.
TITLE	:	Characterization of the binding epitope of a monoclonal antibody to sulphatide. PubMed ID:2455508
JOURNAL	:	Biochem. J.
VOL	:	251 PAGE : 17-22 (1988)

[TOP]

[0053]

AUTHOR	:	Natomi, H., Sugano, K., Iwamori, M., Takaku, F., and Nagai, Y.
TITLE	:	Region-specific distribution of glycosphingolipids in the rabbit gastrointestinal tract: preferential enrichment of sulfoglycolipids in the mucosal regions exposed to acid PubMed ID:3390457
JOURNAL	:	Biochim Biophys Acta.
VOL	:	961 PAGE : 213-222 (1988)

[TOP]

[0054]

AUTHOR	:	Roy, A. B., and Mantle, T. J.
TITLE	:	The anomalous kinetics of sulphatase A PubMed ID:2572216
JOURNAL	:	Biochem J.
VOL	:	261 PAGE : 689-697 (1989)

[TOP]

[0055]

AUTHOR	:	Vrbaski,S.R.,Ristic,V.I.,Petrovic,G.T., and Ristic,M.S.
TITLE	:	Brain lipids in rat after chronic diazepam treatment. PubMed ID:2753868
JOURNAL	:	J. Biochem.
VOL	:	105 PAGE : 705-707 (1989)

[TOP]

[0056]

AUTHOR	:	Nagai, K., Roberts, D. D., Toida, T., Matsumoto, H., Kushi, Y., Handa, S., and Ishizuka, I.
TITLE	:	Mono-sulfated globotetraosylceramide from human kidney PubMed ID:2559078
JOURNAL	:	J Biochem (Tokyo).
VOL	:	106 PAGE : 878-886 (1989)

[TOP]

[0057]

AUTHOR	:	Kean, E. L.
TITLE	:	Rapid, sensitive spectrophotometric method for quantitative determination of sulfatides PubMed ID:5646183
JOURNAL	:	J Lipid Res.
VOL	:	9 PAGE : 319-327 (1968)

[TOP]

[0076]

AUTHOR	:	Tadano, K., and Ishizuka, I.
TITLE	:	Isolation and partial characterization of a novel sulfoglycosphingolipid and ganglioside GM4 from rat kidney PubMed ID:6779816
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	97 PAGE : 126-132 (1980)

[TOP]

[0077]

AUTHOR	:	Ishizuka, I., Nagai, K., Kawaguchi, K., Tadano-Aritomi, K., Toida, T., Hirabayashi, Y., Li, Y. T., and Li, S. C.
TITLE	:	Preparation and enzymatic degradation of monosulfogangliotriaosylceramide PubMed ID:3928630
JOURNAL	:	J Biol Chem.
VOL	:	260 PAGE : 11256-11261 (1985)

[TOP]

[0078]

AUTHOR	:	Nagai, K., and Ishizuka, I.
TITLE	:	Biosynthesis of monosulfogangliotriaosylceramide and GM2 by N-acetylgalactosaminyltransferase from rat brain PubMed ID:3115968
JOURNAL	:	J Biochem (Tokyo).
VOL	:	101 PAGE : 1115-1127 (1987)

[TOP]

[0079]

AUTHOR	:	Tadano, K., and Ishizuka, I.
TITLE	:	Isolation and partial characterization of a novel disulfoglycosphingolipid from rat kidney PubMed ID:7332569
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	103 PAGE : 1006-1013 (1981)

[TOP]

[0080]

AUTHOR	:	Tadano, K., and Ishizuka, I.
TITLE	:	Bis-sulfoglycosphingolipid containing a unique 3-O-sulfated N-acetylgalactosamine from rat kidney PubMed ID:7107569
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 9294-9299 (1982)

[TOP]

[0081]

AUTHOR	:	Tadano, K., Ishizuka, I., Matsuo, M., and Matsumoto, S.
TITLE	:	Bis-sulfated gangliotetraosylceramide from rat kidney PubMed ID:7142156
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 13413-13420 (1982)

[TOP]

[0082]

AUTHOR	:	Leffler,H.,Hansson,G.C., and Stromberg,N.
TITLE	:	A novel sulfoglycosphingolipid of mouse small intestine, IV3-sulfogangliotetraosylceramide, demonstrated by negative ion FAB-MS. PubMed ID:3944094
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 1440-1444 (1986)

[TOP]

[0083]

AUTHOR	:	Hiraiwa, N., Iida, N., Ishizuka, I., Itai, S., Shigeta, K., Kannagi, R., Fukuda, Y., and Imura, H.
TITLE	:	Monoclonal antibodies directed to a disulfated glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), associated with human hepatocellular carcinoma PubMed ID:2846160
JOURNAL	:	Cancer Res.
VOL	:	48 PAGE : 6769-6774 (1988)

[TOP]

[0084]

AUTHOR	:	Nagai, K., Roberts, D. D., Toida, T., Matsumoto, H., Kushi, Y., Handa, S., and Ishizuka, I.
TITLE	:	Mono-sulfated globopentaosylceramide from human kidney PubMed ID:2777788
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 16229-16237 (1989)

[TOP]

[0085]

AUTHOR	:	Chou,D.K.H.,Ilyas,A.A.,Evans,J.E.,Costello,C.,Quarles,R.H., and Jungalawala,F.D.
TITLE	:	Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. PubMed ID:3017944
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 11717-11725 (1986)

[TOP]

[0088]

AUTHOR	:	Taketomi, T., and Yamakawa, T.
TITLE	:	Further Confirmation On The Structure Of Brain Cerebroside Sulfuric Ester PubMed ID:14116626
JOURNAL	:	J Biochem (Tokyo).
VOL	:	55 PAGE : 87-89 (1964)

[TOP]

[0089]

AUTHOR	:	Prokazova, N. V., Mikhailov, A. T., Kocharov, S. L., Malchenko, L. A., Zvezdina, N. D., Buznikov, G., and Bergelson, L. D.
TITLE	:	Unusual gangliosides of eggs and embryos of the sea urchin Strongylocentrotus intermedius. Structure and density-dependence of surface localization PubMed ID:6786889
JOURNAL	:	Eur J Biochem.
VOL	:	115 PAGE : 671-677 (1981)

[TOP]

[0090]

AUTHOR	:	Kochetkov,N.K.,Smirnova,G.P., and Chekareva,N.V.
TITLE	:	Isolation and structural studies of a sulfated sialosphingolipid from the sea urchin Echinocardium Cordatum. PubMed ID:1252492
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	424 PAGE : 274-283 (1976)

[TOP]

[0093]

AUTHOR	:	Iida, N., Toida, T., Kushi, Y., Handa, S., Fredman, P., Svennerholm, L., and Ishizuka, I.
TITLE	:	A sulfated glucosylceramide from rat kidney PubMed ID:2925645
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 5974-5980 (1989)

[TOP]

[0097]

AUTHOR	:	Taketomi, T., Hara, A., Kutsukake, Y., and Sugiyama, E.
TITLE	:	New approach for characterization of lysosulfatide by TLC, fast atom bombardment mass spectrometry and NMR spectroscopy PubMed ID:2398033
JOURNAL	:	J Biochem (Tokyo).
VOL	:	107 PAGE : 680-684 (1990)

[TOP]

[0208]

AUTHOR	:	Ishizuka, I.
TITLE	:	Chemistry and functional distribution of sulfoglycolipids PubMed ID:9640458
JOURNAL	:	Prog Lipid Res.
VOL	:	36 PAGE : 245-319 (1997)

[TOP]

[0212]

AUTHOR	:	Tadano-Aritomi, K., Kasama, T., Handa, S., and Ishizuka, I.
TITLE	:	Isolation and structural characterization of a mono-sulfated isoglobotetraosylceramide, the first sulfoglycosphingolipid of the isoglobo-series, from rat kidney PubMed ID:1396705
JOURNAL	:	Eur J Biochem.
VOL	:	209 PAGE : 305-313 (1992)

[TOP]

[0214]

AUTHOR	:	Tadano-Aritomi, K., Kubo, H., Ireland, P., Okuda, M., Kasama, T., Handa, S., and Ishizuka, I.
TITLE	:	Structural analysis of mono- and bis-sulfated glycosphingolipids by negative liquid secondary ion mass spectrometry with high- and low-energy collision-induced dissociation PubMed ID:7553669
JOURNAL	:	Carbohydr Res.
VOL	:	273 PAGE : 41-52 (1995)

[TOP]

[0215]

AUTHOR	:	Tadano-Aritomi, K., Kubo, H., Ireland, P., Kasama, T., Handa, S., and Ishizuka, I.
TITLE	:	Structural characterization of a novel mono-sulfated gangliotriaosylceramide containing a 3-O-sulfated N-acetylgalactosamine from rat kidney. PubMed ID:8737253
JOURNAL	:	Glycoconjugate J
VOL	:	13 PAGE : 285-293 (1996)

[TOP]

[0216]

AUTHOR	:	Kobayashi, T., Honke, K., Gasa, S., Saga, Y., Miyazaki, T., Tadano-Aritomi, K., Ishizuka, I., and Makita, A.
TITLE	:	Enzymatic sulfation of gangliotriaosylceramide in human renal cancer cells PubMed ID:8586644
JOURNAL	:	J Biochem (Tokyo).
VOL	:	117 PAGE : 987-992 (1995)

[TOP]

[0217]

AUTHOR	:	Tadano-Aritomi, K., Kubo, H., Ireland, P., Hikita, T., and Ishizuka, I.
TITLE	:	Isolation and characterization of a unique sulfated ganglioside, sulfated GM1a, from rat kidney PubMed ID:9499381
JOURNAL	:	Glycobiology.
VOL	:	8 PAGE : 341-350 (1998)

[TOP]

[0223]

AUTHOR	:	Jungalwala, F. B.
TITLE	:	Expression and biological functions of sulfoglucuronyl glycolipids (SGGLs) in the nervous system--a review PubMed ID:7800122
JOURNAL	:	Neurochem Res.
VOL	:	19 PAGE : 945-957 (1994)

[TOP]

[0230]

AUTHOR	:	Deshmukh, G. D., Radin, N. S., Gattone, V. H., 2nd, and Shayman, J. A.
TITLE	:	Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk/cpk) mouse PubMed ID:7806975
JOURNAL	:	J Lipid Res.
VOL	:	35 PAGE : 1611-1618 (1994)

[TOP]

[0231]

AUTHOR	:	Igisu, H., and Suzuki, K.
TITLE	:	Glycolipids of the spinal cord, sciatic nerve, and systemic organs of the twitcher mouse PubMed ID:6693925
JOURNAL	:	J Neuropathol Exp Neurol.
VOL	:	43 PAGE : 22-36 (1984)

[TOP]

[0237]

AUTHOR	:	Tamai, Y., Kojima, H., Saito, S., Uchida, K., Kitajima, R; Komatsu, H., and Moriya, T.
TITLE	:	Metamorphic changes in glycolipids and myelin proteins and 2',3'-cyclic nucleotide 3'-phosphohydrolase in bullfrog and axolotl brain. PubMed ID:8386225
JOURNAL	:	J. Neurochem.
VOL	:	60 PAGE : 1854-1863 (1993)

[TOP]

[0238]

AUTHOR	:	Hama, Y., Li, Y. T., and Li, S. C.
TITLE	:	Interaction of GM2 activator protein with glycosphingolipids PubMed ID:9006924
JOURNAL	:	J Biol Chem.
VOL	:	272 PAGE : 2828-2833 (1997)

[TOP]

[0240]

AUTHOR	:	Yabunaka, N., Honke, K., Ishii, A., Ogiso, Y., Kuzumaki, N., Agishi, Y., and Makita, A.
TITLE	:	Involvement of Ras in the expression of glycolipid sulfotransferase in human renal cancer cells PubMed ID:9178817
JOURNAL	:	Int J Cancer.
VOL	:	71 PAGE : 620-623 (1997)

[TOP]

[0243]

AUTHOR	:	Mikami, T., Tsuchihashi, K., Kashiwagi, M., Yachida, Y., Daino, T., Hashi, K., Akino, T., and Gasa, S.
TITLE	:	Characterization of a O-fatty-acylated sulfatide from equine brain PubMed ID:9692930
JOURNAL	:	Eur J Biochem.
VOL	:	255 PAGE : 289-295 (1998)

[TOP]

[1001]

AUTHOR	:	Tamai, Y., Taketomi, T., and Yamakawa, T.
TITLE	:	New glycolipids in the bovine brain PubMed ID:5299088
JOURNAL	:	Jpn J Exp Med.
VOL	:	37 PAGE : 79-81 (1967)

[TOP]

[1002]

AUTHOR	:	Tamai, Y.
TITLE	:	Further study on the faster running glycolipid in brain PubMed ID:4302096
JOURNAL	:	Jpn J Exp Med.
VOL	:	38 PAGE : 65-73 (1968)

[TOP]

[1003]

AUTHOR	:	Tamai, Y., Kojima, H., Saito, S., Takayama-Abe, K., and Horichi, H.
TITLE	:	Characteristic distribution of glycolipids in gadoid fish nerve tissues and its bearing on phylogeny PubMed ID:1402402
JOURNAL	:	J Lipid Res.
VOL	:	33 PAGE : 1351-1359 (1992)

[TOP]

[1004]

AUTHOR	:	Tamai, Y., Nakamura, K., Takayama-Abe, K., Uchida, K., Kasama, T., and Kobatake, H.
TITLE	:	Less polar glycolipids in alaskan pollack brain: isolation and characterization of acyl galactosyl diglycerol, acyl galactosyl ceramide, and acyl glucosyl ceramide . PubMed ID:8496665
JOURNAL	:	J. Lipid. Res.
VOL	:	34 PAGE : 601-608 (1993)

[TOP]

[1008]

AUTHOR	:	Norton, W. T., and Brotz, M.
TITLE	:	New galactolipids of brain: a monoalkyl-monoacyl-glyceryl galactoside and cerebroside fatty acid esters PubMed ID:13939001
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	12 PAGE : 198-203 (1963)

[TOP]

[1010]

AUTHOR	:	Kishimoto, Y., Wajda, M., and Radin, N. S.
TITLE	:	6-acyl galactosyl ceramides of pig brain: structure and fatty acid composition PubMed ID:4295348
JOURNAL	:	J Lipid Res.
VOL	:	9 PAGE : 27-33 (1968)

[TOP]

[1011]

AUTHOR	:	Klenk, E., and Lohr, J. P.
TITLE	:	[On the ester cerebrosides of brain] PubMed ID:5586922
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	348 PAGE : 1712-1714 (1967)

[TOP]

[1012]

AUTHOR	:	Slomiany, B. L., Slomiany, A., and Horowitz, M. I.
TITLE	:	The I-O-galactosylceramide fatty acid esters from hog stomach PubMed ID:4345280
JOURNAL	:	Biochim Biophys Acta.
VOL	:	280 PAGE : 383-392 (1972)

[TOP]

[1013]

AUTHOR	:	Yasugi, E., Kasama, T., Kojima, H., and Yamakawa, T.
TITLE	:	Occurrence of 2-O-acyl galactosyl ceramide in human and bovine brains PubMed ID:6885740
JOURNAL	:	J Biochem (Tokyo).
VOL	:	93 PAGE : 1595-1599 (1983)

[TOP]

[1014]

AUTHOR	:	Yasugi, E., Saito, E., Kasama, T., Kojima, H., and Yamakawa, T.
TITLE	:	Occurrence of 2-O-acyl galactosyl ceramide in whale brain PubMed ID:7096280
JOURNAL	:	J Biochem (Tokyo).
VOL	:	91 PAGE : 1121-1127 (1982)

[TOP]

[1015]

AUTHOR	:	Makita,A.,Suzuki,C.,Yoshizawa,Z., and Konno,T.
TITLE	:	Glycolipids isolated from the spleen of Gaucher's disease. PubMed ID:5956509
JOURNAL	:	Tohoku J. Exp. Med.
VOL	:	88 PAGE : 277-288 (1966)

[TOP]

[1016]

AUTHOR	:	Gray, G. M., White, R. J., and Majer, J. R.
TITLE	:	1-(3'-O-acyl)-beta-glucosyl-N-dihydroxypentatriacontadienoylsphingosine, a major component of the glucosylceramides of pig and human epidermis PubMed ID:563730
JOURNAL	:	Biochim Biophys Acta.
VOL	:	528 PAGE : 127-137 (1978)

[TOP]

[1017]

AUTHOR	:	Kubota, M., and Taketomi, T.
TITLE	:	Minor glycolipids being less polar than cerebroside in porcine spinal cord PubMed ID:4546073
JOURNAL	:	Jpn J Exp Med.
VOL	:	44 PAGE : 145-150 (1974)

[TOP]

[1018]

AUTHOR	:	Heinz,E.
TITLE	:	Acylgalaktosyldiglyceride aus blatthomogenaten. PubMed ID:6064609
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	144 PAGE : 321-332 (1967)

[TOP]

[1019]

AUTHOR	:	Heinz,E.
TITLE	:	Uber die enzymatische bildung von acylgalaktosyldiglyceride. PubMed ID:6064610
JOURNAL	:	Biochim. Biphys. Acta
VOL	:	144 PAGE : 333-343 (1967)

[TOP]

[1020]

AUTHOR	:	Heinz,E., and Tulloch,A.P.
TITLE	:	Reinvesringtion of the structure of acyl galactosyl diglyceride from spinach leaves. PubMed ID:5808057
JOURNAL	:	Hoppe-Seyler's Z. Physiol. Chem.
VOL	:	350 PAGE : 493-498 (1969)

[TOP]

[1021]

AUTHOR	:	Critchley,C., and Heinz,E.
TITLE	:	Characterization and enzymatic synthesis of acyl galactosyl monoglyceride. PubMed ID:4765101
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	326 PAGE : 184-193 (1973)

[TOP]

[1022]

AUTHOR	:	Heinz,E., Siebertz,H.P. and Linscheid,M.
TITLE	:	Synthesis and enzymatic conversion of an ether analogue of monogalactosyl diacylglycerol
JOURNAL	:	Chem. Phys. Lipids.
VOL	:	24 PAGE : 265-276 (1979)

[TOP]

[1023]

AUTHOR	:	Myhre,D.V.
TITLE	:	Glycolipids of soft wheat flour. I. Isolation and characterization of 1-O-acyl-b-D-galactopyranosyl)-2,3-di-O-acyl-D-glycerols and phytosteryl 6-O-acyl-b-D-glucopyranosides
JOURNAL	:	Can, J. Chem.
VOL	:	46 PAGE : 3071-3077 (1968)

[TOP]

[1024]

AUTHOR	:	Wintermans,J.F.G.M.,Van Besouw,A., and Bogemann,G.
TITLE	:	Galactolipid formation in chloroplast envelopes. II. Isolation-induced changes in galactolipid composition. PubMed ID:7213774
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	663 PAGE : 99-107 (1981)

[TOP]

[1025]

AUTHOR	:	Van Besouw, A., Wintermans, J. F., and Bogemann, G.
TITLE	:	Galactolipid formation in chloroplast envelopes. III. Some observations on galactose incorporation by envelopes with high and low content of diacylglycerol PubMed ID:7011408
JOURNAL	:	Biochim Biophys Acta.
VOL	:	663 PAGE : 108-120 (1981)

[TOP]

[1026]

AUTHOR	:	Nakamura, K., Inagaki, F., and Tamai, Y.
TITLE	:	A novel ganglioside in dogfish brain. Occurrence of a trisialoganglioside with a sialic acid linked to N-acetylgalactosamine PubMed ID:3384822
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 9896-9900 (1988)

[TOP]

[1027]

AUTHOR	:	Kawakami, Y., Nakamura, K., Kojima, H., Suzuki, M., Inagaki, F., Suzuki, A., Sonoki, S., Uchida, A., Murata, Y., and Tamai, Y.
TITLE	:	A novel fucosylated glycosphingolipid with a Gal beta 1-4Glc beta 1-3Gal sequence in plerocercoids of the parasite, Spirometra erinacei PubMed ID:8113220
JOURNAL	:	J Biochem (Tokyo).
VOL	:	114 PAGE : 677-683 (1993)

[TOP]

[1028]

AUTHOR	:	Ando, S., Hirabayashi, Y., Kon, K., Inagaki, F., Tate, S., and Whittaker, V. P.
TITLE	:	A trisialoganglioside containing a sialyl alpha 2-6 N-acetylgalactosamine residue is a cholinergic-specific antigen, Chol-1 alpha PubMed ID:1587788
JOURNAL	:	J Biochem (Tokyo).
VOL	:	111 PAGE : 287-290 (1992)

[TOP]

[1030]

AUTHOR	:	Waki, H., Masuzawa, A., Kon, K., and Ando, S.
TITLE	:	A new O-acetylated trisialoganglioside, 9-O-acetyl GT2, in cod brain PubMed ID:8276754
JOURNAL	:	J Biochem (Tokyo).
VOL	:	114 PAGE : 459-462 (1993)

[TOP]

[1031]

AUTHOR	:	Kitagawa, H., Nakada, H., Fukui, S., Funakoshi, I., Kawasaki, T., Tate, S., Inagaki, F., and Yamashina, I.
TITLE	:	Novel gangliosides containing the sialyl-Le(a) structure from a human rectal adenocarcinoma PubMed ID:8253783
JOURNAL	:	J Biol Chem.
VOL	:	268 PAGE : 26541-26545 (1993)

[TOP]

[1032]

AUTHOR	:	Levery, S. B., Salyan, M. E., Steele, S. J., Kannagi, R., Dasgupta, S., Chien, J. L., Hogan, E. L., van Halbeek, H., and Hakomori, S.
TITLE	:	A revised structure for the disialosyl globo-series gangliosides of human erythrocytes and chicken skeletal muscle PubMed ID:8031119
JOURNAL	:	Arch Biochem Biophys.
VOL	:	312 PAGE : 125-134 (1994)

[TOP]

[1034]

AUTHOR	:	Dasgupta, S., Hogan, E. L., Glushka, J., and van Halbeek, H.
TITLE	:	Branched monosialo gangliosides of the lacto-series isolated from bovine erythrocytes: characterization of a novel ganglioside, NeuGc-isooctaosylceramide PubMed ID:8179322
JOURNAL	:	Arch Biochem Biophys.
VOL	:	310 PAGE : 373-384 (1994)

[TOP]

[1035]

AUTHOR	:	Taki, T., Rokukawa, C., Kasama, T., Kon, K., Ando, S., Abe, T., and Handa, S.
TITLE	:	Human meconium gangliosides. Characterization of a novel I-type ganglioside with the NeuAc alpha 2-6Gal structure PubMed ID:1601853
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 11811-11817 (1992)

[TOP]

[1036]

AUTHOR	:	Hirabayashi, Y., Nakao, T., Irie, F., Whittaker, V. P., Kon, K., and Ando, S.
TITLE	:	Structural characterization of a novel cholinergic neuron-specific ganglioside in bovine brain PubMed ID:1618794
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 12973-12978 (1992)

[TOP]

[1037]

AUTHOR	:	Nohara, K., Suzuki, M., Inagaki, F., Sano, T., and Kaya, K.
TITLE	:	A novel disialoganglioside in rat spleen lymphocytes PubMed ID:1634537
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 14982-14986 (1992)

[TOP]

[1038]

AUTHOR	:	Shimamura, M., Oku, M., and Yamagata, T.
TITLE	:	A novel ganglioside expressed by mouse hematopoietic cell lines PubMed ID:1388159
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 18810-18813 (1992)

[TOP]

[1039]

AUTHOR	:	Nakao, T., Kon, K., Ando, S., Miyatake, T., Yuki, N., Li, Y. T., Furuya, S., and Hirabayashi, Y.
TITLE	:	Novel lacto-ganglio type gangliosides with GM2-epitope in bovine brain which react with IgM from a patient of the amyotrophic lateral sclerosis-like disorder PubMed ID:7691804
JOURNAL	:	J Biol Chem.
VOL	:	268 PAGE : 21028-21034 (1993)

[TOP]

[1040]

AUTHOR	:	Kubo, H., Jiang, G. J., Irie, A., Morita, M., Matsubara, T., and Hoshi, M.
TITLE	:	A novel ceramide trihexoside from the eggs of the sea urchin, Hemicentrotus pulcherrimus PubMed ID:1500414
JOURNAL	:	J Biochem (Tokyo).
VOL	:	111 PAGE : 726-731 (1992)

[TOP]

[1041]

AUTHOR	:	Kubo, H., Jiang, G. J., Irie, A., Suzuki, M., Inagaki, F., and Hoshi, M.
TITLE	:	A novel difucosylated neutral glycosphingolipid from the eggs of the sea urchin, Hemicentrotus pulcherrimus: I. Purification and structural determination of the glycolipid PubMed ID:1400270
JOURNAL	:	J Biochem (Tokyo).
VOL	:	112 PAGE : 281-285 (1992)

[TOP]

[1042]

AUTHOR	:	Persat, F., Bouhours, J. F., Mojon, M., and Petavy, A. F.
TITLE	:	Glycosphingolipids with Gal beta 1----6Gal sequences in metacestodes of the parasite Echinococcus multilocularis PubMed ID:1577719
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 8764-8769 (1992)

[TOP]

[1043]

AUTHOR	:	Stroud, M. R., Levery, S. B., Nudelman, E. D., Salyan, M. E., Towell, J. A., Roberts, C. E., Watanabe, M., and Hakomori, S.
TITLE	:	Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen PubMed ID:2022659
JOURNAL	:	J Biol Chem.
VOL	:	266 PAGE : 8439-8446 (1991)

[TOP]

[1044]

AUTHOR	:	Song, Y., Kitajima, K., Inoue, S., and Inoue, Y.
TITLE	:	Isolation and structural elucidation of a novel type of ganglioside, deaminated neuraminic acid (KDN)-containing glycosphingolipid, from rainbow trout sperm. The first example of the natural occurrence of KDN-ganglioside, (KDN)GM3 PubMed ID:1939215
JOURNAL	:	J Biol Chem.
VOL	:	266 PAGE : 21929-21935 (1991)

[TOP]

[1045]

AUTHOR	:	Straus, A. H., Levery, S. B., Jasiulionis, M. G., Salyan, M. E., Steele, S. J., Travassos, L. R., Hakomori, S., and Takahashi, H. K.
TITLE	:	Stage-specific glycosphingolipids from amastigote forms of Leishmania (L.) amazonensis. Immunogenicity and role in parasite binding and invasion of macrophages PubMed ID:8514804
JOURNAL	:	J Biol Chem.
VOL	:	268 PAGE : 13723-13730 (1993)

[TOP]

[1046]

AUTHOR	:	Hirabayashi, Y., Fujita, S. C., Kon, K., and Ando, S.
TITLE	:	Characterization of a novel Le(x)-active ganglioside from chick intestinal tissues recognized by murine monoclonal antibody 188C1 PubMed ID:1674743
JOURNAL	:	J Biol Chem.
VOL	:	266 PAGE : 10268-10274 (1991)

[TOP]

[1047]

AUTHOR	:	Bouhours, D., Angstrom, J., Jovall, P. A., Hansson, G. C., and Bouhours, J. F.
TITLE	:	Characterization of a novel A-active octaglycosylceramide with type 1 chain repeat inherited as a recessive trait in the epithelial cells of the small intestine of inbred rats PubMed ID:1917983
JOURNAL	:	J Biol Chem.
VOL	:	266 PAGE : 18613-18619 (1991)

[TOP]

[1048]

AUTHOR	:	Nakao, T., Kon, K., Ando, S., and Hirabayashi, Y.
TITLE	:	A NeuGc-containing trisialoganglioside of bovine brain PubMed ID:1742322
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1086 PAGE : 305-309 (1991)

[TOP]

[1049]

AUTHOR	:	Noda, N., Tanaka, R., Miyahara, K., and Kawasaki, T.
TITLE	:	Isolation and characterization of a novel type of glycosphingolipid from Neanthes diversicolor PubMed ID:8334147
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1169 PAGE : 30-38 (1993)

[TOP]

[1050]

AUTHOR	:	Hamanaka, S., Asagami, C., Suzuki, M., Inagaki, F., and Suzuki, A.
TITLE	:	Structure determination of glucosyl beta 1-N-(omega-O-linoleoyl)-acylsphingosines of human epidermis PubMed ID:2753867
JOURNAL	:	J Biochem (Tokyo).
VOL	:	105 PAGE : 684-690 (1989)

[TOP]

[1051]

AUTHOR	:	Levery, S. B., Nudelman, E. D., and Hakomori, S.
TITLE	:	Novel modification of glycosphingolipids by long-chain cyclic acetals: isolation and characterization of plasmalocerebroside from human brain PubMed ID:1606158
JOURNAL	:	Biochemistry.
VOL	:	31 PAGE : 5335-5340 (1992)

[TOP]

[1052]

AUTHOR	:	Yamaguchi, Y., Ohta, M., and Hayashi, A.
TITLE	:	Structural elucidation of a novel phosphonoglycosphingolipid in eggs of the sea hare Aplysia juliana. PubMed ID:1450210
JOURNAL	:	Biochim. Biophys. Acta.
VOL	:	1165 PAGE : 160-166 (1992)

[TOP]

[1053]

AUTHOR	:	Araki, S., Abe, S., Yamada, S., Satake, M., Fujiwara, N., Kon, K., and Ando, S.
TITLE	:	Characterization of two novel pyruvylated glycosphingolipids containing 2'-aminoethylphosphoryl(-6)-galactose from the nervous system of Aplysia kurodai. PubMed ID:1491001
JOURNAL	:	J. Biochem.
VOL	:	112 PAGE : 461-469 (1992)

[TOP]

[1054]

AUTHOR	:	Sugita, M., Fujii, H., Inagaki, F., Suzuki, M., Hayata, C., and Hori,T .
TITLE	:	Polar glycosphingolipids in annelida. A novel series of glycosphingolipids containing choline phosphate from the earthworm, Pheretima hilgendorfi. PubMed ID:1429609
JOURNAL	:	J. Biol. Chem.
VOL	:	267 PAGE : 22595-22598 (1992)

[TOP]

[1055]

AUTHOR	:	Inagaki, F., Tate, S., Kubo, H., and Hoshi, M.
TITLE	:	A novel difucosylated neutral glycosphingolipid from the eggs of the sea urchin, Hemicentrotus pulcherrimus: II. Structural determination by two-dimensional NMR PubMed ID:1400271
JOURNAL	:	J Biochem (Tokyo).
VOL	:	112 PAGE : 286-289 (1992)

[TOP]

[1056]

AUTHOR	:	Hidari, K. I., Irie, F., Suzuki, M., Kon, K., Ando, S., and Hirabayashi, Y.
TITLE	:	A novel ganglioside with a free amino group in bovine brain PubMed ID:8250852
JOURNAL	:	Biochem J.
VOL	:	296 (Pt 1) PAGE : 259-263 (1993)

[TOP]

[1057]

AUTHOR	:	Sugita, M., Hayata, C., Yoshida, T., Suzuki, M., Suzuki, A., Takeda, T., Hori, T., and Nakatani, F.
TITLE	:	A novel fucosylated glycosphingolipid from the millipede, Parafontaria laminata armigera PubMed ID:7947999
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1215 PAGE : 163-169 (1994)

[TOP]

[1058]

AUTHOR	:	Sugita, M., Fujii, H., Dulaney, J. T., Inagaki, F., Suzuki, M., Suzuki, A., and Ohta, S.
TITLE	:	Structural elucidation of two novel amphoteric glycosphingolipid from the earthworm, Pheretima hilgendorfi. PubMed <<8541328>
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	1259 PAGE : 220-226 (1995)

[TOP]

[1059]

AUTHOR	:	Casellato, R., Brocca, P., Li, S. C., Li, Y. T., and Sonnino, S.
TITLE	:	Isolation and structural characterization of N-acetyl- and N-glycolylneuraminic-acid-containing GalNAc-GD1a isomers, IV4GalNAcIV3Neu5AcII3Neu5GcGgOse4Cer and IV4GalNAcIV3Neu5GcII3Neu5AcGgOse4Cer, from bovine brain PubMed ID:8575436
JOURNAL	:	Eur J Biochem.
VOL	:	234 PAGE : 786-793 (1995)

[TOP]

[1060]

AUTHOR	:	Nomura, K., Nakajo, N., Hidari, K. I., Nomura, H., Murata, M., Suzuki, M., Yamana, K., and Hirabayashi, Y.
TITLE	:	Occurrence of a novel fucose-containing pentaglycosylceramide with blood-group-B active determinant in Xenopus blastula cells: its possible involvement in cell-cell adhesion PubMed ID:7702579
JOURNAL	:	Biochem J.
VOL	:	306 (Pt 3) PAGE : 821-827 (1995)

[TOP]

[1061]

AUTHOR	:	Teneberg, S., Jovall, P. A., Karlsson, H., Sjogren, H. O., and Brodin, T.
TITLE	:	Isolation and characterization of a rat testis glycosphingolipid based on gangliotetraosylceramide and having a blood group B determinant extended with beta 3-linked N-acetylgalactosamine PubMed ID:7531688
JOURNAL	:	J Biochem (Tokyo).
VOL	:	116 PAGE : 697-703 (1994)

[TOP]

[1062]

AUTHOR	:	Tadano-Aritomi, K., Okuda, M., Ishizuka, I., Kubo, H., and Ireland, P.
TITLE	:	A novel mono-sulfated pentaglycosylceramide with the isoglobo-series core structure in rat kidney PubMed ID:7834656
JOURNAL	:	Carbohydr Res.
VOL	:	265 PAGE : 49-59 (1994)

[TOP]

[1064]

AUTHOR	:	Song, Y., Kitajima, K., Inoue, S., Khoo, K. H., Morris, H. R., Dell, A., and Inoue, Y.
TITLE	:	Expression of new KDN-gangliosides in rainbow trout testis during spermatogenesis and their structural identification PubMed ID:7540078
JOURNAL	:	Glycobiology.
VOL	:	5 PAGE : 207-218 (1995)

[TOP]

[1065]

AUTHOR	:	Yamada, S., Araki, S., Abe, S., Kon, K., Ando, S., and Satake, M.
TITLE	:	Structural analysis of a novel triphosphonoglycosphingolipid from the egg of the sea hare, Aplysia kurodai PubMed ID:7592541
JOURNAL	:	J Biochem (Tokyo).
VOL	:	117 PAGE : 794-799 (1995)

[TOP]

[1066]

AUTHOR	:	Kawahara, K., Seyde L, U., Matsuura, M., Danbara, H., Rietschel, E. T., and Zahringer, U.
TITLE	:	Chemical structure of glycosphingolipids isolated from Shpingomonas paucimobilis. PubMed ID:1959589
JOURNAL	:	Febs Lett.
VOL	:	292 PAGE : 107-110 (1991)

[TOP]

[1067]

AUTHOR	:	Singh, B. N., Costello, C. E., and Beach, D. H.
TITLE	:	Structures of glycophosphosphingolipids of Tritrichomonas foetus: a novel glycophosphosphingolipid PubMed ID:1897966
JOURNAL	:	Arch Biochem Biophys.
VOL	:	286 PAGE : 409-418 (1991)

[TOP]

[1068]

AUTHOR	:	Previato, J. O., Mendonca-Previato, L., Jones, C., Wait, R., and Fournet, B.
TITLE	:	Structural characterization of a novel class of glycophosphosphingolipids from the protozoan Leptomonas samueli PubMed ID:1447177
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 24279-24286 (1992)

[TOP]

[1069]

AUTHOR	:	Costello, C. E., Glushka, J., van Halbeek, H., and Singh, B. N.
TITLE	:	Structural characterization of novel inositol phosphosphingolipids of Tritrichomonas foetus and Trichomonas vaginalis PubMed ID:8358151
JOURNAL	:	Glycobiology.
VOL	:	3 PAGE : 261-269 (1993)

[TOP]

[1070]

AUTHOR	:	Previato, J. O., Wait, R., Jones, C., and Mendonca-Previato, L.
TITLE	:	Structural analysis of novel rhamnose-branched oligosaccharides from the glycophosphosphingolipids of Leptomonas samueli PubMed ID:8193550
JOURNAL	:	Glycoconj J.
VOL	:	11 PAGE : 23-33 (1994)

[TOP]

[1071]

AUTHOR	:	Jin, W., Rinehart, K. L., and Jares- Erijman, E. A.
TITLE	:	Ophidiacerebrosides: cytotoxic glycosphingolipids containing a novel sphingosine from sea star.
JOURNAL	:	J. Org. Chem.
VOL	:	59 PAGE : 144-147 (1994)

[TOP]

[1072]

AUTHOR	:	Serrano, A. A., Schenkman, S., Yoshida, N., Mehlert, A., Richardson, J. M., and Ferguson, M. A.
TITLE	:	The lipid structure of the glycosylphosphatidylinositol-anchored mucin-like sialic acid acceptors of Trypanosoma cruzi changes during parasite differentiation from epimastigotes to infective metacyclic trypomastigote forms PubMed ID:7592983
JOURNAL	:	J Biol Chem.
VOL	:	270 PAGE : 27244-27253 (1995)

[TOP]

[1073]

AUTHOR	:	Tadano- Aritomi, K., Kubo, H., Ireland, P., Kasama, T., Handa, S., and Ishizuka, I.
TITLE	:	Structural characterization of a novel mono-sulfated gangliotriaosylceramide containing a 3-O-sulfated N-acetylgalactosamine from rat kidney. PubMed ID:8737253
JOURNAL	:	Glycoconj. J.
VOL	:	13 PAGE : 285-293 (1996)

[TOP]

[1074]

AUTHOR	:	Irie, F., Kurono, S., Li, Y. T., Seyama, Y., and Hirabayashi, Y.
TITLE	:	Isolation of three novel cholinergic neuron-specific gangliosides from bovine brain and their in vitro syntheses PubMed ID:8737242
JOURNAL	:	Glycoconj J.
VOL	:	13 PAGE : 177-186 (1996)

[TOP]

[1075]

AUTHOR	:	Muthing, J., Spanbroek, R., Peter-Katalinic, J., Hanisch, F. G., Hanski, C., Hasegawa, A., Unland, F., Lehmann, J., Tschesche, H., and Egge, H.
TITLE	:	Isolation and structural characterization of fucosylated gangliosides with linear poly-N-acetyllactosaminyl chains from human granulocytes PubMed ID:8727787
JOURNAL	:	Glycobiology.
VOL	:	6 PAGE : 147-156 (1996)

[TOP]

[1076]

AUTHOR	:	Ijuin, T., Kitajima, K., Song, Y., Kitazume, S., Inoue, S., Haslam, S. M., Morris, H. R., Dell, A., and Inoue, Y.
TITLE	:	Isolation and identification of novel sulfated and nonsulfated oligosialyl glycosphingolipids from sea urchin sperm PubMed ID:8781971
JOURNAL	:	Glycoconj J.
VOL	:	13 PAGE : 401-413 (1996)

[TOP]

[1078]

AUTHOR	:	Sugita, M., Mizunoma, T., Aoki, K., Dulaney, J. T., Inagaki, F., Suzuki, M., Suzuki, A., Ichikawa, S., Kushida, K., Ohta, S., et al.
TITLE	:	Structural characterization of a novel glycoinositolphospholipid from the parasitic nematode, Ascaris suum PubMed ID:8765138
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1302 PAGE : 185-192 (1996)

[TOP]

[1079]

AUTHOR	:	Kawakami, Y., Nakamura, K., Kojima, H., Suzuki, M., Inagaki, F., Suzuki, A., Ikuta, J., Uchida, A., Murata, Y., and Tamai, Y.
TITLE	:	A novel fucosyltetrahexosylceramide in plerocercoids of the parasite Spirometra erinacei PubMed ID:8774742
JOURNAL	:	Eur J Biochem.
VOL	:	239 PAGE : 905-911 (1996)

[TOP]

[1080]

AUTHOR	:	Yachida, Y., Tsuchihashi, K., and Gasa, S.
TITLE	:	Characterization of novel mono-O-acetylated GM3s containing 9-O-acetyl sialic acid and 6-O-acetyl galactose in equine erythrocytes PubMed ID:8737247
JOURNAL	:	Glycoconj J.
VOL	:	13 PAGE : 225-223 (1996)

[TOP]

[1089]

AUTHOR	:	Hirabayashi, Y., Taki, T., and Matsumoto, M.
TITLE	:	Tumor ganglioside - natural occurrence of GM1b. PubMed ID:456564
JOURNAL	:	Febs Lett
VOL	:	100 PAGE : 253-257 (1979)

[TOP]

[1090]

AUTHOR	:	Watanabe, K., Powell, M. E., and Hakomori, S. I.
TITLE	:	Isolation and characterization of gangliosides with a new sialosyl linkage and core structures. II. Gangliosides of human erythrocyte membranes PubMed ID:468822
JOURNAL	:	J Biol Chem.
VOL	:	254 PAGE : 8223-8229 (1979)

[TOP]

[1091]

AUTHOR	:	Watanabe, K., and Hakomori, S.
TITLE	:	Gangliosides of human erythrocytes. A novel ganglioside with A unique N-acetylneuraminosyl-(2 leads to 3)-N-acetylgalactosamine structure. PubMed ID:518853
JOURNAL	:	Biochem.
VOL	:	18 PAGE : 5502-5504 (1979)

[TOP]

[1092]

AUTHOR	:	Ilyas, A. A., Li, S. C., Chou, D. K., Li, Y. T., Jungalwala, F. B., Dalakas, M. C., and Quarles, R. H.
TITLE	:	Gangliosides GM2, IV4GalNAcGM1b, and IV4GalNAcGC1a as antigens for monoclonal immunoglobulin M in neuropathy associated with gammopathy PubMed ID:2450092
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 4369-4373 (1988)

[TOP]

[1093]

AUTHOR	:	Kuhn R.,and Wiegandt Z.
TITLE	:
JOURNAL	:	Z. Naturforsch.
VOL	:	19 PAGE : 256-257 (1964)

[TOP]

[1094]

AUTHOR	:	Kuhn
TITLE	:
JOURNAL	:	Chem. Ber.
VOL	:	96 PAGE : 866-880 (1963)

[TOP]

[1095]

AUTHOR	:	Wiegandt, H.
TITLE	:	Gangliosides of extraneural organs. PubMed ID:4372157
JOURNAL	:	Hoppe-Seylers Zeitschrift Fur Physiologische Chemie
VOL	:	354 PAGE : 1049-1056 (1973)

[TOP]

[1096]

AUTHOR	:	Ohashi, M.
TITLE	:	A comparison of the ganglioside distributions of fat tissues in various animals by two-dimensional thin layer chromatography PubMed ID:423711
JOURNAL	:	Lipids.
VOL	:	14 PAGE : 52-57 (1979)

[TOP]

[1097]

AUTHOR	:	Holms, E.H. and Hakomori, S.
TITLE	:	Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorene. PubMed ID:7085643
JOURNAL	:	J. Biol. Chem.
VOL	:	257 PAGE : 7698-7703 (1982)

[TOP]

[1098]

AUTHOR	:	Kuhn
TITLE	:
JOURNAL	:	Zschr. Naturf.
VOL	:	18 PAGE : 541-543 (1963)

[TOP]

[1099]

AUTHOR	:	Ando,S., and Yu,R.K.
TITLE	:	Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. PubMed ID:893404
JOURNAL	:	J. Biol. Chem.
VOL	:	252 PAGE : 6247-6250 (1977)

[TOP]

[1100]

AUTHOR	:	Iwamori, M., and Nagai, Y.
TITLE	:	Isolation and characterization of a novel ganglioside, monosialosyl pentahexaosyl ceramide from human brain PubMed ID:739007
JOURNAL	:	J Biochem (Tokyo).
VOL	:	84 PAGE : 1601-1608 (1978)

[TOP]

[1101]

AUTHOR	:	Svennerholm,L.,Mansson,J.E., and Li,Y.T.
TITLE	:	Isolation and structural determination of a novel ganglioside, a disialosylpentahexosylceramide from human brain. PubMed ID:4684701
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 740-742 (1973)

[TOP]

[1102]

AUTHOR	:	Klenk, E. and Naoi, M.
TITLE	:	[On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase] PubMed ID:4302220
JOURNAL	:	H.-S. Zschr. Physiol. Chem.
VOL	:	349 PAGE : 288-292 (1968)

[TOP]

[1103]

AUTHOR	:	Sonnino, S., Ghidoni, R., Galli, G., and Tettamanti, G.
TITLE	:	On the structure of a new, fucose containing ganglioside from pig cerebellum. PubMed ID:702155
JOURNAL	:	J. Neurochem.
VOL	:	31 PAGE : 947-956 (1978)

[TOP]

[1104]

AUTHOR	:	Ishizuka, I. and Wiegandt, H.
TITLE	:	An isomer of trisialoganglioside and the sturcture of tetra- and pentasialogangliosides from fish brain. PubMed ID:4335142
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	260 PAGE : 279-285 (1972)

[TOP]

[1105]

AUTHOR	:	Yu, R. K., and Ando, S.
TITLE	:	Structures of some new complex gangliosides of fish brain PubMed ID:7361620
JOURNAL	:	Adv Exp Med Biol.
VOL	:	125 PAGE : 33-45 (1980)

[TOP]

[1106]

AUTHOR	:	Ohashi, M. and Yamakawa, T.
TITLE	:	Isolation and characterization of glycosphingolipids in pig adipose tissue. PubMed ID:893369
JOURNAL	:	J. Biochem.
VOL	:	81 PAGE : 1675-1690 (1977)

[TOP]

[1107]

AUTHOR	:	Kundu, S. K., Samuelsson, B. E., Pascher, I., and Marcus, D. M.
TITLE	:	New gangliosides from human erythrocytes PubMed ID:6643456
JOURNAL	:	J Biol Chem.
VOL	:	258 PAGE : 13857-13866 (1983)

[TOP]

[1109]

AUTHOR	:	Nilsson, O., Mansson, J. E., Lindholm, L., Holmgren, J., and Svennerholm, L.
TITLE	:	Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody PubMed ID:2984045
JOURNAL	:	FEBS Lett.
VOL	:	182 PAGE : 398-402 (1985)

[TOP]

[1110]

AUTHOR	:	Magnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., Ginsburg, V.
TITLE	:	A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. PubMed ID:7142214
JOURNAL	:	J. Biol. Chem.
VOL	:	257 PAGE : 14365-14369 (1982)

[TOP]

[1111]

AUTHOR	:	Nudelman, E., Fukushi, Y., Levery, S. B., Higuchi, T., and Hakomori, S.
TITLE	:	Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure PubMed ID:3957932
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 5487-5495 (1986)

[TOP]

[1112]

AUTHOR	:	Brodin, T., Hellstrom, I., Hellstrom, K. E., Karlsson, K. A., Sjogren, H. O., Stromberg, N., and Thurin, J.
TITLE	:	Mouse monoclonal antibodies with specificity for the melanoma-associated ganglioside disialyllactosylceramide (GD3) also react with the structural analogue disialylparagloboside PubMed ID:3840699
JOURNAL	:	Biochim Biophys Acta.
VOL	:	837 PAGE : 349-353 (1985)

[TOP]

[1113]

AUTHOR	:	Wiegandt
TITLE	:
JOURNAL	:	Zschr. Naturf.
VOL	:	24 PAGE : 945-946 (1968)

[TOP]

[1114]

AUTHOR	:	Fukushima
TITLE	:
JOURNAL	:	Canc. Res.
VOL	:	44 PAGE : 5279-5285 (1984)

[TOP]

[1115]

AUTHOR	:	Murakami-Murofushi, K., Tadano, K., and Ishizuka, I.
TITLE	:	A novel trisialosyl ganglioside, IV3 alpha (NeuAc)3nLcOse4Cer, from hog kidney cortex PubMed ID:6841359
JOURNAL	:	J Biochem (Tokyo).
VOL	:	93 PAGE : 621-629 (1983)

[TOP]

[1116]

AUTHOR	:	Clausen H., Levery SB., Nudelman ED., Stroud M., Salyan ME., Hakomori S.
TITLE	:	Isolation and characterization of novel glycolipids with blood group A-related structures: galactosyl-A and sialosylgalactosyl-A. PubMed ID:3654659
JOURNAL	:	J. Biol. Chem.
VOL	:	262 PAGE : 14228-14234 (1987)

[TOP]

[1117]

AUTHOR	:	Wiegandt H.
TITLE	:	Monosialo-lactoisohexaosyl-ceramide: a ganglioside from human spleen. PubMed ID:4853255
JOURNAL	:	Eur. J. Biochem.
VOL	:	45 PAGE : 367-369 (1974)

[TOP]

[1118]

AUTHOR	:	Fukushi, Y., Nudelman, E., Levery, S. B., Hakomori, S., and Rauvala, H.
TITLE	:	Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6) PubMed ID:6469974
JOURNAL	:	J Biol Chem.
VOL	:	259 PAGE : 10511-10517 (1984)

[TOP]

[1119]

AUTHOR	:	Hakomori, S., Nudelman, E., Levery, S. B., and Patterson, C. M.
TITLE	:	Human cancer-associated gangliosides defined by a monoclonal antibody (IB9) directed to sialosyl alpha 2 leads to 6 galactosyl residue: a preliminary note PubMed ID:6870892
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	113 PAGE : 791-798 (1983)

[TOP]

[1120]

AUTHOR	:	Watanabe K. Powell M. Hakomori S.
TITLE	:	Isolation and characterization of a novel fucoganglioside of human erythrocyte membranes. PubMed ID:102644
JOURNAL	:	J. Biol. Chem.
VOL	:	253 PAGE : 8962-8967 (1978)

[TOP]

[1121]

AUTHOR	:	Feizi, T., Childs, R. A., Watanabe, K., and Hakomori, S. I.
TITLE	:	Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid PubMed ID:429966
JOURNAL	:	J Exp Med.
VOL	:	149 PAGE : 975-980 (1979)

[TOP]

[1122]

AUTHOR	:	Nudelman, E. D., Levery, S. B., Igarashi, Y., and Hakomori, S.
TITLE	:	Plasmalopsychosine, a novel plasmal (fatty aldehyde) conjugate of psychosine with cyclic acetal linkage. Isolation and characterization from human brain white matter PubMed ID:1597442
JOURNAL	:	J Biol Chem.
VOL	:	267 PAGE : 11007-11016 (1992)

[TOP]

[1123]

AUTHOR	:	Irie, F., Hidari, K. I., Tai, T., Li, Y. T., Seyama, Y., and Hirabayashi, Y.
TITLE	:	Biosynthetic pathway for a new series of gangliosides, GT1a alpha and GQ1b alpha PubMed ID:8082783
JOURNAL	:	FEBS Lett.
VOL	:	351 PAGE : 291-294 (1994)

[TOP]

[1124]

AUTHOR	:	Irie, F., Hashikawa, T., Tai, T., Seyama, Y., and Hirabayashi, Y.
TITLE	:	Distribution of cholinergic neuron-specific gangliosides (GT1a alpha and GQ1b alpha) in the rat central nervous system PubMed ID:7710562
JOURNAL	:	Brain Res.
VOL	:	665 PAGE : 161-166 (1994)

[TOP]

[1125]

AUTHOR	:	Araki S., Satake M., Ando S., Hayashi A., and Fujii N
TITLE	:	Characterization of a diphosphonopentaosylceramide containing 3-O-methylgalactose from the skin of Aplysia kurodai (sea hare) [published erratum appears in J Biol Chem 1988 Jun 15;263(17):8551] PubMed ID:3957918
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 5138-5144 (1986)

[TOP]

[1126]

AUTHOR	:	Arakane, F., Fukunaga, K., Araki, S., Abe, S., Satake, M., Miyazaki, K., Okamura, H., and Miyamoto, E.
TITLE	:	Glycolipids isolated from Aplysia kurodai can activate cyclic adenosine 3',5'-monophosphate-dependent protein kinase from rat brain PubMed ID:8263547
JOURNAL	:	J Neurochem.
VOL	:	62 PAGE : 86-93 (1994)

[TOP]

[1127]

AUTHOR	:	Kawakami, J., Kawakami, Y., Nakamura, K., Kojima, H., Ito, S., and Tamai, Y.
TITLE	:	Three-dimensional structure of a glycosphingolipid having a novel carbohydrate linkage, Galbeta1-4(Fucalpha1-3)Glcbeta1-3Galbeta, determined by theoretical calculations PubMed ID:9557870
JOURNAL	:	Glycoconj J.
VOL	:	15 PAGE : 107-113 (1998)

[TOP]

[1128]

AUTHOR	:	Ito, H., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	First total synthesis of ganglioside GT1a alpha PubMed ID:9468624
JOURNAL	:	Carbohydr Res.
VOL	:	304 PAGE : 187-189 (1997)

[TOP]

[1129]

AUTHOR	:	Sakakura, C., Igarashi, Y., Anand, J. K., Sadozai, K. K., and Hakomori, S.
TITLE	:	Plasmalopsychosine of human brain mimics the effect of nerve growth factor by activating its receptor kinase and mitogen-activated protein kinase in PC12 cells. Induction of neurite outgrowth and prevention of apoptosis PubMed ID:8557709
JOURNAL	:	J Biol Chem.
VOL	:	271 PAGE : 946-952 (1996)

[TOP]

[1130]

AUTHOR	:	Klenk, E., and Gielen, W.
TITLE	:	[On a 2d hexose-containing ganglioside from human brain.] PubMed ID:14033464
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	330 PAGE : 218-226 (1963)

[TOP]

[1131]

AUTHOR	:	Price, H., Kundu, K., and Ledeen, R
TITLE	:	Structures of gangliosides from bovine adrenal medulla. PubMed ID:164890
JOURNAL	:	Biochemistry
VOL	:	14 PAGE : 1512-1518 (1975)

[TOP]

[1132]

AUTHOR	:	Ledeen, R. W., Yu, R. K., and Eng, L. F.
TITLE	:	Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component PubMed ID:4754859
JOURNAL	:	J Neurochem.
VOL	:	21 PAGE : 829-839 (1973)

[TOP]

[1133]

AUTHOR	:	Ando, S., Chang, N. C., and Yu, R. K.
TITLE	:	High-performance thin-layer chromatography and densitometric determination of brain ganglioside compositions of several species PubMed ID:103458
JOURNAL	:	Anal Biochem.
VOL	:	89 PAGE : 437-450 (1978)

[TOP]

[1134]

AUTHOR	:	Ueno, K., Ando, S., and Yu, R. K.
TITLE	:	Gangliosides of human, cat, and rabbit spinal cords and cord myelin PubMed ID:712245
JOURNAL	:	J Lipid Res.
VOL	:	19 PAGE : 863-871 (1978)

[TOP]

[1135]

AUTHOR	:	Kochetkov NK. Smirnova GP. Chekareva NV
TITLE	:	Isolation and structural studies of a sulfated sialosphingolipid from the sea urchin Echinocardium cordatum. PubMed ID:1252492
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	424 PAGE : 274-283 (1976)

[TOP]

[1136]

AUTHOR	:	Hoshi, M., and Nagai, Y.
TITLE	:	Novel sialosphingolipids from spermatozoa of the sea urchin Anthocidaris crassispina PubMed ID:1125301
JOURNAL	:	Biochim Biophys Acta.
VOL	:	388 PAGE : 152-162 (1975)

[TOP]

[1137]

AUTHOR	:	Makita, A., and Yamakawa, T.
TITLE	:	The Glycolipids Of The Brain Of Tay-Sachs' Disease.--The Chemical Structures Of A Globoside And Main Ganglioside PubMed ID:14148094
JOURNAL	:	Jpn J Exp Med.
VOL	:	33 PAGE : 361-368 (1963)

[TOP]

[1138]

AUTHOR	:	Ledeen, R., and Salzman, K.
TITLE	:
JOURNAL	:	Biochemistry
VOL	:	4 PAGE : 2225- (1965)

[TOP]

[1139]

AUTHOR	:	Tallman, J. F., Kolodny, E. H., and Brady, R. O.
TITLE	:	The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule PubMed ID:1121293
JOURNAL	:	Methods Enzymol.
VOL	:	35 PAGE : 541-548 (1975)

[TOP]

[1140]

AUTHOR	:	DeVries, G. H., and Norton, W. T.
TITLE	:	The lipid composition of axons from bovine brain PubMed ID:4364338
JOURNAL	:	J Neurochem.
VOL	:	22 PAGE : 259-264 (1974)

[TOP]

[1141]

AUTHOR	:	Robert, J., Freysz, L., Sensenbrenner, M., Mandel, P., and Rebel, G.
TITLE	:	Gangliosides of glial cells: a comparative study of normal astroblasts in tissue culture and glial cells isolated on sucrose-ficoll gradients PubMed ID:1112407
JOURNAL	:	FEBS Lett.
VOL	:	50 PAGE : 144-146 (1975)

[TOP]

[1142]

AUTHOR	:	Li, Y. T., Mazzotta, M. Y., Wan, C. C., Orth, R., and Li, S. C.
TITLE	:	Hydrolysis of Tay-Sachs ganglioside by beta-hexosaminidase A of human liver and urine PubMed ID:4745777
JOURNAL	:	J Biol Chem.
VOL	:	248 PAGE : 7512-7515 (1973)

[TOP]

[1143]

AUTHOR	:	Yohe, H. C., Roark, D. E., and Rosenberg, A.
TITLE	:	C20-sphingosine as a determining factor in aggregation of gangliosides PubMed ID:993205
JOURNAL	:	J Biol Chem.
VOL	:	251 PAGE : 7083-7087 (1976)

[TOP]

[1144]

AUTHOR	:	Fong, J. W., Ledeen, R. W., Kundu, S. K., and Brostoff, S. W.
TITLE	:	Gangliosides of peripheral nerve myelin PubMed ID:1255166
JOURNAL	:	J Neurochem.
VOL	:	26 PAGE : 157-162 (1976)

[TOP]

[1145]

AUTHOR	:	Suzuki, K., Poduslo, J. F., and Poduslo, S. E.
TITLE	:	Further evidence for a specific ganglioside fraction closely associated with myelin PubMed ID:4873454
JOURNAL	:	Biochim Biophys Acta.
VOL	:	152 PAGE : 576-586 (1968)

[TOP]

[1146]

AUTHOR	:	Dacremont, G., and Hildebrand, J.
TITLE	:	Characterization of two gangliosides from human leukemic polymorphonuclear leukocytes PubMed ID:1062221
JOURNAL	:	Biochim Biophys Acta.
VOL	:	424 PAGE : 315-322 (1976)

[TOP]

[1147]

AUTHOR	:	Naiki, M., Marcus, D.M., and Ledeen, R.
TITLE	:	Properties of antisera to ganglioside GM1 and asialo GM1 PubMed ID:4364954
JOURNAL	:	J Immunol.
VOL	:	113 PAGE : 84-93 (1974)

[TOP]

[1148]

AUTHOR	:	Kanfer, J. N., Carter, T. P., and Katzen, H. M.
TITLE	:	Lipolytic action of cholera toxin on fat cells. Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor PubMed ID:1002701
JOURNAL	:	J Biol Chem.
VOL	:	251 PAGE : 7610-7619 (1976)

[TOP]

[1149]

AUTHOR	:	van Heyningen, S.
TITLE	:	Binding of ganglioside by the chains of tetanus toxin PubMed ID:964380
JOURNAL	:	FEBS Lett.
VOL	:	68 PAGE : 5-7 (1976)

[TOP]

[1150]

AUTHOR	:	Wiegandt, H., Ziegler, W., Staerk, J., Kranz, T., Ronneberger, H. J., Zilg, H., Karlsson, K. A., and Samuelsson, B. E.
TITLE	:	Studies of the ligand binding to cholera toxin, I. The lipophilic moiety of sialoglycolipids PubMed ID:1002130
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	357 PAGE : 1637-1646 (1976)

[TOP]

[1151]

AUTHOR	:	Simpson, L. L., and Rapport, M. M.
TITLE	:	The binding of botulinum toxin to membrane lipids: sphingolipids, steroids and fatty acids PubMed ID:4936886
JOURNAL	:	J Neurochem.
VOL	:	18 PAGE : 1751-1759 (1971)

[TOP]

[1152]

AUTHOR	:	Fishman, P.H., and Brady, R.O.
TITLE	:	Biosynthesis and function of gangliosides
JOURNAL	:	Science
VOL	:	194 PAGE : 906-915 (1979)

[TOP]

[1153]

AUTHOR	:	Taki, T., Hirabayashi, Y., Ishiwata, Y., Matsumoto, M., and Kojima, K.
TITLE	:	Biosynthesis of different gangliosides in two types of rat ascites hepatoma cells with different degrees of cell adhesiveness PubMed ID:32912
JOURNAL	:	Biochim Biophys Acta.
VOL	:	572 PAGE : 113-120 (1979)

[TOP]

[1154]

AUTHOR	:	Hirabayashi, Y.,Taki, and T. Matsumoto, M.
TITLE	:	Tumor ganglioside - natural occurrence of GM1b. PubMed ID:456564
JOURNAL	:	FEBS Lett.
VOL	:	100 PAGE : 253-257 (1979)

[TOP]

[1155]

AUTHOR	:	Wiegandt, H.
TITLE	:	Gangliosides of extraneural organs. PubMed ID:4372157
JOURNAL	:	Hoppe-Seylers Z. Physiol. Chem.
VOL	:	354 PAGE : 1049-1056 (1973)

[TOP]

[1156]

AUTHOR	:	Ghidoni, R., Sonnino, S., Tettamanti, G., Wiegandt, H., and Zambotti, V.
TITLE	:	On the structure of two new gangliosides from beef brain PubMed ID:965992
JOURNAL	:	J Neurochem.
VOL	:	27 PAGE : 511-515 (1976)

[TOP]

[1157]

AUTHOR	:	Suzuki, A., Ishizuka, I., and Yamakawa, T.
TITLE	:	Isolation and characterization of a ganglioside containing fucose from boar testis PubMed ID:1213997
JOURNAL	:	J Biochem (Tokyo).
VOL	:	78 PAGE : 947-954 (1975)

[TOP]

[1158]

AUTHOR	:	Ohashi, M., and Yamakawa, T.
TITLE	:	Isolation and characterization of glycosphingolipids in pig adipose tissue. PubMed ID:893369
JOURNAL	:	J. Biochem.
VOL	:	81 PAGE : 1675-1690 (1977)

[TOP]

[1159]

AUTHOR	:	Koscielak J. Plasek A. Gorniak H. Gardas A. Gregor A.
TITLE	:	Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. PubMed ID:4745728
JOURNAL	:	Eur. J. Biochem.
VOL	:	37 PAGE : 214-225 (1973)

[TOP]

[1160]

AUTHOR	:	Uemura K. Yuzawa M. Taketomi T.
TITLE	:	Characterization of major glycolipids in bovine erythrocyte membrane. PubMed ID:564898
JOURNAL	:	J. Biochem.
VOL	:	83 PAGE : 463-471 (1978)

[TOP]

[1161]

AUTHOR	:	Wherrett, J. R.
TITLE	:	Characterization of the major ganglioside in human red cells and of a related tetrahexosyl ceramide in white cells PubMed ID:4756121
JOURNAL	:	Biochim Biophys Acta.
VOL	:	326 PAGE : 63-73 (1973)

[TOP]

[1162]

AUTHOR	:	Li, Y.T., Mansson. J.E., Vanier, M.T., and Svennerholm, L.
TITLE	:	Structure of the major glucosamine-containing ganglioside of human tissues. PubMed ID:4698234
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 2634-2636 (1973)

[TOP]

[1163]

AUTHOR	:	Higashi, H., Naiki, M., Matuo, S., and Okouchi, K.
TITLE	:	Antigen of "serum sickness" type of heterophile antibodies in human sera: indentification as gangliosides with N-glycolylneuraminic acid PubMed ID:412499
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	79 PAGE : 388-395 (1977)

[TOP]

[1164]

AUTHOR	:	Fukuda, M. N., Watanabe, K., and Hakomori, S. I.
TITLE	:	Release of oligosaccharides from various glycosphingolipids by endo-beta-galactosidase PubMed ID:99449
JOURNAL	:	J Biol Chem.
VOL	:	253 PAGE : 6814-6819 (1978)

[TOP]

[1165]

AUTHOR	:	Stellner, K., Watanabe, K., and Hakomori, S.
TITLE	:	Isolation and characterization of glycosphingolipids with blood group H specificity from membranes of human erythrocytes. PubMed ID:4734896
JOURNAL	:	Biochemistry
VOL	:	12 PAGE : 656-661 (1973)

[TOP]

[1166]

AUTHOR	:	Wiegandt, H.
TITLE	:	Monosialo-lactoisohexaosyl-ceramide: a ganglioside from human spleen. PubMed ID:4853255
JOURNAL	:	Eur. J. Biochem.
VOL	:	45 PAGE : 367-369 (1974)

[TOP]

[1167]

AUTHOR	:	Watanabe K. Powell M. Hakomori S.
TITLE	:	Isolation and characterization of a novel fucoganglioside of human erythrocyte membranes. PubMed ID:102644
JOURNAL	:	J. Biol. Chem.
VOL	:	253 PAGE : 8962-8967 (1978)

[TOP]

[1168]

AUTHOR	:	Sugita, M., and Hori, T.
TITLE	:	New types of gangliosides in starfish with sialic acid residues in the inner part of their carbohydrate chains. PubMed ID:977556
JOURNAL	:	J. Biochem.
VOL	:	80 PAGE : 637-640 (1976)

[TOP]

[1169]

AUTHOR	:	Handa, N., and Handa, S.
TITLE	:	The chemistry of lipids of posthemolytic residue or stroma of erythrocytes. XIV. Chemical structure of glycolipid of cat erythrocyte stroma PubMed ID:4285851
JOURNAL	:	Jpn J Exp Med.
VOL	:	35 PAGE : 331-341 (1965)

[TOP]

[1170]

AUTHOR	:	Price H. Kundu S. Ledeen R.
TITLE	:	Structures of gangliosides from bovine adrenal medulla. PubMed ID:164890
JOURNAL	:	Biochem.
VOL	:	14 PAGE : 1512-1518 (1975)

[TOP]

[1171]

AUTHOR	:	Robert, J., Rebel, G., and Mandel, P.
TITLE	:	Glycosphingolipids from cultured astroblasts PubMed ID:894142
JOURNAL	:	J Lipid Res.
VOL	:	18 PAGE : 517-522 (1977)

[TOP]

[1172]

AUTHOR	:	Iwamori, M., and Nagai, Y.
TITLE	:	Isolation and characterization of GD3 ganglioside having a novel disialosyl residue from rabbit thymus PubMed ID:711756
JOURNAL	:	J Biol Chem.
VOL	:	253 PAGE : 8328-8331 (1978)

[TOP]

[1173]

AUTHOR	:	Hakomori, S., Wang, S. M., and Young, W. W., Jr.
TITLE	:	Isoantigenic expression of Forssman glycolipid in human gastric and colonic mucosa: its possible identity with "A-like antigen" in human cancer PubMed ID:268649
JOURNAL	:	Proc Natl Acad Sci U S A.
VOL	:	74 PAGE : 3023-3027 (1977)

[TOP]

[1174]

AUTHOR	:	Rauvala, H.
TITLE	:	Isolation and partial characterization of human kidney gangliosides PubMed ID:1252493
JOURNAL	:	Biochim Biophys Acta.
VOL	:	424 PAGE : 284-295 (1976)

[TOP]

[1175]

AUTHOR	:	Handa, S., and Burton, R. M.
TITLE	:	Biosynthesis of glycolipids: incorporation of N-acetyl galactosamine by a rat brain particulate preparation PubMed ID:5367943
JOURNAL	:	Lipids.
VOL	:	4 PAGE : 589-598 (1969)

[TOP]

[1176]

AUTHOR	:	Holm, M., Mansson, J. E., Vanier, M. T., and Svennerholm, L.
TITLE	:	Gangliosides of human, bovine and rabbit retina PubMed ID:4345145
JOURNAL	:	Biochim Biophys Acta.
VOL	:	280 PAGE : 356-364 (1972)

[TOP]

[1177]

AUTHOR	:	Klenk, E. and Naoi, M.
TITLE	:	[On a component of the mixture of brain gangliosides, which is transferred to the Tay-Sachs ganglioside under the influence of neuraminidase][German] PubMed ID:4302220
JOURNAL	:	Hoppe-Seylers Z. Physiol. Chem.
VOL	:	349 PAGE : 288-292 (1968)

[TOP]

[1178]

AUTHOR	:	Mora, P. T., Brady, R. O., Bradley, R. M., and McFarland, V. W.
TITLE	:	Gangliosides in DNA virus-transformed and spontaneously transformed tumorigenic mouse cell lines PubMed ID:4311252
JOURNAL	:	Proc Natl Acad Sci U S A.
VOL	:	63 PAGE : 1290-1296 (1969)

[TOP]

[1179]

AUTHOR	:	Brady, R. O., Borek, C., and Bradley, R. M.
TITLE	:	Composition and synthesis of gangliosides in rat hepatocyte and hepatoma cell lines PubMed ID:4311199
JOURNAL	:	J Biol Chem.
VOL	:	244 PAGE : 6552-6554 (1969)

[TOP]

[1180]

AUTHOR	:	Whatley, R., Ng, S. K., Rogers, J., McMurray, W. C., and Sanwal, B. D.
TITLE	:	Developmental changes in gangliosides during myogenesis of a rat myoblast cell line and its drug resistant variants PubMed ID:58659
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	70 PAGE : 180-185 (1976)

[TOP]

[1181]

AUTHOR	:	Tallman, J. F., and Brady, R. O.
TITLE	:	The purification and properties of a mammalian neuraminidase (sialidase) PubMed ID:4711815
JOURNAL	:	Biochim Biophys Acta.
VOL	:	293 PAGE : 434-443 (1973)

[TOP]

[1182]

AUTHOR	:	Sonnino, S., Ghidoni, R., Galli, G., and Tettamanti, G.
TITLE	:	On the structure of a new, fucose containing ganglioside from pig cerebellum. PubMed ID:702155
JOURNAL	:	J. Neurochem.
VOL	:	31 PAGE : 947-956 (1978)

[TOP]

[1183]

AUTHOR	:	Li, Y.T., Mansson, J.E., Vanier, M.T., and Svennerholm, L.
TITLE	:	Structure of the major glucosamine-containing ganglioside of human tissues. PubMed ID:4698234
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 2634-2636 (1973)

[TOP]

[1184]

AUTHOR	:	Rauvala, H., Krusius, T., and Finne, J.
TITLE	:	Disialosyl paragloboside. A novel ganglioside isolated from human kidney PubMed ID:737190
JOURNAL	:	Biochim Biophys Acta.
VOL	:	531 PAGE : 266-279 (1978)

[TOP]

[1185]

AUTHOR	:	Ando, S., and Yu, R.K.
TITLE	:	Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain. PubMed ID:893404
JOURNAL	:	J. Biol. Chem.
VOL	:	252 PAGE : 6247-6250 (1977)

[TOP]

[1186]

AUTHOR	:	Siddiqui, B., and Hakomori, S.
TITLE	:	Change of glycolipid pattern in Morris hepatomas 5123 and 7800 PubMed ID:4321976
JOURNAL	:	Cancer Res.
VOL	:	30 PAGE : 2930-2936 (1970)

[TOP]

[1187]

AUTHOR	:	Lee, G., Aloj, S. M., Brady, R. O., and Kohn, L. D.
TITLE	:	The structure and function of glycoprotein hormone receptors: ganglioside interactions with human chorionic gonadotropin PubMed ID:187196
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	73 PAGE : 370-377 (1976)

[TOP]

[1188]

AUTHOR	:	Ishizuka I. Wiegandt H.
TITLE	:	An isomer of trisialoganglioside and the sturcture of tetra- and pentasialogangliosides from fish brain. PubMed ID:4335142
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	260 PAGE : 279-289 (1972)

[TOP]

[1189]

AUTHOR	:	Matsuura F.
TITLE	:	Phosphonosphingoglycolipid, a novel sphingolipid from the viscera of Turbo cornutus. PubMed ID:890866
JOURNAL	:	Chem. Phys. Lipids
VOL	:	19 PAGE : 223-242 (1977)

[TOP]

[1190]

AUTHOR	:	Booth, D. A., Goodwin, H., and Cumings, J. N.
TITLE	:	Abnormal gangliosides in Tay-Sachs disease, Niemann-Pick's disease, and gargoylism PubMed ID:4959256
JOURNAL	:	J Lipid Res.
VOL	:	7 PAGE : 337-340 (1966)

[TOP]

[1191]

AUTHOR	:	Slomiany, A., Kojima, K., Banas-Gruszka, Z., and Slomiany, B. L.
TITLE	:	Structure of a novel sulfated sialoglycosphingolipid from bovine gastric mucosa PubMed ID:7271781
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	100 PAGE : 778-784 (1981)

[TOP]

[1192]

AUTHOR	:	Schwarting, G.A., Carroll, P.G., DeWolf, W.C.
TITLE	:	Fucosyl-globoside and sialosyl-globoside are new glycolipids isolated from human teratocarcinoma cells. PubMed ID:6847688
JOURNAL	:	Biochem. Biophys. Res. Communications.
VOL	:	112 PAGE : 935-940 (1983)

[TOP]

[1193]

AUTHOR	:	Nakamura, K., Hashimoto, Y., Suzuki, M., Suzuki, A., and Yamakawa, T.
TITLE	:	Characterization of GM1b in mouse spleen PubMed ID:6520127
JOURNAL	:	J Biochem (Tokyo).
VOL	:	96 PAGE : 949-957 (1984)

[TOP]

[1194]

AUTHOR	:	Ariga, T., and Yu, R. K.
TITLE	:	Isolation and characterization of ganglioside GM1b from normal human brain PubMed ID:3572254
JOURNAL	:	J Lipid Res.
VOL	:	28 PAGE : 285-291 (1987)

[TOP]

[1195]

AUTHOR	:	Hirabayashi Y. Taki T. Matsumoto M.
TITLE	:	Tumor ganglioside - natural occurrence of GM1b. PubMed ID:456564
JOURNAL	:	FEBS Lett.
VOL	:	100 PAGE : 253-257 (1979)

[TOP]

[1196]

AUTHOR	:	Holmes EH. Hakomori S.
TITLE	:	Isolation and characterization of a new fucoganglioside accumulated in precancerous rat liver and in rat hepatoma induced by N-2-acetylaminofluorene. PubMed ID:7085643
JOURNAL	:	J. Biolo Chem.
VOL	:	257 PAGE : 7698-7703 (1982)

[TOP]

[1197]

AUTHOR	:	Baumann, H., Nudelman, E., Watanabe, K., and Hakomori, S.
TITLE	:	Neutral fucolipids and fucogangliosides of rat hepatoma HTC and H35 cells, rat liver, and hepatocytes PubMed ID:445466
JOURNAL	:	Cancer Res.
VOL	:	39 PAGE : 2637-2643 (1979)

[TOP]

[1198]

AUTHOR	:	Macher, B. A., Pacuszka, T., Mullin, B. R., Sweeley, C. C., Brady, R. O., and Fishman, P. H.
TITLE	:	Isolation and identification of a fucose-containing ganglioside from bovine thyroid gland PubMed ID:497244
JOURNAL	:	Biochim Biophys Acta.
VOL	:	588 PAGE : 35-43 (1979)

[TOP]

[1199]

AUTHOR	:	Ariga, T., Kobayashi, K., Kuroda, Y., Yu, R. K., Suzuki, M., Kitagawa, H., Inagaki, F., and Miyatake, T.
TITLE	:	Characterization of tumor-associated fucogangliosides from PC 12 pheochromocytoma cells PubMed ID:3654655
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 14146-14153 (1987)

[TOP]

[1200]

AUTHOR	:	Bouhours, J. F., Bouhours, D., and Hansson, G. C.
TITLE	:	Developmental changes of gangliosides of the rat stomach. Appearance of a blood group B-active ganglioside PubMed ID:3680254
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 16370-16375 (1987)

[TOP]

[1201]

AUTHOR	:	Breimer ME. Hansson GC. Karlsson KA. Leffler H.
TITLE	:	Glycosphingolipids of rat tissues. Different composition of epithelial and nonepithelial cells of small intestine. PubMed ID:7053385
JOURNAL	:	J. Biol. Chem.
VOL	:	257 PAGE : 557-568 (1982)

[TOP]

[1202]

AUTHOR	:	Breimer, M. E., Hansson, G. C., Karlsson, K. A., and Leffler, H.
TITLE	:	The preparative separation of sialic acid-containing lipids from sulphate group-containing glycolipids from small intestine of different animals. Analysis by thin-layer chromatography and detection of novel species PubMed ID:6885733
JOURNAL	:	J Biochem (Tokyo).
VOL	:	93 PAGE : 1473-1485 (1983)

[TOP]

[1203]

AUTHOR	:	Wiegandt H.
TITLE	:	Gangliosides of extraneural organs. PubMed ID:4372157
JOURNAL	:	Hoppe-Seylers Z. Physiol. Chem.
VOL	:	354 PAGE : 1049-1056 (1973)

[TOP]

[1204]

AUTHOR	:	Ohashi, M., and Yamakawa, T.
TITLE	:	Isolation and characterization of glycosphingolipids in pig adipose tissue. [Journal Article] PubMed ID:893369
JOURNAL	:	J. Biochem.
VOL	:	81 PAGE : 1675-1690 (1977)

[TOP]

[1205]

AUTHOR	:	Kochetkov NK., Smirnova GP., and Chekareva NV.
TITLE	:	Isolation and structural studies of a sulfated sialosphingolipid from the sea urchin Echinocardium cordatum. PubMed ID:1252492
JOURNAL	:	Biochim. Biophys. Acta.
VOL	:	424 PAGE : 274- (1976)

[TOP]

[1206]

AUTHOR	:	Kochetkov NK., and Smirnova GP
TITLE	:
JOURNAL	:	J. Bioorg. Chem.
VOL	:	3 PAGE : 1048- ()

[TOP]

[1207]

AUTHOR	:	Klenk, E., and Gielen, W.
TITLE	:	[On A Single Hexosamine-Free Ganglioside From The Human Brain Separated By Chromatography.] PubMed ID:14058280
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	333 PAGE : 162-165 (1963)

[TOP]

[1208]

AUTHOR	:	Fredman, P., Mansson, J. E., Svennerholm, L., Samuelsson, B., Pascher, I., Pimlott, W., Karlsson, K. A., and Klinghardt, G. W.
TITLE	:	Chemical structures of three fucogangliosides isolated from nervous tissue of mini-pig PubMed ID:7262075
JOURNAL	:	Eur J Biochem.
VOL	:	116 PAGE : 553-564 (1981)

[TOP]

[1209]

AUTHOR	:	Guo, N., Her, G., Reinhold, VN., Brennan, MJ., Siraganian, RP., and Ginsburg, V.
TITLE	:
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 740- (1973)

[TOP]

[1210]

AUTHOR	:	Macher, B. A., Klock, J. C., Fukuda, M. N., and Fukuda, M.
TITLE	:	Isolation and structural characterization of human lymphocyte and neutrophil gangliosides PubMed ID:6780555
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 1968-1974 (1981)

[TOP]

[1211]

AUTHOR	:	Rauvala, H.
TITLE	:	Gangliosides of human kidney PubMed ID:1002698
JOURNAL	:	J Biol Chem.
VOL	:	251 PAGE : 7517-7520 (1976)

[TOP]

[1212]

AUTHOR	:	Fukushima, K., Hirota, M., Terasaki, P. I., Wakisaka, A., Togashi, H., Chia, D., Suyama, N., Fukushi, Y., Nudelman, E., and Hakomori, S.
TITLE	:	Characterization of sialosylated Lewisx as a new tumor-associated antigen PubMed ID:6386148
JOURNAL	:	Cancer Res.
VOL	:	44 PAGE : 5279-5285 (1984)

[TOP]

[1213]

AUTHOR	:	Spitalnik, S. L., Spitalnik, P. F., Civin, C. I., Ball, E. D., Schwartz, J. F., and Ginsburg, V.
TITLE	:	Sialylated glycolipid antigens on human leukemic cell lines PubMed ID:3732420
JOURNAL	:	Exp Hematol.
VOL	:	14 PAGE : 643-647 (1986)

[TOP]

[1214]

AUTHOR	:	Watanabe, K., and Hakomori, S.
TITLE	:	Gangliosides of human erythrocytes. A novel ganglioside with a unique N-acetylneuraminosyl-(2 leads to 3)-N-acetylgalactosamine structure. PubMed ID:518853
JOURNAL	:	Biochemistry
VOL	:	18 PAGE : 5502-5504 (1979)

[TOP]

[1215]

AUTHOR	:	Itoh, T., Li, Y. T., Li, S. C., and Yu, R. K.
TITLE	:	Isolation and characterization of a novel monosialosylpentahexosyl ceramide from Tay-Sachs brain PubMed ID:7451432
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 165-169 (1981)

[TOP]

[1216]

AUTHOR	:	Law, K. L., and Smith, D. F.
TITLE	:	III6NeuAcLc4Cer in human SW1116 colorectal carcinoma cells: a possible oncofetal antigen that is not dependent on Lewis gene expression PubMed ID:3674877
JOURNAL	:	Arch Biochem Biophys.
VOL	:	258 PAGE : 315-323 (1987)

[TOP]

[1217]

AUTHOR	:	Hanqing, M., Avrova, N., Mansson, J. E., Molin, K., and Svennerholm, L.
TITLE	:	Gangliosides and neutral glycosphingolipids of normal tissue and oat cell carcinoma of human lung PubMed ID:3019414
JOURNAL	:	Biochim Biophys Acta.
VOL	:	878 PAGE : 360-370 (1986)

[TOP]

[1218]

AUTHOR	:	Magnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., Ginsburg, V.
TITLE	:	A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. PubMed ID:7142214
JOURNAL	:	J. Biol. Chem.
VOL	:	257 PAGE : 14365-14369 (1982)

[TOP]

[1219]

AUTHOR	:	Mansson, J. E., Fredman, P., Nilsson, O., Lindholm, L., Holmgren, J., and Svennerholm, L.
TITLE	:	Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma PubMed ID:3978112
JOURNAL	:	Biochim Biophys Acta.
VOL	:	834 PAGE : 110-117 (1985)

[TOP]

[1220]

AUTHOR	:	Falk, K. E., Karlsson, K. A., Larson, G., Thurin, J., Blaszczyk, M., Steplewski, Z., and Koprowski, H.
TITLE	:	Mass spectrometry of a human tumor glycolipid antigen being defined by mouse monoclonal antibody NS-19-9 PubMed ID:6188455
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	110 PAGE : 383-391 (1983)

[TOP]

[1221]

AUTHOR	:	Taki, T., Matsuo, K., Yamamoto, K., Matsubara, T., Hayashi, A., Abe, T., and Matsumoto, M.
TITLE	:	Human placenta gangliosides PubMed ID:3374272
JOURNAL	:	Lipids.
VOL	:	23 PAGE : 192-198 (1988)

[TOP]

[1222]

AUTHOR	:	Fukuda, M. N., Dell, A., Oates, J. E., Wu, P., Klock, J. C., Fukuda, M.
TITLE	:	Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. PubMed ID:3881421
JOURNAL	:	J. Biol. Chem.
VOL	:	260 PAGE : 1067-1082 (1985)

[TOP]

[1223]

AUTHOR	:	Niemann, H., Watanabe, K., and Hakomori, S.
TITLE	:	Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: the structural requirements for i-specificities PubMed ID:78708
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	81 PAGE : 1286-1293 (1978)

[TOP]

[1224]

AUTHOR	:	Chien, J. L., Li, S. C., Laine, R. A., and Li, Y. T.
TITLE	:	Characterization of gangliosides from bovine erythrocyte membranes PubMed ID:649619
JOURNAL	:	J Biol Chem.
VOL	:	253 PAGE : 4031-4035 (1978)

[TOP]

[1225]

AUTHOR	:	Watanabe, K., Powell, M., Hakomori, S.
TITLE	:	Isolation and characterization of a novel fucoganglioside of human erythrocyte membranes. PubMed ID:102644
JOURNAL	:	J. Biolo. Chem.
VOL	:	253 PAGE : 8962-8967 (1978)

[TOP]

[1226]

AUTHOR	:	Kannagi, R., Roelcke, D., Peterson, K. A., Okada, Y., Levery, S. B., and Hakomori, S.
TITLE	:	Characterization of an epitope (determinant) structure in a developmentally regulated glycolipid antigen defined by a cold agglutinin Fl, recognition of alpha-sialosyl and alpha-L-fucosyl groups in a branched structure PubMed ID:6194883
JOURNAL	:	Carbohydr Res.
VOL	:	120 PAGE : 143-157 (1983)

[TOP]

[1227]

AUTHOR	:	Hanada, E., and Konno, K.
TITLE	:	Characterization of the lacto series of gangliosides, especially of disialo-lacto-N-norhexaosyl ceramide isolated from adult bovine nasal cartilage PubMed ID:3839238
JOURNAL	:	J Biochem (Tokyo).
VOL	:	97 PAGE : 569-577 (1985)

[TOP]

[1228]

AUTHOR	:	Kundu, SK.,
TITLE	:
JOURNAL	:	Fed. Proc., Fed. Am. Soc. Exp. Biol.
VOL	:	40 PAGE : 1545- (1981)

[TOP]

[1229]

AUTHOR	:	Iwamori, M., and Nagai, Y.
TITLE	:	Monosialogangliosides of rabbit skeletal muscle. Characterization of N-acetylneuraminosyl lacto-N-noroctaosyl ceramide PubMed ID:7251579
JOURNAL	:	J Biochem (Tokyo).
VOL	:	89 PAGE : 1253-1264 (1981)

[TOP]

[1230]

AUTHOR	:	Higashi, H., Ikuta, K., Ueda, S., Kato, S., Hirabayashi, Y., Matsumoto, M., and Naiki, M.
TITLE	:	Characterization of N-glycolyneuraminic acid-containing glycosphingolipids from a Marek's disease lymphoma-derived chicken cell line, MSB1, as tumor-associated heterophile Hanganutziu-Deicher antigens PubMed ID:6202681
JOURNAL	:	J Biochem (Tokyo).
VOL	:	95 PAGE : 785-794 (1984)

[TOP]

[1231]

AUTHOR	:	Sekine M., Suzuki M., Inagaki F., Suzuki A., and Yamakawa, T.
TITLE	:	A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney. PubMed ID:2885312
JOURNAL	:	J. Biochem.
VOL	:	101 PAGE : 553-562 (1987)

[TOP]

[1232]

AUTHOR	:	Sekine, M., Hashimoto, Y., Inagaki, F., Yamakawa, T., and Suzuki, A.
TITLE	:	The expression of IV6 beta[Gal beta 1-4(Fuc alpha 1-3)GlcNAc]-Gb5Cer in mouse kidney is controlled by the Gsl-5 gene through regulation of UDP-GlcNAc:Gb5Cer beta 1-6N-acetylglucosaminyltransferase activity PubMed ID:2146256
JOURNAL	:	J Biochem (Tokyo).
VOL	:	108 PAGE : 103-108 (1990)

[TOP]

[1233]

AUTHOR	:	Angstrom, J., Breimer, M. E., Falk, K. E., Hansson, G. C., Karlsson, K. A., and Leffler, H.
TITLE	:	Chemical characterization of penta-, hexa-, hepta-, octa-, and nonaglycosylceramides of rat small intestine having a globoside-like terminus PubMed ID:7054174
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 682-688 (1982)

[TOP]

[1234]

AUTHOR	:	Nohara, K., Suzuki, M., Inagaki, F., Ito, H., and Kaya, K.
TITLE	:	Identification of novel gangliosides containing lactosaminyl-GM1 structure from rat spleen PubMed ID:2387854
JOURNAL	:	J Biol Chem.
VOL	:	265 PAGE : 14335-14339 (1990)

[TOP]

[1235]

AUTHOR	:	Bartoszewicz, Z., Koscielak, J., and Pacuszka, T.
TITLE	:	Structure of a new disialoganglioside GD1c from spontaneous murine thymoma PubMed ID:3094941
JOURNAL	:	Carbohydr Res.
VOL	:	151 PAGE : 77-88 (1986)

[TOP]

[1236]

AUTHOR	:	Nakamura, K., Suzuki, M., Taya, C., Inagaki, F., Yamakawa, T., and Suzuki, A.
TITLE	:	A sialidase-susceptible ganglioside, IV3 alpha(NeuGc alpha 2-8NeuGc)-Gg4Cer, is a major disialoganglioside in WHT/Ht mouse thymoma and thymocytes PubMed ID:1783616
JOURNAL	:	J Biochem (Tokyo).
VOL	:	110 PAGE : 832-841 (1991)

[TOP]

[1237]

AUTHOR	:	Klenk E.and Rennkamp F.
TITLE	:
JOURNAL	:	Hoppe-Seyler's Z. Physiol. Chem.
VOL	:	273 PAGE : 253- (1942)

[TOP]

[1238]

AUTHOR	:	Klenk, E., and Lauenstein, K.
TITLE	:	[Glycolipids and sphingomyelins in the stroma of horse erythrocytes.] PubMed ID:13128711
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	295 PAGE : 164-173 (1953)

[TOP]

[1239]

AUTHOR	:	Rapport MM., Skipski, VP., Alonzo, NF.
TITLE	:
JOURNAL	:	Nature
VOL	:	181 PAGE : 1803- (1958)

[TOP]

[1240]

AUTHOR	:	Makita, A., and Yamakawa, T.
TITLE	:	Biochemistry Of Organ Glycolipids. Iii. The Structures Of Human Kidney Cerebroside Sulfuric Ester, Ceramide Dihexoside And Ceramide Trihexoside PubMed ID:14170087
JOURNAL	:	J Biochem (Tokyo).
VOL	:	55 PAGE : 365-370 (1964)

[TOP]

[1241]

AUTHOR	:	Macher, B. A., and Klock, J. C.
TITLE	:	Isolation and chemical characterization of neutral glycosphingolipids of human neutrophils PubMed ID:7354081
JOURNAL	:	J Biol Chem.
VOL	:	255 PAGE : 2092-2096 (1980)

[TOP]

[1242]

AUTHOR	:	Shapiro, D. and Rachaman, ES.
TITLE	:
JOURNAL	:	Nature
VOL	:	201 PAGE : 878- (1964)

[TOP]

[1244]

AUTHOR	:	Martensson, E.
TITLE	:
JOURNAL	:	Acta Chem. Scand.
VOL	:	17 PAGE : 1174- (1963)

[TOP]

[1245]

AUTHOR	:	McKibbin, J. M.
TITLE	:	The composition of the glycolipids in dog intestine PubMed ID:5793718
JOURNAL	:	Biochemistry.
VOL	:	8 PAGE : 679-685 (1969)

[TOP]

[1246]

AUTHOR	:	Slomiany, B. L., Slomiany, A., and Horowitz, M. I.
TITLE	:	Sulfatides of hog gastric mucosa PubMed ID:4367973
JOURNAL	:	Biochim Biophys Acta.
VOL	:	348 PAGE : 388-396 (1974)

[TOP]

[1247]

AUTHOR	:	Sugita, M. and Hori, T
TITLE	:	New types of gangliosides in starfish with sialic acid residues in the inner part of their carbohydrate chains. PubMed ID:977556
JOURNAL	:	J. Biochem.
VOL	:	80 PAGE : 637-640 (1976)

[TOP]

[1248]

AUTHOR	:	Sugita, M.
TITLE	:	Studies on the glycosphingolipids of the starfish, Asterina pectinifera. II. Isolation and characterization of a novel ganglioside with an internal sialic acid residue. PubMed ID:113398
JOURNAL	:	J. Biochem.
VOL	:	86 PAGE : 289-300 (1979)

[TOP]

[1249]

AUTHOR	:	Sugita, M.
TITLE	:	Studies on the glycosphingolipids of the starfish, Asterina pectinifera. III. Isolation and structural studies of two novel gangliosides containing internal sialic acid residues. PubMed ID:511847
JOURNAL	:	J. Biochem.
VOL	:	86 PAGE : 765-772 (1979)

[TOP]

[1250]

AUTHOR	:	Sweeley, C. C., and Klionsky, B.
TITLE	:	Fabry's Disease: Classification As A Sphingolipidosis And Partial Characterization Of A Novel Glycolipid PubMed ID:14081947
JOURNAL	:	J Biol Chem.
VOL	:	238 PAGE : 3148-3150 (1963)

[TOP]

[1251]

AUTHOR	:	Li YT., Li SC., Dawson G.
TITLE	:	Anomeric structure of ceramide digalactoside isolated from the kidney of a patient with Fabry's disease. PubMed ID:5012456
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	260 PAGE : 88-92 (1972)

[TOP]

[1252]

AUTHOR	:	Miyatake, T.
TITLE	:	A study on glycolipids in Fabry's isease PubMed ID:5307429
JOURNAL	:	Jpn J Exp Med.
VOL	:	39 PAGE : 35-45 (1969)

[TOP]

[1253]

AUTHOR	:	Makita, A.
TITLE	:	Biochemistry Of Organ Glycolipids. Ii. Isolation Of Human Kidney Glycolipids PubMed ID:14162508
JOURNAL	:	J Biochem (Tokyo).
VOL	:	55 PAGE : 269-276 (1964)

[TOP]

[1254]

AUTHOR	:	Adams, E. P., and Gray, G. M.
TITLE	:	The carbohydrate structures of the neutral ceramide glycolipids in kidneys of different mouse strains with special reference to the ceramide dihexosides PubMed ID:5696946
JOURNAL	:	Chem Phys Lipids.
VOL	:	2 PAGE : 147-155 (1968)

[TOP]

[1255]

AUTHOR	:	Nakamura, K., Fujita, R., Ueno, K., Handa, S.
TITLE	:	Glycosphingolipids of porcine pancreas. PubMed ID:6746593
JOURNAL	:	J. Biochem.
VOL	:	95 PAGE : 1137-1144 (1984)

[TOP]

[1256]

AUTHOR	:	Handa, S., Ariga, T., Miyatake, T., Yamakawa, T.
TITLE	:	Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease. PubMed ID:5551655
JOURNAL	:	J. Biochem.
VOL	:	69 PAGE : 625-627 (1971)

[TOP]

[1257]

AUTHOR	:	Vance, D. E., and Sweeley, C. C.
TITLE	:	Quantitative determination of the neutral glycosyl ceramides in human blood PubMed ID:6057492
JOURNAL	:	J Lipid Res.
VOL	:	8 PAGE : 621-630 (1967)

[TOP]

[1258]

AUTHOR	:	Svennerholm, E., and Svennerholm, L.
TITLE	:	The Separation Of Neutral Blood-Serum Glycolipids By Thin-Layer Chromatography PubMed ID:14067617
JOURNAL	:	Biochim Biophys Acta.
VOL	:	70 PAGE : 432-441 (1963)

[TOP]

[1259]

AUTHOR	:	Ariga, T., Suzuki, M., Yu, R. K., Kuroda, Y., Shimada, I., Inagaki, F., Miyatake, T.
TITLE	:	Accumulation of unique globo-series glycolipids in PC 12h pheochromocytoma cells. PubMed ID:2912970
JOURNAL	:	J Biol. Chem.
VOL	:	264 PAGE : 1516-1521 (1989)

[TOP]

[1260]

AUTHOR	:	Larson G.
TITLE	:	Globoseries glycosphingolipids of human meconium. PubMed ID:3010864
JOURNAL	:	Arch. Biochem. Biophys.
VOL	:	246 PAGE : 531-545 (1986)

[TOP]

[1261]

AUTHOR	:	Arita, H., and Kawanami, J.
TITLE	:	Cytolipin R from rat spleen PubMed ID:893368
JOURNAL	:	J Biochem (Tokyo).
VOL	:	81 PAGE : 1661-1664 (1977)

[TOP]

[1262]

AUTHOR	:	Yamakawa, T.
TITLE	:
JOURNAL	:	Colloq. Ges. Physiol. Chem.
VOL	:	16 PAGE : 87- (1966)

[TOP]

[1263]

AUTHOR	:	Seyama, Y., and Yamakawa, T.
TITLE	:	Chemical structure of glycolipid of guinea pig red blood cell membrane PubMed ID:4847216
JOURNAL	:	J Biochem (Tokyo).
VOL	:	75 PAGE : 837-842 (1974)

[TOP]

[1264]

AUTHOR	:	Svennerholm, L., and Raal, A.
TITLE	:	Composition of brain ganglio-sides PubMed ID:13918690
JOURNAL	:	Biochim Biophys Acta.
VOL	:	53 PAGE : 422-424 (1961)

[TOP]

[1265]

AUTHOR	:	Gatt, S., and Berman, E. R.
TITLE	:	Studies on brain lipids in Tay-Sachs' disease. I. Isolation of two sialic acid-free glycolipids PubMed ID:13946796
JOURNAL	:	J Neurochem.
VOL	:	10 PAGE : 43-49 (1963)

[TOP]

[1266]

AUTHOR	:	Taketomi, T., and Kawamura, N.
TITLE	:	Cerebral and visceral glycolipids in a case of Tay-Sachs disease PubMed ID:4314931
JOURNAL	:	J Biochem (Tokyo).
VOL	:	66 PAGE : 165-174 (1969)

[TOP]

[1267]

AUTHOR	:	Gregoire PE., Jonniaux G., Loeb H., Voet W. and Capaelle R.
TITLE	:	[Biochemical study of cerebral and hepatic lipids in a case of Tay-Sachs disease]
JOURNAL	:	Rev. Fr. Etud. Clin. Biol.
VOL	:	14 PAGE : 568- (1969)

[TOP]

[1268]

AUTHOR	:	Kannagi, R., Levery, S. B., Hakomori, S.
TITLE	:	Hybrid type glycolipids (lacto-ganglio series) with a novel branched structure. Their presence in undifferentiated murine leukemia cells and their dependence on differentiation. PubMed ID:6234312
JOURNAL	:	J. Biol. Chem.
VOL	:	259 PAGE : 8444-8451 (1984)

[TOP]

[1269]

AUTHOR	:	Slomiany, A., Slomiany, B. L., and Annese, C.
TITLE	:	Sulfated trihexosylceramide from gastric mucosa containing N-acetylglucosamine PubMed ID:7408896
JOURNAL	:	Eur J Biochem.
VOL	:	109 PAGE : 471-474 (1980)

[TOP]

[1270]

AUTHOR	:	Ando, S., Kon, K., Nagai, Y., and Yamakawa, T.
TITLE	:	A novel pentaglycosyl ceramide containing di-beta-N-acetylgalactos-aminyl residue (Para-Forssman glycolipid) isolated from human erythrocyte membrane PubMed ID:6814203
JOURNAL	:	Adv Exp Med Biol.
VOL	:	152 PAGE : 71-81 (1982)

[TOP]

[1271]

AUTHOR	:	Angstrom, J., Karlsson, H., Karlsson, K. A., Larson, G., and Nilson, K.
TITLE	:	GalNAc beta 1----3 terminated glycosphingolipids of human erythrocytes PubMed ID:3800377
JOURNAL	:	Arch Biochem Biophys.
VOL	:	251 PAGE : 440-449 (1986)

[TOP]

[1272]

AUTHOR	:	Slomiany, A., and Slomiany, B. L.
TITLE	:	Water-soluble glycosphingolipids of dog gastric mucosa. Characterization of a branched ceramide heptasaccharide PubMed ID:891524
JOURNAL	:	Eur J Biochem.
VOL	:	76 PAGE : 491-498 (1977)

[TOP]

[1273]

AUTHOR	:	Leffler, H., Hansson, G. C., Stromberg, N.
TITLE	:	A novel sulfoglycosphingolipid of mouse small intestine, IV3-sulfogangliotetraosylceramide, demonstrated by negative ion fast atom bombardment mass spectrometry. PubMed ID:3944094
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 1440-1444 (1986)

[TOP]

[1274]

AUTHOR	:	Fredman, P., Mattsson, L., Andersson, K., Davidsson, P., Ishizuka, I., Jeansson, S., Mansson, J. E., Svennerholm, L.
TITLE	:	Characterization of the binding epitope of a monoclonal antibody to sulphatide. PubMed ID:2455508
JOURNAL	:	Biochem. J.
VOL	:	251 PAGE : 17-22 (1988)

[TOP]

[1275]

AUTHOR	:	Kannagi, R., Levery, S. B., Hakomori, S.
TITLE	:	Hybrid type glycolipids (lacto-ganglio series) with a novel branched structure. Their presence in undifferentiated murine leukemia cells and their dependence on differentiation. PubMed ID:6234312
JOURNAL	:	J. Biol. Chem.
VOL	:	259 PAGE : 8444-8451 (1984)

[TOP]

[1276]

AUTHOR	:	Ariga, T., Kohriyama, T., Freddo, L., Latov, N., Saito, M., Kon, K., Ando, S., Suzuki, M., Hemling, M. E., Rinehart, K. L., Jr., et al.
TITLE	:	Characterization of sulfated glucuronic acid containing glycolipids reacting with IgM M-proteins in patients with neuropathy PubMed ID:2433270
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 848-853 (1987)

[TOP]

[1277]

AUTHOR	:	Chou, D. K., Ilyas, A. A., Evans, J. E., Costello, C., Quarles, R. H. and Jungalwala, F. B.
TITLE	:	Structure of sulfated glucuronyl glycolipids in the nervous system reacting with HNK-1 antibody and some IgM paraproteins in neuropathy. PubMed ID:3017944
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 11717-11725 (1986)

[TOP]

[1278]

AUTHOR	:	Slomiany, B. L., and Slomiany, A.
TITLE	:	Isolation and characterization of the sulfated neolactotetraosylceramide from hog gastric mucosa PubMed ID:649586
JOURNAL	:	J Biol Chem.
VOL	:	253 PAGE : 3517-3520 (1978)

[TOP]

[1300]

AUTHOR	:	Breimer, M. E., Hansson, G. C., Karlsson, K. A., Leffler, H.
TITLE	:	Glycosphingolipids of rat tissues. Different composition of epithelial and nonepithelial cells of small intestine. PubMed ID:7053385
JOURNAL	:	J. Biol. Chem.
VOL	:	257 PAGE : 557-568 (1982)

[TOP]

[1301]

AUTHOR	:	Ariga, T., Suzuki, M., Yu, R. K., Kuroda, Y., Shimada, I., Inagaki, F., Miyatake, T.
TITLE	:	Accumulation of unique globo-series glycolipids in PC 12h pheochromocytoma cells. PubMed ID:2912970
JOURNAL	:	J. Biol. Chem.
VOL	:	264 PAGE : 1516-1521 (1989)

[TOP]

[1302]

AUTHOR	:	Larson, G.
TITLE	:	Globoseries glycosphingolipids of human meconium. PubMed ID:3010864
JOURNAL	:	Arch. Biochem. Biophys.
VOL	:	246 PAGE : 531-545 (1986)

[TOP]

[1303]

AUTHOR	:	Kannagi, R., Levery, S. B., Ishigami, F., Hakomori, S., Shevinsky, L. H., Knowles, B. B., Solter, D.
TITLE	:	New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. PubMed ID:6863318
JOURNAL	:	J. Biol. Chem.
VOL	:	258 PAGE : 8934-8942 (1983)

[TOP]

[1304]

AUTHOR	:	Breimer, M. E., Karlsson, K. A.
TITLE	:	Chemical and immunological identification of glycolipid-based blood group ABH and Lewis antigens in human kidney. PubMed ID:6830844
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	755 PAGE : 170-177 (1983)

[TOP]

[1305]

AUTHOR	:	Sekine, M., Suzuki, M., Inagaki, F., Suzuki, A., Yamakawa, T.
TITLE	:	A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney. PubMed ID:2885312
JOURNAL	:	J. Biochem.
VOL	:	101 PAGE : 553-562 (1987)

[TOP]

[1306]

AUTHOR	:
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[1307]

AUTHOR	:	Karlsson, K. A., Larson, G.
TITLE	:	Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a--b+) secretor. PubMed ID:6782103
JOURNAL	:	J. Biol. Chem.
VOL	:	256 PAGE : 3512-3524 (1981)

[TOP]

[1308]

AUTHOR	:	Fukuda, M. N., Dell, A., Oates, J. E., Wu, P., Klock, J. C., Fukuda, M.
TITLE	:	Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. PubMed ID:3881421
JOURNAL	:	J. Biol. Chem.
VOL	:	260 PAGE : 1067-1082 (1985)

[TOP]

[1309]

AUTHOR	:	Okada, Y., Kannagi, R., Levery, S. B., and Hakomori, S.
TITLE	:	Glycolipid antigens with blood group I and i specificities from human adult and umbilical cord erythrocytes PubMed ID:6203982
JOURNAL	:	J Immunol.
VOL	:	133 PAGE : 835-842 (1984)

[TOP]

[1310]

AUTHOR	:	Breimer, M. E., Hansson, G. C., Karlsson, K. A., and Leffler, H.
TITLE	:	Isolation and partial characterization of blood group A and H active glycosphingolipids of rat small intestine PubMed ID:6798034
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 906-912 (1982)

[TOP]

[1312]

AUTHOR	:	Hansson, G. C., Karlsson, K. A., and Thurin, J.
TITLE	:	Glycolipids of rat large intestine. Characterization of a novel blood group B-active tetraglycosylceramide absent from small intestine PubMed ID:7437454
JOURNAL	:	Biochim Biophys Acta.
VOL	:	620 PAGE : 270-280 (1980)

[TOP]

[1313]

AUTHOR	:	Slomiany, B. L., Slomiany, A., and Horowitz, M. I.
TITLE	:	Characterization of three new fucolipids from hog gastric mucosa PubMed ID:1175629
JOURNAL	:	Eur J Biochem.
VOL	:	56 PAGE : 353-358 (1975)

[TOP]

[1314]

AUTHOR	:	Schwarting, G. A., Carroll, P. G., DeWolf, W. C.
TITLE	:	Fucosyl-globoside and sialosyl-globoside are new glycolipids isolated from human teratocarcinoma cells. PubMed ID:6847688
JOURNAL	:	Biochem. Biophys. Res. Commun.
VOL	:	112 PAGE : 935-940 (1983)

[TOP]

[1315]

AUTHOR	:	Bremer, E. G., Levery, S. B., Sonnino, S., Ghidoni, R., Canevari, S., Kannagi, R., and Hakomori, S.
TITLE	:	Characterization of a glycosphingolipid antigen defined by the monoclonal antibody MBr1 expressed in normal and neoplastic epithelial cells of human mammary gland PubMed ID:6501317
JOURNAL	:	J Biol Chem.
VOL	:	259 PAGE : 14773-14777 (1984)

[TOP]

[1316]

AUTHOR	:	Kannagi, R., Levery, S. B., and Hakomori, S.
TITLE	:	Blood group H antigen with globo-series structure. Isolation and characterization from human blood group O erythrocytes PubMed ID:6479351
JOURNAL	:	FEBS Lett.
VOL	:	175 PAGE : 397-401 (1984)

[TOP]

[1317]

AUTHOR	:	Breimer, M. E., and Jovall, P. A.
TITLE	:	Structural characterization of a blood group A heptaglycosylceramide with globo-series structure. The major glycolipid based blood group A antigen of human kidney PubMed ID:3965299
JOURNAL	:	FEBS Lett.
VOL	:	179 PAGE : 165-172 (1985)

[TOP]

[1318]

AUTHOR	:	Clausen, H., Watanabe, K., Kannagi, R., Levery, S. B., Nudelman, E., Arao-Tomono, Y., and Hakomori, S.
TITLE	:	Blood group A glycolipid (Ax) with globo-series structure which is specific for blood group A1 erythrocytes: one of the chemical bases for A1 and A2 distinction PubMed ID:6497890
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	124 PAGE : 523-529 (1984)

[TOP]

[1319]

AUTHOR	:	Slomiany, B. L., and Slomiany, A.
TITLE	:	Forssman glycolipid variants of dog gastric mucosa. Structure of a branched ceramide octasaccharide PubMed ID:414913
JOURNAL	:	Eur J Biochem.
VOL	:	83 PAGE : 105-111 (1978)

[TOP]

[1320]

AUTHOR	:	Hansson, G. C., Bouhours, J. F., and Angstrom, J.
TITLE	:	Characterization of neutral blood group B-active glycosphingolipids of rat gastric mucosa. A novel type of blood group active glycosphingolipid based on isogloboside PubMed ID:3654605
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 13135-13141 (1987)

[TOP]

[1321]

AUTHOR	:	Taki, T., Hirabayashi, Y., Matsumoto, M., Kojima, K.
TITLE	:	Enzymic synthesis of a new type of fucose-containing glycolipid with fucosyltransferase of rat ascites hepatoma cell, AH 7974F. PubMed ID:32911
JOURNAL	:	Biochimica et Biophysica Acta
VOL	:	572 PAGE : 105-112 (1979)

[TOP]

[1322]

AUTHOR	:	Taki, T., Kimura, H., Gasa, S., Nakamura, M., and Matsumoto, M.
TITLE	:	A new type of blood group B active glycosphingolipid in rat bone marrow cells. Occurrence of the glycolipid in rat immunocytes and ascites hepatoma PubMed ID:3997820
JOURNAL	:	J Biol Chem.
VOL	:	260 PAGE : 6219-6225 (1985)

[TOP]

[1323]

AUTHOR	:	Stellner, K., Watanabe, K., Hakomori, S.
TITLE	:	Isolation and characterization of glycosphingolipids with blood group H specificity from membranes of human erythrocytes. PubMed ID:4734896
JOURNAL	:	Biochemistry
VOL	:	12 PAGE : 656-661 (1973)

[TOP]

[1324]

AUTHOR	:	Koscielak, J., Plasek, A., Gorniak, H., Gardas, A., Gregor, A.
TITLE	:	Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. PubMed ID:4745728
JOURNAL	:	Eur. J. Biochem.
VOL	:	37 PAGE : 214-225 (1973)

[TOP]

[1325]

AUTHOR	:	Hanfland, P.
TITLE	:	Characterization of B and H blood-group active glycosphingolopids from human B erythrocyte membranes PubMed ID:812611
JOURNAL	:	Chem Phys Lipids.
VOL	:	15 PAGE : 105-124 (1975)

[TOP]

[1326]

AUTHOR	:	Hakomori, S., Andrews, H. D.
TITLE	:	Sphingoglycolipids with Leb activity, and the co-presence of Lea-, Leb-glycolipids in human tumor tissue. PubMed ID:5417196
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	202 PAGE : 225-228 (1970)

[TOP]

[1328]

AUTHOR	:	McKibbin, J. M., Spencer, W. A., Smith, E. L., Mansson, J. E., Karlsson, K. A., Samuelsson, B. E., Li, Y. T., and Li, S. C.
TITLE	:	Lewis blood group fucolipids and their isomers from human and canine intestine PubMed ID:6798032
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 755-760 (1982)

[TOP]

[1329]

AUTHOR	:	Gooi, H. C., Feizi, T., Kapadia, A., Knowles, B. B., Solter, D., and Evans, M. J.
TITLE	:	Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains PubMed ID:6165896
JOURNAL	:	Nature.
VOL	:	292 PAGE : 156-158 (1981)

[TOP]

[1330]

AUTHOR	:	Hakomori, S., Nudelman, E., Levery, S., Solter, D., and Knowles, B. B.
TITLE	:	The hapten structure of a developmentally regulated glycolipid antigen (SSEA-1) isolated from human erythrocytes and adenocarcinoma: a preliminary note PubMed ID:6117281
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	100 PAGE : 1578-1586 (1981)

[TOP]

[1331]

AUTHOR	:	Abe, K., McKibbin, J. M., and Hakomori, S.
TITLE	:	The monoclonal antibody directed to difucosylated type 2 chain (Fuc alpha 1 leads to 2Gal beta 1 leads to 4[Fuc alpha 1 leads to 3]GlcNAc; Y Determinant) PubMed ID:6194156
JOURNAL	:	J Biol Chem.
VOL	:	258 PAGE : 11793-11797 (1983)

[TOP]

[1332]

AUTHOR	:	Wherrett, J. R., Hakomori, S. I.
TITLE	:	Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease. PubMed ID:4735571
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 3046-3051 (1973)

[TOP]

[1333]

AUTHOR	:	Watanabe, K., and Hakomori, S. I.
TITLE	:	Status of blood group carbohydrate chains in ontogenesis and in oncogenesis PubMed ID:60462
JOURNAL	:	J Exp Med.
VOL	:	144 PAGE : 645-653 (1976)

[TOP]

[1334]

AUTHOR	:	Clausen, H., Levery, S. B., Nudelman, E., Baldwin, M., and Hakomori, S.
TITLE	:	Further characterization of type 2 and type 3 chain blood group A glycosphingolipids from human erythrocyte membranes PubMed ID:3801409
JOURNAL	:	Biochemistry.
VOL	:	25 PAGE : 7075-7085 (1986)

[TOP]

[1335]

AUTHOR	:	Breimer, M. E.
TITLE	:	Tissue specificity of glycosphingolipids as expressed in pancreas and small intestine of blood group A and B human individuals PubMed ID:6198960
JOURNAL	:	Arch Biochem Biophys.
VOL	:	228 PAGE : 71-85 (1984)

[TOP]

[1336]

AUTHOR	:	Yoda, Y., Makita, A., and Gasa, S.
TITLE	:	Blood-group A and the related glycolipids of human lung PubMed ID:7068580
JOURNAL	:	J Biochem (Tokyo).
VOL	:	91 PAGE : 627-632 (1982)

[TOP]

[1337]

AUTHOR	:	McKibbin, J. M., Smith, E. L., Mansson, J. E., Li, Y. T.
TITLE	:	Characterization of dog small intestinal fucolipids with human blood group A activity. Differences in dog and human A-active fucolipids. PubMed ID:402937
JOURNAL	:	Biochemistry
VOL	:	16 PAGE : 1223-1228 (1977)

[TOP]

[1338]

AUTHOR	:	Clausen, H., Levery, S. B., Nudelman, E. D., Stroud, M., Salyan, M. E., Hakomori, S.
TITLE	:	Isolation and characterization of novel glycolipids with blood group A-related structures: galactosyl-A and sialosylgalactosyl-A. PubMed ID:3654659
JOURNAL	:	J. Biol. Chem.
VOL	:	262 PAGE : 14228-14234 (1987)

[TOP]

[1339]

AUTHOR	:	Breimer, M. E., Hansson, G. C., Karlsson, K. A., Leffler, H., Pimlott, W., and Samuelsson, B. E.
TITLE	:	Selected ion monitoring of glycospingolipid mixtures. Identification of several blood group type glycolipids in the small intestine of an individual rabbit PubMed ID:476287
JOURNAL	:	Biomed Mass Spectrom.
VOL	:	6 PAGE : 231-241 (1979)

[TOP]

[1341]

AUTHOR	:	Angstrom, J., Falk, P., Hansson, G. C., Holgersson, J., Karlsson, H., Karlsson, K. A., Stromberg, N., and Thurin, J.
TITLE	:	The mono- and difucosyl blood group B glycosphingolipids of rat large intestine differ in type of core saccharide PubMed ID:3651504
JOURNAL	:	Biochim Biophys Acta.
VOL	:	926 PAGE : 79-86 (1987)

[TOP]

[1342]

AUTHOR	:	Kannagi, R., Levery, S. B., and Hakomori, S.
TITLE	:	Lea-active heptaglycosylceramide, a hybrid of type 1 and type 2 chain, and the pattern of glycolipids with Lea, Leb, X (Lex), and Y (Ley) determinants in human blood cell membranes (ghosts). Evidence that type 2 chain can elongate repetitively but type 1 chain cannot PubMed ID:3997830
JOURNAL	:	J Biol Chem.
VOL	:	260 PAGE : 6410-6415 (1985)

[TOP]

[1343]

AUTHOR	:	Martensson, S., Due, C., Pahlsson, P., Nilsson, B., Eriksson, H., Zopf, D., Olsson, L., and Lundblad, A.
TITLE	:	A carbohydrate epitope associated with human squamous lung cancer PubMed ID:2450645
JOURNAL	:	Cancer Res.
VOL	:	48 PAGE : 2125-2131 (1988)

[TOP]

[1344]

AUTHOR	:	Clausen, H., Levery, S. B., Kannagi, R., and Hakomori, S.
TITLE	:	Novel blood group H glycolipid antigens exclusively expressed in blood group A and AB erythrocytes (type 3 chain H). I. Isolation and chemical characterization PubMed ID:3944091
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 1380-1387 (1986)

[TOP]

[1345]

AUTHOR	:	Clausen, H., Levery, S. B., Nudelman, E., Tsuchiya, S., and Hakomori, S.
TITLE	:	Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction PubMed ID:2579390
JOURNAL	:	Proc Natl Acad Sci U S A.
VOL	:	82 PAGE : 1199-1203 (1985)

[TOP]

[1346]

AUTHOR	:	Bjork, S., Breimer, M. E., Hansson, G. C., Karlsson, K. A., and Leffler, H.
TITLE	:	Structures of blood group glycosphingolipids of human small intestine. A relation between the expression of fucolipids of epithelial cells and the ABO, Le and Se phenotype of the donor PubMed ID:3571286
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 6758-6765 (1987)

[TOP]

[1347]

AUTHOR	:	Breimer, M. E., Karlsson, K. A., and Samuelsson, B. E.
TITLE	:	Characterization of a blood group H type pentaglycosylceramide of human pancreas based on a type 1 carbohydrate chain PubMed ID:7217056
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 3810-3816 (1981)

[TOP]

[1348]

AUTHOR	:	Hakomori, S., Jeanloz, R. W.
TITLE	:
JOURNAL	:	J. Biol. Chem.
VOL	:	238 PAGE : 3606- (1964)

[TOP]

[1349]

AUTHOR	:	Hakomori, S. I.
TITLE	:	Release of carbohydrates from sphingoglycolipid by osmium-catalyzed periodate oxidation followed by treatment with mild alkali PubMed ID:4291317
JOURNAL	:	J Lipid Res.
VOL	:	7 PAGE : 789-792 (1966)

[TOP]

[1350]

AUTHOR	:	Hakomori, S. I., Koscielak, J., Bloch, K. J., and Jeanloz, R. W.
TITLE	:	Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma PubMed ID:6018768
JOURNAL	:	J Immunol.
VOL	:	98 PAGE : 31-38 (1967)

[TOP]

[1351]

AUTHOR	:	Marcus, D. M., and Cass, L. E.
TITLE	:	Glycosphingolipids with Lewis blood group activity: uptake by human erythrocytes PubMed ID:5778002
JOURNAL	:	Science.
VOL	:	164 PAGE : 553-555 (1969)

[TOP]

[1352]

AUTHOR	:	Brockhaus, M., Magnani, J. L., Blaszczyk, M., Steplewski, Z., Koprowski, H., Karlsson, K. A., Larson, G., and Ginsburg, V.
TITLE	:	Monoclonal antibodies directed against the human Leb blood group antigen PubMed ID:7309759
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 13223-13225 (1981)

[TOP]

[1353]

AUTHOR	:	Egge, H., and Hanfland, P.
TITLE	:	Immunochemistry of the Lewis-blood-group system: mass spectrometric analysis of permethylated Le(a)-, Le(b)-, and H-type 1 (LedH) blood-group active and related glycosphingolipids from human plasma PubMed ID:7294834
JOURNAL	:	Arch Biochem Biophys.
VOL	:	210 PAGE : 396-404 (1981)

[TOP]

[1354]

AUTHOR	:	Clausen, H., Levery, S. B., McKibbin, J. M., and Hakomori, S.
TITLE	:	Blood group A determinants with mono- and difucosyl type 1 chain in human erythrocyte membranes PubMed ID:4041428
JOURNAL	:	Biochemistry.
VOL	:	24 PAGE : 3578-3586 (1985)

[TOP]

[1355]

AUTHOR	:	Jovall, P. A., Lindstrom, K., Pascher, I., Pimlott, W., and Samuelsson, B. E.
TITLE	:	Identification of a blood group A active hexaglycosylceramide with a type 1 carbohydrate chain in plasma of an A1 Le(a-b-) secretor PubMed ID:3662532
JOURNAL	:	Arch Biochem Biophys.
VOL	:	257 PAGE : 409-415 (1987)

[TOP]

[1356]

AUTHOR	:	Breimer, M. E., Karlsson, K. A., and Samuelsson, B. E.
TITLE	:	Characterization of a human intestinal difucosyl heptaglycosylceramide with a blood group B determinant and a type 1 carbohydrate chain PubMed ID:7054167
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 1079-1085 (1982)

[TOP]

[1357]

AUTHOR	:
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[1358]

AUTHOR	:	Slomiany, A., Slomiany, B. L., and Horowitz, M. I.
TITLE	:	Structural study of the blood group A active glycolipids of hog gastric mucosa PubMed ID:4360683
JOURNAL	:	J Biol Chem.
VOL	:	249 PAGE : 1225-1230 (1974)

[TOP]

[1359]

AUTHOR	:	Slomiany, A., Slomiany, B. L.
TITLE	:	Blood group A active difucosyl glycolipid from hog gastric mucosa. PubMed ID:1125299
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	388 PAGE : 135-145 (1975)

[TOP]

[1360]

AUTHOR	:	Slomiany, B. L., Slomiany, A.
TITLE	:	Branched blood group A-active fucolipids of hog gastric mucosa. PubMed ID:192301
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	486 PAGE : 531-540 (1977)

[TOP]

[1361]

AUTHOR	:	Watanabe, K., Laine, R. A., and Hakomori, S. I.
TITLE	:	On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes PubMed ID:807238
JOURNAL	:	Biochemistry.
VOL	:	14 PAGE : 2725-2733 (1975)

[TOP]

[1362]

AUTHOR	:	Kannagi, R., Nudelman, E., Levery, S. B., and Hakomori, S.
TITLE	:	A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1 PubMed ID:6129244
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 14865-14874 (1982)

[TOP]

[1363]

AUTHOR	:	Nudelman, E., Levery, S. B., Kaizu, T., and Hakomori, S.
TITLE	:	Novel fucolipids of human adenocarcinoma: characterization of the major Ley antigen of human adenocarcinoma as trifucosylnonaosyl Ley glycolipid (III3FucV3FucVI2FucnLc6) PubMed ID:3733752
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 11247-11253 (1986)

[TOP]

[1364]

AUTHOR	:	Hakomori, S., Nudelman, E., Levery, S. B., and Kannagi, R.
TITLE	:	Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain PubMed ID:6707026
JOURNAL	:	J Biol Chem.
VOL	:	259 PAGE : 4672-4680 (1984)

[TOP]

[1365]

AUTHOR	:	Fukuda, M. N., and Levery, S. B.
TITLE	:	Glycolipids of fetal, newborn, and adult erythrocytes: glycolipid pattern and structural study of H3-glycolipid from newborn erythrocytes PubMed ID:6639942
JOURNAL	:	Biochemistry.
VOL	:	22 PAGE : 5034-5040 (1983)

[TOP]

[1366]

AUTHOR	:	Hanfland, P., Kordowicz, M., Niermann, H., Egge, H., Dabrowski, U., Peter-Katalinic, J., and Dabrowski, J.
TITLE	:	Purification and structures of branched blood-group-B-active glycosphingolipids from human erythrocyte membranes PubMed ID:6510415
JOURNAL	:	Eur J Biochem.
VOL	:	145 PAGE : 531-542 (1984)

[TOP]

[1367]

AUTHOR	:	Fukuda, M. N., and Hakomori, S.
TITLE	:	Structures of branched blood group A-active glycosphingolipids in human erythrocytes and polymorphism of A- and H-glycolipids in A1 and A2 subgroups PubMed ID:7053380
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 446-455 (1982)

[TOP]

[1368]

AUTHOR	:	Breimer, M. E., Falk, K. E., Hansson, G. C., and Karlsson, K. A.
TITLE	:	Structural identification of two ten-sugar branched chain glycosphingolipids of blood group H type present in epithelial cells of rat small intestine PubMed ID:6796590
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 50-59 (1982)

[TOP]

[1369]

AUTHOR	:	Hansson, G. C.
TITLE	:	The structure of two blood group A-active glycosphingolipids with 12 sugars and a branched chain present in the epithelial cells of rat small intestine PubMed ID:6885761
JOURNAL	:	J Biol Chem.
VOL	:	258 PAGE : 9612-9615 (1983)

[TOP]

[1370]

AUTHOR	:	Gardas, A.
TITLE	:	A structural study on a macro-glycolipid containing 22 sugars isolated from human erythrocytes PubMed ID:964264
JOURNAL	:	Eur J Biochem.
VOL	:	68 PAGE : 177-183 (1976)

[TOP]

[1371]

AUTHOR	:	Gardas, A.
TITLE	:	Studies on the I-blood-group-active sites on macro-glycolipids from human erythrocytes PubMed ID:823020
JOURNAL	:	Eur J Biochem.
VOL	:	68 PAGE : 185-191 (1976)

[TOP]

[1372]

AUTHOR	:	Slomiany, B. L., and Slomiany, A.
TITLE	:	Complex glycosphingolipids with blood-group A specificity PubMed ID:838059
JOURNAL	:	FEBS Lett.
VOL	:	73 PAGE : 175-180 (1977)

[TOP]

[1373]

AUTHOR	:	Slomiany, A., and Horowitz, M. I.
TITLE	:	Blood group A active glycolipids of hog gastric mucosa. Isolation and partial characterization PubMed ID:4737735
JOURNAL	:	J Biol Chem.
VOL	:	248 PAGE : 6232-6238 (1973)

[TOP]

[1374]

AUTHOR	:	Slomiany, A., and Slomiany, B. L.
TITLE	:	Structure of the ceramide octadekahexoside isolated from gastric mucosa PubMed ID:7387673
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	93 PAGE : 770-775 (1980)

[TOP]

[1375]

AUTHOR	:	Slomiany, B. L., and Slomiany, A.
TITLE	:	Blood-group-(A + H) complex fucolipids of hog gastric mucosa PubMed ID:710419
JOURNAL	:	Eur J Biochem.
VOL	:	90 PAGE : 39-49 (1978)

[TOP]

[1376]

AUTHOR	:	Slomiany, B. L., Slomiany, A.
TITLE	:	Structural studies on branched fucosphingolipids of hog gastric mucosa. PubMed ID:912820
JOURNAL	:	Chem. Phys. Lipids
VOL	:	20 PAGE : 57-69 (1977)

[TOP]

[1377]

AUTHOR	:	Slomiany, B. L., Slomiany, A., Galicki, N. I., and Kojima, K.
TITLE	:	Complex fucolipids of hog gastric mucosa. Structure of the ceramide eikosahexoside PubMed ID:6257515
JOURNAL	:	Eur J Biochem.
VOL	:	113 PAGE : 27-32 (1980)

[TOP]

[1378]

AUTHOR	:	Karlsson, K. A., and Larson, G.
TITLE	:	Structural characterization of lactotetraosylceramide, a novel glycosphingolipid isolated from human meconium PubMed ID:479198
JOURNAL	:	J Biol Chem.
VOL	:	254 PAGE : 9311-9316 (1979)

[TOP]

[1379]

AUTHOR	:	Karlsson, K. A., and Larson, G.
TITLE	:	Molecular characterization of cell surface antigens of fetal tissue. Detailed analysis of glycosphingolipids of meconium of a human O Le(a--b+) secretor. PubMed ID:6782103
JOURNAL	:	J. Biol. Chem.
VOL	:	256 PAGE : 3512-3524 (1981)

[TOP]

[1380]

AUTHOR	:	Hanfland, P., Egge, H., Dabrowski, U., Kuhn, S., Roelcke, D., and Dabrowski, J.
TITLE	:	Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes PubMed ID:7295682
JOURNAL	:	Biochemistry.
VOL	:	20 PAGE : 5310-5319 (1981)

[TOP]

[1381]

AUTHOR	:	Fukuda MN. Dell A. Oates JE. Wu P. Klock JC. Fukuda M.
TITLE	:	Structures of glycosphingolipids isolated from human granulocytes. The presence of a series of linear poly-N-acetyllactosaminylceramide and its significance in glycolipids of whole blood cells. PubMed ID:3881421
JOURNAL	:	J. Biol. Chem.
VOL	:	260 PAGE : 1067-1082 (1985)

[TOP]

[1382]

AUTHOR	:	Watanabe K. Matsubara T. Hakomori S.
TITLE	:	alpha-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors. PubMed ID:1262328
JOURNAL	:	J. Biol. Chem.
VOL	:	251 PAGE : 2385-2387 (1976)

[TOP]

[1383]

AUTHOR	:	Breimer, M. E., Hansson, G. C., Karlsson, K. A., and Leffler, H.
TITLE	:	Glycolipids of rat small intestine. Characterization of a novel blood group H-active triglycosylceramide PubMed ID:7353025
JOURNAL	:	Biochim Biophys Acta.
VOL	:	617 PAGE : 85-96 (1980)

[TOP]

[1384]

AUTHOR	:	Ugorski, M., Nilsson, B., Schroer, K., Cashel, J. A., and Zopf, D.
TITLE	:	Gas chromatography/mass spectrometry analysis of oligosaccharides from neutral glycosphingolipids of murine B cell hybridomas PubMed ID:6608522
JOURNAL	:	J Biol Chem.
VOL	:	259 PAGE : 481-486 (1984)

[TOP]

[1386]

AUTHOR	:	Makita A, Suzuki C, Yosizawa Z, Konno T.
TITLE	:	Glycolipids isolated from the spleen of Gaucher's disease. PubMed ID:5956509
JOURNAL	:	Tohoku J. Exp. Med.
VOL	:	88 PAGE : 277-288 (1966)

[TOP]

[1387]

AUTHOR	:	Oshima, M.
TITLE	:	Identification of glucosyl sphingosine from Gaucher's spleen by gas chromatography-electron impact and GC-chemical ionization mass spectrometry PubMed ID:965366
JOURNAL	:	J Biochem (Tokyo).
VOL	:	80 PAGE : 53-59 (1976)

[TOP]

[1388]

AUTHOR	:	Raghavan, S. S., Mumford, R. A., and Kanfer, J. N.
TITLE	:	Isolation and characterization of glucosylsphingosine from Gaucher's spleen PubMed ID:4414001
JOURNAL	:	J Lipid Res.
VOL	:	15 PAGE : 484-490 (1974)

[TOP]

[1389]

AUTHOR	:	Curtino, J. A., and Caputto, R.
TITLE	:	Enzymatic synthesis of glucosylsphingosine by rat brain microsomes PubMed ID:5055824
JOURNAL	:	Lipids.
VOL	:	7 PAGE : 525-527 (1972)

[TOP]

[1390]

AUTHOR	:	Watanabe K. Matsubara T. Hakomori S.
TITLE	:	a-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors. PubMed ID:1262328
JOURNAL	:	J. Biol. Chem.
VOL	:	251 PAGE : 2385-2387 (1976)

[TOP]

[1391]

AUTHOR	:	Karlsson, K. A., Samuelsson, B. E., and Steen, G. O.
TITLE	:	Identification of a xylose-containing cerebroside in the salt gland of the herring gull PubMed ID:4335795
JOURNAL	:	J Lipid Res.
VOL	:	13 PAGE : 169-176 (1972)

[TOP]

[1392]

AUTHOR	:	Yamamoto, A., Yano, I., Masui, M., Yabuuchi, E.
TITLE	:	Isolation of a novel sphingoglycolipid containing glucuronic acid and 2-hydroxy fatty acid from Flavobacterium devorans ATCC 10829. PubMed ID:659393
JOURNAL	:	J. Biochem.
VOL	:	83 PAGE : 1213-1216 (1978)

[TOP]

[1393]

AUTHOR	:	Sugita, M.
TITLE	:	Studies on the glycosphingolipids of the starfish, Asterina pectinifera. I. The isolation and characterization of ceramide mono- and di-hexosides. PubMed ID:591503
JOURNAL	:	J. Biochem.
VOL	:	82 PAGE : 1307-1312 (1977)

[TOP]

[1394]

AUTHOR	:	De Baecque, C., Johnson, A. B., Naiki, M., Schwarting, G., and Marcus, D. M.
TITLE	:	Ganglioside localization in cerebellar cortex: an immunoperoxidase study with antibody to GM1 ganglioside PubMed ID:963536
JOURNAL	:	Brain Res.
VOL	:	114 PAGE : 117-122 (1976)

[TOP]

[1395]

AUTHOR	:	Yamakawa, T., Yokoyama, S., and Handa, N.
TITLE	:	Chemistry of lipids of posthemolytic residue or stroma of erythrocytes. XI. Structure of globoside, the main mucolipid of human erythrocytes PubMed ID:14002301
JOURNAL	:	J Biochem (Tokyo).
VOL	:	53 PAGE : 28-36 (1963)

[TOP]

[1396]

AUTHOR	:	Makita, A., and Yamakawa, T.
TITLE	:	Biochemistry of organ glycolipid. I. Ceramide-oligohexosides of human, equine and bovine spleens PubMed ID:14468728
JOURNAL	:	J Biochem (Tokyo).
VOL	:	51 PAGE : 124-133 (1962)

[TOP]

[1397]

AUTHOR	:	Yamakawa, T.
TITLE	:
JOURNAL	:	J. Biochem.
VOL	:	48 PAGE : 490- (1960)

[TOP]

[1398]

AUTHOR	:	Klenk, E., Wlter, H.
TITLE	:
JOURNAL	:	Z. Phisiol. Chem.
VOL	:	291 PAGE : 259- (1952)

[TOP]

[1399]

AUTHOR	:	Rapport, M
TITLE	:
JOURNAL	:	Cancer Res.
VOL	:	21 PAGE : 1225- (1961)

[TOP]

[1400]

AUTHOR	:	Svennerholm, E., Svennerholm, L.
TITLE	:
JOURNAL	:	Nature
VOL	:	198 PAGE : 688- (1963)

[TOP]

[1401]

AUTHOR	:	Kawanami J. Tsuji T.
TITLE	:	Lipids of cancer tissues. 3. Glycolipids of human hepatoma tissue. PubMed ID:4302095
JOURNAL	:	Jpn. J. Exp. Med.
VOL	:	38 PAGE : 11-18 (1968)

[TOP]

[1402]

AUTHOR	:	Kawanami J. Tsuji T.
TITLE	:	Lipids of cancer tissues. IV. Glycolipids of human hepatoma tissue.PubMed ID:4302095
JOURNAL	:	Jpn. J. Exp. Med.
VOL	:	38 PAGE : 11-18 (1968)

[TOP]

[1403]

AUTHOR	:	Svennerholm, L., Bruce, A., Mansson, J. E., Rynmark, B. M., and Vanier, M. T.
TITLE	:	Sphinolipids of human skeletal muscle PubMed ID:4648787
JOURNAL	:	Biochim Biophys Acta.
VOL	:	280 PAGE : 626-636 (1972)

[TOP]

[1404]

AUTHOR	:	Norton, W. T., and Poduslo, S. E.
TITLE	:	Neuronal perikarya and astroglia of rat brain: chemical composition during myelination PubMed ID:5542708
JOURNAL	:	J Lipid Res.
VOL	:	12 PAGE : 84-90 (1971)

[TOP]

[1405]

AUTHOR	:	Shapiro, D.,
TITLE	:
JOURNAL	:	Chem. Phys. Lipids
VOL	:	1 PAGE : 54- (1966)

[TOP]

[1406]

AUTHOR	:	Handa S. Ariga T. Miyatake T. Yamakawa T.
TITLE	:	Presence of alpha-anomeric glycosidic configuration in the glycolipids accumulated in kidney with Fabry's disease. PubMed ID:5551655
JOURNAL	:	J. Biochem.
VOL	:	69 PAGE : 625-627 (1971)

[TOP]

[1407]

AUTHOR	:	Wherrett JR., Hakomori SI.
TITLE	:	Characterization of a blood group B glycolipid, accumulating in the pancreas of a patient with Fabry's disease. PubMed ID:4735571
JOURNAL	:	J. Biol. Chem.
VOL	:	248 PAGE : 3046-3051 (1973)

[TOP]

[1408]

AUTHOR	:	Gahmberg, CG., Hakomori, S.
TITLE	:	Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific ceramide tetrasaccharide for transformants. PubMed ID:164440
JOURNAL	:	J. Biol. Chem.
VOL	:	250 PAGE : 2438-2446 (1975)

[TOP]

[1409]

AUTHOR	:	Miras, C. J., Mantzos, J. D., and Levis, G. M.
TITLE	:	The isolation and partial characterization of glycolipids of normal human leucocytes PubMed ID:5911526
JOURNAL	:	Biochem J.
VOL	:	98 PAGE : 782-786 (1966)

[TOP]

[1410]

AUTHOR	:	Gray, G. M.
TITLE	:	The effect of testosterone on the biosynthesis of the neutral glycosphingolipids in the C57-BL mouse kidney PubMed ID:5113506
JOURNAL	:	Biochim Biophys Acta.
VOL	:	239 PAGE : 494-500 (1971)

[TOP]

[1411]

AUTHOR	:	Kishimoto, Y., Davies, W. E., and Radin, N. S.
TITLE	:	Developing rat brain: changes in cholesterol, galactolipids, and the individual fatty acids of gangliosides and glycerophosphatides PubMed ID:5865381
JOURNAL	:	J Lipid Res.
VOL	:	6 PAGE : 532-536 (1965)

[TOP]

[1412]

AUTHOR	:	Cuzner, M. L., and Davison, A. N.
TITLE	:	The lipid composition of rat brain myelin and subcellular fractions during development PubMed ID:5721466
JOURNAL	:	Biochem J.
VOL	:	106 PAGE : 29-34 (1968)

[TOP]

[1413]

AUTHOR	:	Hess, H.H., Pope, A.(1972) in Handbook of Neurochemistry, p.289, Plenum Press, New York
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[1414]

AUTHOR	:	Berry, J.F.,
TITLE	:
JOURNAL	:	J. Am. Oil Chem. Soc.
VOL	:	42 PAGE : 492- (1965)

[TOP]

[1415]

AUTHOR	:	Singh, H.
TITLE	:	Glycolipids of peripheral nerve: isolation and characterization of glycolipids from rabbit sciatic nerve PubMed ID:4701552
JOURNAL	:	J Lipid Res.
VOL	:	14 PAGE : 41-49 (1973)

[TOP]

[1416]

AUTHOR	:	Karlsson, K. A., and Martensson, E.
TITLE	:	Studies on sphingosines. XIV. On the phytosphingosine content of the major human kidney glycolipids PubMed ID:4296332
JOURNAL	:	Biochim Biophys Acta.
VOL	:	152 PAGE : 230-233 (1968)

[TOP]

[1417]

AUTHOR	:	Hori, T.
TITLE	:
JOURNAL	:	J. Biochem.
VOL	:	64 PAGE : 113- (1968)

[TOP]

[1418]

AUTHOR	:	Abe, T., and Norton, W. T.
TITLE	:	The characterization of sphingolipids from neurons and astroglia of immature rat brain PubMed ID:4373537
JOURNAL	:	J Neurochem.
VOL	:	23 PAGE : 1025-1036 (1974)

[TOP]

[1419]

AUTHOR	:	O'Brien, J. S., Fillerup, D. L., and Mead, J. F.
TITLE	:	Brain Lipids: I. Quantification And Fatty Acid Composition Of Cerebroside Sulfate In Human Cerebral Gray And White Matter PubMed ID:14173315
JOURNAL	:	J Lipid Res.
VOL	:	15 PAGE : 109-116 (1964)

[TOP]

[1420]

AUTHOR	:	Kochetkov, N. K., Zhukova, I. G., and Glukhoded, I. S.
TITLE	:	Sphingoplasmalogens. A New Type Of Sphingolipids PubMed ID:14102764
JOURNAL	:	Biochim Biophys Acta.
VOL	:	70 PAGE : 716-719 (1963)

[TOP]

[1421]

AUTHOR	:	Rosenberg, A., and Chargaff, E.
TITLE	:	A reinvestigation of the cerebroside deposited in Gaucher's disease PubMed ID:13610835
JOURNAL	:	J Biol Chem.
VOL	:	233 PAGE : 1323-1326 (1958)

[TOP]

[1422]

AUTHOR	:	Svennerholm, L.
TITLE	:
JOURNAL	:	J. Neurochem.
VOL	:	11 PAGE : 839- (1964)

[TOP]

[1423]

AUTHOR	:	Nishimura K., Yamakawa, T.
TITLE	:
JOURNAL	:	Lipids
VOL	:	3 PAGE : 262- (1968)

[TOP]

[1424]

AUTHOR	:	Dubois, C., Manuguerra, J. C., Hauttecoeur, B., and Maze, J.
TITLE	:	Monoclonal antibody A2B5, which detects cell surface antigens, binds to ganglioside GT3 (II3 (NeuAc)3LacCer) and to its 9-O-acetylated derivative PubMed ID:2303428
JOURNAL	:	J Biol Chem.
VOL	:	265 PAGE : 2797-2803 (1990)

[TOP]

[1425]

AUTHOR	:	Laine, R., Sweeley, C. C., Li, Y. T., Kisic, A., and Rapport, M. M.
TITLE	:	On the structure of cytolipin R, a ceramide tetrahexoside hapten from rat lymphosarcoma PubMed ID:5068000
JOURNAL	:	J Lipid Res.
VOL	:	13 PAGE : 519-524 (1972)

[TOP]

[1426]

AUTHOR	:	Siddiqui, B., Kawanami, J., Li, Y. T., and Hakomori, S.
TITLE	:	Structures of ceramide tetrasaccharides from various sources: uniqueness of rat kidney ceramide tetrasaccharide PubMed ID:4342427
JOURNAL	:	J Lipid Res.
VOL	:	13 PAGE : 657-662 (1972)

[TOP]

[1427]

AUTHOR	:	Hansson, G. C., Karlsson, K. A., Leffler, H., and Stromberg, N.
TITLE	:	Gangliotetraosylceramide is a major glycolipid of epithelial cells of mouse small intestine PubMed ID:7075779
JOURNAL	:	FEBS Lett.
VOL	:	139 PAGE : 291-294 (1982)

[TOP]

[1428]

AUTHOR	:	Siddiqui, B., and Hakomori, S.
TITLE	:	A ceramide tetrasaccharide of human erythrocyte membrane reacting with anti-type XIV pneumococcal polysaccharide antiserum PubMed ID:4149633
JOURNAL	:	Biochim Biophys Acta.
VOL	:	330 PAGE : 147-155 (1973)

[TOP]

[1429]

AUTHOR	:	Wiegandt, H., and Bucking, H. W.
TITLE	:	Carbohydrate components of extraneuronal gangliosides from bovine and human spleen, and bovine kidney PubMed ID:5502663
JOURNAL	:	Eur J Biochem.
VOL	:	15 PAGE : 287-292 (1970)

[TOP]

[1430]

AUTHOR	:	Slomiany, B. L., Slomiany, A., and Horowitz, M. I.
TITLE	:	Characterization of blood-group-H-active ceramide tetrasaccharide from hog-stomach mucosa PubMed ID:4365813
JOURNAL	:	Eur J Biochem.
VOL	:	43 PAGE : 161-165 (1974)

[TOP]

[1431]

AUTHOR	:	Hori, T., Sugita, M., Kanbayashi, J., Itasaka, O.
TITLE	:	Studies on glycosphingolipids of fresh-water bivalves. III. Isolation and characterization of a novel globoside containing mannose from spermatozoa of the fresh-water bivalve, Hyriopsis schlegelii. PubMed ID:845129
JOURNAL	:	Journal of Biochemistry
VOL	:	81 PAGE : 107-114 (1977)

[TOP]

[1432]

AUTHOR	:	Siddiqui, B., and Hakomori, S.
TITLE	:	A revised structure for the Forssman glycolipid hapten PubMed ID:4328838
JOURNAL	:	J Biol Chem.
VOL	:	246 PAGE : 5766-5769 (1971)

[TOP]

[1433]

AUTHOR	:	Taketomi, T., and Kawamura, N.
TITLE	:	Chemical and immunological characterization of caprine erythrocyte glycolipids in comparison with porcine erythrocyte glycolipids PubMed ID:4630111
JOURNAL	:	J Biochem (Tokyo).
VOL	:	72 PAGE : 799-806 (1972)

[TOP]

[1434]

AUTHOR	:	Kawanami, J.
TITLE	:	The appearance of Forssman hapten in human tumor PubMed ID:4634984
JOURNAL	:	J Biochem (Tokyo).
VOL	:	72 PAGE : 783-785 (1972)

[TOP]

[1435]

AUTHOR	:	Makita, A., Yokoyama, T., and Takahashi, W.
TITLE	:	Enzymatic degradation of Forssman hapten: a reinvestigation of the chemical structure PubMed ID:4803517
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	354 PAGE : 1149-1152 (1973)

[TOP]

[1436]

AUTHOR	:	Ishibashi, T., Kijimoto, S., and Makita, A.
TITLE	:	Biosynthesis of globoside and Forssman hapten from trihexosylceramide and properties of beta-N-acetyl-galactosaminyltransferase of guinea pig kidney PubMed ID:4433547
JOURNAL	:	Biochim Biophys Acta.
VOL	:	337 PAGE : 92-106 (1974)

[TOP]

[1437]

AUTHOR	:	Naiki, M., Kamimura, H., Taketomi, T., and Ichikawa, R.
TITLE	:	Chemical, physico-chemical and morphological properties of Forssman hapten purified from caprine erythrocytes PubMed ID:4538153
JOURNAL	:	Jpn J Exp Med.
VOL	:	42 PAGE : 205-219 (1972)

[TOP]

[1438]

AUTHOR	:	Eto, T., Ichikawa, Y., Nishimura, K., Ando, S., and Yamakawa, T.
TITLE	:	Chemistry of lipid of the posthemyolytic residue or stroma of erythrocytes. XVI. Occurrence of ceramide pentasaccharide in the membrane of erythrocytes and reticulocytes of rabbit PubMed ID:4304380
JOURNAL	:	J Biochem (Tokyo).
VOL	:	64 PAGE : 205-213 (1968)

[TOP]

[1439]

AUTHOR	:	Koscielak, J., Plasek, A., Gorniak, H., Gardas, A., Gregor, A.
TITLE	:	Structures of fucose-containing glycolipids with H and B blood-group activity and of sialic acid and glucosamine-containing glycolipid of human-erythrocyte membrane. PubMed ID:4745728
JOURNAL	:	European Journal of Biochemistry
VOL	:	37 PAGE : 214-225 (1973)

[TOP]

[1440]

AUTHOR	:	Taki, T., Hirabayashi, Y., Matsumoto, M., Kojima, K.
TITLE	:	Enzymic synthesis of a new type of fucose-containing glycolipid with fucosyltransferase of rat ascites hepatoma cell, AH 7974F. PubMed ID:32911
JOURNAL	:	Biochimica et Biophysica Acta
VOL	:	572 PAGE : 105-112 (1979)

[TOP]

[1441]

AUTHOR	:	Naiki, M., Fong, J., Ledeen, R., and Marcus, D. M.
TITLE	:	Structure of the human erythrocyte blood group P1 glycosphingolipid PubMed ID:1182121
JOURNAL	:	Biochemistry.
VOL	:	14 PAGE : 4831-4837 (1975)

[TOP]

[1442]

AUTHOR	:	Hakomori, S., Stellner, K., and Watanabe, K.
TITLE	:	Four antigenic variants of blood group A glycolipid: examples of highly complex, branched chain glycolipid of animal cell membrane PubMed ID:4629810
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	49 PAGE : 1061-1068 (1972)

[TOP]

[1443]

AUTHOR	:	Hakomori, S., and Strycharz, G. D.
TITLE	:	Investigations on cellular blood-group substances. I. Isolation and chemical composition of blood-group ABH and Le-b isoantigens of sphingoglycolipid nature PubMed ID:5677817
JOURNAL	:	Biochemistry.
VOL	:	7 PAGE : 1279-1286 (1968)

[TOP]

[1444]

AUTHOR	:	McKibbin, J. M., Smith, E. L., Mansson, J. E., Li, Y. T.
TITLE	:	Characterization of dog small intestinal fucolipids with human blood group A activity. Differences in dog and human A-active fucolipids. PubMed ID:402937
JOURNAL	:	Biochemistry
VOL	:	16 PAGE : 1223-1228 (1977)

[TOP]

[1445]

AUTHOR	:	Hanada, E., Handa, S., Konno, K., and Yamakawa, T.
TITLE	:	Characterization of glycolipids from rat granuloma and macrophage PubMed ID:564346
JOURNAL	:	J Biochem (Tokyo).
VOL	:	83 PAGE : 85-90 (1978)

[TOP]

[1446]

AUTHOR	:	Hanfland, P., and Egge, H.
TITLE	:	Mass spectrometric analysis of permethylated glycosphingolipids I. Sequence analysis of two blood-group B active glycosphingolipids from human B erythrocyte membranes PubMed ID:1204134
JOURNAL	:	Chem Phys Lipids.
VOL	:	15 PAGE : 243-247 (1975)

[TOP]

[1447]

AUTHOR	:	Slomiany, B. L., Slomiany, A., and Horowitz, M. I.
TITLE	:	Blood group A active ceramide hexasaccharide lacking N-acetylglucosamine isolated from hog stomach mucosa PubMed ID:4358094
JOURNAL	:	Biochim Biophys Acta.
VOL	:	326 PAGE : 224-231 (1973)

[TOP]

[1448]

AUTHOR	:	Slomiany, B. L., Slomiany, A.
TITLE	:	Structural studies on branched fucosphingolipids of hog gastric mucosa. PubMed ID:912820
JOURNAL	:	Chem. Phys. Lipids
VOL	:	20 PAGE : 57-69 (1977)

[TOP]

[1449]

AUTHOR	:	Slomiany, A., Slomiany, B. L.
TITLE	:	Blood group A active difucosyl glycolipid from hog gastric mucosa. PubMed ID:1125299
JOURNAL	:	Biochimica et Biophysica Acta
VOL	:	388 PAGE : 135-145 (1975)

[TOP]

[1450]

AUTHOR	:	Hakomori, S., Andrews, H.D.
TITLE	:	Sphingoglycolipids with Leb activity, and the co-presence of Lea-, Leb-glycolipids in human tumor tissue. PubMed ID:5417196
JOURNAL	:	Biochim. Biophys. Acta.
VOL	:	202 PAGE : 225-228 (1970)

[TOP]

[1451]

AUTHOR	:	Slomiany, B. L., Slomiany, A.
TITLE	:	Branched blood group A-active fucolipids of hog gastric mucosa. PubMed ID:192301
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	486 PAGE : 531-540 (1977)

[TOP]

[1452]

AUTHOR	:	Ariga, T., Yu, R. K., Scarsdale, J. N., Suzuki, M., Kuroda, Y., Kitagawa, H., and Miyatake, T.
TITLE	:	Accumulation of a globo-series glycolipid having Gal alpha 1-3Gal in PC12h pheochromocytoma cells PubMed ID:3167050
JOURNAL	:	Biochemistry.
VOL	:	27 PAGE : 5335-5340 (1988)

[TOP]

[1453]

AUTHOR	:	Breimer, M. E., Karlsson, K. A.
TITLE	:	Chemical and immunological identification of glycolipid-based blood group ABH and Lewis antigens in human kidney. PubMed ID:6830844
JOURNAL	:	Biochimica et Biophysica Acta
VOL	:	755 PAGE : 170-177 (1983)

[TOP]

[1454]

AUTHOR	:	Kannagi, R., Levery, S. B., Ishigami, F., Hakomori, S., Shevinsky, L. H., Knowles, B. B., Solter, D.
TITLE	:	New globoseries glycosphingolipids in human teratocarcinoma reactive with the monoclonal antibody directed to a developmentally regulated antigen, stage-specific embryonic antigen 3. PubMed ID:6863318
JOURNAL	:	J. Biol. Chem.
VOL	:	258 PAGE : 8934-8942 (1983)

[TOP]

[1455]

AUTHOR	:	Kannagi, R., Cochran, N. A., Ishigami, F., Hakomori, S., Andrews, P. W., Knowles, B. B., and Solter, D.
TITLE	:	Stage-specific embryonic antigens (SSEA-3 and -4) are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells PubMed ID:6141938
JOURNAL	:	Embo J.
VOL	:	2 PAGE : 2355-2361 (1983)

[TOP]

[1456]

AUTHOR	:	Ando, S., Kon, K., Isobe, M., Nagai, Y., and Yamakawa, T.
TITLE	:	Existence of glucosaminyl lactosyl ceramide (amino CTH-I) in human erythrocyte membranes as a possible precursor of blood group-active glycolipids PubMed ID:950338
JOURNAL	:	J Biochem (Tokyo).
VOL	:	79 PAGE : 625-632 (1976)

[TOP]

[1457]

AUTHOR	:	Fukuda, M. N., Bothner, B., Lloyd, K. O., Rettig, W. J., Tiller, P. R., and Dell, A.
TITLE	:	Structures of glycosphingolipids isolated from human embryonal carcinoma cells. The presence of mono- and disialosyl glycolipids with blood group type 1 sequence PubMed ID:3514610
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 5145-5153 (1986)

[TOP]

[1458]

AUTHOR	:	Kannagi, R., Fukuda, M. N., and Hakomori, S.
TITLE	:	A new glycolipid antigen isolated from human erythrocyte membranes reacting with antibodies directed to globo-N-tetraosylceramide (globoside) PubMed ID:7068643
JOURNAL	:	J Biol Chem.
VOL	:	257 PAGE : 4438-4442 (1982)

[TOP]

[1459]

AUTHOR	:	Nudelman, E. D., Mandel, U., Levery, S. B., Kaizu, T., and Hakomori, S.
TITLE	:	A series of disialogangliosides with binary 2----3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens PubMed ID:2509467
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 18719-18725 (1989)

[TOP]

[1460]

AUTHOR	:	Egge, H., Kordowicz, M., Peter-Katalinic, J., and Hanfland, P.
TITLE	:	Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids PubMed ID:3857231
JOURNAL	:	J Biol Chem.
VOL	:	260 PAGE : 4927-4935 (1985)

[TOP]

[1461]

AUTHOR	:	Uchida, Y., Iwamori, M., Nagai, Y.
TITLE	:	Distinct differences in lipid composition between epidermis and dermis from footpad and dorsal skin of guinea pigs. PubMed ID:3184502
JOURNAL	:	Jpn. J. Exp. Med.
VOL	:	58 PAGE : 153-161 (1988)

[TOP]

[1462]

AUTHOR	:	Hamanaka, S., Handa, S., and Yamakawa, T.
TITLE	:	Ganglioside compositions of erythrocytes from various strains of inbred mice. Ocurrence of sialosylgalactosylceramide in red blood cells of inbred mice PubMed ID:521447
JOURNAL	:	J Biochem (Tokyo).
VOL	:	86 PAGE : 1623-1626 (1979)

[TOP]

[1463]

AUTHOR	:	Hanai, N., Dohi, T., Nores, G. A., and Hakomori, S.
TITLE	:	A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth PubMed ID:2834372
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 6296-6301 (1988)

[TOP]

[1464]

AUTHOR	:	Furukawa, K., Chait, B. T., and Lloyd, K. O.
TITLE	:	Identification of N-glycolylneuraminic acid-containing gangliosides of cat and sheep erythrocytes. 252Cf fission fragment ionization mass spectrometry in the analysis of glycosphingolipids PubMed ID:3170570
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 14939-14947 (1988)

[TOP]

[1465]

AUTHOR	:	Cheresh, D. A., Varki, A. P., Varki, N. M., Stallcup, W. B., Levine, J., and Reisfeld, R. A.
TITLE	:	A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside PubMed ID:6203895
JOURNAL	:	J Biol Chem.
VOL	:	259 PAGE : 7453-7459 (1984)

[TOP]

[1466]

AUTHOR	:	Sanai, Y., Yamasaki, M., and Nagai, Y.
TITLE	:	Monoclonal antibody directed to a Hanganutziu-Deicher active ganglioside, GM2 (NeuGc) PubMed ID:2449247
JOURNAL	:	Biochim Biophys Acta.
VOL	:	958 PAGE : 368-374 (1988)

[TOP]

[1467]

AUTHOR	:	Gowda, D. C., Reuter, G., Shukla, A. K., and Schauer, R.
TITLE	:	Identification of a disialoganglioside (GD1a) containing terminal N-acetyl-9-O-acetylneuraminic acid in rat erythrocytes PubMed ID:6440851
JOURNAL	:	Hoppe Seylers Z Physiol Chem.
VOL	:	365 PAGE : 1247-1253 (1984)

[TOP]

[1468]

AUTHOR	:	Guo, N. H., Her, G. R., Reinhold, V. N., Brennan, M. J., Siraganian, R. P., and Ginsburg, V.
TITLE	:	Monoclonal antibody AA4, which inhibits binding of IgE to high affinity receptors on rat basophilic leukemia cells, binds to novel alpha-galactosyl derivatives of ganglioside GD1b PubMed ID:2526814
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 13267-13272 (1989)

[TOP]

[1469]

AUTHOR	:	Ghidoni, R., Sonnino, S., Tettamanti, G., Baumann, N., Reuter, G., and Schauer, R.
TITLE	:	Isolation and characterization of a trisialoganglioside from mouse brain, containing 9-O-acetyl-N-acetylneuraminic acid PubMed ID:7391062
JOURNAL	:	J Biol Chem.
VOL	:	255 PAGE : 6990-6995 (1980)

[TOP]

[1470]

AUTHOR	:	Ostrander, G. K., Levery, S. B., Hakomori, S., and Holmes, E. H.
TITLE	:	Isolation and characterization of the major acidic glycosphingolipids from the liver of the English sole (Parophrys vetulus). Presence of a novel ganglioside with a Forssman antigen determinant PubMed ID:3257757
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 3103-3110 (1988)

[TOP]

[1471]

AUTHOR	:	Nakamura, K., Suzuki, M., Inagaki, F., Yamakawa, T., and Suzuki, A.
TITLE	:	A new ganglioside showing choleragenoid-binding activity in mouse spleen PubMed ID:3611042
JOURNAL	:	J Biochem (Tokyo).
VOL	:	101 PAGE : 825-835 (1987)

[TOP]

[1472]

AUTHOR	:	Iwamori, M., Sunada, S., Ishihara, E., Moki, M., Fujimoto, S., and Nagai, Y.
TITLE	:	Differential expression of fucosyl GM1 and a disialoganglioside with a NeuAc alpha 2-6GalNAc linkage (GD1e) in various rat ascites hepatoma cells PubMed ID:2420639
JOURNAL	:	FEBS Lett.
VOL	:	198 PAGE : 66-70 (1986)

[TOP]

[1473]

AUTHOR	:	Taki, T., Hirabayashi, Y., Ishikawa, H., Ando, S., Kon, K., Tanaka, Y., and Matsumoto, M.
TITLE	:	A ganglioside of rat ascites hepatoma AH 7974F cells. Occurrence of a novel disialoganglioside (GD1 alpha) with a unique N-acetylneuraminosyl (alpha 2-6)-N-acetylgalactosamine structure PubMed ID:3949760
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 3075-3078 (1986)

[TOP]

[1474]

AUTHOR	:	Taki, T., Maeda, H., Arai, K., Matsumoto, M., Kon, K., and Ando, S.
TITLE	:	Appearance of a novel type of ganglioside (GD1 alpha) in a differentiation-resistant clone of mouse myeloid leukemia cells, M1-R1 PubMed ID:3163528
JOURNAL	:	Cell Struct Funct.
VOL	:	13 PAGE : 61-72 (1988)

[TOP]

[1475]

AUTHOR	:	Ohashi, M. (1981) in Proceedings of the 6th International Symposium on Glycoconjugates (Yamakawa,T., Osawa, T., Handa S., eds), pp.33-34, Japan Scientific Societeis Press, Tokyo
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[1476]

AUTHOR	:	Takamizawa, K., Iwamori, M., Mutai, M., and Nagai, Y.
TITLE	:	Gangliosides of bovine buttermilk. Isolation and characterization of a novel monosialoganglioside with a new branching structure PubMed ID:3957935
JOURNAL	:	J Biol Chem.
VOL	:	261 PAGE : 5625-5630 (1986)

[TOP]

[1477]

AUTHOR	:	DeGasperi, R., Koerner, T. A., Quarles, R. H., Ilyas, A. A., Ishikawa, Y., Li, S. C., and Li, Y. T.
TITLE	:	Isolation and characterization of gangliosides with hybrid neolacto-ganglio-type sugar chains PubMed ID:3680292
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 17149-17155 (1987)

[TOP]

[1478]

AUTHOR	:	Sekine, M., Nakamura, K., Suzuki, M., Inagaki, F., Yamakawa, T., and Suzuki, A.
TITLE	:	A single autosomal gene controlling the expression of the extended globoglycolipid carrying SSEA-1 determinant is responsible for the expression of two extended globogangliosides PubMed ID:2902074
JOURNAL	:	J Biochem (Tokyo).
VOL	:	103 PAGE : 722-729 (1988)

[TOP]

[1479]

AUTHOR	:	Blaszczyk-Thurin, M., Thurin, J., Hindsgaul, O., Karlsson, K. A., Steplewski, Z., and Koprowski, H.
TITLE	:	Y and blood group B type 2 glycolipid antigens accumulate in a human gastric carcinoma cell line as detected by monoclonal antibody. Isolation and characterization by mass spectrometry and NMR spectroscopy PubMed ID:2432062
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 372-379 (1987)

[TOP]

[1480]

AUTHOR	:	Nudelman, E. D., Levery, S. B., Stroud, M. R., Salyan, M. E., Abe, K., and Hakomori, S.
TITLE	:	A novel tumor-associated, developmentally regulated glycolipid antigen defined by monoclonal antibody ACFH-18 PubMed ID:3417685
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 13942-13951 (1988)

[TOP]

[1481]

AUTHOR	:	Ostrander, G. K., Levery, S. B., Eaton, H. L., Salyan, M. E., Hakomori, S., and Holmes, E. H.
TITLE	:	Isolation and characterization of four major neutral glycosphingolipids from the liver of the English sole (Parophrys vetulus). Presence of a novel branched lacto-ganglio-iso-globo hybrid structure PubMed ID:3198597
JOURNAL	:	J Biol Chem.
VOL	:	263 PAGE : 18716-18725 (1988)

[TOP]

[1482]

AUTHOR	:	Ohashi, M.
TITLE	:	A new type of ganglioside. The structures of three novel gangliosides from the fat body of the frog PubMed ID:6968312
JOURNAL	:	J Biochem (Tokyo).
VOL	:	88 PAGE : 583-589 (1980)

[TOP]

[1483]

AUTHOR	:	Abraham, W., Wertz, P. W., and Downing, D. T.
TITLE	:	Linoleate-rich acylglucosylceramides of pig epidermis: structure determination by proton magnetic resonance PubMed ID:4031654
JOURNAL	:	J Lipid Res.
VOL	:	26 PAGE : 761-766 (1985)

[TOP]

[1484]

AUTHOR	:	Hamanaka, S., Takemoto, T., Hamanaka, Y., Asagami, C., Suzuki, M., Suzuki, A., and Otsuka, F.
TITLE	:	Structure determination of glycosphingolipids of cultured human keratinocytes PubMed ID:8461327
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1167 PAGE : 1-8 (1993)

[TOP]

[1485]

AUTHOR	:	Uchida Y., Iwamori M., and Nagai Y.
TITLE	:	Distinct differences in lipid composition between epidermis and dermis from fotpad and dorsal skin of guinea pigs. PubMed ID:3184502
JOURNAL	:	Jpn. J. Exp. Med.
VOL	:	58 PAGE : 153-161 (1988)

[TOP]

[1486]

AUTHOR	:	Ariga, T., Tao, R. V., Lee, B. C., Yamawaki, M., Yoshino, H., Scarsdale, N. J., Kasama, T., Kushi, Y., and Yu, R. K.
TITLE	:	Glycolipid composition of human cataractous lenses. Characterization of Lewisx glycolipids PubMed ID:7905480
JOURNAL	:	J Biol Chem.
VOL	:	269 PAGE : 2667-2675 (1994)

[TOP]

[1487]

AUTHOR	:	Cooling, L. L., Zhang, D. S., Walker, K. E., and Koerner, T. A.
TITLE	:	Detection in human blood platelets of sialyl Lewis X gangliosides, potential ligands for CD62 and other selectins PubMed ID:8563144
JOURNAL	:	Glycobiology.
VOL	:	5 PAGE : 571-581 (1995)

[TOP]

[1488]

AUTHOR	:	Kubo H., Irie A., Inagaki F., Hoshi M.
TITLE	:
JOURNAL	:	J. Biochem.
VOL	:	104 PAGE : 775- (1975)

[TOP]

[1489]

AUTHOR	:	Irie A., Kubo H., Inagaki F., Hoshi M.
TITLE	:
JOURNAL	:	J. Biochem.
VOL	:	108 PAGE : 531-536 (1992)

[TOP]

[1490]

AUTHOR	:	Helling, F., Dennis, R. D., Weske, B., Nores, G., Peter-Katalinic, J., Dabrowski, U., Egge, H., and Wiegandt, H.
TITLE	:	Glycosphingolipids in insects. The amphoteric moiety, N-acetylglucosamine-linked phosphoethanolamine, distinguishes a group of ceramide oligosaccharides from the pupae of Calliphora vicina (Insecta: Diptera) PubMed ID:1889407
JOURNAL	:	Eur J Biochem.
VOL	:	200 PAGE : 409-421 (1991)

[TOP]

[1491]

AUTHOR	:	Smirnova, G. P., Kochetkov, N. K., and Sadovskaya, V. L.
TITLE	:	Gangliosides of the starfish Aphelasterias japonica, evidence for a new linkage between two N-glycolylneuraminic acid residues through the hydroxy group of the glycolic acid residue PubMed ID:3593756
JOURNAL	:	Biochim Biophys Acta.
VOL	:	920 PAGE : 47-55 (1987)

[TOP]

[1492]

AUTHOR	:	Hitoshi, S., Kusunoki, S., Kon, K., Chiba, A., Waki, H., Ando, S., and Kanazawa, I.
TITLE	:	A novel ganglioside, 9-O-acetyl GD1b, is recognized by serum antibodies in Guillain-Barre syndrome PubMed ID:8964919
JOURNAL	:	J Neuroimmunol.
VOL	:	66 PAGE : 95-101 (1996)

[TOP]

[1493]

AUTHOR	:	Bouhours, D., Liaigre, J., Naulet, J., Maume, D., and Bouhours, J. F.
TITLE	:	A novel glycosphingolipid expressed in pig kidney: Gal alpha 1-3Lewis(x) hexaglycosylceramide PubMed ID:9076511
JOURNAL	:	Glycoconj J.
VOL	:	14 PAGE : 29-38 (1997)

[TOP]

[1494]

AUTHOR	:	Niimura, Y., Tomori, M., Toida, T., and Ishizuka, I.
TITLE	:	Unique gangliosides in transporting organs of salmon.
JOURNAL	:	3rd Rinsho-ken International Conference Abstract
VOL	:	PAGE : 92-93 (1988)

[TOP]

[1495]

AUTHOR	:	Yamamoto, H., Iida-Tanaka, N., Kasama, T., Ishizuka, I., Kushi, Y., and Handa, S.
TITLE	:	Isolation and characterization of a novel Forssman active acidic glycosphingolipid with branched isoglobo-, ganglio-, and neolacto-series hybrid sugar chains PubMed ID:10220585
JOURNAL	:	J Biochem (Tokyo).
VOL	:	125 PAGE : 923-930 (1999)

[TOP]

[1496]

AUTHOR	:	Koscielak, J., Miller-Podraza, H., Krauze, R., and Cedergren, B.
TITLE	:	Glycolipid composition of blood group P erythrocytes PubMed ID:955088
JOURNAL	:	FEBS Lett.
VOL	:	66 PAGE : 250-253 (1976)

[TOP]

[1497]

AUTHOR	:	Nakamura, K., Kojima, H., Suzuki, M., Suzuki, A., and Tamai, Y.
TITLE	:	Novel polysialogangliosides of skate brain structural determination of tetra, penta and hexasialogangliosides with a NeuAc-GalNAc linkage PubMed ID:10931205
JOURNAL	:	Eur J Biochem.
VOL	:	267 PAGE : 5198-5208 (2000)

[TOP]

[1498]

AUTHOR	:	Taki, T., Kuroyanagi, M., Yoshioka, H., and Handa, S.
TITLE	:	13C-nuclear magnetic resonance of glycosphingolipids PubMed ID:1639757
JOURNAL	:	J Biochem (Tokyo).
VOL	:	111 PAGE : 614-619 (1992)

[TOP]

[1499]

AUTHOR	:	Kushi, Y., Ogura, K., Rokukawa, C., and Handa, S.
TITLE	:	Blood group A-active glycosphingolipids analysis by the combination of TLC-immunostaining assay and TLC/SIMS mass spectrometry PubMed ID:2398034
JOURNAL	:	J Biochem (Tokyo).
VOL	:	107 PAGE : 685-688 (1990)

[TOP]

[2001]

AUTHOR	:	Hori, T., Itasaka, O., Inoue, H., and Yamada, K.
TITLE	:	Further Study Of Structural Components Of The Pyridine Insoluble Sphingolipid From Corbicula, Corbicula Sandai And The Distribution In Other Species PubMed ID:14235506
JOURNAL	:	J Biochem (Tokyo).
VOL	:	56 PAGE : 477-479 (1964)

[TOP]

[2002]

AUTHOR	:	Rouser, G., Kritchevsky, G., Heller, D., and Lieber, E.
TITLE	:	Lipid composition of beef brain, beef liver, and the sea anemone: two approaches to quantitative fractionation of complex lipid mixture.
JOURNAL	:	J. Am. Oil Chemist's Soc.
VOL	:	40 PAGE : 425-454 (1963)

[TOP]

[2003]

AUTHOR	:	Hori, T., Itasaka, O., and Inoue, H.
TITLE	:	Biochemistry of shellfish lipid. 3. Purification and elemental analysis of ceramide aminoethylphosphonate from Corbicula complex lipid mixtures PubMed ID:5962677
JOURNAL	:	J Biochem (Tokyo).
VOL	:	59 PAGE : 570-573 (1966)

[TOP]

[2004]

AUTHOR	:	Hori, T., Arakawa, I., Sugita, M., and Itasaka, O.
TITLE	:	Biochemistry of shellfish lipids. IX. Enzymatic hydrolysis of ceramide 2-aminoethylphosphonate and sphingoethanolamine PubMed ID:4304003
JOURNAL	:	J Biochem (Tokyo).
VOL	:	64 PAGE : 533-536 (1968)

[TOP]

[2005]

AUTHOR	:	Hori, T., and Sugita, M. (1984) Chemistry of phosphonolipids in Biochemistry of Natural C-P Compounds (Hori,T.,Horiguchi,A.,and Hayashi,A. eds), pp124-144, Maruzen, Kyoto.
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[2006]

AUTHOR	:	Hori,T (1978) Phosphonolipids, in Biochemistry of C-P compounds (Hori,T. and Horiguchi,M., eds), pp50-75, Gakkai Syuppan Center, Tokyo (in Japanese)
TITLE	:
JOURNAL	:
VOL	:	PAGE : - ()

[TOP]

[2007]

AUTHOR	:	Hori, T., Itasaka, O., Inoue, H., and Akai, M.
TITLE	:	Occurrence Of A New Phosphosphingoside In The Pound-Snail, Heterogen Longispira PubMed ID:14326225
JOURNAL	:	Jpn J Exp Med.
VOL	:	35 PAGE : 81-84 (1965)

[TOP]

[2008]

AUTHOR	:	Hori, T., Itasaka, O., Inoue, H., Gamo, M., and Arakawa, I.
TITLE	:	Biochemistry of shellfish lipids. IV. Purification and characterization of a new phosphosphingolipid in the pond-snail, Heterogen longispira PubMed ID:5297261
JOURNAL	:	Jpn J Exp Med.
VOL	:	36 PAGE : 85-89 (1966)

[TOP]

[2009]

AUTHOR	:	Kunsman, J.E., Jr., Katz, I., and Keeney, M.
TITLE	:
JOURNAL	:	Abstr. Amer. Chem. Soc. 152 Meeting, N.Y.
VOL	:	PAGE : -255- (1966)

[TOP]

[2010]

AUTHOR	:	LaBach, J. P., and White, D. C.
TITLE	:	Identification of ceramide phosphorylethanolamine and ceramide phosphorylglycerol in the lipids of an anaerobic bacterium PubMed ID:4309192
JOURNAL	:	J Lipid Res.
VOL	:	10 PAGE : 528-534 (1969)

[TOP]

[2011]

AUTHOR	:	Rizza, V., Tucker, A. N., and White, D. C.
TITLE	:	Lipids of Bacteroides melaninogenicus PubMed ID:5411759
JOURNAL	:	J Bacteriol.
VOL	:	101 PAGE : 84-91 (1970)

[TOP]

[2012]

AUTHOR	:	Dawson, R. M., and Kemp, P.
TITLE	:	The aminoethylphosphonate-containing lipids of rumen protozoa PubMed ID:4967076
JOURNAL	:	Biochem J.
VOL	:	105 PAGE : 837-842 (1967)

[TOP]

[2013]

AUTHOR	:	Crone, H. D.,and Bridges, R. G.
TITLE	:	The Phospholipids Of The Housefly, Musca Domestica PubMed ID:14097353
JOURNAL	:	Biochem J.
VOL	:	89 PAGE : 11-21 (1963)

[TOP]

[2014]

AUTHOR	:	Hori, T., Itasaka, O., Sugita, M., and Arakawa, I.
TITLE	:	Isolation of sphingoethanolamine from pupae of the green-bottle fly, Lucilia caesar PubMed ID:5707810
JOURNAL	:	J Biochem (Tokyo).
VOL	:	64 PAGE : 123-124 (1968)

[TOP]

[2015]

AUTHOR	:	Dawson, R. M., and Kemp, P.
TITLE	:	Isolation of ceramide phosphorylethanolamine from the blowfly Calliphora erythrocephala PubMed ID:5721468
JOURNAL	:	Biochem J.
VOL	:	106 PAGE : 319-320 (1968)

[TOP]

[2016]

AUTHOR	:	Subrahmanyam, D., Motoru, L.B., and Rao, R.H.
TITLE	:	On the phospholipids of Culex pipiens fatigans.
JOURNAL	:	Lipids
VOL	:	6 PAGE : 867-872 (1971)

[TOP]

[2017]

AUTHOR	:	Yasuda, S.
TITLE	:	Studies on the lipids of Japanese littleneck, Tapes japonica Deshayes, II. Composition of phospholipids (in Japanese).
JOURNAL	:	Yukagaku
VOL	:	16 PAGE : 596-600 (1967)

[TOP]

[2018]

AUTHOR	:	Itasaka, O., Hori, T., Uno, A., and Iwamori, M.
TITLE	:	Occurrence of ceramide phosphorylethanolamine containing hydroxy fatty acid in a bivalve PubMed ID:4690231
JOURNAL	:	J Biochem (Tokyo).
VOL	:	73 PAGE : 191-193 (1973)

[TOP]

[2019]

AUTHOR	:	Muehlenberg, B. A., Sribney, M., and Duffe, M. K.
TITLE	:	Occurrence and biosynthesis of ceramide phosphorylethanolamine in chicken and rat liver PubMed ID:5014537
JOURNAL	:	Can J Biochem.
VOL	:	50 PAGE : 166-173 (1972)

[TOP]

[2020]

AUTHOR	:	Hori, T., Sugita, M., and Itasaka, O.
TITLE	:	Biochemistry of shellfish lipids. X. Isolation of a sphingolipid containing 2-monomethylaminoethylphosphonic acid from shellfish PubMed ID:5789188
JOURNAL	:	J Biochem (Tokyo).
VOL	:	65 PAGE : 451-457 (1969)

[TOP]

[2021]

AUTHOR	:	Hayashi, A., Matsuura, F., and Matsubara, T.
TITLE	:	Isolation and characterization of a new sphingolipid containing 2-N-methylaminoethylphosphonic acid from the viscera of Turbo cornutus.
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	176 PAGE : 208-210 (1969)

[TOP]

[2022]

AUTHOR	:	Sugita, M., Shirai, S., Itasaka, O., and Hori, T.
TITLE	:	Neutral glycosphingolipids containing mannose from the bivalve Corbicula sandai PubMed ID:1137982
JOURNAL	:	J Biochem (Tokyo).
VOL	:	77 PAGE : 125-130 (1975)

[TOP]

[2023]

AUTHOR	:	Sugita, M., Nishida, M., and Hori, T.
TITLE	:	Studies on glycosphingolipids of larvae of the green-bottle fly, Lucilia caesar. I. Isolation and characterization of glycosphingolipids having novel sugar sequences PubMed ID:7130143
JOURNAL	:	J Biochem (Tokyo).
VOL	:	92 PAGE : 327-334 (1982)

[TOP]

[2024]

AUTHOR	:	Itasaka, O., Sugita, M., Kataoka, H., and Hori, T.
TITLE	:	Di- and trimannosylceramides in hepatopancreas of a fresh-water bivalve, Hyriopsis schlegelii PubMed ID:6830833
JOURNAL	:	Biochim Biophys Acta.
VOL	:	751 PAGE : 8-13 (1983)

[TOP]

[2025]

AUTHOR	:	Sugita, M., Nakae, H., Yamamura, T., Takamiya, Y., Itasaka, O., and Hori, T.
TITLE	:	The occurrence of glycosphingolipids containing mannose in the sea-water bivalve, Meretrix lusoria (Hamaguri) PubMed ID:4044558
JOURNAL	:	J Biochem (Tokyo).
VOL	:	98 PAGE : 27-34 (1985)

[TOP]

[2026]

AUTHOR	:	Hori, T., Sugita, M., Kanbayashi, J., and Itasaka, O.
TITLE	:	Isolation and characterization of a novel globoside containing mannose from spermatozoa of the freshwater bivalve, Hyriopsis schlegelii.
JOURNAL	:	J. Biochem.
VOL	:	81 PAGE : 107-114 (1977)

[TOP]

[2027]

AUTHOR	:	Hori, T., Takeda, H., Sugita, M., and Itasaka, O.
TITLE	:	Structure of branched globoside containing mannose from spermatozoa of the fresh-water bivalve, Hyriopsis schlegelii.
JOURNAL	:	J. Biochem.
VOL	:	82 PAGE : 1281-1285 (1977)

[TOP]

[2028]

AUTHOR	:	Itasaka, O., and Hori, T.
TITLE	:	Studies on glycosphingolipids of fresh-water bivalves. V. The structure of a novel ceramide octasaccharide containing mannose-6-phosphate found in the bivalve, Corbicula sandai PubMed ID:457643
JOURNAL	:	J Biochem (Tokyo).
VOL	:	85 PAGE : 1469-1481 (1979)

[TOP]

[2029]

AUTHOR	:	Sugita, M., Yamamoto, T., Masuda, S., Itasaka, O., and Hori, T.
TITLE	:	Studies on glycosphingolipids of fresh-water bivalves. VI. Isolation and chemical characterization of neutral glycosphingolipids from spermatozoa of the fresh-water bivalve, Hyriopsis schlegelii PubMed ID:7338520
JOURNAL	:	J Biochem (Tokyo).
VOL	:	90 PAGE : 1529-1535 (1981)

[TOP]

[2030]

AUTHOR	:	Hori, T., Sugita, M., Ando, S., Kuwahara, M., Kumauchi, K., Sugie, E., and Itasaka, O.
TITLE	:	Characterization of a novel glycosphingolipid, ceramide nonasaccharide, isolated from spermatozoa of the fresh water bivalve, Hyriopsis schlegelii PubMed ID:7287744
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 10979-10985 (1981)

[TOP]

[2031]

AUTHOR	:	Hori, T., Sugita, M., Ando, S., Tsukada, K., Shiota, K., Tsuzuki, M., and Itasaka, O.
TITLE	:	Isolation and characterization of a 4-O-methylglucuronic acid-containing glycosphingolipid from spermatozoa of a fresh water bivalve, Hyriopsis schlegelii PubMed ID:6822554
JOURNAL	:	J Biol Chem.
VOL	:	258 PAGE : 2239-2245 (1983)

[TOP]

[2032]

AUTHOR	:	Sugita, M., Inoue, T., Itasaka, O., and Hori, T.
TITLE	:	The localization of 4-O-methylglucuronic acid-containing glycosphingolipid on the cell surface of bivalve spermatozoa by use of an immunological method PubMed ID:6427200
JOURNAL	:	J Biochem (Tokyo).
VOL	:	95 PAGE : 737-742 (1984)

[TOP]

[2033]

AUTHOR	:	Itasaka, O., Kosuga, M., Okayama, M., and Hori, T.
TITLE	:	Characterization of a novel ceramide octasaccharide isolated from whole tissue of a fresh-water bivalve, Corbicula sandai.
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	750 PAGE : 440-446 (1983)

[TOP]

[2034]

AUTHOR	:	Sugita, M., Nakano, Y., Nose, T., Itasaka, O., and Hori, T.
TITLE	:	Neutral glycosphingolipids of ova of the fresh-water bivalve, Hyriopsis schlegelii PubMed ID:6706918
JOURNAL	:	J Biochem (Tokyo).
VOL	:	95 PAGE : 47-55 (1984)

[TOP]

[2035]

AUTHOR	:	Sugita, M.
TITLE	:	Studies on the glycosphingolipids of the sterfish, asterina pectinifera II. Isolation and characterization of a novel ganglioside with an internal sialic acid residue.
JOURNAL	:	J. Biochem.
VOL	:	86 PAGE : 289-300 (1979)

[TOP]

[2036]

AUTHOR	:	Sugita, M.
TITLE	:	Studies on the glycosphingolipids of the sterfish, asterina pectinifera. III. Isolation and structural studies of two novel gangliosides containing internal sialic acid residues.
JOURNAL	:	J. Biochem.
VOL	:	86 PAGE : 765-772 (1979)

[TOP]

[2037]

AUTHOR	:	Sugita, M., Iwasaki, Y., and Hori, T.
TITLE	:	Studies on glycosphingolipids of larvae of the green-bottle fly, Lucilia caesar. II. Isolation and structural studies of three glycosphingolipids with novel sugar sequences PubMed ID:7142125
JOURNAL	:	J Biochem (Tokyo).
VOL	:	92 PAGE : 881-887 (1982)

[TOP]

[2038]

AUTHOR	:	Itonori, S., Kamemura, K., Narushima, M., Sonku, N., Itasaka, O., Hori, T., and Sugita, M.
TITLE	:	Characterization of a new phosphonocerebroside, N-methyl-2-aminoethyl-phosphonylglucosylceramide, from the antarctic krill,Euphausia superba. PubMed ID:1998750
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	1081 PAGE : 321-327 (1991)

[TOP]

[2039]

AUTHOR	:	Berger, H., Jones, P., and Hanahan, D. J.
TITLE	:	Structural studies on lipids of Tetrahymena pyriformis W PubMed ID:4337562
JOURNAL	:	Biochim Biophys Acta.
VOL	:	260 PAGE : 617-629 (1972)

[TOP]

[2040]

AUTHOR	:	Kaneshiro, E. S., Meyer, K. B., and Rhoads, D. E.
TITLE	:	The glyceryl ethers of Paramecium phospholipids and phosphonolipids PubMed ID:3430407
JOURNAL	:	J Protozool.
VOL	:	34 PAGE : 357-361 (1987)

[TOP]

[2041]

AUTHOR	:	Sugita, M., and Hori, T.
TITLE	:	Isolation of diacylglycerol-2-aminoethylphosphonate from Tetrahymena pyriformis PubMed ID:5091943
JOURNAL	:	J Biochem (Tokyo).
VOL	:	69 PAGE : 1149-1150 (1971)

[TOP]

[2042]

AUTHOR	:	Jonah, M., and Erwin, J. A.
TITLE	:	The lipids of membraneous cell organelles isolated from the ciliate, Tetrahymena pyriformis PubMed ID:4100604
JOURNAL	:	Biochim Biophys Acta.
VOL	:	231 PAGE : 80-92 (1971)

[TOP]

[2043]

AUTHOR	:	Tamari, M., Ogawa, M., Hasegawa, S., and Kametaka, M.
TITLE	:	Etudes sur les phosphonolipides de la bile de boeuf.
JOURNAL	:	Agr. Biol. Chem.
VOL	:	40 PAGE : 2057-2062 (1976)

[TOP]

[2044]

AUTHOR	:	Tamari, M., Ogawa, M., and Kametaka, M.
TITLE	:	A new bile acid conjugate, ciliatocholic acid, from bovine gall bladder bile PubMed ID:1002674
JOURNAL	:	J Biochem (Tokyo).
VOL	:	80 PAGE : 371-377 (1976)

[TOP]

[2045]

AUTHOR	:	Araki, S., Satake, M., Ando, S., Hayashi, A., and Fujii, N.
TITLE	:	Characterization of diphosphonopentaosylceramide containing 3-O-methyl-galactose from the skin of Aplysia kurodai(sea hare).
JOURNAL	:	J. Biol. Chem.
VOL	:	261 PAGE : 5138-5144 (1986)

[TOP]

[2046]

AUTHOR	:	Araki, S., Komai, Y., and Satake, M.
TITLE	:	A novel sphingophosphonoglycolipid containing 3-O-methylgalactose isolated from the skin of the marine gastropod Aplysia kurodai PubMed ID:7358651
JOURNAL	:	J Biochem (Tokyo).
VOL	:	87 PAGE : 503-510 (1980)

[TOP]

[2047]

AUTHOR	:	Abe, S., Watanabe, Y., Araki, S., Kumanishi, T., and Satake, M.
TITLE	:	Immunochemical and histochemical studies on a phosphonoglycosphingolipid, SGL-II, isolated from the sea gastropod Aplysia kurodai PubMed ID:3182764
JOURNAL	:	J Biochem (Tokyo).
VOL	:	104 PAGE : 220-226 (1988)

[TOP]

[2048]

AUTHOR	:	Abe, S., Araki, S., and Satake, M.
TITLE	:	A novel group of glycolipids in tissue of aplysia : two-dimensional thin-layer chromatographic analysis.
JOURNAL	:	Bioemd. Res.
VOL	:	7 PAGE : 47-51 (1986)

[TOP]

[2049]

AUTHOR	:	Araki, S., Abe, S., Odani, S., Ando, S., Fujii, N., and Satake, M.
TITLE	:	Structure of a triphosphonopentaosylceramide containing 4-O-methyl-N-acetylglucosamine from the skin of the sea hare, Aplysia kurodai PubMed ID:3654654
JOURNAL	:	J Biol Chem.
VOL	:	262 PAGE : 14141-14145 (1987)

[TOP]

[2050]

AUTHOR	:	Araki, S., Abe, S., Ando, S., Fujii, N., and Satake, M.
TITLE	:	Isolation and characterization of a novel 2-aminoethylphosphonyl-glycosphingolipid from the sea hare, Aplysia kurodai PubMed ID:3571197
JOURNAL	:	J Biochem (Tokyo).
VOL	:	101 PAGE : 145-152 (1987)

[TOP]

[2051]

AUTHOR	:	Araki, S., Abe, S., Ando, S., Kon, K., Fujiwara, N., and Satake, M.
TITLE	:	Structure of phosphonoglycosphingolipid containing pyruvylated galactose in nerve fibers of Aplysia kurodai PubMed ID:2584202
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 19922-19927 (1989)

[TOP]

[2052]

AUTHOR	:	Yamaguchi, Y., Ohta, M., and Hayashi, A.
TITLE	:	Structural elucidation of a novel phosphonoglycosphingolipid in eggs of the sea hare Aplysia juliana. PubMed ID:1450210
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	1165 PAGE : 160-166 (1992)

[TOP]

[2053]

AUTHOR	:	Matsubara, T., and Hayashi, A.
TITLE	:	Occurrence of phosphonotetraglycosyl ceramide in the sea hare Dolabella auricularia PubMed ID:8431492
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1166 PAGE : 55-63 (1993)

[TOP]

[2054]

AUTHOR	:	Araki, S., Abe, S., Satake, M., Hayashi, A., Kon, K., and Ando, S.
TITLE	:	Novel phosphonoglycosphingolipids containing pyruvylated galactose from the nervous system of Aplysia kurodai PubMed ID:2050147
JOURNAL	:	Eur J Biochem.
VOL	:	198 PAGE : 689-695 (1991)

[TOP]

[2055]

AUTHOR	:	Abe, S., Araki, S., Satake, M., Fujiwara, N., Kon, K., and Ando, S.
TITLE	:	Structure of triphosphonoglycosphingolipid containing N-acetylgalactosamine 6-O-2-aminoethylphosphonate in the nervous system of Aplysia kurodai PubMed ID:2033079
JOURNAL	:	J Biol Chem.
VOL	:	266 PAGE : 9939-9943 (1991)

[TOP]

[2056]

AUTHOR	:	Araki, S., Abe, S., Yamada, S., Satake, M., Fujiwara, N., Kon, K., and Ando, S.
TITLE	:	Characterization of two novel pyruvated glycosphingolipids containig 2'-aminoethylphosphoryl(-6)-galactose from the nervous system of Aplysia kurodai. PubMed ID:1491001
JOURNAL	:	J. Biochem.
VOL	:	112 PAGE : 461-469 (1992)

[TOP]

[2057]

AUTHOR	:	Sugita, M., Itonori, S., Inagaki, F., and Hori, T.
TITLE	:	Characterization of two glucuronic acid-containing glycosphingolipids in larvae of the green-bottle fly, Lucilia caesar PubMed ID:2768250
JOURNAL	:	J Biol Chem.
VOL	:	264 PAGE : 15028-15033 (1989)

[TOP]

[2058]

AUTHOR	:	Sugita, M., Inagaki, F., Naito, H., and Hori, T.
TITLE	:	Studies on glycosphingolipids in larvae of the green-bottle fly, Lucilia caesar: two neutral glycosphingolipids having large straight oligosaccharide chains with eight and nine sugars PubMed ID:2391351
JOURNAL	:	J Biochem (Tokyo).
VOL	:	107 PAGE : 899-903 (1990)

[TOP]

[2059]

AUTHOR	:	Itonori,S.,Kamemura,K.,Narushima,K.,Sonku,N.,Itasaka,O.,Hori,T.,and Sugita,M.
TITLE	:	Characterization of a new phosphonocerebroside, N-methyl-2-aminoethylphosphonylglucosylceramide, from the antarctic krill, Euphausia superba. PubMed ID:1998750
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	1081 PAGE : 321-327 (1991)

[TOP]

[2060]

AUTHOR	:	Itonori, S., Nishizawa, M., Suzuki, M., Inagaki, F., Hori, T., and Sugita, M.
TITLE	:	Polar glycosphingolipids in insect: chemical structures of glycosphingolipid series containing 2'-aminoethylphosphoryl-(----6)-N-acetylglucosamine as a polar group from larvae of the green-bottle fly, Lucilia caesar PubMed ID:1778972
JOURNAL	:	J Biochem (Tokyo).
VOL	:	110 PAGE : 479-485 (1991)

[TOP]

[2061]

AUTHOR	:	Sugita,M.,Hayata,C.,Suzuki,M.,Takeda,T.,Mizunoma,T.,Makino,T.,Narushima,K.and Hori,T.
TITLE	:	Isolation and characterization of neutral glycosphingolipids from annelida (earthworm, Pheretima hilgendorfi).
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	41 PAGE : 568-573 (1992)

[TOP]

[2062]

AUTHOR	:	Sugita,M.,Fujii,H.,Inagaki,F.,Suzuki,M.,Hayata,C.,and Hori,T.
TITLE	:	Polar glycosphingolipids in annelida: a novel series of glycosphingolipids containing choline phosphate from the earthworm, Pheretima hilgendorf. PubMed ID:1429609
JOURNAL	:	J. Biol. Chem.
VOL	:	267 PAGE : 22595-22598 (1992)

[TOP]

[2063]

AUTHOR	:	Sugita,M.,Makino,T.,Hayata,C.,Suzuki,M.,Suzuki,A.,Hori,T.,Miwa,S., and Nakatani,F.
TITLE	:	Neutral and amphoteric glycosphingolipids from annelida (lugworm, Tylorrhynchus heterochetus).
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	42 PAGE : 935-941 (1993)

[TOP]

[2064]

AUTHOR	:	Itonori, S., Hiratsuka, M., Sonku, N., Tsuji, H., Itasaka, O., Hori, T., and Sugita, M.
TITLE	:	Immunogenic properties of mannose-containing ceramide disaccharide and immunochemical detection of its hapten in the two kinds of crustacean, Euphausia superba and Macrobrachium nipponense PubMed ID:1536864
JOURNAL	:	Biochim Biophys Acta.
VOL	:	1123 PAGE : 263-268 (1992)

[TOP]

[2065]

AUTHOR	:	Sugita,M.,Hayata,C.,Hori,T.,Morikawa,A., and Miwa S.
TITLE	:	Production of polyclonal antibody specific for mannose-containing triglycosylceramide (amino-CTH) and immunochemical detection of its hapten in crustacean.
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	42 PAGE : 649-655 (1992)

[TOP]

[2066]

AUTHOR	:	Sugita,M.,Mizunoma,T.,Hayata,C.,Hori,T.,Nakatani,F., and Aoki,K.
TITLE	:	Classification into arthro-series of neutral glycosphingolipids from porcine roundworm, Ascaris suum, (Aschelminthes, Nematoda).
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	43 PAGE : 495-501 (1994)

[TOP]

[2067]

AUTHOR	:	Sugita,M.,Mizunoma,T.,Inagaki,F.,Suzuki,M.,Suzuki,A.,Hori,T.,Nakatani,F., and Ohta,S.
TITLE	:	Occurrence of novel neogala series glycosphingolipids with a mannose at the non-reducing terminal in annelida (earthworm, Pheretima hilgendorfi).
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	43 PAGE : 1052-1062 (1994)

[TOP]

[2068]

AUTHOR	:	Sugita,M.,Fujii,H.,Dulaney,J.T.,Inagaki,F.,Suzuki,M.,Suzuki,A., and Ohta,S.
TITLE	:	Structural elucidation of two novel amphoteric glycosphingolipids from the earthworm, Pheretima hilgendorfi. PubMed ID:8541328
JOURNAL	:	Biochim. Biophys. Acta
VOL	:	1259 PAGE : 220-226 (1995)

[TOP]

[2069]

AUTHOR	:	Sugita,M.,Morikawa,A.,Dulaney,J.T.,and Okada,A.
TITLE	:	Glycosphingolipids with Gala1-6Gal and Galb1-6Gal sequences in the leech, Hirudo nipponia.
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	45 PAGE : 731-740 (1996)

[TOP]

[2070]

AUTHOR	:	Sugita,M.,Ohta,S.,Morikawa,A.,Dulaney,J.T.,Ichikawa,S.,Kushida,K.,Inagaki,F.,Suzuki,M., and Suzuki,A.
TITLE	:	Novel neogala series glycosphingolipids with glucose at the non-reducing termini in the earthworm, Pheretima sp.
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	46 PAGE : 755-766 (1997)

[TOP]

[2071]

AUTHOR	:	Sugita,M.,Aoki,K.,Dulaney,J.T.,Suzuki,M.,Suzuki,A.,Nishizawa,N., and Sakata,A.
TITLE	:	Acidic glycolipids from marine annelida (lugworm, Tylorrhynchus heterochetus): Occurrence of methylinositol phosphate-containing sphingolipids.
JOURNAL	:	J. Jpn. Oil Chem. Soc.
VOL	:	47 PAGE : 695-702 (1998)

[TOP]

[2072]

AUTHOR	:	Itasaka, O., Sugita, M., Yoshizaki, H. and Hori, T.
TITLE	:	Determination of the anomeric configurations of Corbicula ceramide di- and trihexoside by chromium trioxide oxidation.
JOURNAL	:	Journal of Biochemistry
VOL	:	80 PAGE : 935-936 (1976)

[TOP]

[2073]

AUTHOR	:	Hori, T., Itasaka, O., and Kamimura, M.
TITLE	:	Biochemistry of shellfish lipids. 8. Occurrence of ceramide mono- and dihexoside in corbicula, Corbicula sandai PubMed <<5708320, 5715507>>
JOURNAL	:	J Biochem (Tokyo).
VOL	:	64 PAGE : 125-128 (1968)

[TOP]

[2074]

AUTHOR	:	Sugita, M., Willians, M., Dulaney, J. T., and Moser, H. W.
TITLE	:	Ceramidase and ceramide synthesis in human kidney and cerebellum. Description of a new alkaline ceramidase PubMed ID:238641
JOURNAL	:	Biochim Biophys Acta.
VOL	:	398 PAGE : 125-131 (1975)

[TOP]

[2075]

AUTHOR	:	M. Sugita, F. Inagaki, T. Ariga, and T. Hori.
TITLE	:
JOURNAL	:	Rensho-ken Conf., 3rd, abstr.
VOL	:	PAGE : 16- (1988)

[TOP]

[2076]

AUTHOR	:	Itasaka, O., Kosuga, M., Okayama, M., and Hori, T.
TITLE	:	Characterization of a novel ceramide octasaccharide isolated from whole tissue of a fresh-water bivalve, Corbicula sandai.
JOURNAL	:	Biochimica et Biophysica Acta
VOL	:	750 PAGE : 440-446 (1983)

[TOP]

[2077]

AUTHOR	:	Hori, T., Sugita, M., and Shimizu, H.
TITLE	:	Identification of beta-D-mannosylceramide in hepatopancreas of the fresh-water bivalve, Hyriopsis schlegelii PubMed ID:7284415
JOURNAL	:	Biochim Biophys Acta.
VOL	:	665 PAGE : 170-173 (1981)

[TOP]

[2078]

AUTHOR	:	Carter, H. E., Strobach, D. R., and Hawthorne, J. N.
TITLE	:	Biochemistry of the sphingolipids. 18. Complete structure of tetrasaccharide phytoglycolipid PubMed ID:5777335
JOURNAL	:	Biochemistry.
VOL	:	8 PAGE : 383-388 (1969)

[TOP]

[2079]

AUTHOR	:	Carter, H. E., and Kisic, A.
TITLE	:	Countercurrent distribution of inosol lipids of plant seeds PubMed ID:4307829
JOURNAL	:	J Lipid Res.
VOL	:	10 PAGE : 356-362 (1969)

[TOP]

[2080]

AUTHOR	:	Wagner, H., and Zofcsik, W.
TITLE	:	[On new sphingolipids of yeast] PubMed ID:5985652
JOURNAL	:	Biochem Z.
VOL	:	344 PAGE : 314-316 (1966)

[TOP]

[2081]

AUTHOR	:	Smith, S. W., and Lester, R. L.
TITLE	:	Inositol phosphorylceramide, a novel substance and the chief member of a major group of yeast sphingolipids containing a single inositol phosphate PubMed ID:4364653
JOURNAL	:	J Biol Chem.
VOL	:	249 PAGE : 3395-3405 (1974)

[TOP]

[2082]

AUTHOR	:	Wagner, H., Zofcsik, W.,Heng, I.
TITLE	:	[Sphingolipids and glycolipids of fungi and higher plants. V. On the structure of the phytoglycolipid from Arachis hypogaea L]
JOURNAL	:	Zeitschrift fur Naturforschung. Teil B: Chemie, Biochemie, Biophysik, Biologie
VOL	:	24 PAGE : 922-927 (1969)

[TOP]

[2083]

AUTHOR	:	Lester, R. L., Smith, S. W., Wells, G. B., Rees, D. C., and Angus, W. W.
TITLE	:	The isolation and partial characterization of two novel sphingolipids from Neurospora crassa: di(inositolphosphoryl)ceramide and ((gal)3glu)ceramide PubMed ID:4364652
JOURNAL	:	J Biol Chem.
VOL	:	249 PAGE : 3388-3394 (1974)

[TOP]

[2084]

AUTHOR	:	S. Steiner, A. Smith, C. J. Waechter, and R. L. Lester
TITLE	:	Isolation and partial characterization of a major inositol-containing lipid in baker's yeast, mannosyl-diinositol, diphosphoryl-ceramide.
JOURNAL	:	Proc. Natl. Acad. Sci. U.S.A.
VOL	:	64 PAGE : 1042-1048 (1969)

[TOP]

[2085]

AUTHOR	:	Brennan, P. J., and Roe, J.
TITLE	:	The occurrence of a phosphorylated glycosphingolipid in Aspergillus niger PubMed ID:1156383
JOURNAL	:	Biochem J.
VOL	:	147 PAGE : 179-180 (1975)

[TOP]

[2086]

AUTHOR	:	Brennan, P. J., and Losel, D. M.
TITLE	:	Physiology of fungal lipids: selected topics PubMed ID:352108
JOURNAL	:	Adv Microb Physiol.
VOL	:	17 PAGE : 47-179 (1978)

[TOP]

[2087]

AUTHOR	:	Hsieh, T. C.,Kaul, K.,Laine, R. A.,Lester, R. L.
TITLE	:	Structure of a major glycophosphoceramide from tobacco leaves, PSL-I: 2-deoxy-2-acetamido-D-glucopyranosyl(alpha1 leads to 4)-D-glucuronopyranosyl(alpha1 leads to 2)myoinositol-1-O-phosphoceramide.
JOURNAL	:	Biochemistry
VOL	:	17 PAGE : 3575-3581 (1978)

[TOP]

[2088]

AUTHOR	:	R. A, Laine
TITLE	:
JOURNAL	:	Int. Congr. Pure Appl. Chem.
VOL	:	27 PAGE : 193- (1980)

[TOP]

[2089]

AUTHOR	:	Laine, R. A.
TITLE	:	Enhancement of detection for partially methylated alditol acetates by chemical ionization mass spectrometry PubMed ID:6172052
JOURNAL	:	Anal Biochem.
VOL	:	116 PAGE : 383-388 (1981)

[TOP]

[2090]

AUTHOR	:	K. Kaul and R. L. Lester
TITLE	:
JOURNAL	:	Plant Physiol.
VOL	:	55 PAGE : 120- (1975)

[TOP]

[2091]

AUTHOR	:	Kaul, K., and Lester, R. L.
TITLE	:	Isolation of six novel phosphoinositol-containing sphingolipids from tobacco leaves PubMed ID:687599
JOURNAL	:	Biochemistry.
VOL	:	17 PAGE : 3569-3575 (1978)

[TOP]

[2092]

AUTHOR	:	Hsieh, T. C., Lester, R. L., and Laine, R. A.
TITLE	:	Glycophosphoceramides from plants. Purification and characterization of a novel tetrasaccharide derived from tobacco leaf glycolipids PubMed ID:7263625
JOURNAL	:	J Biol Chem.
VOL	:	256 PAGE : 7747-7755 (1981)

[TOP]

[2093]

AUTHOR	:	R. A. Laine, T. C. -Y. Hsieh and R. L. Lester
TITLE	:
JOURNAL	:	ACS Symp. Ser.
VOL	:	128 PAGE : 65- (1980)

[TOP]

[2094]

AUTHOR	:	Barr, K., Laine, R. A., and Lester, R. L.
TITLE	:	Carbohydrate structures of three novel phosphoinositol-containing sphingolipids from the yeast Histoplasma capsulatum PubMed ID:6509038
JOURNAL	:	Biochemistry.
VOL	:	23 PAGE : 5589-5596 (1984)

[TOP]

[2095]

AUTHOR	:	Hayashi, A., and Matsuura, F.
TITLE	:	Isolation of a new sphingophosphonolipid containing galactose from the viscera of Turbo cornutus PubMed ID:5141114
JOURNAL	:	Biochim Biophys Acta.
VOL	:	248 PAGE : 133-136 (1971)

[TOP]

[2096]

AUTHOR	:	A. Hayashi and F. Matsuura
TITLE	:	Characterization of aminoalkylphosphonyl cerebrosides in muscle tissue of Turbo cornutus.
JOURNAL	:	Chem. Phys. Lipids
VOL	:	22 PAGE : 9-23 (1978)

[TOP]

[2097]

AUTHOR	:	Matsuura, F.
TITLE	:	The identification of aminoalkylphosphonyl cerebrosides in the marine gastropod, Monodonta labio PubMed ID:422541
JOURNAL	:	J Biochem (Tokyo).
VOL	:	85 PAGE : 433-441 (1979)

[TOP]

[2098]

AUTHOR	:	F. Matsuura
TITLE	:	Phosphonosphingoglycolipid, a novel sphingolipid from the viscera of Turbo cornutus.
JOURNAL	:	Vhem. Phys. Lipids
VOL	:	19 PAGE : 223-242 (1977)

[TOP]

[3001]

AUTHOR	:	Murase, T., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A facile, regio- and stereo-selective synthesis of ganglioside GM3 PubMed ID:2776130
JOURNAL	:	Carbohydr Res.
VOL	:	188 PAGE : 71-80 (1989)

[TOP]

[3002]

AUTHOR	:	Ladisch, S., Hasegawa, A., Li, R., and Kiso, M.
TITLE	:	Immunosuppressive activity of chemically synthesized gangliosides PubMed ID:7827069
JOURNAL	:	Biochemistry.
VOL	:	34 PAGE : 1197-1202 (1995)

[TOP]

[3003]

AUTHOR	:	Murase, T., Kameyama, A., Kartha, K. P. R., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A facile, regio and stereoselective synthesis of ganglioside GM4 and its position isomer.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	82 PAGE : 265-283 (1989)

[TOP]

[3004]

AUTHOR	:	Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Stereoselective synthesis of sialyl-lactotetraosylceramide and sialylneolactotetraosylceramide PubMed ID:2379209
JOURNAL	:	Carbohydr Res.
VOL	:	200 PAGE : 269-285 (1990)

[TOP]

[3005]

AUTHOR	:	Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of tumor-associated ganglioside, sialyl Lewis X.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	10 PAGE : 549-560 (1991)

[TOP]

[3006]

AUTHOR	:	Hasegawa, A., Hotta, K., Kameyama, A., Ishida, H., and Kiso, M.
TITLE	:	Total synthesis of sialyl-a(2-6)-lactotetraosylceramide and sialyl-a(2-6)-neolactotetraosylceramide.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	10 PAGE : 439-459 (1991)

[TOP]

[3007]

AUTHOR	:	Prabhanjan, H., Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Regio- and stereo-selective synthesis of ganglioside GM1b and some positional analogs PubMed ID:1811854
JOURNAL	:	Carbohydr Res.
VOL	:	220 PAGE : 127-143 (1991)

[TOP]

[3008]

AUTHOR	:	Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of sialyl-a(2-6)-Lewis X.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	105 PAGE : 729-738 (1991)

[TOP]

[3009]

AUTHOR	:	Prabhanjan, H., Aoyama, K., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of disialoganglioside GD1 alpha and its positional isomer PubMed ID:1446313
JOURNAL	:	Carbohydr Res.
VOL	:	233 PAGE : 87-99 (1992)

[TOP]

[3010]

AUTHOR	:	Hasegawa, A., Nagahama, T., Ohki, H., and Kiso, M.
TITLE	:	A facile total synthesis of ganglioside GM2.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	11 PAGE : 699-714 (1992)

[TOP]

[3011]

AUTHOR	:	Ishida, H., Ohta, Y., Tsukada, Y., Kiso, M., and Hasegawa, A.
TITLE	:	A synthetic approach to polysialogangliosides containing alpha-sialyl-(2-->8)-sialic acid: total synthesis of ganglioside GD3 PubMed ID:8370046
JOURNAL	:	Carbohydr Res.
VOL	:	246 PAGE : 75-88 (1993)

[TOP]

[3012]

AUTHOR	:	Terada, T., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of KDN-gangliosides GM4 and GM3.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	1245 PAGE : 425-440 (1993)

[TOP]

[3013]

AUTHOR	:	Terada, T., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of KDN-lactotetraosylceramide, KDN-neolactotetraosylceramide, and KDN-Lewis X ganglioside PubMed ID:8050096
JOURNAL	:	Carbohydr Res.
VOL	:	259 PAGE : 201-218 (1994)

[TOP]

[3014]

AUTHOR	:	Hotta, K., Komba, S., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of a-series ganglioside GM1a.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	135 PAGE : 665-677 (1994)

[TOP]

[3015]

AUTHOR	:	Terada, T., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of KDN-a-(2-6)-lactotetraosylceramide and KDN-a-(2-6)-neolactotetraosylceramide.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	146 PAGE : 751-768 (1995)

[TOP]

[3016]

AUTHOR	:	Isogai, Y., Kawase, T., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of sulfated glucuronyl paraglobosides.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	158 PAGE : 1001-1023 (1996)

[TOP]

[3017]

AUTHOR	:	Terada, T., Toyoda, T., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	synthesis of KDN-gangliosides GM1, GM2, and GD1a.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	146 PAGE : 769-790 (1995)

[TOP]

[3018]

AUTHOR	:	Ishida, H., Miyawaki, R., Kiso, M., and Hasegawa, A.
TITLE	:	Systematic synthesis of alpha-sialyl-(2 --> 3)- and -(2 --> 6)-isoglobopentaosylceramides (V3Neu5AciGb5Cer and V6Neu5AciGb5Cer) PubMed ID:8653718
JOURNAL	:	Carbohydr Res.
VOL	:	284 PAGE : 179-190 (1996)

[TOP]

[3019]

AUTHOR	:	Isogai, Y., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of sulfated glycuronyl lactosaminyl paraglobosides.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	159 PAGE : 1119-1137 (1996)

[TOP]

[3020]

AUTHOR	:	Kameyama, A., Ehara, T., Yamada, Y., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A total synthesis of sialyl dimeric Lex ganglioside.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	14 PAGE : 507-523 (1995)

[TOP]

[3021]

AUTHOR	:	Ehara, T., Kameyama, A., Yamada, Y., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of VIM-2 ganglioside isolated from human chronic myelogenous leukemia cells PubMed ID:8721147
JOURNAL	:	Carbohydr Res.
VOL	:	281 PAGE : 237-252 (1996)

[TOP]

[3022]

AUTHOR	:	Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of tumor-associated ganglioside, sialyl-Lea.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	135 PAGE : 641-654 (1994)

[TOP]

[3023]

AUTHOR	:	Hotta, K., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	First total synthesis of a cholinergic neuron-specific ganglioside GQ1ba.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	1445 PAGE : 491-506 (1995)

[TOP]

[3024]

AUTHOR	:	Hotta, K., Kawase, T., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A total synthesis of b-series ganglioside GQ1b.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	14 PAGE : 961-975 (1995)

[TOP]

[3025]

AUTHOR	:	Ishida, H., Miyawaki, R., Kiso, M., and Hasegawa, A.
TITLE	:	First total synthesis of sialyl globopentaosyl ceramide (V3Neu5AcGb5Cer) and its positional isomer (V6Neu5AcGb5Cer).
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	152 PAGE : 163-185 (1996)

[TOP]

[3026]

AUTHOR	:	Komba, S., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis and biological activities of three sulfated sialyl Le(x) ganglioside analogues for clarifying the real carbohydrate ligand structure of L-selectin PubMed ID:9007268
JOURNAL	:	Bioorg Med Chem.
VOL	:	4 PAGE : 1833-1847 (1996)

[TOP]

[3027]

AUTHOR	:	Ishida, H., Ito, Y., Tanahashi, E., Li, Y. T., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of 6'-GM2, a regioisomer of ganglioside GM2, for studying the mechanism of action of GM2 activator PubMed ID:9291574
JOURNAL	:	Carbohydr Res.
VOL	:	302 PAGE : 223-227 (1997)

[TOP]

[3028]

AUTHOR	:	Ishida, H.-K., Ando, H., Ito, H., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of gangliosides GD1c and GT1a.
JOURNAL	:	Journal of Carbohydrate Chemistry
VOL	:	1645 PAGE : 413-428 (1997)

[TOP]

[3029]

AUTHOR	:	Ishida, H., Ohta, Y., Tsukada, Y., Isogai, Y., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A facile total synthesis of ganglioside GD2 PubMed ID:8137365
JOURNAL	:	Carbohydr Res.
VOL	:	252 PAGE : 283-290 (1994)

[TOP]

[3030]

AUTHOR	:	Ishida, H.-K., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Total synthesis of ganglioside GQ1b and the related polysialogangliosides.
JOURNAL	:	Tetrahedron: Asymmetry
VOL	:	5 PAGE : 2493-2515 (1994)

[TOP]

[3031]

AUTHOR	:	Ito, H., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	First total synthesis of ganglioside GT1a alpha PubMed ID:9679279
JOURNAL	:	Carbohydr Res.
VOL	:	306 PAGE : 581-585 (1998)

[TOP]

[3032]

AUTHOR	:	Suzuki, Y., Nakao, T., Ito, T., Watanabe, N., Toda, Y., Xu, G., Suzuki, T., Kobayashi, T., Kimura, Y., Yamada, A., et al.
TITLE	:	Structural determination of gangliosides that bind to influenza A, B, and C viruses by an improved binding assay: strain-specific receptor epitopes in sialo-sugar chains PubMed ID:1376537
JOURNAL	:	Virology.
VOL	:	189 PAGE : 121-131 (1992)

[TOP]

[3033]

AUTHOR	:	Foxall, C., Watson, S. R., Dowbenko, D., Fennie, C., Lasky, L. A., Kiso, M., Hasegawa, A., Asa, D., and Brandley, B. K.
TITLE	:	The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide PubMed ID:1374413
JOURNAL	:	J Cell Biol.
VOL	:	117 PAGE : 895-902 (1992)

[TOP]

[3034]

AUTHOR	:	Hanisch, F. G., Hanski, C., and Hasegawa, A.
TITLE	:	Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence PubMed ID:1350509
JOURNAL	:	Cancer Res.
VOL	:	52 PAGE : 3138-3144 (1992)

[TOP]

[3035]

AUTHOR	:	Suzuki, Y., Toda, Y., Tamatani, T., Watanabe, T., Suzuki, T., Nakao, T., Murase, K., Kiso, M., Hasegawa, A., Tadano-Aritomi, K., et al.
TITLE	:	Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain. PubMed ID:7678958
JOURNAL	:	Biochemical and biophysical research communications
VOL	:	190 PAGE : 426-434 (1993)

[TOP]

[3036]

AUTHOR	:	Xu, G., Suzuki, T., Hanagata, G., Deya, E., Kiso, M., Hasegawa, A., and Suzuki, Y.
TITLE	:	Drift of the sialyl-linkage specific recognition of the sialidase of influenza B virus isolates PubMed ID:8486603
JOURNAL	:	J Biochem (Tokyo).
VOL	:	113 PAGE : 304-307 (1993)

[TOP]

[3037]

AUTHOR	:	Ohmori, K., Takada, A., Ohwaki, I., Takahashi, N., Furukawa, Y., Maeda, M., Kiso, M., Hasegawa, A., Kannagi, M., and Kannagi, R.
TITLE	:	A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells PubMed ID:7693048
JOURNAL	:	Blood.
VOL	:	82 PAGE : 2797-2805 (1993)

[TOP]

[3038]

AUTHOR	:	Xu, G., Suzuki, T., Tahara, H., Kiso, M., Hasegawa, A., and Suzuki, Y.
TITLE	:	Specificity of sialyl-sugar chain mediated recognition by the hemagglutinin of human influenza B virus isolates PubMed ID:8206868
JOURNAL	:	J Biochem (Tokyo).
VOL	:	115 PAGE : 202-207 (1994)

[TOP]

[3039]

AUTHOR	:	Li, Y. T., Yuziuk, J. A., Li, S. C., Nematalla, A., Hasegawa, A., Kimura, M., and Nakagawa, H.
TITLE	:	A novel sialidase capable of cleaving 3-deoxy-D-glycero-D-galacto-2-nonulosonic acid (KDN) PubMed ID:8161211
JOURNAL	:	Arch Biochem Biophys.
VOL	:	310 PAGE : 243-246 (1994)

[TOP]

[3040]

AUTHOR	:	Yang, L. J., Zeller, C. B., Shaper, N. L., Kiso, M., Hasegawa, A., Shapiro, R. E., and Schnaar, R. L.
TITLE	:	Gangliosides are neuronal ligands for myelin-associated glycoprotein PubMed ID:8570640
JOURNAL	:	Proc Natl Acad Sci U S A.
VOL	:	93 PAGE : 814-818 (1996)

[TOP]

[3041]

AUTHOR	:	Furuya, S., Irie, F., Hashikawa, T., Nakazawa, K., Kozakai, A., Hasegawa, A., Sudo, K., and Hirabayashi, Y.
TITLE	:	Ganglioside GD1 alpha in cerebellar Purkinje cells. Its specific absence in mouse mutants with Purkinje cell abnormality and altered immunoreactivity in response to conjunctive stimuli causing long-term desensitization PubMed ID:7528216
JOURNAL	:	J Biol Chem.
VOL	:	269 PAGE : 32418-32425 (1994)

[TOP]

[3042]

AUTHOR	:	Saiki, I., Koike, C., Obata, A., Fujii, H., Murata, J., Kiso, M., Hasegawa, A., Komazawa, H., Tsukada, H., Azuma, I., et al.
TITLE	:	Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation PubMed ID:8631600
JOURNAL	:	Int J Cancer.
VOL	:	65 PAGE : 833-839 (1996)

[TOP]

[3043]

AUTHOR	:	Yuziuk, J. A., Nakagawa, H., Hasegawa, A., Kiso, M., Li, S. C., and Li, Y. T.
TITLE	:	Two different sialidases, KDN-sialidase and regular sialidase in the starfish Asterina pectinifera PubMed ID:8645142
JOURNAL	:	Biochem J.
VOL	:	315 (Pt 3) PAGE : 1041-1048 (1996)

[TOP]

[3044]

AUTHOR	:	Dinh, Q., Weng, N. P., Kiso, M., Ishida, H., Hasegawa, A., and Marcus, D. M.
TITLE	:	High affinity antibodies against Lex and sialyl Lex from a phage display library PubMed ID:8752923
JOURNAL	:	J Immunol.
VOL	:	157 PAGE : 732-738 (1996)

[TOP]

[3045]

AUTHOR	:	Mitsuoka, C., Kawakami-Kimura, N., Kasugai-Sawada, M., Hiraiwa, N., Toda, K., Ishida, H., Kiso, M., Hasegawa, A., and Kannagi, R.
TITLE	:	Sulfated sialyl Lewis X, the putative L-selectin ligand, detected on endothelial cells of high endothelial venules by a distinct set of anti-sialyl Lewis X antibodies PubMed ID:9015359
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	230 PAGE : 546-551 (1997)

[TOP]

[3046]

AUTHOR	:	Collins, B. E., Kiso, M., Hasegawa, A., Tropak, M. B., Roder, J. C., Crocker, P. R., and Schnaar, R. L.
TITLE	:	Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin PubMed ID:9201997
JOURNAL	:	J Biol Chem.
VOL	:	272 PAGE : 16889-16895 (1997)

[TOP]

[3047]

AUTHOR	:	Galustian, C., Lawson, A. M., Komba, S., Ishida, H., Kiso, M., and Feizi, T.
TITLE	:	Sialyl-Lewis(x) sequence 6-O-sulfated at N-acetylglucosamine rather than at galactose is the preferred ligand for L-selectin and de-N-acetylation of the sialic acid enhances the binding strength PubMed ID:9400621
JOURNAL	:	Biochem Biophys Res Commun.
VOL	:	240 PAGE : 748-751 (1997)

[TOP]

[3048]

AUTHOR	:	Mitsuoka, C., Sawada-Kasugai, M., Ando-Furui, K., Izawa, M., Nakanishi, H., Nakamura, S., Ishida, H., Kiso, M., and Kannagi, R.
TITLE	:	Identification of a major carbohydrate capping group of the L-selectin ligand on high endothelial venules in human lymph nodes as 6-sulfo sialyl Lewis X PubMed ID:9556613
JOURNAL	:	J Biol Chem.
VOL	:	273 PAGE : 11225-11233 (1998)

[TOP]

[3049]

AUTHOR	:	Li, Y. T., Li, S. C., Hasegawa, A., Ishida, H., Kiso, M., Bernardi, A., Brocca, P., Raimondi, L., and Sonnino, S.
TITLE	:	Structural basis for the resistance of Tay-Sachs ganglioside GM2 to enzymatic degradation PubMed ID:10187778
JOURNAL	:	J Biol Chem.
VOL	:	274 PAGE : 10014-10018 (1999)

[TOP]

[3050]

AUTHOR	:	Suzuki, Y., Nishi, H., Hidari, K., Hirabayashi, Y., Matsumoto, M., Kobayashi, T., Watarai, S., Yasuda, T., Nakayama, J., Maeda, H., et al.
TITLE	:	A new monoclonal antibody directed to sialyl alpha 2-3lactoneotetraosylceramide and its application for detection of human gastrointestinal neoplasms PubMed ID:1864848
JOURNAL	:	J Biochem (Tokyo).
VOL	:	109 PAGE : 354-360 (1991)

[TOP]

[3051]

AUTHOR	:	Tyrrell, D., James, P., Rao, N., Foxall, C., Abbas, S., Dasgupta, F., Nashed, M., Hasegawa, A., Kiso, M., Asa, D., et al.
TITLE	:	Structural requirements for the carbohydrate ligand of E-selectin PubMed ID:1719556
JOURNAL	:	Proc Natl Acad Sci U S A.
VOL	:	88 PAGE : 10372-10376 (1991)

[TOP]

[3052]

AUTHOR	:	Ando, H., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	A synthetic approach to the c-series gangliosides containing sialyl-alpha(2-->8)sialyl-alpha(2-->8)sialic acid: synthesis of ganglioside GT4, alpha(2-->6) GT4 and GT3 PubMed ID:9202407
JOURNAL	:	Carbohydr Res.
VOL	:	300 PAGE : 207-217 (1997)

[TOP]

[3053]

AUTHOR	:	Tanahashi, E., Murase, K., Shibuya, M., Igarashi, Y., Ishida, H., Hasegawa, A., and Kiso, M.
TITLE	:	Synthetic studies on selectin ligands/inhibitors: a systematic synthesis of sulfatide and its higher congeners carrying 2-(tetradecyl)hexadecyl group as a ceramide substitute.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	166 PAGE : 831-858 (1997)

[TOP]

[3054]

AUTHOR	:	Hasegawa, A., Kojima, Y., Ogawa, M., and Kiso, M.
TITLE	:	Synthesis of sialyl-a(2-6)-D-glucopyranosyl, 2-acetamido-2-deoxyhexopyranosyl, and sialyl-a(2-3)-2-acetamido-2-deoxy-D-glucopyranosyl ceramide or the analogs at the lipophilic part.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	11 PAGE : 343-357 (1992)

[TOP]

[3055]

AUTHOR	:	Hasegawa, A., Ogawa, M., and Kiso, M.
TITLE	:	Synthesis of a ganglioside GM3 position isomer, N-acetylneuraminosyl-alpha (2----6)-lactosyl-beta(1----1)-ceramide PubMed ID:1368337
JOURNAL	:	Biosci Biotechnol Biochem.
VOL	:	56 PAGE : 535-536 (1992)

[TOP]

[3056]

AUTHOR	:	Hasegawa, A., Ogawa, H., and Kiso, M.
TITLE	:	Synthesis of a position isomer of ganglioside GD3 having an alpha-Neu5Ac-(2----9)-alpha-Neu5Ac linkage PubMed ID:1591760
JOURNAL	:	Carbohydr Res.
VOL	:	224 PAGE : 185-192 (1992)

[TOP]

[3057]

AUTHOR	:	Hasegawa, A., Ando, T., Kameyama, A., and Kiso, M.
TITLE	:	Stereocontrolled synthesis of sialyl Lewis x epitope and its ceramide derivative.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	11 PAGE : 645-658 (1992)

[TOP]

[3058]

AUTHOR	:	Hotta, K., Ito, K., Kameyama, A., Ishida, H., Kiso, M., and Hasegawa, A.
TITLE	:	Stereocontrolled synthesis of positional isomers of tumor-associated ganglioside antigens, sialyl Lewis x and sialyl paragloboside.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	14 PAGE : 115-133 (1995)

[TOP]

[3059]

AUTHOR	:	Hasegawa, A., Ito, K., Ishida, H., and Kiso, M.
TITLE	:	Synthesis of sialyl and sulfo Lewis X analogs containing a ceramide or 2-(tetradecyl)hexadecyl residue.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	14 PAGE : 353-368 (1995)

[TOP]

[3060]

AUTHOR	:	Hasegawa, A., Uchimura, A., Ishida, H., and Kiso, M.
TITLE	:	Synthesis of a sialyl Lewis X ganglioside analogue containing N-glycolyl in place of the N-acetyl group in the N-acetylneuraminic acid residue PubMed ID:7612995
JOURNAL	:	Biosci Biotechnol Biochem.
VOL	:	59 PAGE : 1091-1094 (1995)

[TOP]

[3061]

AUTHOR	:	Komba, S., Galustian, C., Ishida, H., Feizi, T., Kannagi, R., and Kiso, M.
TITLE	:	First total synthesis of 6-sulfo de-N-acetyl-sialyl lewis x ganglioside: a superior ligand for human l-selectin.
JOURNAL	:	Angew. Chem. Int. Ed. Engl
VOL	:	38 PAGE : 1131-1133 (1999)

[TOP]

[3062]

AUTHOR	:	Hasegawa, A., Adachi, K., Yoshida, M., and Kiso, M.
TITLE	:	Synthesis of ganglioside GM3 analogs containing the chemically modified sialic acids.
JOURNAL	:	J. Carbohydr. Chem.
VOL	:	11 PAGE : 95-116 (1992)

[TOP]

[3063]

AUTHOR	:	Hasegawa, A., Adachi, K., Yoshida, M., and Kiso, M.
TITLE	:	Synthesis of a series of ganglioside GM3 analogs containing a deoxy-N-acetylneuraminic acid residue PubMed ID:1394301
JOURNAL	:	Carbohydr Res.
VOL	:	230 PAGE : 273-288 (1992)

[TOP]

[3064]

AUTHOR	:	Yoshida, M., Uchimura, A., Kiso, M., and Hasegawa, A.
TITLE	:	Synthesis of chemically modified sialic acid-containing sialyl-Le X ganglioside analogues recognized by the selectin family.
JOURNAL	:	Glycoconjugate J.
VOL	:	10 PAGE : 3-5 (1993)

[TOP]

[3065]

AUTHOR	:	Hasegawa, A., Ando, T., Kato, M., Ishida, H., and Kiso, M.
TITLE	:	Synthesis of deoxy-L-fucose-containing sialyl Lewis X ganglioside analogues PubMed ID:8004640
JOURNAL	:	Carbohydr Res.
VOL	:	257 PAGE : 67-80 (1994)

[TOP]

[3066]

AUTHOR	:	Suzuki, Y., Toda, Y., Tamatani, T., Watanabe, T., Suzuki, T., Nakao, T., Murase, K., Kiso, M., Hasegawa, A., Tadano-Aritomi, K., Ishizuka, I., and Miyasaka, M.
TITLE	:	Sulfated glycolipids are ligands for a lymphocyte homing receptor, L-selectin (LECAM-1), binding epitope in sulfated sugar chain. PubMed ID:7678958
JOURNAL	:	Biochem. Biophys. Res. Commun.
VOL	:	190 PAGE : 426-434 (1993)

[TOP]

[3067]

AUTHOR	:	Mulligan, M. S., Miyasaka, M., Suzuki, Y., Kawashima, H., Iizuka, M., Hasegawa, A., Kiso, M., Warner, R. L., Ward, P. A., Suzuki, T., et al.
TITLE	:	Anti-inflammatory effects of sulfatides in selectin-dependent acute lung injury PubMed ID:8527408
JOURNAL	:	Int Immunol.
VOL	:	7 PAGE : 1107-1113 (1995)

[TOP]

[3068]

AUTHOR	:	Konno, A., Nunogami, K., Wada, T., Yachie, A., Suzuki, Y., Takahashi, N., Suzuki, T., Miyamoto, D., Kiso, M., Hasegawa, A., et al.
TITLE	:	Inhibitory action of sulfatide, a putative ligand for L-selectin, on B cell proliferation and Ig production PubMed ID:8982775
JOURNAL	:	Int Immunol.
VOL	:	8 PAGE : 1905-1913 (1996)

[TOP]

[3069]

AUTHOR	:	Mulligan, M. S., Warner, R. L., Lowe, J. B., Smith, P. L., Suzuki, Y., Miyasaka, M., Yamaguchi, S., Ohta, Y., Tsukada, Y., Kiso, M., et al.
TITLE	:	In vitro and in vivo selectin-blocking activities of sulfated lipids and sulfated sialyl compounds PubMed ID:9645605
JOURNAL	:	Int Immunol.
VOL	:	10 PAGE : 569-575 (1998)

[TOP]

[3070]

AUTHOR	:	Vandekerckhove, F., Schenkman, S., Pontes de Carvalho, L., Tomlinson, S., Kiso, M., Yoshida, M., Hasegawa, A., and Nussenzweig, V.
TITLE	:	Substrate specificity of the Trypanosoma cruzi trans-sialidase PubMed ID:1282052
JOURNAL	:	Glycobiology.
VOL	:	2 PAGE : 541-548 (1992)

[TOP]

[3071]

AUTHOR	:	Brandley, B. K., Kiso, M., Abbas, S., Nikrad, P., Srivasatava, O., Foxall, C., Oda, Y., and Hasegawa, A.
TITLE	:	Structure-function studies on selectin carbohydrate ligands. Modifications to fucose, sialic acid and sulphate as a sialic acid replacement PubMed ID:7510548
JOURNAL	:	Glycobiology.
VOL	:	3 PAGE : 633-641 (1993)

[TOP]

[3072]

AUTHOR	:	Taketomi, T., Sugiyama, E.
TITLE	:	Extraction and Analysis of Multiple Sphingolipids from a Single Sample. PubMed ID:11070864
JOURNAL	:	Methods in Enzymology
VOL	:	312 PAGE : 80-101 (2000)

[TOP]

[5057]

AUTHOR	:	Watanebe, K., Matsubara, T., Hakomori, S.
TITLE	:	a-L-Fucopyranosylceramide, a novel glycolipid accumulated in some of the human colon tumors.
JOURNAL	:	J. Biol. Chem.
VOL	:	251 PAGE : 2385-2387 (1976)

[TOP]

[5080]

AUTHOR	:	Hakomori, S. I., Siddiqui, B., Li, Y. T., Li, S. C., and Hellerqvist, C. G.
TITLE	:	Anomeric structure of globoside and ceramide grihexoside of human erythrocytes and hamster fibroblasts PubMed ID:5103071
JOURNAL	:	J Biol Chem.
VOL	:	246 PAGE : 2271-2277 (1971)

[TOP]

[5081]

AUTHOR	:	Clarke J. T. R., Wolfe L. S.
TITLE	:	Evidence for a terminal a-D-Galactopyranosyl residue in galactosylgalactosylceramide from human kidney.
JOURNAL	:	J. Biol. Chem.
VOL	:	216 PAGE : 5563-5569 (1971)

[TOP]

[5082]

AUTHOR	:	Esselman, W. J., Ackermann, J. R., and Sweeley, C. C.
TITLE	:	Glycosphingolipids of membrane fractions from normal and transplanted canine kidney PubMed ID:4200922
JOURNAL	:	J Biol Chem.
VOL	:	248 PAGE : 7310-7317 (1973)

[TOP]

[5087]

AUTHOR	:	Stoffyn, P., Stoffyn, A., and Hauser, G.
TITLE	:	Structure of trihexosylceramide biosynthesized in vitro PubMed ID:4690582
JOURNAL	:	J Biol Chem.
VOL	:	248 PAGE : 1920-1923 (1973)

[TOP]

[5090]

AUTHOR	:	Rosenfelder, G., Young, W. W., Jr., and Hakomori, S. I.
TITLE	:	Association of the glycolipid pattern with antigenic alterations in mouse fibroblasts transformed by murine sarcoma virus PubMed ID:192447
JOURNAL	:	Cancer Res.
VOL	:	37 PAGE : 1333-1339 (1977)

[TOP]

[5094]

AUTHOR	:	Itasaka, O., Sugita, M., Yoshizaki, H., Hori, T.
TITLE	:	Determination of the anomeric configurations of Corbicula ceramide Di- and trihexoside by chromium trioxide oxidation. PubMed ID:1002687
JOURNAL	:	J. Biochem.
VOL	:	80 PAGE : 935-936 (1976)

[TOP]

[5112]

AUTHOR	:	Gahmberg, C. G., Hakomoru, S.
TITLE	:	Surface carbohydrates of hamster fibroblasts. I. Chemical characterization of surface-labeled glycosphingolipids and aspecific ceramide tetrasaccharide for transformants. PubMed ID:164440
JOURNAL	:	J. Biol. Chem.
VOL	:	250 PAGE : 2438-2446 (1975)

[TOP]

[5125]

AUTHOR	:	Uemura, K., Yazawa, M., Taketomi, T.
TITLE	:	Characterization of major glycolipid in bovine erythrocyte membrane. PubMed ID:564898
JOURNAL	:	J. Biochem.
VOL	:	83 PAGE : 463-471 (1978)

[TOP]

[5126]

AUTHOR	:	Stellner, K., and Hakomori, S.
TITLE	:	A ceramide pentasaccharide of human erythrocyte membrane PubMed ID:4814335
JOURNAL	:	J Biol Chem.
VOL	:	249 PAGE : 1022-1025 (1974)

[TOP]

[5134]

AUTHOR	:	Hori, T., Takeda, T., Sugita, M., Itasaka, O.
TITLE	:	Studies on glycosphingolipids of fresh-water bivalves. IV. Structure of a branched globoside containing mannose from spermatozoa of the fresh-water bivalve, Hyriopsis schlegelii. PubMed ID:591501
JOURNAL	:	J. BIOCHEM.
VOL	:	82 PAGE : 1281-1285 (1977)

[TOP]

[5153]

AUTHOR	:	Fukuda, M. N., Fukuda, M., and Hakomori, S.
TITLE	:	Cell surface modification by endo-beta-galactosidase. Change of blood group activities and release of oligosaccharides from glycoproteins and glycosphingolipids of human erythrocytes PubMed ID:87393
JOURNAL	:	J Biol Chem.
VOL	:	254 PAGE : 5458-5465 (1979)

[TOP]

[6001]

AUTHOR	:	Yamamoto,A.,Yano,I.,Masui,M., and Yabuuchi,E.
TITLE	:	Isolation of a Novel Sphingoglycolipid Containing Glucuronic Acid and 2-Hydroxy Fatty Acid from Flavobacterium devorans ATCC 10829. PubMed ID:659393
JOURNAL	:	J.Biochem.
VOL	:	83 PAGE : 1213-1216 (1978)

[TOP]

[6002]

AUTHOR	:	Yabuuchi,E.,Tanimura,E.,Ohyama,A.,Yano,I., and Yamamoto,A.
TITLE	:	Flavobacterium devorans ATCC 10829: a Strain of Pseudomonas paucimobilis.
JOURNAL	:	J.Gen.Appl.Microbiol.
VOL	:	25 PAGE : 95-107 (1979)

[TOP]

[6003]

AUTHOR	:	Kawahara,K.,Seydel,U.,Matsuura,M.,Danbara,H.,Rietschel,E.,T., and Z$
TITLE	:	Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilispau. PubMed ID:1959589
JOURNAL	:	FEBS
VOL	:	292 PAGE : 107-110 (1991)

[TOP]

[6004]

AUTHOR	:	Mizuno,S.,Kobayashi,K.,Tanaka,A.,Ijyuinn,T.,Hotta,H.,Yabuuchi,E.,Yamamoto,A., and Yano,I.
TITLE	:	Taxonomy of Shingomonas species by sphingoglycolipid series containing glucronic acid.
JOURNAL	:	Shishituseikagakukennkyuu
VOL	:	34 PAGE : 51-54 (1992)

[TOP]

[6005]

AUTHOR	:	Miyazaki, Y., Oka, S., Yamaguchi, S., Mizuno, S., and Yano, I.
TITLE	:	Stimulation of phagocytosis and phagosome-lysosome fusion by glycosphingolipids from Sphingomonas paucimobilis PubMed ID:8543558
JOURNAL	:	J Biochem (Tokyo).
VOL	:	118 PAGE : 271-277 (1995)

[TOP]

[6006]

AUTHOR	:	Yabuuchi, E., Kosako, Y., Naka, T., Suzuki, S., and Yano, I.
TITLE	:	Proposal of Sphingomonas suberifaciens (van Bruggen, Jochimsen and Brown 1990) comb. nov., sphingomonas natatoria (Sly 1985) comb. nov., Sphingomonas ursincola (Yurkov et al. 1997) comb. nov., and emendation of the genus Sphingomonas PubMed ID:10385200
JOURNAL	:	Microbiol Immunol.
VOL	:	43 PAGE : 339-349 (1999)

[TOP]